Bubble detector measurements of a mixed radiation field from antiproton annihilation

International Nuclear Information System (INIS)

Bassler, Niels; Knudsen, Helge; Moller, Soren Pape; Petersen, Jorgen B.; Rahbek, Dennis; Uggerhoj, Ulrik I.

2006-01-01

In the light of recent progress in the study of the biological potential of antiproton tumour treatment it is important to be able to characterize the neutron intensity arising from antiproton annihilation using simple, compact and reliable detectors. The intensity of fast neutrons from antiproton annihilation on polystyrene has been measured with bubble detectors and a multiplicity has been derived as well as an estimated neutron equivalent dose. Additionally the sensitivity of bubble detectors towards protons was measured

Searching for antiproton decay at the Fermilab Antiproton Accumulator

International Nuclear Information System (INIS)

Geer, S.

1995-09-01

This paper describes an experimental search for antiproton decay at the Fermilab Antiproton Accumulator. The E868 (APEX) experimental setup is described. The APEX data is expected to be sensitive to antiproton decay if the antiproton lifetimes is less than a few times 100,000 years

Bubble detector measurements of a mixed radiation field from antiproton annihilation

DEFF Research Database (Denmark)

Bassler, Niels; Knudsen, Helge; Møller, Søren Pape

2006-01-01

In the light of recent progress in the study of the biological potential of antiproton tumour treatment it is important to be able to characterize the neutron intensity arising from antiproton annihilation using simple, compact and reliable detectors. The intensity of fast neutrons from antiproto...

Weighing the antiproton

Energy Technology Data Exchange (ETDEWEB)

Hayano, Ryugo S., E-mail: hayano@phys.s.u-tokyo.ac.jp [University of Tokyo, Department of Physics (Japan)

2013-03-15

Antiprotonic helium is a metastable three-body neutral atom consisting of an antiproton, a helium nucleus and an electron, which we serendipitously discovered some 20 years ago. The antiproton, which normally annihilates within a few picoseconds when injected into matter, can be 'stored' in this system for up to several microseconds, and laser spectroscopy is possible within this time window. From the laser transition frequency, the antiproton-to-electron mass ratio can be deduced to high precision. Recent progress at CERN's antiproton decelerator (AD) will be discussed.

Atomic physics of the antimatter explored with slow antiprotons

International Nuclear Information System (INIS)

Torii, Hiroyuki A.

2010-01-01

Frontiers of antimatter physics are reviewed, with a focus on our ASACUSA collaboration, doing research on 'Atomic Spectroscopy And Collisions Using Slow Antiprotons' at the 'Antiproton Decelerator' facility at CERN. Antiprotonic helium atoms give a unique test ground for testing CPT invariance between particles and antiparticles. Laser spectroscopy of this exotic atom has reached a precision of a few parts per billion in determation of the antiproton mass. We also have developed techniques to decelerate antiprotons and cool them to sub-eV energies in an electromagnetic trap at ultra-high vacuum and extract them as an ultra-slow beam at typically 250 eV. This unique low-energy beam opens up the possibility to study ionization and formation of antiprotonic atoms. The antihydrogen has been synthesized at low temperature in nested Penning traps by ATRAP and ATHENA(presently ALPHA) collaborations. Confinement of this neutral anti-atoms in a trap with magnetic field gradient is being studied, with an aim of 1S-2S laser spectroscopy in the future. ASACUSA has prepared a cusp trap for production of antihydrogen atoms, and aims at microwave spectroscopy between the hyperfine states of spin-polarized antihydrogen. A wide variety of low-energy antiproton physics also includes measurement of nuclear scattering, radiational biological effects, and gravity test of antimatter. (author)

Design study of an Antiproton Collector for the Antiproton Accumulator (ACOL)

International Nuclear Information System (INIS)

Wilson, E.J.N.

1983-01-01

The Report gives a full description of an Antiproton Collector Ring which, placed around the existing Antiproton Accumulator at CERN, would enhance the antiproton flux available to both the SPS and LEAR by a factor of ten. The new ring and the focusing devices which precede it are designed to accept a much larger fraction of the antiproton production cone from the target. Each pulse of particles will be pre-cooled before being fed to the Antiproton Accumulator, where improved stochastic cooling systems will build up the stack. A full list of parameters is included. (orig.)

Physics using cold antiprotons

CERN Document Server

Hayano, R S

2004-01-01

Recent progress of low-energy antiproton physics by atomic spectroscopy and collisions using slow antiprotons collaboration at CERN AD is presented. High-precision spectroscopy of antiprotonic helium - a neutral three-body system pe**-He**2**+(=pHe**+) produced when antiprotons (p) are stopped in various phases of helium - has tested 3-body QED theories as well as proton-vs-antiproton CPT to within similar to 10**-**8. This was achieved by using a newly- developed radiofrequency quadrupole decelerator. Other ongoing and future experiments using low-energy antiprotons are discussed.

Antiproton Accumulator (AA)

CERN Multimedia

Photographic Service

1980-01-01

The AA in its final stage of construction, before it disappeared from view under concrete shielding. Antiprotons were first injected, stochastically cooled and accumulated in July 1980. From 1981 on, the AA provided antiprotons for collisions with protons, first in the ISR, then in the SPS Collider. From 1983 on, it also sent antiprotons, via the PS, to the Low-Energy Antiproton Ring (LEAR). The AA was dismantled in 1997 and shipped to Japan.

Practical Uses of Antiprotons

International Nuclear Information System (INIS)

Jackson, Gerald P.

2003-01-01

The production of commercial quantities of antiprotons has been a reality for many years now. The deceleration and trapping of antiprotons is a relatively new activity, but has been sufficiently proven to be translated into a business enterprise. Now that NASA has a portable Penning trap for transporting antiprotons, all the elements are in place to begin the commercial distribution of antiprotons. The list of potential customers for antiprotons is continuously growing, with detailed market analyses already performed on some medical and propulsion applications. In this paper these applications are reviewed, along with their appetite for antiprotons and the steps needed to bring them to market.

Practical Uses of Antiprotons

Science.gov (United States)

Jackson, Gerald P.

The production of commercial quantities of antiprotons has been a reality for many years now. The deceleration and trapping of antiprotons is a relatively new activity, but has been sufficiently proven to be translated into a business enterprise. Now that NASA has a portable Penning trap for transporting antiprotons, all the elements are in place to begin the commercial distribution of antiprotons. The list of potential customers for antiprotons is continuously growing, with detailed market analyses already performed on some medical and propulsion applications. In this paper these applications are reviewed, along with their appetite for antiprotons and the steps needed to bring them to market.

Antiproton production

International Nuclear Information System (INIS)

Lazarus, D.M.

1987-01-01

The results for the antiproton momentum spectrum produced in proton reactions on lead at the CERN Antiproton Accumulator is scaled to AGS operating conditions using the Sanford-Wang formula with no correction for target material. Yield predictions as a function of momentum are shown for 28.3 GeV protons on beryllium and results are converted to antiproton beam flux. The AGS Medium Energy Separated Beam has a flux which is a factor of 2 lower than Sanford-Wang predictions. This may be due to factors affecting beam acceptance

Search for antiproton decay at the Fermilab antiproton accumulator

International Nuclear Information System (INIS)

Geer, S.; Marriner, J.; Ray, R.; Streets, J.; Lindgren, M.; Muller, T.; Quackenbush, J.; Armstrong, T.

1994-01-01

A search for antiproton decay has been made at the Fermilab antiproton accumulator. Limits are placed on five antiproton decay modes. At the 95% C.L. we find that τ bar p /B(bar p→e - γ)>1848 yr, τ bar p /B(bar p→e 0 π 0 )>554 yr, τ bar p /B(bar p→e - η)>171 yr,τ bar p /B(bar p→e - K S 0 )>29 yr, and τ bar p /B(bar p→e - K L 0 )>9 yr

Deceleration of Antiprotons in Support of Antiproton Storage/Utilization Research

International Nuclear Information System (INIS)

Howe, Steven D.; Jackson, Gerald P.; Pearson, J. Boise; Lewis, Raymond A.

2005-01-01

Antimatter has the highest energy density known to mankind. Many concepts have been studied that use antimatter for propulsion. All of these concepts require the development of high density storage. H-bar Technologies, under contract with the NASA Marshall Space Flight Center, has undertaken the first step toward development of high density storage. Demonstration of the ability to store antiprotons in a Penning Trap provides the technology to pursue research in alternative storage methods that may lead to eventually to high density concepts. H-bar Technologies has undertaken research activity on the detailed design and operations required to decelerate and redirect the Fermi National Accelerator Laboratory (FNAL) antiproton beam to lay the groundwork for a source of low energy antiprotons. We have performed a detailed assessment of an antiproton deceleration scheme using the FNAL Main Injector, outlining the requirements to significantly and efficiently lower the energy of antiprotons. This task shall require a combination of: theoretical/computation simulations, development of specialized accelerator controls programming, modification of specific Main Injector hardware, and experimental testing of the modified system. Testing shall be performed to characterize the system with a goal of reducing the beam momentum from 8.9 GeV/c to a level of 1 GeV/c or less. We have designed an antiproton degrader system that will integrate with the FNAL decelerated/transferred beam. The degrader shall be designed to maximize the number of low energy antiprotons with a beam spot sized for acceptance by the Mark I test hardware

Hyperfine Structure Measurements of Antiprotonic $^3$He using Microwave Spectroscopy

CERN Document Server

Friedreich, Susanne

The goal of this project was to measure the hyperfine structure of $\\overline{\\text{p}}^3$He$^+$ using the technique of laser-microwave-laser spectroscopy. Antiprotonic helium ($\\overline{\\text{p}}$He$^+$) is a neutral exotic atom, consisting of a helium nucleus, an electron and an antiproton. The interactions of the angular momenta of its constituents cause a hyperfine splitting ({HFS}) within the energy states of this new atom. The 3\\% of formed antiprotonic helium atoms which remain in a metastable, radiative decay-dominated state have a lifetime of about 1-3~$\\mu$s. This time window is used to do spectroscopic studies. The hyperfine structure of $\\overline{\\text{p}}^4$He$^+$ was already extensively investigated before. From these measurements the spin magnetic moment of the antiproton can be determined. A comparison of the result to the proton magnetic moment provides a test of {CPT} invariance. Due to its higher complexity the new exotic three-body system of $\\overline{\\text{p}}^3$He$^+$ is a cross-check...

Simulation of an antiprotons beam applied to the radiotherapy; Simulacao de um feixe de antiprotons aplicado a radioterapia

Energy Technology Data Exchange (ETDEWEB)

Prata, Leonardo de Almeida

2006-07-15

Results for the interaction of a antiproton beam with constituent nuclei of the organic matter are presented. This method regards of the application of an computational algorithm to determine quantitatively the differential cross sections for the scattered particles, starting from the interaction of these antiprotons with the nuclei, what will allow in the future to draw the isodose curve for antiproton therapy, once these beams are expected to be used in cancer treatment soon. The calculation will be done through the application of the concepts of the method of intranuclear cascade, providing yield and differential cross sections of the scattered particles, present in the software MCMC. Th algorithm was developed based on Monte Carlo's method, already taking into account a validate code. The following physical quantities are presented: the yield of secondary particles, their spectral and angular distributions for these interactions. For the energy range taken into account the more important emitted particles are protons, neutrons and pions. Results shown that emitted secondary particles can modify the isodose curves, because they present high yield and energy for transverse directions. (author)

Simulation of an antiprotons beam applied to the radiotherapy; Simulacao de um feixe de antiprotons aplicado a radioterapia

Energy Technology Data Exchange (ETDEWEB)

Prata, Leonardo de Almeida

2006-07-15

Results for the interaction of a antiproton beam with constituent nuclei of the organic matter are presented. This method regards of the application of an computational algorithm to determine quantitatively the differential cross sections for the scattered particles, starting from the interaction of these antiprotons with the nuclei, what will allow in the future to draw the isodose curve for antiproton therapy, once these beams are expected to be used in cancer treatment soon. The calculation will be done through the application of the concepts of the method of intranuclear cascade, providing yield and differential cross sections of the scattered particles, present in the software MCMC. Th algorithm was developed based on Monte Carlo's method, already taking into account a validate code. The following physical quantities are presented: the yield of secondary particles, their spectral and angular distributions for these interactions. For the energy range taken into account the more important emitted particles are protons, neutrons and pions. Results shown that emitted secondary particles can modify the isodose curves, because they present high yield and energy for transverse directions. (author)

Antiprotonic-hydrogen atoms

International Nuclear Information System (INIS)

Batty, C.J.

1989-07-01

Experimental studies of antiprotonic-hydrogen atoms have recently made great progress following the commissioning of the low energy antiproton facility (LEAR) at CERN in 1983. At the same time our understanding of the atomic cascade has increased considerably through measurements of the X-ray spectra. The life history of the p-bar-p atom is considered in some detail, from the initial capture of the antiproton when stopping in hydrogen, through the atomic cascade with the emission of X-rays, to the final antiproton annihilation and production of mesons. The experiments carried out at LEAR are described and the results compared with atomic cascade calculations and predictions of strong interaction effects. (author)

ASACUSA hits antiproton jackpot

CERN Multimedia

2001-01-01

The Japanese-European ASACUSA collaboration, which takes its name from the oldest district of Tokyo, approaches the antimatter enigma in a different way from the other two AD experiments, by inserting antiprotons into ordinary atoms. Last month the collaboration succeeded in trapping about a million antiprotons. The ASACUSA antiproton trap (lower cylinder), surmounted by its liquid helium reservoir. Looking on are Ken Yoshiki-Franzen, Zhigang Wang, Takahito Tasaki, Suzanne Reed, John Eades, Masaki Hori, Yasunori Yamazaki, Naofumi Kuroda, Jun Sakaguchi, Berti Juhasz, Eberhard Widmann and Ryu Hayano. A key element of the ASACUSA apparatus is its decelerating Radiofrequency Quadrupole magnet, RFQD. After tests with protons in Aarhus, this was installed in ASACUSA's antiproton beam last October (Bulletin 41/2000, 9 October 2000). Constructed by Werner Pirkl's group in PS Division, the RFQD works by applying an electric field to the AD antiproton pulse the opposite direction to its motion. As the antiprotons slo...

The CERN antiproton collector

International Nuclear Information System (INIS)

Autin, B.

1984-01-01

The Antiproton Collector is a new ring of much larger acceptance than the present accumulator. It is designed to receive 10 8 antiprotons per PS cycle. In order to be compatible with the Antiproton Accumulator, the momentum spread and the emittances are reduced from 6% to 0.2% and from 200 π mm mrad to 25 π mm mrad respectively. In addition to the ring itself, the new target area and the modifications to the stochastic systems of the Antiproton Accumulator are described. (orig.)

Antiproton complex at the FAIR project

International Nuclear Information System (INIS)

Dolinskii, A.; Knie, K.; Dimopoulou, C.; Gostishchev, V.; Litvinov, S.; Nolden, F.; Steck, M.

2011-01-01

This report summarizes a set of calculations for the antiproton production in a complex composed of target area, collector, separator, beam line and collector ring for the antiproton source of the future FAIR facility (Facility for Antiproton and Ion Research) at GSI, Darmstadt, Germany. The emphasis is on the optimization of the accumulation rate of antiprotons in order to maximize the luminosity of experiments with cooled antiproton beams in the High Energy Storage Ring (HESR). Results of simulations for each component of the antiproton production complex are presented in order to identify the present limitations of the antiproton production rate.

The antiproton decelerator: AD

International Nuclear Information System (INIS)

Baird, S.; Berlin, D.; Boillot, J.; Bosser, J.; Brouet, M.; Buttkus, J.; Caspers, F.; Chohan, V.; Dekkers, D.; Eriksson, T.; Garoby, R.; Giannini, R.; Grobner, O.; Gruber, J.; Hemery, J.Y.; Koziol, H.; Maccaferri, R.; Maury, S.; Metzger, C.; Metzmacher, K.; Moehl, D.; Mulder, H.; Paoluzzi, M.; Pedersen, F.; Riunaud, J.P.; Serre, C.; Simon, D.J.; Tranquille, G.; Tuyn, J.; Williams, B.

1997-01-01

In view of a possible future programme of physics with low-energy antiprotons, a simplified scheme for the provision of antiprotons at 100 MeV/c has been studied. It uses the present target area and the modified antiproton collector (AC) in its present location. In this report the modifications and the operation are discussed. (orig.)

Antiproton physics at BNL

Energy Technology Data Exchange (ETDEWEB)

Lazarus, D.M. (Brookhaven National Lab., Upton, NY (United States))

1993-06-07

A review of antiproton physics at the Brookhaven AGS in past decade is given as well as a description of the present high energy physics program. Existing and potential facilities for antiproton physics at the AGS are discussed and are found to provide useful antiproton intensities over the momentum range proposed for SUPERLEAR in a multiple user environment. (orig.)

Current perspectives of radiation therapy. History of radiation therapy

International Nuclear Information System (INIS)

Itami, Jun

2011-01-01

More than 100 years have passed since the discovery of X-Strahlen by Roentgen. The history of radiation therapy has evolved under mutual stimulating relationships of the external beam radiation therapy by X-ray tubes and accelerators, and the internal radiation therapy employing radium and other radionuclides. The currently employed technologies in radiation therapy have its origin already till nineteen sixties and the development of physics and engineering have realized the original concept. (author)

Biological effectiveness of antiproton annihilation

DEFF Research Database (Denmark)

Holzscheiter, M.H.; Agazaryan, N.; Bassler, Niels

2004-01-01

We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in ‘‘biological dose’’ in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct...... measurement of the biological effects of antiproton annihilation. The experiment has been approved by the CERN Research Board for running at the CERN Antiproton Decelerator (AD) as AD-4/ACE (Antiproton Cell Experiment) and has begun data taking in June of 2003. The background, description and the current...

Biological effectiveness of antiproton annihilation

CERN Document Server

Holzscheiter, Michael H.; Bassler, Niels; Beyer, Gerd; De Marco, John J.; Doser, Michael; Ichioka, Toshiyasu; Iwamoto, Keisuke S.; Knudsen, Helge V.; Landua, Rolf; Maggiore, Carl; McBride, William H.; Møller, Søren Pape; Petersen, Jorgen; Smathers, James B.; Skarsgard, Lloyd D.; Solberg, Timothy D.; Uggerhøj, Ulrik I.; Withers, H.Rodney; Vranjes, Sanja; Wong, Michelle; Wouters, Bradly G.

2004-01-01

We describe an experiment designed to determine whether or not the densely ionizing particles emanating from the annihilation of antiprotons produce an increase in “biological dose” in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The experiment has been approved by the CERN Research Board for running at the CERN Antiproton Decelerator (AD) as AD-4/ACE (Antiproton Cell Experiment) and has begun data taking in June of 2003. The background, description and the current status of the experiment are given.

LEAP [Low-Energy Antiproton]: A balloon-borne search for low-energy cosmic-ray antiprotons

International Nuclear Information System (INIS)

Moats, A.R.M.

1989-01-01

The LEAP (Low-Energy Antiproton) experiment is a search for cosmic-ray antiprotons in the 120 MeV to 1.2 GeV kinetic energy range. The motivation for this project was the result announced by Buffington et. al. (1981) that indicated an anomalously high antiproton flux below 300 MeV; this result has compelled theorists to propose sources of primary antiprotons above the small secondary antiproton flux produced by high energy cosmic-ray collisions with nuclei in the interstellar medium. LEAP consisted of the NMSU magnetic spectrometer, a time-of-flight system designed at Goddard Space Flight Center, two scintillation detectors, and a Cherenkov counter designed and built at the University of Arizona. Analysis of flight data performed by the high-energy astrophysics group at Goddard Space Flight Center revealed no antiproton candidates found in the 120 MeV to 360 MeV range; 3 possible antiproton candidate events were found in the 500 MeV to 1.2 GeV range in an analysis done here at the University of Arizona. However, since it will be necessary to sharpen the calibration on all of the LEAP systems in order to positively identify these events as antiprotons, only an upper limit has been determined at present. Thus, combining the analyses performed at the University of Arizona and Goddard Space Flight Center, 90% confidence upper limits of 3.5 x 10 -5 in the 120 MeV to 360 MeV range and 2.3 x 10 -4 in the 500 MeV to 1.2 GeV range for the antiproton/proton ratio is indicated by the LEAP results. LEAP disagrees sharply with the results of the Buffington group, indicating a low antiproton flux at these energies

Design of a High Luminosity 100 TeV Proton Antiproton Collider

Energy Technology Data Exchange (ETDEWEB)

Oliveros Tuativa, Sandra Jimena [Univ. of Mississippi, Oxford, MS (United States)

2017-04-01

Currently new physics is being explored with the Large Hadron Collider at CERN and with Intensity Frontier programs at Fermilab and KEK. The energy scale for new physics is known to be in the multi-TeV range, signaling the need for a future collider which well surpasses this energy scale. A 10$^{\\,34}$ cm$^{-2}$ s$^{-1}$ luminosity 100 TeV proton-antiproton collider is explored with 7$\\times$ the energy of the LHC. The dipoles are 4.5\\,T to reduce cost. A proton-antiproton collider is selected as a future machine for several reasons. The cross section for many high mass states is 10 times higher in $p\\bar{p}$ than $pp$ collisions. Antiquarks for production can come directly from an antiproton rather than indirectly from gluon splitting. The higher cross sections reduce the synchrotron radiation in superconducting magnets and the number of events per bunch crossing, because lower beam currents can produce the same rare event rates. Events are also more centrally produced, allowing a more compact detector with less space between quadrupole triplets and a smaller $\\beta^{*}$ for higher luminosity. To adjust to antiproton beam losses (burn rate), a Fermilab-like antiproton source would be adapted to disperse the beam into 12 different momentum channels, using electrostatic septa, to increase antiproton momentum capture 12 times. At Fermilab, antiprotons were stochastically cooled in one Debuncher and one Accumulator ring. Because the stochastic cooling time scales as the number of particles, two options of 12 independent cooling systems are presented. One electron cooling ring might follow the stochastic cooling rings for antiproton stacking. Finally antiprotons in the collider ring would be recycled during runs without leaving the collider ring, by joining them to new bunches with snap bunch coalescence and synchrotron damping. These basic ideas are explored in this work on a future 100 TeV proton-antiproton collider and the main parameters are presented.

Design of a High Luminosity 100 TeV Proton-Antiproton Collider

Science.gov (United States)

Oliveros Tautiva, Sandra Jimena

Currently new physics is being explored with the Large Hadron Collider at CERN and with Intensity Frontier programs at Fermilab and KEK. The energy scale for new physics is known to be in the multi-TeV range, signaling the need for a future collider which well surpasses this energy scale. A 10 34 cm-2 s-1 luminosity 100 TeV proton-antiproton collider is explored with 7x the energy of the LHC. The dipoles are 4.5 T to reduce cost. A proton-antiproton collider is selected as a future machine for several reasons. The cross section for many high mass states is 10 times higher in pp than pp collisions. Antiquarks for production can come directly from an antiproton rather than indirectly from gluon splitting. The higher cross sections reduce the synchrotron radiation in superconducting magnets and the number of events per bunch crossing, because lower beam currents can produce the same rare event rates. Events are also more centrally produced, allowing a more compact detector with less space between quadrupole triplets and a smaller beta* for higher luminosity. To adjust to antiproton beam losses (burn rate), a Fermilab-like antiproton source would be adapted to disperse the beam into 12 different momentum channels, using electrostatic septa, to increase antiproton momentum capture 12 times. At Fermilab, antiprotons were stochastically cooled in one Debuncher and one Accumulator ring. Because the stochastic cooling time scales as the number of particles, two options of 12 independent cooling systems are presented. One electron cooling ring might follow the stochastic cooling rings for antiproton stacking. Finally antiprotons in the collider ring would be recycled during runs without leaving the collider ring, by joining them to new bunches with snap bunch coalescence and synchrotron damping. These basic ideas are explored in this work on a future 100 TeV proton-antiproton collider and the main parameters are presented.

Analog measurement of delayed antiproton annihilation time spectra in a high intensity pulsed antiproton beam

International Nuclear Information System (INIS)

Niestroj, A.; Hayano, R.S.; Ishikawa, T.; Tamura, H.; Torii, H.A.; Morita, N.; Yamazaki, T.; Sugai, I.; Nakayoshi, K.; Horvath, D.; Eades, J.; Widmann, E.

1996-01-01

An analog detection system has been developed to measure delayed antiproton annihilation time spectra for laser resonance spectroscopy of metastable antiprotonic helium atoms using the high-intensity pulsed beam of antiprotons from LEAR at CERN. (orig.)

Cryogenic tunable microwave cavity at 13GHz for hyperfine spectroscopy of antiprotonic helium

International Nuclear Information System (INIS)

Sakaguchi, J.; Gilg, H.; Hayano, R.S.; Ishikawa, T.; Suzuki, K.; Widmann, E.; Yamaguchi, H.; Caspers, F.; Eades, J.; Hori, M.; Barna, D.; Horvath, D.; Juhasz, B.; Torii, H.A.; Yamazaki, T.

2004-01-01

For the precise measurement of the hyperfine structure of antiprotonic helium, microwave radiation of 12.9GHz frequency is needed, tunable over +/-100MHz. A cylindrical microwave cavity is used whose front and rear faces are meshed to allow the antiprotons and laser beams to enter. The cavity is embedded in a cryogenic helium gas target. Frequency tuning of ∼300MHz with Q values of 2700-3000 was achieved using over-coupling and an external triple stub tuner. We also present Monte-Carlo simulations of the stopping distribution of antiprotons in the low-density helium gas using the GEANT4 package with modified energy loss routines

Antiproton compression and radial measurements

CERN Document Server

Andresen, G B; Bowe, P D; Bray, C C; Butler, E; Cesar, C L; Chapman, S; Charlton, M; Fajans, J; Fujiwara, M C; Funakoshi, R; Gill, D R; Hangst, J S; Hardy, W N; Hayano, R S; Hayden, M E; Humphries, A J; Hydomako, R; Jenkins, M J; Jorgensen, L V; Kurchaninov, L; Lambo, R; Madsen, N; Nolan, P; Olchanski, K; Olin, A; Page R D; Povilus, A; Pusa, P; Robicheaux, F; Sarid, E; Seif El Nasr, S; Silveira, D M; Storey, J W; Thompson, R I; Van der Werf, D P; Wurtele, J S; Yamazaki, Y

2008-01-01

Control of the radial profile of trapped antiproton clouds is critical to trapping antihydrogen. We report detailed measurements of the radial manipulation of antiproton clouds, including areal density compressions by factors as large as ten, achieved by manipulating spatially overlapped electron plasmas. We show detailed measurements of the near-axis antiproton radial profile, and its relation to that of the electron plasma. We also measure the outer radial profile by ejecting antiprotons to the trap wall using an octupole magnet.

Biological Effectiveness of Antiproton Annihilation

DEFF Research Database (Denmark)

Maggiore, C.; Agazaryan, N.; Bassler, N.

2004-01-01

from the annihilation of antiprotons produce an increase in ‘‘biological dose’’ in the vicinity of the narrow Bragg peak for antiprotons compared to protons. This experiment is the first direct measurement of the biological effects of antiproton annihilation. The background, description, and status...

Interaction of antiprotons with nuclei

Czech Academy of Sciences Publication Activity Database

Hrtánková, Jaroslava; Mareš, Jiří

2016-01-01

Roč. 945, JAN (2016), s. 197-215 ISSN 0375-9474 R&D Projects: GA ČR(CZ) GA15-04301S Institutional support: RVO:61389005 Keywords : antiproton-nucleus interaction * antiproton annihilation * antiproton nuclear bound states Subject RIV: BE - Theoretical Physics Impact factor: 1.916, year: 2016

Laser spectroscopy of antiprotonic helium

CERN Document Server

Hori, M

2005-01-01

When antiprotons (i.e. the antimatter counterpart of protons) are stopped in helium gas, 97% of them annihilate within picoseconds by reacting with the helium nuclei; a 3% fraction, however, survive with an anomalously long lifetime of several microseconds. This longevity is due to the formation of antiprotonic helium, which is a three-body Rydberg atom composed of an antiproton, electron, and helium nucleus. The ASACUSA experimental collaboration has recently synthesized large numbers of these atoms using CERN's Antiproton Decelerator facility, and measured the atom's transition frequencies to 60 parts per billion by laser spectroscopy. By comparing the experimental results with recent three-body QED calculations and the known antiproton cyclotron frequency, we were able to show that the antiproton mass and charge are the same as the corresponding proton values to a precision of 10 parts per billion. Ongoing and future series of experiments will further improve the experimental precision by using chirp-compe...

The future of the antiproton accumulator

International Nuclear Information System (INIS)

Autin, B.

1983-01-01

When the Antiproton Accumulator was designed in 1977, it was considered as an element of the high energy proton-antiproton collision experiments in the CERN Super Proton Synchrotron. Since that time, antiproton physics has become more and more popular: a second experimental area was built in the SPS, the Intersecting Storage Rings started a special antiproton programme and a considerable interest has bloomed in the energy range of nuclear physics with the LEAR machine. Moreover, any projection on hadron physics in the coming years shows an insatiable appetite of experimentalists for more antiprotons. Therefore, basic studies have been pursued since the beginning of last year to transform the accumulator into an abundant source of antiprotons

Perspectives for polarized antiprotons

International Nuclear Information System (INIS)

Lenisa, Paolo

2012-01-01

Polarized antiprotons would open a new window in hadron physics providing access to a wealth of single and double spin observables in proton-antiproton interactions. The PAX Collaboration aims to perform the first ever measurement of the spin-dependence of the proton-antiproton cross section at the AD ring at CERN. The spin-dependence of the cross section could in principle be exploited by the spin-filtering technique for the production of a polarized antiproton beam. As a preparatory phase to the experimentation at AD, the PAX Collaboration has initiated a series of dedicated studies with protons at the COSY-ring in Juelich (Germany), aimed at the commissioning of the experimental apparatus and confirmation of the predictions for spin-filtering with protons.

PHYSICS WITH ULTRA-LOW ENERGY ANTIPROTONS

Energy Technology Data Exchange (ETDEWEB)

M. HOLZSCHEITER

2001-02-01

In this report the author describes the current status of the antiproton deceleration (AD) facility at CERN, and highlights the physics program with ultra-low energy antiproton at this installation. He also comments on future possibilities provided higher intensity antiproton beams become available at Fermilab, and review possibilities for initial experiments using direct degrading of high energy antiprotons in material has been developed and proven at CERN.

New Experiments with Antiprotons

Science.gov (United States)

Kaplan, D. M.

2011-12-01

Fermilab operates the world's most intense antiproton source. Recently proposed experiments can use those antiprotons either parasitically during Teva-tron Collider running or after the Tevatron Collider finishes in about 2011. For example, the annihilation of 8 GeV antiprotons might make the world's most intense source of tagged D0 mesons, and thus the best near-term opportunity to study charm mixing and search for new physics via its CP-violation signature. Other possible precision measurements include properties of the X(3872) and the charmonium system. An experiment using a Penning trap and an atom interferometer could make the world's first measurement of the gravitational force on antimatter. These and other potential measurements using antiprotons could yield a broad physics program at Fermilab in the post-Tevatron era.

Charge asymmetry in alignment of atoms excited by protons and antiprotons

International Nuclear Information System (INIS)

Balashov, V.V.; Sokolik, A.A.; Stysin, A.V.

2007-01-01

The multichannel diffraction approximation is used to consider excitation of lithium atom by proton and antiproton impact. Calculations are performed for the energy range 100 keV - 1 MeV of incoming proton and anti-proton which should be reliable enough due to the general requirements of the multichannel diffraction approximation. The sign-of-charge effect in the alignment of produced 1s 2 3d excited state and in the linear polarization of the subsequent spontaneous 1s 2 3d → 1s 2 2p radiation is expected to be considerable. The clear sign-of-charge effect in the polarization occurs for projectile energies below 1 MeV and become stronger when going to lower energies and the difference between the proton case and the anti-proton one looks considerable enough for experimental observation

The antiproton depth–dose curve in water

CERN Document Server

Bassler, N; Jäkel, O; Knudsen, H V; Kovacevic, S

2008-01-01

We have measured the depth–dose curve of 126 MeV antiprotons in a water phantom using ionization chambers. Since the antiproton beam provided by CERN has a pulsed structure and possibly carries a high-LET component from the antiproton annihilation, it is necessary to correct the acquired charge for ion recombination effects. The results are compared with Monte Carlo calculations and were found to be in good agreement. Based on this agreement we calculate the antiproton depth–dose curve for antiprotons and compare it with that for protons and find a doubling of the physical dose in the peak region for antiprotons.

Proton-antiproton collider physics

CERN Document Server

Altarelli, Guido

1989-01-01

This volume reviews the physics studied at the CERN proton-antiproton collider during its first phase of operation, from the first physics run in 1981 to the last one at the end of 1985. The volume consists of a series of review articles written by physicists who are actively involved with the collider research program. The first article describes the proton-antiproton collider facility itself, including the antiproton source and its principle of operation based on stochastic cooling. The subsequent six articles deal with the various physics subjects studied at the collider. Each article descr

Simulation of an antiprotons beam applied to the radiotherapy

International Nuclear Information System (INIS)

Prata, Leonardo de Almeida

2006-07-01

Results for the interaction of a antiproton beam with constituent nuclei of the organic matter are presented. This method regards of the application of an computational algorithm to determine quantitatively the differential cross sections for the scattered particles, starting from the interaction of these antiprotons with the nuclei, what will allow in the future to draw the isodose curve for antiproton therapy, once these beams are expected to be used in cancer treatment soon. The calculation will be done through the application of the concepts of the method of intranuclear cascade, providing yield and differential cross sections of the scattered particles, present in the software MCMC. Th algorithm was developed based on Monte Carlo's method, already taking into account a validate code. The following physical quantities are presented: the yield of secondary particles, their spectral and angular distributions for these interactions. For the energy range taken into account the more important emitted particles are protons, neutrons and pions. Results shown that emitted secondary particles can modify the isodose curves, because they present high yield and energy for transverse directions. (author)

CERN: Antiprotons probe the nuclear stratosphere

Energy Technology Data Exchange (ETDEWEB)

Anon.

1995-06-15

The outer periphery of heavy stable nuclei is notoriously difficult to study experimentally. While the well understood electromagnetic interaction between electrons (or muons) and protons has given the nuclear charge (or proton) distribution with high precision for almost all stable nuclei, neutron distribution studies are much less precise. This is especially true for large nuclear distances, where the nuclear density is small. A few previous experiments probing the nuclear ''stratosphere'' suggested that far from the centre of the nucleus (of the order of 2 nuclear radii) this stratosphere may be composed predominantly of neutrons. At the end of the sixties the term ''neutron halo'' was introduced to describe this phenomenon, but experimental evidence was scarce or even controversial, and remained so for almost a quarter of a century. Recently, the Warsaw/Munich/Berlin collaboration working within the PS203 experiment at CERN's LEAR low energy antiproton ring, proposed a new method to study the nuclear periphery using stopped antiprotons. The halo now looks firmer. A 200 MeV/c beam of antiprotons was slowed down by interactions with atomic electrons. When antiproton kinetic energy drops well below 1 keV, the particles are captured in the outermost orbits of ''exotic atoms'', where the antiprotons take the place of the usual orbital electrons. With the lower orbits in this antiprotonic atom empty, the antiproton drops toward the nuclear surface, first emitting Auger electrons and later predominantly antiprotonic X-rays. Due to the strong interaction between antiprotons and nucleons, the antiproton succumbs to annihilation with a nucleon in the rarified nuclear stratosphere, far above the innermost Bohr orbit of the atom. The annihilation probability in heavy nuclei is maximal where the nuclear density is about 3% of its central value and extends to densities many orders of magnitude smaller. Antiproton annihilation on a proton or on a neutron at the nuclear

Two-photon laser spectroscopy of antiprotonic helium and the antiproton-to-electron mass ratio

CERN Document Server

Hori, Masaki; Barna, Daniel; Andreas Dax,; Hayano, Ryugo; Friedreich, Susanne; Juhász, Bertalan; Pask, Thomas; Widmann, Eberhard; Horváth, Dezső; Venturelli, Luca; Zurlo, Nicola; 10.1038/nature10260

2013-01-01

Physical laws are believed to be invariant under the combined transformations of charge, parity and time reversal (CPT symmetry). This implies that an antimatter particle has exactly the same mass and absolute value of charge as its particle counterpart. Metastable antiprotonic helium ($\\bar{p}He^+$) is a three-body atom2 consisting of a normal helium nucleus, an electron in its ground state and an antiproton ($\\bar{p}$) occupying a Rydberg state with high principal and angular momentum quantum numbers, respectively n and l, such that n ≈ l + 1 ≈ 38. These atoms are amenable to precision laser spectroscopy, the results of which can in principle be used to determine the antiproton-to-electron mass ratio and to constrain the equality between the antiproton and proton charges and masses. Here we report two-photon spectroscopy of antiprotonic helium, in which $\\bar{p}^{3}He^{+}$ and $\\bar{p}^{4}He^{+}$ isotopes are irradiated by two counter-propagating laser beams. This excites nonlinear, two-phot...

The biological effectiveness of antiproton irradiation

International Nuclear Information System (INIS)

Holzscheiter, Michael H.; Bassler, Niels; Agazaryan, Nzhde; Beyer, Gerd; Blackmore, Ewart; DeMarco, John J.; Doser, Michael; Durand, Ralph E.; Hartley, Oliver; Iwamoto, Keisuke S.; Knudsen, Helge V.; Landua, Rolf; Maggiore, Carl; McBride, William H.; Moller, Soren Pape; Petersen, Jorgen; Skarsgard, Lloyd D.; Smathers, James B.; Solberg, Timothy D.; Uggerhoj, Ulrik I.; Vranjes, Sanja; Withers, H. Rodney; Wong, Michelle; Wouters, Bradly G.

2006-01-01

Background and purpose: Antiprotons travel through tissue in a manner similar to that for protons until they reach the end of their range where they annihilate and deposit additional energy. This makes them potentially interesting for radiotherapy. The aim of this study was to conduct the first ever measurements of the biological effectiveness of antiprotons. Materials and methods: V79 cells were suspended in a semi-solid matrix and irradiated with 46.7 MeV antiprotons, 48 MeV protons, or 6 Co γ-rays. Clonogenic survival was determined as a function of depth along the particle beams. Dose and particle fluence response relationships were constructed from data in the plateau and Bragg peak regions of the beams and used to assess the biological effectiveness. Results: Due to uncertainties in antiproton dosimetry we defined a new term, called the biologically effective dose ratio (BEDR), which compares the response in a minimally spread out Bragg peak (SOBP) to that in the plateau as a function of particle fluence. This value was ∼3.75 times larger for antiprotons than for protons. This increase arises due to the increased dose deposited in the Bragg peak by annihilation and because this dose has a higher relative biological effectiveness (RBE). Conclusion: We have produced the first measurements of the biological consequences of antiproton irradiation. These data substantiate theoretical predictions of the biological effects of antiproton annihilation within the Bragg peak, and suggest antiprotons warrant further investigation

Hendee's radiation therapy physics

CERN Document Server

Pawlicki, Todd; Starkschall, George

2016-01-01

The publication of this fourth edition, more than ten years on from the publication of Radiation Therapy Physics third edition, provides a comprehensive and valuable update to the educational offerings in this field. Led by a new team of highly esteemed authors, building on Dr Hendee’s tradition, Hendee’s Radiation Therapy Physics offers a succinctly written, fully modernised update. Radiation physics has undergone many changes in the past ten years: intensity-modulated radiation therapy (IMRT) has become a routine method of radiation treatment delivery, digital imaging has replaced film-screen imaging for localization and verification, image-guided radiation therapy (IGRT) is frequently used, in many centers proton therapy has become a viable mode of radiation therapy, new approaches have been introduced to radiation therapy quality assurance and safety that focus more on process analysis rather than specific performance testing, and the explosion in patient-and machine-related data has necessitated an ...

CERN: Antiprotons probe the nuclear stratosphere

International Nuclear Information System (INIS)

Anon.

1995-01-01

The outer periphery of heavy stable nuclei is notoriously difficult to study experimentally. While the well understood electromagnetic interaction between electrons (or muons) and protons has given the nuclear charge (or proton) distribution with high precision for almost all stable nuclei, neutron distribution studies are much less precise. This is especially true for large nuclear distances, where the nuclear density is small. A few previous experiments probing the nuclear ''stratosphere'' suggested that far from the centre of the nucleus (of the order of 2 nuclear radii) this stratosphere may be composed predominantly of neutrons. At the end of the sixties the term ''neutron halo'' was introduced to describe this phenomenon, but experimental evidence was scarce or even controversial, and remained so for almost a quarter of a century. Recently, the Warsaw/Munich/Berlin collaboration working within the PS203 experiment at CERN's LEAR low energy antiproton ring, proposed a new method to study the nuclear periphery using stopped antiprotons. The halo now looks firmer. A 200 MeV/c beam of antiprotons was slowed down by interactions with atomic electrons. When antiproton kinetic energy drops well below 1 keV, the particles are captured in the outermost orbits of ''exotic atoms'', where the antiprotons take the place of the usual orbital electrons. With the lower orbits in this antiprotonic atom empty, the antiproton drops toward the nuclear surface, first emitting Auger electrons and later predominantly antiprotonic X-rays. Due to the strong interaction between antiprotons and nucleons, the antiproton succumbs to annihilation with a nucleon in the rarified nuclear stratosphere, far above the innermost Bohr orbit of the atom. The annihilation probability in heavy nuclei is maximal where the nuclear density is about 3% of its central value and extends to densities many orders of magnitude smaller

Calculations of antiproton nucleus quasi-bound states using the Paris (N)over-barN potential

Czech Academy of Sciences Publication Activity Database

Hrtánková, Jaroslava; Mareš, Jiří

2018-01-01

Roč. 969, č. 1 (2018), s. 45-59 ISSN 0375-9474 R&D Projects: GA ČR(CZ) GA15-04301S Institutional support: RVO:61389005 Keywords : antiproton-nucleus interaction * Paris (N)over-barN potential * antiproton-nuclear bound states Subject RIV: BE - Theoretical Physics OBOR OECD: Atomic, molecular and chemical physics ( physics of atoms and molecules including collision, interaction with radiation, magnetic resonances, Mössbauer effect) Impact factor: 1.916, year: 2016

Lattices for antiproton rings

International Nuclear Information System (INIS)

Autin, B.

1984-01-01

After a description of the constraints imposed by the cooling of Antiprotons on the lattice of the rings, the reasons which motivate the shape and the structure of these machines are surveyed. Linear and non-linear beam optics properties are treated with a special amplification to the Antiproton Accumulator. (orig.)

Antiproton-nucleus potentials from global fits to antiprotonic X-rays and radiochemical data

Czech Academy of Sciences Publication Activity Database

Friedman, E.; Gal, A.; Mareš, Jiří

2005-01-01

Roč. 761, 3/4 (2005), s. 283-295 ISSN 0375-9474 R&D Projects: GA AV ČR IAA1048305 Institutional research plan: CEZ:AV0Z10480505 Keywords : antiproton-nuclear interaction * RMF calculations * antiproton X-rays Subject RIV: BE - Theoretical Physics Impact factor: 1.950, year: 2005

Dose Determination using alanine detectors in a Mixed Neutron and Gamma Field for Boron Neutron Capture Therapy of Liver Malignancies

DEFF Research Database (Denmark)

Schmitz, T.; Blaickner, M.; Ziegner, M.

2011-01-01

Introduction Boron Neutron Capture Therapy for liver malignancies is being investigated at the University of Mainz. One important aim is the set-up of a reliable dosimetry system. Alanine dosimeters have previously been applied for dosimetry of mixed radiation fields in antiproton therapy, and ma...

Comparison of electromagnetic and hadronic models generated using Geant 4 with antiproton dose measured in CERN.

Science.gov (United States)

Tavakoli, Mohammad Bagher; Reiazi, Reza; Mohammadi, Mohammad Mehdi; Jabbari, Keyvan

2015-01-01

After proposing the idea of antiproton cancer treatment in 1984 many experiments were launched to investigate different aspects of physical and radiobiological properties of antiproton, which came from its annihilation reactions. One of these experiments has been done at the European Organization for Nuclear Research known as CERN using the antiproton decelerator. The ultimate goal of this experiment was to assess the dosimetric and radiobiological properties of beams of antiprotons in order to estimate the suitability of antiprotons for radiotherapy. One difficulty on this way was the unavailability of antiproton beam in CERN for a long time, so the verification of Monte Carlo codes to simulate antiproton depth dose could be useful. Among available simulation codes, Geant4 provides acceptable flexibility and extensibility, which progressively lead to the development of novel Geant4 applications in research domains, especially modeling the biological effects of ionizing radiation at the sub-cellular scale. In this study, the depth dose corresponding to CERN antiproton beam energy by Geant4 recruiting all the standard physics lists currently available and benchmarked for other use cases were calculated. Overall, none of the standard physics lists was able to draw the antiproton percentage depth dose. Although, with some models our results were promising, the Bragg peak level remained as the point of concern for our study. It is concluded that the Bertini model with high precision neutron tracking (QGSP_BERT_HP) is the best to match the experimental data though it is also the slowest model to simulate events among the physics lists.

The biological effectiveness of antiproton irradiation

DEFF Research Database (Denmark)

Holzscheiter, Michael H.; Bassler, Niels; Agazaryan, Nzhde

2006-01-01

ever measurements of the biological effectiveness of antiprotons. Materials and methods: V79 cells were suspended in a semi-solid matrix and irradiated with 46.7 MeV antiprotons, 48 MeV protons, or 60Co c-rays. Clonogenic survival was determined as a function of depth along the particle beams. Dose...... and particle fluence response relationships were constructed from data in the plateau and Bragg peak regions of the beams and used to assess the biological effectiveness. Results: Due to uncertainties in antiproton dosimetry we defined a new term, called the biologically effective dose ratio (BEDR), which...... has a higher relative biological effectiveness (RBE). Conclusion: We have produced the first measurements of the biological consequences of antiproton irradiation. These data substantiate theoretical predictions of the biological effects of antiproton annihilation within the Bragg peak, and suggest...

The relative biological effectiveness of antiprotons

DEFF Research Database (Denmark)

Holzscheiter, Michael H.; Alsner, Jan; Bassler, Niels

2016-01-01

Background and purpose: Aside from the enhancement of physical dose deposited by antiprotons annihilating in tissue-like material compared to protons of the same range a further increase of biological effective dose has been demonstrated. This enhancement can be expressed in an increase of the re......Background and purpose: Aside from the enhancement of physical dose deposited by antiprotons annihilating in tissue-like material compared to protons of the same range a further increase of biological effective dose has been demonstrated. This enhancement can be expressed in an increase...... of the relative biological effectiveness (RBE) of antiprotons near the end of range. We have performed the first-ever direct measurement of the RBE of antiprotons both at rest and in flight. Materials and methods: Experimental data were generated on the RBE of an antiproton beam entering a tissue-like target...

Risk management of radiation therapy. Survey by north Japan radiation therapy oncology group

International Nuclear Information System (INIS)

Aoki, Masahiko; Abe, Yoshinao; Yamada, Shogo; Hareyama, Masato; Nakamura, Ryuji; Sugita, Tadashi; Miyano, Takashi

2004-01-01

A North Japan Radiation Oncology Group (NJRTOG) survey was carried out to disclose the risk management of radiation therapy. During April 2002, we sent questionnaires to radiation therapy facilities in northern Japan. There were 31 replies from 27 facilities. Many incidents and accidents were reported, including old cases. Although 60% of facilities had a risk management manual and/or risk manager, only 20% had risk management manuals for radiation therapy. Eighty five percent of radiation oncologists thought that incidents may be due to a lack of manpower. Ninety percent of radiation oncologists want to know the type of cases happened in other facilities. The risk management system is still insufficient for radiation therapy. We hope that our data will be a great help to develop risk management strategies for radiation therapy for all radiation oncologists in Japan. (author)

Some preliminary considerations on antiproton-nucleus experiments

International Nuclear Information System (INIS)

Yavin, A.I.

1981-05-01

The antiproton as a probe of the atomic nucleus is discussed in the expectation that fairly intense beams of high quality will be available in 1983 at the Low Energy Antiproton Ring (LEAR) facility at CERN and possibly also in some other laboratories at a later date. Several antiproton-nucleus experiments are proposed, and the possibility of observing antiprotonic nuclei as well as antineutronic nuclei is discussed. It is demonstrated that even for the study of the elementary nucleon-antinucleon systems it could be advantageous to use nuclei rather than protons as target. The possibility of investigating several antiprotonic atomic systems is also briefly discussed [fr

LEAR: antiproton extraction lines

CERN Multimedia

Photographic Service

1992-01-01

Antiprotons, decelerated in LEAR to a momentum of 100 MeV/c (kinetic energy of 5.3 MeV), were delivered to the experiments in an "Ultra-Slow Extraction", dispensing some 1E9 antiprotons over times counted in hours. Beam-splitters and a multitude of beam-lines allowed several users to be supplied simultaneously.

CERN: Antiprotons resist annihilation

International Nuclear Information System (INIS)

Anon.

1992-01-01

Ask any particle physicist what is the eventual fate of an antiproton in matter and he will likely tell you that It annihilates'. True as this answer is, it hides a number of fascinating questions about the actual 'route' followed by the antiproton into the nucleus where it finally stops before annihilating with a nuclear particle

Measurement of interaction between antiprotons

Energy Technology Data Exchange (ETDEWEB)

Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Alekseev, I.; Alford, J.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Averichev, G. S.; Bairathi, V.; Banerjee, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandenburg, J. D.; Brandin, A. V.; Bunzarov, I.; Butterworth, J.; Caines, H.; Calderón de la Barca Sánchez, M.; Campbell, J. M.; Cebra, D.; Cervantes, M. C.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chattopadhyay, S.; Chen, J. H.; Chen, X.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; De Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; di Ruzza, B.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Du, C. M.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Engelage, J.; Eppley, G.; Esha, R.; Evdokimov, O.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Greiner, L.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, A.; Gupta, S.; Guryn, W.; Hamad, A.; Hamed, A.; Haque, R.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Hofman, D. J.; Horvat, S.; Huang, B.; Huang, H. Z.; Huang, X.; Huck, P.; Humanic, T. J.; Igo, G.; Jacobs, W. W.; Jang, H.; Jiang, K.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z. H.; Kikoła, D. P.; Kisel, I.; Kisiel, A.; Klein, S.; Kochenda, L.; Koetke, D. D.; Kollegger, T.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kulakov, I.; Kumar, L.; Kycia, R. A.; Lamont, M. A. C.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, X.; Li, Z. M.; Li, Y.; Li, W.; Li, X.; Li, C.; Lisa, M. A.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, X.; Ma, G. L.; Ma, R.; Ma, Y. G.; Ma, L.; Magdy, N.; Majka, R.; Manion, A.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; McDonald, D.; Meehan, K.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nandi, B. K.; Nasim, Md.; Nayak, T. K.; Nigmatkulov, G.; Nogach, L. V.; Noh, S. Y.; Novak, J.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V.; Olvitt, D.; Page, B. S.; Pak, R.; Pan, Y. X.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Peterson, A.; Pile, P.; Planinic, M.; Pluta, J.; Poljak, N.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roy, A.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Seger, J.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, M. K.; Sharma, B.; Shen, W. Q.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Skoby, M. J.; Smirnov, N.; Smirnov, D.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Stepanov, M.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Sumbera, M.; Summa, B.; Sun, Z.; Sun, X. M.; Sun, Y.; Sun, X.; Surrow, B.; Svirida, N.; Szelezniak, M. A.; Tang, Z.; Tang, A. H.; Tarnowsky, T.; Tawfik, A.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Trzeciak, B. A.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; Van Buren, G.; van Nieuwenhuizen, G.; Vandenbroucke, M.; Varma, R.; Vasiliev, A. N.; Vertesi, R.; Videbæk, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, G.; Wang, H.; Wang, J. S.; Wang, Y.; Wang, Y.; Wang, F.; Webb, J. C.; Webb, G.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y. F.; Xiao, Z. G.; Xie, W.; Xin, K.; Xu, Y. F.; Xu, Q. H.; Xu, H.; Xu, N.; Xu, Z.; Yang, Y.; Yang, C.; Yang, S.; Yang, Y.; Yang, Q.; Ye, Z.; Yepes, P.; Yi, L.; Yip, K.; Yoo, I. -K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, J. B.; Zhang, Z.; Zhang, J.; Zhang, S.; Zhang, X. P.; Zhang, J.; Zhang, Y.; Zhao, J.; Zhong, C.; Zhou, L.; Zhu, X.; Zoulkarneeva, Y.; Zyzak, M.

2015-11-04

© 2015 Macmillan Publishers Limited. All rights reserved. One of the primary goals of nuclear physics is to understand the force between nucleons, which is a necessary step for understanding the structure of nuclei and how nuclei interact with each other. Rutherford discovered the atomic nucleus in 1911, and the large body of knowledge about the nuclear force that has since been acquired was derived from studies made on nucleons or nuclei. Although antinuclei up to antihelium-4 have been discovered and their masses measured, little is known directly about the nuclear force between antinucleons. Here, we study antiproton pair correlations among data collected by the STAR experiment at the Relativistic Heavy Ion Collider (RHIC), where gold ions are collided with a centre-of-mass energy of 200 gigaelectronvolts per nucleon pair. Antiprotons are abundantly produced in such collisions, thus making it feasible to study details of the antiproton-antiproton interaction. By applying a technique similar to Hanbury Brown and Twiss intensity interferometry, we show that the force between two antiprotons is attractive. In addition, we report two key parameters that characterize the corresponding strong interaction: the scattering length and the effective range of the interaction. Our measured parameters are consistent within errors with the corresponding values for proton-proton interactions. Our results provide direct information on the interaction between two antiprotons, one of the simplest systems of antinucleons, and so are fundamental to understanding the structure of more-complex antinuclei and the ir properties.

Measurement of interaction between antiprotons

Science.gov (United States)

The Star Collaboration; Adamczyk, L.; Adkins, J. K.; Agakishiev, G.; Aggarwal, M. M.; Ahammed, Z.; Alekseev, I.; Alford, J.; Aparin, A.; Arkhipkin, D.; Aschenauer, E. C.; Averichev, G. S.; Bairathi, V.; Banerjee, A.; Bellwied, R.; Bhasin, A.; Bhati, A. K.; Bhattarai, P.; Bielcik, J.; Bielcikova, J.; Bland, L. C.; Bordyuzhin, I. G.; Bouchet, J.; Brandenburg, J. D.; Brandin, A. V.; Bunzarov, I.; Butterworth, J.; Caines, H.; Calderón de La Barca Sánchez, M.; Campbell, J. M.; Cebra, D.; Cervantes, M. C.; Chakaberia, I.; Chaloupka, P.; Chang, Z.; Chattopadhyay, S.; Chen, J. H.; Chen, X.; Cheng, J.; Cherney, M.; Christie, W.; Contin, G.; Crawford, H. J.; Das, S.; de Silva, L. C.; Debbe, R. R.; Dedovich, T. G.; Deng, J.; Derevschikov, A. A.; di Ruzza, B.; Didenko, L.; Dilks, C.; Dong, X.; Drachenberg, J. L.; Draper, J. E.; Du, C. M.; Dunkelberger, L. E.; Dunlop, J. C.; Efimov, L. G.; Engelage, J.; Eppley, G.; Esha, R.; Evdokimov, O.; Eyser, O.; Fatemi, R.; Fazio, S.; Federic, P.; Fedorisin, J.; Feng, Z.; Filip, P.; Fisyak, Y.; Flores, C. E.; Fulek, L.; Gagliardi, C. A.; Garand, D.; Geurts, F.; Gibson, A.; Girard, M.; Greiner, L.; Grosnick, D.; Gunarathne, D. S.; Guo, Y.; Gupta, A.; Gupta, S.; Guryn, W.; Hamad, A.; Hamed, A.; Haque, R.; Harris, J. W.; He, L.; Heppelmann, S.; Heppelmann, S.; Hirsch, A.; Hoffmann, G. W.; Hofman, D. J.; Horvat, S.; Huang, B.; Huang, H. Z.; Huang, X.; Huck, P.; Humanic, T. J.; Igo, G.; Jacobs, W. W.; Jang, H.; Jiang, K.; Judd, E. G.; Kabana, S.; Kalinkin, D.; Kang, K.; Kauder, K.; Ke, H. W.; Keane, D.; Kechechyan, A.; Khan, Z. H.; Kikoła, D. P.; Kisel, I.; Kisiel, A.; Klein, S.; Kochenda, L.; Koetke, D. D.; Kollegger, T.; Kosarzewski, L. K.; Kraishan, A. F.; Kravtsov, P.; Krueger, K.; Kulakov, I.; Kumar, L.; Kycia, R. A.; Lamont, M. A. C.; Landgraf, J. M.; Landry, K. D.; Lauret, J.; Lebedev, A.; Lednicky, R.; Lee, J. H.; Li, X.; Li, Z. M.; Li, Y.; Li, W.; Li, X.; Li, C.; Lisa, M. A.; Liu, F.; Ljubicic, T.; Llope, W. J.; Lomnitz, M.; Longacre, R. S.; Luo, X.; Ma, G. L.; Ma, R.; Ma, Y. G.; Ma, L.; Magdy, N.; Majka, R.; Manion, A.; Margetis, S.; Markert, C.; Masui, H.; Matis, H. S.; McDonald, D.; Meehan, K.; Minaev, N. G.; Mioduszewski, S.; Mishra, D.; Mohanty, B.; Mondal, M. M.; Morozov, D. A.; Mustafa, M. K.; Nandi, B. K.; Nasim, Md.; Nayak, T. K.; Nigmatkulov, G.; Nogach, L. V.; Noh, S. Y.; Novak, J.; Nurushev, S. B.; Odyniec, G.; Ogawa, A.; Oh, K.; Okorokov, V.; Olvitt, D.; Page, B. S.; Pak, R.; Pan, Y. X.; Pandit, Y.; Panebratsev, Y.; Pawlik, B.; Pei, H.; Perkins, C.; Peterson, A.; Pile, P.; Planinic, M.; Pluta, J.; Poljak, N.; Poniatowska, K.; Porter, J.; Posik, M.; Poskanzer, A. M.; Putschke, J.; Qiu, H.; Quintero, A.; Ramachandran, S.; Raniwala, R.; Raniwala, S.; Ray, R. L.; Ritter, H. G.; Roberts, J. B.; Rogachevskiy, O. V.; Romero, J. L.; Roy, A.; Ruan, L.; Rusnak, J.; Rusnakova, O.; Sahoo, N. R.; Sahu, P. K.; Sakrejda, I.; Salur, S.; Sandweiss, J.; Sarkar, A.; Schambach, J.; Scharenberg, R. P.; Schmah, A. M.; Schmidke, W. B.; Schmitz, N.; Seger, J.; Seyboth, P.; Shah, N.; Shahaliev, E.; Shanmuganathan, P. V.; Shao, M.; Sharma, M. K.; Sharma, B.; Shen, W. Q.; Shi, S. S.; Shou, Q. Y.; Sichtermann, E. P.; Sikora, R.; Simko, M.; Skoby, M. J.; Smirnov, N.; Smirnov, D.; Song, L.; Sorensen, P.; Spinka, H. M.; Srivastava, B.; Stanislaus, T. D. S.; Stepanov, M.; Stock, R.; Strikhanov, M.; Stringfellow, B.; Sumbera, M.; Summa, B.; Sun, Z.; Sun, X. M.; Sun, Y.; Sun, X.; Surrow, B.; Svirida, N.; Szelezniak, M. A.; Tang, Z.; Tang, A. H.; Tarnowsky, T.; Tawfik, A.; Thomas, J. H.; Timmins, A. R.; Tlusty, D.; Tokarev, M.; Trentalange, S.; Tribble, R. E.; Tribedy, P.; Tripathy, S. K.; Trzeciak, B. A.; Tsai, O. D.; Ullrich, T.; Underwood, D. G.; Upsal, I.; van Buren, G.; van Nieuwenhuizen, G.; Vandenbroucke, M.; Varma, R.; Vasiliev, A. N.; Vertesi, R.; Videbæk, F.; Viyogi, Y. P.; Vokal, S.; Voloshin, S. A.; Vossen, A.; Wang, G.; Wang, H.; Wang, J. S.; Wang, Y.; Wang, Y.; Wang, F.; Webb, J. C.; Webb, G.; Wen, L.; Westfall, G. D.; Wieman, H.; Wissink, S. W.; Witt, R.; Wu, Y. F.; Xiao, Z. G.; Xie, W.; Xin, K.; Xu, Y. F.; Xu, Q. H.; Xu, H.; Xu, N.; Xu, Z.; Yang, Y.; Yang, C.; Yang, S.; Yang, Y.; Yang, Q.; Ye, Z.; Yepes, P.; Yi, L.; Yip, K.; Yoo, I.-K.; Yu, N.; Zbroszczyk, H.; Zha, W.; Zhang, J. B.; Zhang, Z.; Zhang, J.; Zhang, S.; Zhang, X. P.; Zhang, J.; Zhang, Y.; Zhao, J.; Zhong, C.; Zhou, L.; Zhu, X.; Zoulkarneeva, Y.; Zyzak, M.

2015-11-01

One of the primary goals of nuclear physics is to understand the force between nucleons, which is a necessary step for understanding the structure of nuclei and how nuclei interact with each other. Rutherford discovered the atomic nucleus in 1911, and the large body of knowledge about the nuclear force that has since been acquired was derived from studies made on nucleons or nuclei. Although antinuclei up to antihelium-4 have been discovered and their masses measured, little is known directly about the nuclear force between antinucleons. Here, we study antiproton pair correlations among data collected by the STAR experiment at the Relativistic Heavy Ion Collider (RHIC), where gold ions are collided with a centre-of-mass energy of 200 gigaelectronvolts per nucleon pair. Antiprotons are abundantly produced in such collisions, thus making it feasible to study details of the antiproton-antiproton interaction. By applying a technique similar to Hanbury Brown and Twiss intensity interferometry, we show that the force between two antiprotons is attractive. In addition, we report two key parameters that characterize the corresponding strong interaction: the scattering length and the effective range of the interaction. Our measured parameters are consistent within errors with the corresponding values for proton-proton interactions. Our results provide direct information on the interaction between two antiprotons, one of the simplest systems of antinucleons, and so are fundamental to understanding the structure of more-complex antinuclei and their properties.

Spectroscopy of antiproton helium atoms

International Nuclear Information System (INIS)

Hayano, Ryugo

2005-01-01

Antiproton helium atom is three-body system consisting of an antiproton, electrons and a helium nucleus (denoted by the chemical symbol, p-bar H + ). The authors produced abundant atoms of p-bar 4 He + , and p-bar 3 He + in a cooled He gas target chamber stopping the p-bar beam decelerated to approximately 100 keV in the Antiproton Decelerator at CERN. A precision laser spectroscopy on the atomic transitions in the p-bar 4 He + , and in p-bar 3 He + was performed. Principle of laser spectroscopy and various modifications of the system to eliminate factors affecting the accuracy of the experiment were described. Deduced mass ratio of antiproton and proton, (|m p -bar - m p |)/m p reached to the accuracy of 10 ppb (10 -8 ) as of 2002, as adopted in the recent article of the Particle Data Group by P.J. Mohr and B.N. Taylor. This value is the highest precise data for the CPT invariance in baryon. In future, antihydrogen atoms will be produced in the same facility, and will provide far accurate value of antiproton mass thus enabling a better confirmation of CPT theorem in baryon. (T. Tamura)

Autoresonant Excitation of Antiproton Plasmas

CERN Document Server

Andresen, Gorm B; Baquero-Ruiz, Marcelo; Bertsche, William; Bowe, Paul D; Butler, Eoin; Carpenter, P T; Cesar, Claudio L; Chapman, Steven; Charlton, Michael; Fajans, Joel; Friesen, Tim; Fujiwara, Makoto C; Gill, David R; Hangst, Jeffrey S; Hardy, Walter N; Hayden, Michael E; Humphries, Andrew J; Hurt, J L; Hydomako, Richard; Jonsell, Svante; Madsen, Niels; Menary, Scott; Nolan, Paul; Olchanski, Konstantin; Olin, Art; Povilus, Alexander; Pusa, Petteri; Robicheaux, Francis; Sarid, Eli; Silveira, Daniel M; So, Chukman; Storey, James W; Thompson, Robert I; van der Werf, Dirk P; Wurtele, Jonathan S; Yamazaki, Yasunori

2011-01-01

We demonstrate controllable excitation of the center-of-mass longitudinal motion of a thermal antiproton plasma using a swept-frequency autoresonant drive. When the plasma is cold, dense, and highly collective in nature, we observe that the entire system behaves as a single-particle nonlinear oscillator, as predicted by a recent theory. In contrast, only a fraction of the antiprotons in a warm plasma can be similarly excited. Antihydrogen was produced and trapped by using this technique to drive antiprotons into a positron plasma, thereby initiating atomic recombination.

ALPHA freezes antiprotons

CERN Multimedia

CERN Bulletin

2010-01-01

Laboratories like CERN can routinely produce many different types of antiparticles. In 1995, the PS210 experiment formed the first antihydrogen atoms and a few years later, in 2002, ATRAP and ATHENA were already able to produce several thousand of them. However, no experiment in the world has succeeded in ‘trapping’ these anti-atoms in order to study them. This is the goal of the ALPHA experiment, which has recently managed to cool down the antiprotons to just a few Kelvin. This represents a major step towards trapping the anti-atom, thus opening a new avenue into the investigation of antimatter properties.   Members of the ALPHA collaboration working on the apparatus in the Antiproton Decelerator experimental hall at CERN. Just like the atom, the anti-atom is neutral. Unlike the atom, the anti-atom is made up of antiprotons (as opposed to protons in the atom) and positrons (as opposed to electrons). In order to thoroughly study the properties of the anti-atoms, scien...

Radiation therapy for digestive tumors

International Nuclear Information System (INIS)

Piedbois, P.; Levy, E.; Thirion, P.; Martin, L.; Calitchi, E.; Otmezguine, Y.; Le Bourgeois, J.P.

1995-01-01

This brief review of radiation therapy of digestive tumors in 1994 seeks to provide practical answers to the most commonly asked questions: What is the place of radiation therapy versus chemotherapy for the treatment of these patients ? What are the approved indications of radiation therapy and which avenues of research are being explored ? Radiation therapy is used in over two-thirds of patients referred to an oncology department for a gastrointestinal tract tumor. The main indications are reviewed: cancer of the rectum and anal canal and, to a lesser extent, cancer of the esophagus and pancreas. The main focuses of current research include radiation therapy-chemotherapy combinations, intraoperative radiation therapy, and radiation therapy of hepatobiliary tumors. (authors). 23 refs., 1 fig

The Antiproton Depth-Dose Curve in Water

DEFF Research Database (Denmark)

Bassler, Niels; Holzscheiter, Michael; Jäkel, Oliver

2008-01-01

We have measured the depth-dose curve of 126 MeV antiprotons in a water phantom using ionization chambers. Since the antiproton beam provided by CERN has a pulsed structure and possibly carries a high-LET component from the antiproton annihilation, it is necessary to correct the acquired charge...

Beam position pickup for antiprotons to the ISR

CERN Multimedia

CERN PhotoLab

1981-01-01

The Antiproton Project, launched for proton-antiproton collisions in the SPS (SPS collider), had a side-line for p-pbar collisions in the ISR. A new transfer line, TT6, was constructed to transport antiprotons from the 26 GeV PS to the injection line TT1 of ISR ring 2. Antiprotons were a scarce commodity. For setting up the lines, beam diagnostic devices in the antiproton path had to work reliably and precisely with just a few low-intensity pilot pules: single bunches of about 2x10**9 antiprotons every few hours. Electrostatic pickup electrodes were used to measure beam position. They could be mounted for measurement in the horizontal plane, as in this picture, or at 90 deg, for the vertical plane.

Antiproton fast ignition for inertial confinement fusion

International Nuclear Information System (INIS)

Perkins, L.J.

1999-01-01

With 180 MJ/microg, antiprotons offer the highest stored energy per unit mass of any known entity. The use of antiprotons to promote fast ignition in an inertial confinement fusion (ICF) capsule and produce high target gains with only modest compression of the main fuel is investigated. Unlike standard fast ignition where the ignition energy is supplied by energetic, short pulse laser, the energy here is supplied through the ionization energy deposited when antiprotons annihilate at the center of a compressed fuel capsule. This can be considered in-situ fast ignition as it obviates the need for the external injection of the ignition energy. In the first of two candidate schemes, the antiproton package is delivered by a low-energy ion beam. In the second, autocatalytic scheme, the antiprotons are preemplaced at the center of the capsule prior to compression. In both schemes, the author estimates that ∼10 12 antiprotons are required to initiate fast ignition in a typical ICF capsule and show that incorporation of a thin, heavy metal shell is desirable to enhance energy deposition within the ignitor zone. In addition to eliminating the need for a second, energetic fast laser and vulnerable final optics, this scheme would achieve central ignition without reliance on laser channeling through halo plasma or Hohlraum debris. However, in addition to the practical difficulties of storage and manipulation of antiprotons at low energy, the other large uncertainty for the practicality of such a speculative scheme is the ultimate efficiency of antiproton production in an external, optimized facility. Estimates suggest that the electrical wall plug energy per pulse required for the separate production of the antiprotons is of the same order as that required for the conventional slow compression driver

Intensity-Frontier Antiproton Physics with The Antiproton Annihilation Spectrometer (TAPAS) at Fermilab

Energy Technology Data Exchange (ETDEWEB)

Apollinari, Giorgio; /Fermilab; Asner, David M.; /PNL, Richland; Baldini, Wander; /INFN, Ferrara; Bartoszek, Larry; Broemmelsiek, Daniel R.; Brown, Charles N.; /Fermilab; Chakravorty, Alak; /St. Xavier U., Chicago; Colas, Paul; /Saclay; Derwent, Paul; /Fermilab; Drutskoy, Alexey; /Moscow, ITEP; Fortner, Michael; /Northern Illinois U. /Saclay /Indian Inst. Tech., Hyderabad

2011-11-01

The Fermilab Antiproton Source is the world's most intense source of antimatter. With the Tevatron program now behind us, this unique facility can help make the case for Fermilab's continued accelerator operations. The Antiproton Source can be used for unique, dedicated antimatter studies, including medium-energy {bar p}-annihilation experiments. We propose to assemble a powerful, yet cost-effective, solenoidal magnetic spectrometer for antiproton-annihilation events, and to use it at the Fermilab Antiproton Accumulator to measure the charm production cross section, study rare hyperon decays, search for hyperon CP asymmetry, precisely measure the properties of several charmonium and nearby states, and make the first measurements of the Drell-Yan continuum in medium-energy antiproton annihilation. Should the charm production cross section be as large as some have proposed, we will also be able to measure D{sup 0}-{bar D}{sup 0} mixing with high precision and discover (or sensitively limit) charm CP violation. The observation of charm or hyperon CP violation would be evidence for physics beyond the Standard Model, with possible implications for the origin of the baryon asymmetry of the universe - the question of what happened to all the antimatter that must have been produced in the Big Bang. The experiment will be carried out by an international collaboration and will require some four years of running time. As possibly the sole hadron experiment in progress at Fermilab during that time, it will play an important role in maintaining a broad particle physics program at Fermilab and in the U.S. It will thus help us to continue attracting creative and capable young people into science and technology, and introducing them to the important technologies of accelerators, detectors, and data acquisition and analysis - key roles in society that accelerator-based particle physics has historically played.

A reservoir trap for antiprotons

CERN Document Server

Smorra, Christian; Franke, Kurt; Nagahama, Hiroki; Schneider, Georg; Higuchi, Takashi; Van Gorp, Simon; Blaum, Klaus; Matsuda, Yasuyuki; Quint, Wolfgang; Walz, Jochen; Yamazaki, Yasunori; Ulmer, Stefan

2015-01-01

We have developed techniques to extract arbitrary fractions of antiprotons from an accumulated reservoir, and to inject them into a Penning-trap system for high-precision measurements. In our trap-system antiproton storage times > 1.08 years are estimated. The device is fail-safe against power-cuts of up to 10 hours. This makes our planned comparisons of the fundamental properties of protons and antiprotons independent from accelerator cycles, and will enable us to perform experiments during long accelerator shutdown periods when background magnetic noise is low. The demonstrated scheme has the potential to be applied in many other precision Penning trap experiments dealing with exotic particles.

CERN accelerator school: Antiprotons for colliding beam facilities

International Nuclear Information System (INIS)

Bryant, P.; Newman, S.

1984-01-01

This is a specialized course which addresses a wide spectrum of theoretical and technological problems confronting the designer of an antiproton facility for high-energy-physics research. A broad and profound basis is provided by the lecturers' substantial experience gained over many years with CERN's unique equipment. Topics include beam optics, special lattices for antiproton accumulation and storage rings, antiproton production, stochastic cooling, acceleration and storage, r.f. noise, r.f. beam manipulations, beam-beam interaction, beam stability due to ion accumulation, and diagnostics. The SPS (Super Proton Synchrotron) panti p collider, LEAR (the Low Energy Antiproton Ring at CERN), antiprotons in the ISR (Intersecting Storage Rings), the new antiproton collector (ACOL) and gas jet targets are also discussed. A table is included listing the parameters of all CERN's accelerators and storage rings. See hints under the relevant topics. (orig./HSI)

Antiprotons are another matter

International Nuclear Information System (INIS)

Hynes, M.V.

1987-01-01

Theories of gravity abound, whereas experiments in gravity are few in number. An important experiment in gravity that has not been performed is the measurement of the gravitational acceleration of antimatter. Although there have been attempts to infer these properties from those of normal matter, none of these theoretical arguments are compelling. Modern theories of gravity that attempt to unify gravity with the other forces of nature predict that in principle antimatter can fall differently than normal matter in the Earth's field. Some of these supergravity theories predict that antimatter will fall faster, and that normal matter will fall with a small Baryon-number dependance in the earth's field. All of these predictions violate the Weak Equivalence Principle, a cornerstone of General Relativity, but are consistent with CPT conservation. In our approved experiment at LEAR (PS-200) we will test the Weak Equivalence Principle for antimatter by measuring the gravitational acceleration of the antiproton. Through a series of deceleration stages, antiprotons from LEAR will be lowered in energy to ∼4 Kelvin at which energy the gravitational effect will be measureable. The measurement will employ the time-of-flight technique wherein the antiprotons are released vertically in a drift tube. The spectrum of time-of-flight measurements can be used to extract the gravitational acceleration experienced by the particles. The system will be calibrated using H - ions which simulates the electromagnetic behavior of the antiproton, yet is a baryon to ∼0.1%. To extract the gravitational acceleration of the antiproton relative to the H - ion with a statistical precision of 1% will require the release of ∼10 6 to 10 7 particles

Antiprotons are another matter

International Nuclear Information System (INIS)

Hynes, M.V.

1988-01-01

Theories of gravity abound whereas experiments in gravity are few in number. An important experiment in gravity that has not been performed is the measurement of the gravitational acceleration of antimatter. Although there have been attempts to infer this property from those of normal matter, none of these theoretical arguments are compelling. Modern theories of gravity that attempt to unify gravity with the other forces of nature predict that in principle antimatter can fall differently than normal matter in the Earth's field. Some of these supergravity theories predict that antimatter will fall faster and that normal matter will fall with a small Baryon-number dependence in the Earth's field. All of these predictions violate the Weak Equivalence Principle, a cornerstone of General Relativity, but are consistent with CPT conservation. In our approved experiment at LEAR (PS-200) we will test the Weak Equivalence Principle for antimatter by measuring the gravitational acceleration of the antiproton. Through a series of deceleration stages, antiprotons from LEAR will be lowered in energy to ≅ 4 Kelvin at which energy the gravitational effect will be measureable. The measurement will employ the time-of-flight technique wherein the antiprotons are released vertically in a drift tube. The spectrum of time-of-flight measurements can be used to extract the gravitational acceleration experienced by the particles. The system will be calibrated using H - ions which simulate the electromagnetic behavior of the antiproton yet are baryons to ≅ 0.1%. To extract the gravitational acceleration of the antiproton relative to the H - ion with a statistical precision of 1% will require the release of ≅ 10 6 -10 7 particles. (orig.)

Compression of Antiproton Clouds for Antihydrogen Trapping

CERN Document Server

Andresen, G B; Bowe, P D; Bray, C C; Butler, E; Cesar, C L; Chapman, S; Charlton, M; Fajans, J; Fujiwara, M C; Funakoshi, R; Gill, D R; Hangst, J S; Hardy, W N; Hayano, R S; Hayden, M E; Hydomako, R; Jenkins, M J; Jørgensen, L V; Kurchaninov, L; Lambo, R; Madsen, N; Nolan, P; Olchanski, K; Olin, A; Povilus, A; Pusa, P; Robicheaux, F; Sarid, E; Seif El Nasr, S; Silveira, D M; Storey, J W; Thompson, R I; Van der Werf, D P; Wurtele, J S; Yamazaki, Y

2008-01-01

Control of the radial profile of trapped antiproton clouds is critical to trapping antihydrogen. We report the first detailed measurements of the radial manipulation of antiproton clouds, including areal density compressions by factors as large as ten, by manipulating spatially overlapped electron plasmas. We show detailed measurements of the near-axis antiproton radial profile and its relation to that of the electron plasma.

In the steps of the antiproton

CERN Multimedia

Amsler, Claude

2015-01-01

Sixty years after the discovery of the antiproton at Berkeley, a look at some of the ways that studies with antiprotons at CERN have cast light on basic physics and, in particular, on fundamental symmetries.

Evidence For The Production Of Slow Antiprotonic Hydrogen In Vacuum

CERN Document Server

Zurlo, N.; Amsler, C.; Bonomi, G.; Carraro, C.; Cesar, C.L.; Charlton, M.; Doser, M.; Fontana, A.; Funakoshi, R.; Genova, P.; Hayano, R.S.; Jorgensen, L.V.; Kellerbauer, A.; Lagomarsino, V.; Landua, R.; Lodi Rizzini, E.; Macri, M.; Madsen, N.; Manuzio, G.; Mitchard, D.; Montagna, P.; Posada, L.G.; Pruys, H.; Regenfus, C.; Rotondi, A.; Testera, G.; der Werf, D.P.Van; Variola, A.; Venturelli, L.; Yamazaki, Y.

2006-01-01

We present evidence showing how antiprotonic hydrogen, the quasistable antiproton-proton (pbar-p) bound system, has been synthesized following the interaction of antiprotons with the hydrogen molecular ion (H2+) in a nested Penning trap environment. From a careful analysis of the spatial distributions of antiproton annihilation events, evidence is presented for antiprotonic hydrogen production with sub-eV kinetic energies in states around n=70, and with low angular momenta. The slow antiprotonic hydrogen may be studied using laser spectroscopic techniques.

Physics at CERN's Antiproton Decelerator

CERN Document Server

Hori, M

2013-01-01

The Antiproton Decelerator of CERN began operation in 1999 to serve experiments for studies of CPT invariance by precision laser and microwave spectroscopy of antihydrogen ($\\bar{\\rm H}$) and antiprotonic helium ($\\bar{p}{\\rm He}^+$). The first 12 years of operation saw cold $\\bar{\\rm H}$ synthesized by overlapping clouds of positrons ($e^+$) and antiprotons ($\\bar{p}$) confined in magnetic Penning traps. Cold $\\bar{\\rm H}$ was also produced in collisions between Rydberg positronium atoms and $\\bar{p}$. Ground-state $\\bar{\\rm H}$ was later trapped for up to $\\sim 1000$ s in a magnetic bottle trap, and microwave transitions excited between its hyperfine levels. In the $\\bar{p}{\\rm He}^+$ atom, UV transitions were measured to a precision of (2.3-5) $\\times$ $10^{-9}$ by sub-Doppler two-photon laser spectroscopy. From this the antiproton-to-electron mass ratio was determined as $M_{\\bar{p}}/m_e=$1836.1526736(23), which agrees with the p value. Microwave spectroscopy of $\\bar{p}{\\rm He}^+$ yielded a measurement o...

Recent progress of laser spectroscopy experiments on antiprotonic helium

Science.gov (United States)

Hori, Masaki

2018-03-01

The Atomic Spectroscopy and Collisions Using Slow Antiprotons (ASACUSA) collaboration is currently carrying out laser spectroscopy experiments on antiprotonic helium ? atoms at CERN's Antiproton Decelerator facility. Two-photon spectroscopic techniques have been employed to reduce the Doppler width of the measured ? resonance lines, and determine the atomic transition frequencies to a fractional precision of 2.3-5 parts in 109. More recently, single-photon spectroscopy of buffer-gas cooled ? has reached a similar precision. By comparing the results with three-body quantum electrodynamics calculations, the antiproton-to-electron mass ratio was determined as ?, which agrees with the known proton-to-electron mass ratio with a precision of 8×10-10. The high-quality antiproton beam provided by the future Extra Low Energy Antiproton Ring (ELENA) facility should enable further improvements in the experimental precision. This article is part of the Theo Murphy meeting issue `Antiproton physics in the ELENA era'.

The PANDA experiment: Antiproton physics at FAIR

International Nuclear Information System (INIS)

Montagna, P.

2011-01-01

The new Facility for Antiproton and Ion Research (FAIR), under construction at the GSI laboratory at Darmstadt, in a few years will make available, among different types of beams, even antiproton beams with unique features. Through a High Energy Storage Ring (HESR) for antiprotons, an antiproton beam will be available in a momentum range from 1.5 to 15 GeV/c, which will interact on a hydrogen target. The products of the interaction, including hadronic systems with strangeness and/or charm, will be detected with the PANDA magnetic spectrometer (antiProton ANnihilation at DArmstadt), and the spectroscopic analysis will allow a detailed investigation on a number of open problems of the hadronic physics, as the quark confinement, the existence of non-conventional meson states (so-called glueballs and hybrids), the structure of hadrons and of the strong interaction, with particular attention to charmonium spectroscopy. An overview of the scientific program of PANDA and the current status of the project will be presented.

The physics of radiation therapy

CERN Document Server

Khan, Faiz M

2009-01-01

Dr. Khan's classic textbook on radiation oncology physics is now in its thoroughly revised and updated Fourth Edition. It provides the entire radiation therapy team—radiation oncologists, medical physicists, dosimetrists, and radiation therapists—with a thorough understanding of the physics and practical clinical applications of advanced radiation therapy technologies, including 3D-CRT, stereotactic radiotherapy, HDR, IMRT, IGRT, and proton beam therapy. These technologies are discussed along with the physical concepts underlying treatment planning, treatment delivery, and dosimetry. This Fourth Edition includes brand-new chapters on image-guided radiation therapy (IGRT) and proton beam therapy. Other chapters have been revised to incorporate the most recent developments in the field. This edition also features more than 100 full-color illustrations throughout.

Radiation therapy for prostate cancer

International Nuclear Information System (INIS)

Nakamura, Katsumasa

2001-01-01

In Japan, where the mortality rate of prostate cancer is lower than in Western countries, radical prostatectomy or hormonal therapy has been applied more frequently than radiation therapy. However, the number of patients with prostate cancer has been increasing recently and the importance of radiation therapy has rapidly been recognized. Although there have been no randomized trials, results from several institutions in Western countries suggest that similar results of cancer control are achieved with either radiation therapy or radical prostatectomy. For higher-risk cases, conformal high-dose therapy or adjuvant hormonal therapy is more appropriate. In this article, the results of radiation therapy for prostate cancer were reviewed, with a view to the appropriate choice of therapy in Japan. (author)

Antiproton chain of the FAIR storage rings

International Nuclear Information System (INIS)

Katayama, T; Kamerdzhiev, V; Lehrach, A; Maier, R; Prasuhn, D; Stassen, R; Stockhorst, H; Herfurth, F; Lestinsky, M; Litvinov, Yu A; Steck, M; Stöhlker, T

2015-01-01

In the Modularized Start Version of the Facility of Antiproton and Ion Research (FAIR) at Darmstadt Germany, the 3 GeV antiprotons are precooled in the collector ring and accumulated in the high energy storage ring (HESR). They are further accelerated to 14 GeV or decelerated to 1 GeV for the experiments with a high-density internal target. The powerful beam cooling devices, stochastic cooling and electron cooling will support the provision of a high-resolution antiproton beam. The other option of FAIR is to prepare the low energy, 300 keV antiproton beam connecting the existing storage rings ESR and CRYRING with HESR. Beam physics issues related with these concepts are described. (paper)

Measuring and manipulating an accumulated stack of antiprotons in the CERN antiproton accumulator

International Nuclear Information System (INIS)

Johson, R.; van der Meer, S.; Pederson, F.

1983-01-01

The antiproton stack is observed through Schottky scans, both longitudinal and transverse. A particular feature is the wide dynamic range needed for observing both the dense core and the freshly-deposited tail. Separating batches of antiprotons from the stack (unstacking) is a highly automated process including the measurement of the momentum distribution and the generation of a suitable RF function to remove a slice of the desired density. Multiple slices may be removed successively and a process for locally flattening the distribution to obtain equal batch intensities is used. When successive batches are unstacked and ejected, the process may have to be aborted if the particles do not arrive correctly at the user. A ''restack'' facility is provided to return any antiprotons to the stack that have been unstacked but not ejected. A missing-bucket scheme for unstacking low-intensity batches for LEAR is also described

Observation of Ultra-Slow Antiprotons using Micro-channel Plate

Science.gov (United States)

Imao, H.; Torii, H. A.; Nagata, Y.; Toyoda, H.; Shimoyama, T.; Enomoto, Y.; Higaki, H.; Kanai, Y.; Mohri, A.; Yamazaki, Y.

2008-08-01

Our group ASACUSA-MUSASHI has succeeded in accumulating several million antiprotons and extracting them as monochromatic ultra-slow antiproton beams (10 eV-1 keV) at CERN AD. We have observed ultra-slow antiprotons using micro-channel plates (MCP). The integrated pulse area of the output signals generated when the MCP was irradiated by ultra-slow antiprotons was 6 times higher than that by electrons. As a long-term effect, we also observed an increase in the background rate presumably due to the radioactivation of the MCP surface. Irradiating the antiproton beams on the MCP induces antiproton-nuclear annihilations only on the first layer of the surface. Low-energy and short-range secondary particles like charged nuclear fragments caused by the "surface nuclear reactions" would be the origin of our observed phenomena.

Fermilab Antiproton source, Recycler ring and Main Injector

Energy Technology Data Exchange (ETDEWEB)

Nagaitsev, Sergei [Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States)

2013-03-22

The antiproton source for a proton-antiproton collider at Fermilab was proposed in 1976 [1]. The proposal argued that the requisite luminosity (~10²⁹ cm^-2sec^-1) could be achieved with a facility that would produce and cool approximately 10¹¹ antiprotons per day. Funding for the Tevatron I project (to construct the Antiproton source) was initiated in 1981 and the Tevatron ring itself was completed, as a fixed target accelerator, in the summer of 1983 and the Antiproton Source was completed in 1985. At the end of its operations in 2011, the Fermilab antiproton production complex consisted of a sophisticated target system, three 8-GeV storage rings (namely the Debuncher, Accumulator and Recycler), 25 independent multi-GHz stochastic cooling systems, the world’s only relativistic electron cooling system and a team of technical experts equal to none. Sustained accumulation of antiprotons was possible at the rate of greater than 2.5×10¹¹ per hour. Record-size stacks of antiprotons in excess of 3×10¹² were accumulated in the Accumulator ring and 6×10¹² in the Recycler. In some special cases, the antiprotons were stored in rings for more than 50 days. Note, that over the years, some 10¹⁶ antiprotons were produced and accumulated at Fermilab, which is about 17 nanograms and more than 90% of the world’s total man-made quantity of nuclear antimatter. The accelerator complex at Fermilab supported a broad physics program including the Tevatron Collider Run II [2], neutrino experiments using 8 GeV and 120 GeV proton beams, as well as a test beam facility and other fixed target experiments using 120 GeV primary proton beams. The following sections provide a brief description of Fermilab accelerators as they operated at the end of the Collider Run II (2011).

An analytical simulation of the ion-antiproton instabilities in the CERN Antiproton Accumulator

International Nuclear Information System (INIS)

Dainelli, A.; Pusterla, M.

1988-01-01

A direct map method with a Mathieu approach to tune modulation is proposed and used to simulate nonlinear effects on particle motion that are generated by a beam-beam-like interaction of antiprotons with ions of the residual gas in the CERN Antiproton Accumulator. Two different Gaussian ion distributions are used, and the effects of the simulated beam-beam force on the particle motion is studied in phase space, with a particular attention to high-order nonlinear resonances. (author) 16 refs., 4 figs

The CERN antiproton programme

International Nuclear Information System (INIS)

Herr, H.

1979-01-01

A diagram and basic parameters of the ICE (Initial Cooling Experiment) storage ring constructed in CERN are examined. The experimental results of stochastic and electron cooling and the results of measuring of the antiproton lifetime are discussed. The main parameters of the antiproton storage are listed. Comparison between stochastic and electron cooling has shown that the latter is characterized by shorter cooling time independent of the particle number in a beam. Advantage of stochastic cooling lies in its possible usage at higher energies [ru

The Fermilab proton-antiproton collider upgrades

International Nuclear Information System (INIS)

Marriner, J.P.

1996-10-01

The plans for increases in the Tevatron proton-antiproton collider luminosity in the near future (Run II) and the more distant future (TeV33) are described. While there are many important issues, the fundamental requirement is to produce more antiprotons and to use them more efficiently

PANDA : Strong Interaction Studies with Antiprotons

NARCIS (Netherlands)

Peters, Klaus; Schmitt, Lars; Stockmanns, Tobias; Messchendorp, Johan

2017-01-01

The Antiproton Anihilation in Darmstadt (PANDA) collaboration at the Facility for Antiproton and Ion Research (FAIR) is a cooperation of more than 400 scientists from 19 countries. FAIR will be an accelerator facility leading the European research in nuclear and hadron physics in the coming decade.

Measurement of antiproton production in $p$–He collisions at LHCb to constrain the secondary cosmic antiproton flux

CERN Document Server

Graziani, Giacomo

2018-01-01

The flux of cosmic ray antiprotons is a powerful tool for indirect detection of dark matter. The sensitivity is limited by the uncertainty on the predicted antiproton flux from scattering of primary rays on the interstellar medium. This is, in turn, limited by the knowledge of production cross-sections, notably in p–He scattering. Thanks to its internal gas target, the LHCb experiment performed the first measurement of antiproton production from collisions of LHC proton beams on He nuclei at rest. The results and prospects are presented.

Radiation therapy

International Nuclear Information System (INIS)

Bader, J.L.; Glatstein, E.

1987-01-01

The radiation oncologist encounters the critically ill immunosuppressed patient in four settings. First, the newly diagnosed cancer patient presents for initial evaluation and treatment, with immunosuppression from the cancer itself, malnutrition, concomitant infectious disease, prior drug or alcohol abuse or other medical problems. Second, the previously treated cancer patient presents with metastatic or recurrent primary cancer causing local symptoms. Immune dysfunction in this setting may be due to prior chemotherapy and/or radiation as well as any of the original factors. Third, the patient previously treated with radiation presents with a life-threatening problem possibly due to complications of prior therapy. In this setting, the radiation oncologist is asked to evaluate the clinical problem and to suggest whether radiation might be causing part or all of the problem and what can be done to treat these sequelae of radiation. Fourth, the patient with a benign diagnosis (not cancer) is seen with a problem potentially emeliorated by radiation (e.g., kidney transplant rejection, preparation for transplant, or intractable rheumatoid arthritis). This chapter reviews these four issues and presents clinical and radiobiologic principles on which recommendations for therapy are based

Prospects for antiproton experiments at Fermilab

International Nuclear Information System (INIS)

Kaplan, Daniel M.

2012-01-01

Fermilab operates the world’s most intense antiproton source. Newly proposed experiments can use those antiprotons either parasitically during Tevatron Collider running or after the end of the Tevatron Collider program. For example, the annihilation of 5 to 8 GeV antiprotons is expected to yield world-leading sensitivities to hyperon rare decays and CP violation. It could also provide the world’s most intense source of tagged D 0 mesons, and thus the best near-term opportunity to study charm mixing and, via CP violation, to search for new physics. Other measurements that could be made include properties of the X(3872) and the charmonium system. An experiment using a Penning trap and an atom interferometer could make the world’s most precise measurement of the gravitational force on antimatter. These and other potential measurements using antiprotons offer a great opportunity for a broad and exciting physics program at Fermilab in the post-Tevatron era.

Antiproton rate estimates for the 1996 E866 experiment

International Nuclear Information System (INIS)

Shea, J.Y.; Garcia-Solis, E.J.; Stanskas, P.J.

1996-01-01

There has always been a strong interest to study antiprotons produced in relativistic heavy ion collisions. A specific point has been a puzzle for years in that both ARC and RQMD predict the correct antiproton yield for Au+Au collisions at the AGS, but with two entirely different physical explanations. The RQMD is able to describe available data by relying on the enhanced production of antiprotons, followed by the annihilation of a large fraction of the produced antiprotons. Conversely, ARC describes the data by producing less antiprotons initially, but the annihilation of the antiprotons is open-quotes screenedclose quotes in the high density environment of the collision on account of collisions with mesons. It is then particularly interesting to studying the shadowing effect in the Au-Au collisions at the AGS to shine a light in the theoretical debate in heavy-ion collisions

Experimental setup and first measurement of DNA damage induced along and around an antiproton beam

DEFF Research Database (Denmark)

Kavanagh, J. N.; Currell, F. J.; Timson, D. J.

2010-01-01

a further enhancement due to their annihilation at the end of the path. The work presented here aimed to establish and validate an experimental procedure for the quantification of plasmid and genomic DNA damage resulting from antiproton exposure. Immunocytochemistry was used to assess DNA damage in directly......Radiotherapy employs ionizing radiation to induce lethal DNA lesions in cancer cells while minimizing damage to healthy tissues. Due to their pattern of energy deposition, better therapeutic outcomes can, in theory, be achieved with ions compared to photons. Antiprotons have been proposed to offer...... and indirectly exposed human fibroblasts irradiated in both plateau and Bragg peak regions of a 126 MeV antiproton beam at CERN. Cells were stained post irradiation with an anti-γ-H2AX antibody. Quantification of the γ-H2AX foci-dose relationship is consistent with a linear increase in the Bragg peak region...

Capture, Electron-Cooling and Compression of Antiprotons in a Large Penning-Trap for Physics Experiments with an Ultra-Low Energy Extracted Antiproton Beam

CERN Multimedia

2002-01-01

% PS200 \\\\ \\\\The availability of ultra-low energy antiprotons is a crucial ingredient for the execution of the gravity measurements PS200. We have developed a method to provide such low energy antiprotons based on a large Penning trap (the PS200 catching trap). This system can accept a fast-extracted pulse from LEAR, reduce the energy of the antiprotons in the pulse from 5.9~MeV to several tens of kilovolts using a degrading foil, and then capture the antiprotons in a large Penning trap. These antiprotons are cooled by electrons previously admitted to the trap and are collected in a small region at the center of the trap. We have demonstrated our capability to capture up to 1~million antiprotons from LEAR in a single shot, electron cool these antiprotons, and transfer up to 95\\% of them into the inner, harmonic region. A storage time in excess of 1 hour was observed. These results have been obtained with the cryogenic trap vacuum coupled to a room temperature vacuum at about l0$ ^- ^{1} ^0 $ Torr, which is an...

Radiation therapy in old patients. Side effects and results of radiation therapy in old patients

International Nuclear Information System (INIS)

Geinitz, H.; Zimmermann, F.B.; Molls, M.

1999-01-01

Background: Despite a growing number of elderly patients receiving radiation therapy little is known about side effects and outcome of irradiation in this section of the population. Methods: In a review article epidemiologic data, aspects of radiation-biology as well as side effects and outcome of radiation therapy of elderly patients are discussed. Results: Cancer incidence rises with age and is exceeding 3.5% for males older than 85 years. With a life expectancy of more than 4 years, curative therapy is indicated even at this age. Furthermore, several retrospective studies indicate that local control and disease-Specific survival after radiation therapy of elderly patients is comparable with that of younger persons. The exception contains elderly patients with grade-III to IV gliomas or with rectal carcinoma who show a reduced survival which is perhaps caused by less aggressive combined treatment (tumor resection). Although some biological and molecular data indicate a rise in radiation sensitivity with growing age like the reduction of the capacity of some DNA-repair enzymes, there is no convincing evidence in animal studies or in retrospective clinical studies that radiation therapy is generally less well tolerated by older individuals. Some age-depending differences in organ toxicities are described in 3 large studies, which evaluate the data of patients who were enrolled in different EORTC-trials: Older patients suffer more of functional mucositis in case of radiation therapy to the head and neck, they have an increased weight loss and a higher frequency of late esophageal damage when irradiated in the thorax, and they show a higher prevalence of sexual dysfunction when treated with radiation therapy to the pelvis. On the other hand younger patients suffer more from acute toxicity like skin damage, nausea, and deterioration of the performance status during pelvic radiotherapy. When discussing the dose intensity of radiation therapy concomitant disease which

Radiation therapy

International Nuclear Information System (INIS)

Peschel, R.E; Fisher, J.J.

1986-01-01

The new insights and controversies concerning the radiobiological properties of malignant melanoma and how these relate to new clinical approaches are reviewed. The recent clinical experience with large individual fraction sizes is analyzed. The treatment of malignant melanoma in certain specialized sites is also described. An attempt is made to place in perspective the usefulness of radiation therapy in the treatment of this complex disease. Finally, certain new applications for radiation therapy both alone and in combustion with other treatment modalities are proposed that may ultimately prove appropriate for clinical trials

The discovery of the antiproton

International Nuclear Information System (INIS)

Chamberlain, Owen

1989-01-01

A number of groups of particle physicists competed to provide track evidence of the existence of Dirac's postulated antiproton in the mid-1950s. The work of the several teams is described briefly. The author describes the work of his own group on the Bevatron in more detail, and how they finally observed the antiproton. The article finishes with an assessment of the importance of this discovery. (UK)

Chemotherapy and molecular target therapy combined with radiation therapy

International Nuclear Information System (INIS)

Akimoto, Tetsuo

2012-01-01

Combined chemotherapy and radiation therapy has been established as standard treatment approach for locally advanced head and neck cancer, esophageal cancer and so on through randomized clinical trials. However, radiation-related morbidity such as acute toxicity also increased as treatment intensity has increased. In underlining mechanism for enhancement of normal tissue reaction in chemo-radiation therapy, chemotherapy enhanced radiosensitivity of normal tissues in addition to cancer cells. Molecular target-based drugs combined with radiation therapy have been expected as promising approach that makes it possible to achieve cancer-specific enhancement of radiosensitivity, and clinical trials using combined modalities have been performed to evaluate the feasibility and efficacy of this approach. In order to obtain maximum radiotherapeutic gain, a detailed understanding of the mechanism underlying the interaction between radiation and Molecular target-based drugs is indispensable. Among molecular target-based drugs, inhibitors targeting epidermal growth factor receptor (EGFR) and its signal transduction pathways have been vigorously investigated, and mechanisms regarding the radiosensitizing effect have been getting clear. In addition, the results of randomized clinical trials demonstrated that radiation therapy combined with cetuximab resulted in improvement of overall and disease-specific survival rate compared with radiation therapy in locally advanced head and neck cancer. In this review, clinical usefulness of chemo-radiation therapy and potential molecular targets for potentiation of radiation-induced cell killing are summarized. (author)

Measurement of 0.25-3.2 GeV antiprotons in the cosmic radiation

DEFF Research Database (Denmark)

Mitchell, J.W.; Barbier, L.M.; Christian, E.R.

1996-01-01

The balloon-borne Isotope Matter-Antimatter Experiment (IMAX) was flown from Lynn Lake, Manitoba, Canada on 16-17 July 1992. Using velocity and magnetic rigidity to determine mass, we have directly measured the abundances of cosmic ray antiprotons and protons in the energy range from 0.25 to 3.2 ...

Extra Low ENergy Antiproton

CERN Multimedia

To produce dense antiproton beams at very low energies (110 keV), it has been proposed to install a small decelerator ring between the existing AD ring and the experimental area. Phase-space blowup during deceleration is compensated by electron cooling such that the final emittances are comparable to the 5MeV beam presently delivered by the AD. An immediate consequence is a significant increase in the number of trapped antiprotons at the experiments as outlined in the proposal CERN/SPSC-2009-026; SPCS-P-338. This report describes the machine parameters and layout of the proposal ELENA (Extra Low ENergy Antiproton)ring also gives an approximate estimate of cost and manpower needs. Since the initial estimate, published in 2007 (CERN-AB-2007-079), the ELENA design has evolved considerably. This is due to a new location in the AD hall to acommodate for the possibility of another experimental zone, as suggested by the SPCS, and also due to improvements in the ring optics and layout. The cost estimate that is prese...

Studies of Lear antiproton deceleration: radiofrequency quadripole or synchrotron

International Nuclear Information System (INIS)

Iazzourene, F.

1987-06-01

The aim of this work is to study a radiofrequency quadrupole (RFQ) and a synchrotron as decelerating systems for antiprotons extracted from the Low Energy Antiproton Ring (LEAR) at CERN. Antiprotons at energies lower than those available from LEAR are need by some experiments, eg. the measurement of the mass difference between protons and antiprotons with 10 -9 accuracy, using a Smith and Princeton spectrometer, and the measurement of gravitation on the antiprotons, using a trap. Depending on the LEAR performances, one can conclude that the RFQ is suitable for the experiment on the gravitation, and the synchrotron, owing to its electron cooling system, is a better solution for the experiment on the mass difference measurement, because of the very small acceptance of the spectrometer [fr

The Antiproton-Ion-Collider at FAIR

International Nuclear Information System (INIS)

Kruecken, R.; Fabbietti, L.; Faestemann, T.; Homolka, J.; Kienle, P.; Ring, P.; Suzuki, K.; Bosch, F.; Franzke, B.; Kozhuharov, Ch.; Litvinov, Y.; Nolden, F.; Cargnelli, M.; Fuhrmann, H.; Hirtl, A.; Marton, J.; Widmann, E.; Zmeskal, J.; Hayano, R. S.; Lenske, H.

2006-01-01

An antiproton-ion collider (AIC) has been proposed for the FAIR Project at Darmstadt to independently determine rms radii for protons and neutrons in stable and short lived nuclei by means of antiproton annihilation at medium energies. The AIC makes use of the ELISe electron ion collider complex to store, cool and collide antiprotons of 30 MeV energy with short lived radioactive ions in the NESR. The exotic nuclei are produced by projectile fragmentation or projectile fission and separated in the Super FRS. By detecting the loss of stored ions using the Schottky method the total absorption cross-section for antiprotons on the stored ions with mass A will be measured. Cross sections for the absorption on protons and neutrons, respectively, will be measured by the detection of residual nuclei with A-1 either by the Schottky method or by detecting them in recoil detectors after the first dipole stage of the NESR following the interaction zone. The absorption cross sections are in first order directly proportional to the mean square radii

Antiprotonic Radioactive Atom for Nuclear Structure Studies

International Nuclear Information System (INIS)

Wada, M.; Yamazaki, Y.

2005-01-01

A future experiment to synthesize antiprotonic radioactive nuclear ions is proposed for nuclear structure studies. Antiprotonic radioactive nuclear atom can be synthesized in a nested Penning trap where a cloud of antiprotons is prestored and slow radioactive nuclear ions are bunch-injected into the trap. By observing of the ratio of π+ and π- produced in the annihilation process, we can deduce the different abundance of protons and neutrons at the surface of the nuclei. The proposed method would provide a unique probe for investigating the nuclear structure of unstable nuclei

What can an antiproton and a nucleus learn from each other

International Nuclear Information System (INIS)

Garreta, D.

1984-01-01

This chapter attempts to show that the - p-nucleus interaction may provide very useful information, both about the elementary - NN interaction and about nuclear structure. Topics covered include simple features which make a low-energy antiproton an interesting probe of the nucleus; simple features which make a nucleus an interesting target for an antiproton; antiproton-nucleus elastic scattering; antiproton-nucleus inelastic scattering; proton knock-out reactions on nuclei; and annihilation of the antiprotons in nuclei. The aim of experiment PS184 at the Low-Energy Antiproton Ring (LEAR) is to provide accurate data with regard to the - p-nucleus interaction in the following areas: the angular distribution of antiprotons elastically scattered from 12 C, 40 Ca, and 208 Pb; the excitation energy spectra and some angular distributions of antiprotons inelastically scattered from 12 C, 40 Ca, and 208 Pb; and the excitation energy spectra for proton knock-out reaction on 6 Li, 45 Sc, 123 Sb, and 209 B; at forward angles

Study on external beam radiation therapy

International Nuclear Information System (INIS)

Kim, Mi Sook; Yoo, Seoung Yul; Yoo, Hyung Jun; Ji, Young Hoon; Lee, Dong Han; Lee, Dong Hoon; Choi, Mun Sik; Yoo, Dae Heon; Lee, Hyo Nam; Kim, Kyeoung Jung

1999-04-01

To develop the therapy technique which promote accuracy and convenience in external radiation therapy, to obtain the development of clinical treatment methods for the global competition. The contents of the R and D were 1. structure, process and outcome analysis in radiation therapy department. 2. Development of multimodality treatment in radiation therapy 3. Development of computation using networking techniques 4. Development of quality assurance (QA) system in radiation therapy 5. Development of radiotherapy tools 6. Development of intraoperative radiation therapy (IORT) tools. The results of the R and D were 1. completion of survey and analysis about Korea radiation therapy status 2. Performing QA analysis about ICR on cervix cancer 3. Trial of multicenter randomized study on lung cancers 4. Setting up inter-departmental LAN using MS NT server and Notes program 5. Development of ionization chamber and dose-rate meter for QA in linear accelerator 6. Development on optimized radiation distribution algorithm for multiple slice 7. Implementation on 3 dimensional volume surface algorithm and 8. Implementation on adaptor and cone for IORT

Study on external beam radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Kim, Mi Sook; Yoo, Seoung Yul; Yoo, Hyung Jun; Ji, Young Hoon; Lee, Dong Han; Lee, Dong Hoon; Choi, Mun Sik; Yoo, Dae Heon; Lee, Hyo Nam; Kim, Kyeoung Jung

1999-04-01

To develop the therapy technique which promote accuracy and convenience in external radiation therapy, to obtain the development of clinical treatment methods for the global competition. The contents of the R and D were 1. structure, process and outcome analysis in radiation therapy department. 2. Development of multimodality treatment in radiation therapy 3. Development of computation using networking techniques 4. Development of quality assurance (QA) system in radiation therapy 5. Development of radiotherapy tools 6. Development of intraoperative radiation therapy (IORT) tools. The results of the R and D were 1. completion of survey and analysis about Korea radiation therapy status 2. Performing QA analysis about ICR on cervix cancer 3. Trial of multicenter randomized study on lung cancers 4. Setting up inter-departmental LAN using MS NT server and Notes program 5. Development of ionization chamber and dose-rate meter for QA in linear accelerator 6. Development on optimized radiation distribution algorithm for multiple slice 7. Implementation on 3 dimensional volume surface algorithm and 8. Implementation on adaptor and cone for IORT.

Radiation therapy for operable rectal cancer

International Nuclear Information System (INIS)

Bondar, G.V.; Semikoz, N.G.; Bashejev, V.Kh.; Borota, O.V.; Bondarenko, M.V.; Kiyashko, O.Yu.

2012-01-01

The authors present a review of the literature on modern tendencies of radiation therapy application to treatment of operable rectal cancer. Many randomized control studies compared the efficacy of combination of radiation therapy (pre-operative or post-operative) and surgery versus surgery only demonstrating various results. Meta-analysis of the data on efficacy of combination of radiation therapy and standard surgery revealed 22 randomized control studies (14 with pre-operative radiation therapy and 8 with post-operative radiation therapy) with total number of 8507 patients (Colorectal Cancer Collaborative Group, 2000). The use of combination treatment reduced the number of isolated locoregional relapses both with pre-operative (22.5 - 12.5 %; p < 0.00001) and post-operative radiation therapy (25.8 - 16.7 %; p - 0.00001). The influence on total survival was not significant (62 % vs. 63 %; p - 0.06).

Job satisfaction among radiation therapy educators.

Science.gov (United States)

Swafford, Larry G; Legg, Jeffrey S

2007-01-01

Job satisfaction is one of the most consistent variables related to employee retention and is especially relevant considering the shortage of radiation therapists and radiation therapy educators in the United States. To investigate job satisfaction levels among radiation therapy educators certified by the American Registry of Radiologic Technologists and employed in programs accredited by the Joint Review Committee on Education in Radiologic Technology. The long form of the Minnesota Satisfaction Questionnaire (MSQ) was mailed to 158 radiation therapy educators to measure job satisfaction. Overall job satisfaction and subscales were calculated based on MSQ methodology. A total of 90 usable surveys were returned for a 56.9% response rate. With a "general satisfaction" score of 69.64, radiation therapy educators ranked in the lowest 25th percentile of the nondisabled norm scale for job satisfaction. Respondents reported higher degrees of job satisfaction on the moral values, social service and achievement subscales. Lower job satisfaction levels were associated with the company policies and practices, advancement and compensation subscales. Radiation therapy educators report low job satisfaction. Educational institutions must tailor recruitment and retention efforts to better reflect the positive aspects of being a radiation therapy educator. Furthermore, improving retention and recruitment efforts might help offset the current shortages of radiation therapy educators and, ultimately, clinical radiation therapists.

Antiproton Induced Fission and Fragmentation of Nuclei

CERN Multimedia

2002-01-01

The annihilation of slow antiprotons with nuclei results in a large highly localized energy deposition primarily on the nuclear surface. \\\\ \\\\ The study of antiproton induced fission and fragmentation processes is expected to yield new information on special nuclear matter states, unexplored fission modes, multifragmentation of nuclei, and intranuclear cascades.\\\\ \\\\ In order to investigate the antiproton-nucleus interaction and the processes following the antiproton annihilation at the nucleus, we propose the following experiments: \\item A)~Measurement of several fragments from fission and from multifragmentation in coincidence with particle spectra, especially neutrons and kaons. \\item B)~Precise spectra of $\\pi$, K, n, p, d and t with time-of-flight techniques. \\item C)~Installation of the Berlin 4$\\pi$ neutron detector with a 4$\\pi$ Si detector placed inside for fragments and charged particles. This yields neutron multiplicity distributions and consequently distributions of thermal excitation energies and...

Experimental setup and first measurement of DNA damage induced along and around an antiproton beam

International Nuclear Information System (INIS)

Kavanagh, J.N.; Currell, F.J.; Prise, K.M.; Schettino, G.; Currell, F.J.; Timson, D.J.; Holzscheiter, M.H.; Bassler, N.; Herrmann, R.

2010-01-01

Radiotherapy employs ionizing radiation to induce lethal DNA lesions in cancer cells while minimizing damage to healthy tissues. Due to their pattern of energy deposition, better therapeutic outcomes can, in theory, be achieved with ions compared to photons. Antiprotons have been proposed to offer a further enhancement due to their annihilation at the end of the path. The work presented here aimed to establish and validate an experimental procedure for the quantification of plasmid and genomic DNA damage resulting from antiproton exposure. Immunocytochemistry was used to assess DNA damage in directly and indirectly exposed human fibroblasts irradiated in both plateau and Bragg peak regions of a 126 MeV antiproton beam at CERN. Cells were stained post irradiation with an anti-γ-H2AX antibody. Quantification of the γ-H2AX foci-dose relationship is consistent with a linear increase in the Bragg peak region. A qualitative analysis of the foci detected in the Bragg peak and plateau region indicates significant differences highlighting the different severity of DNA lesions produced along the particle path. Irradiation of desalted plasmid DNA with 5 Gy antiprotons at the Bragg peak resulted in a significant portion of linear plasmid in the resultant solution. (authors)

Antiproton-nucleus experiments at LEAR and KAON

International Nuclear Information System (INIS)

Yavin, A.I.

1989-12-01

Antimatter and matter-antimatter systems are briefly discussed. Results of the antiproton-nucleus scattering experiments at LEAR are described, with the emphasis on unfinished experiments and on proposed experiments yet untouched. A few remarks on antiproton and antideuteron experiments at KAON are then presented

Antiproton production

International Nuclear Information System (INIS)

Allaby, J.V.

1984-01-01

The basic definitions used in the physics literature on particle production are reviewed. The data on anti p production are interpreted in order to provide an estimate of the yield of anti p's from typical target at the antiproton accumulator, including the effects of re-absorption in the target. (orig.)

A low-energy antiproton detector prototype for AFIS

Energy Technology Data Exchange (ETDEWEB)

Meng, Lingxin; Greenwald, Daniel; Hahn, Alexander; Hauptmann, Philipp; Konorov, Igor; Losekamm, Martin; Paul, Stephan; Poeschl, Thomas; Renker, Dieter [Technische Universitaet Muenchen (Germany)

2014-07-01

Antiprotons are produced in interactions of primary cosmic rays with earth's exosphere, where a fraction of them will be confined in the geomagnetic field in the inner van Allen Belt. The antiproton-to-proton flux ratio predicted by theory is in good agreement with recent results from the South Atlantic Anomaly (SAA) published by the PAMELA collaboration. We have designed the AFIS (Antiproton Flux in Space) project in order to extend the measurable range of antiprotons towards the low-energy region. In scope of this project a small antiproton detector consisting of scintillating fibers and silicon photomultipliers is being developed as payload for a CubeSat traversing the SAA in Low Earth Orbit. For the proof of concept we have built a prototype called ''CubeZero'' which completed its first test using pion and proton beams at PSI, Switzerland. Our primary goal was to investigate on the performance of tracking and Bragg peak identification in hardware and software. Analysis of detector performance based on data taken during this beam test is presented in this talk.

Basal cell carcinoma after radiation therapy

International Nuclear Information System (INIS)

Shimbo, Keisuke; Terashi, Hiroto; Ishida, Yasuhisa; Tahara, Shinya; Osaki, Takeo; Nomura, Tadashi; Ejiri, Hirotaka

2008-01-01

We reported two cases of basal cell carcinoma (BCC) that developed after radiation therapy. A 50-year-old woman, who had received an unknown amount of radiation therapy for the treatment of intracranial germinoma at the age of 22, presented with several tumors around the radiation ulcer. All tumors showed BCC. A 33-year-old woman, who had received an unknown amount of radiation therapy on the head for the treatment of leukemia at the age of 2, presented with a black nodule within the area of irradiation. The tumor showed BCC. We discuss the occurrence of BCC after radiation therapy. (author)

What can an antiproton and a nucleus learn from each other

International Nuclear Information System (INIS)

Garreta, D.

1982-05-01

Simple features which make a low-energy antiproton an interesting probe of the nucleus, and a nucleus an interesting target for an antiproton are presented. Then antiproton-nucleus inelastic and elastic scattering, proton knock-out reactions on nuclei, annihilation of the antiproton in nuclei are reviewed. The aims of the experiment PS184 at LEAR are given

Search for squarks and gluinos via radiative decays of neutralinos in proton-antiproton collisions at √s=1.8TeV

International Nuclear Information System (INIS)

Abe, F.; Albrow, M.; Amidei, D.; Anway-Wiese, C.; Apollinari, G.; Atac, M.; Auchincloss, P.; Azzi, P.; Bacchetta, N.; Baden, A.R.; Badgett, W.; Bailey, M.W.; Bamberger, A.; de Barbaro, P.; Barbaro-Galtieri, A.; Barnes, V.E.; Barnett, B.A.; Bartalini, P.; Bauer, G.; Baumann, T.; Bedeschi, F.; Behrends, S.; Belforte, S.; Bellettini, G.; Bellinger, J.; Benjamin, D.; Benlloch, J.; Bensinger, J.; Beretvas, A.; Berge, J.P.; Bertolucci, S.; Biery, K.; Bhadra, S.; Binkley, M.; Bisello, D.; Blair, R.; Blocker, C.; Bodek, A.; Bolognesi, V.; Booth, A.W.; Boswell, C.; Brandenburg, G.; Brown, D.; Buckley-Geer, E.; Budd, H.S.; Busetto, G.; Byon-Wagner, A.; Byrum, K.L.; Campagnari, C.; Campbell, M.; Caner, A.; Carey, R.; Carithers, W.; Carlsmith, D.; Carroll, J.T.; Cashmore, R.; Castro, A.; Cen, Y.; Cervelli, F.; Chadwick, K.; Chapman, J.; Chiarelli, G.; Chinowsky, W.; Cihangir, S.; Clark, A.G.; Cobal, M.; Connor, D.; Contreras, M.; Cooper, J.; Cordelli, M.; Crane, D.; Cunningham, J.D.; Day, C.; DeJongh, F.; Dell'Agnello, S.; Dell'Orso, M.; Demortier, L.; Denby, B.; Derwent, P.F.; Devlin, T.; Dickson, M.; Donati, S.; Drucker, R.B.; Dunn, A.; Einsweiler, K.; Elias, J.E.; Ely, R.; Eno, S.; Errede, S.; Etchegoyen, A.; Farhat, B.; Frautschi, M.; Feldman, G.J.; Flaugher, B.; Foster, G.W.; Franklin, M.; Freeman, J.; Frisch, H.; Fuess, T.; Fukui, Y.; Gagliardi, G.; Garfinkel, A.F.; Gauthier, A.; Geer, S.; Gerdes, D.W.; Giannetti, P.; Giokaris, N.; Giromini, P.; Gladney, L.; Gold, M.; Gonzalez, J.; Goulianos, K.; Grassmann, H.; Grieco, G.M.; Grindley, R.; Grosso-Pilcher, C.; Haber, C.; Hahn, S.R.; Handler, R.; Hara, K.; Harral, B.; Harris, R.M.; Hauger, S.A.; Hauser, J.; Hawk, C.; Hessing, T.; Hollebeek, R.; Holloway, L.; Hoelscher, A.; Hong, S.; Houk, G.; Hu, P.; Hubbard, B.; Huffman, B.T.; Hughes, R.; Hurst, P.; Huth, J.; Hylen, J.; Incagli, M.; Ino, T.; Iso, H.; Jensen, H.; Jessop, C.P.; Johnson, R.P.; Joshi, U.; Kadel, R.W.; Kamon, T.; Kanda, S.; Kardelis, D.A.

1995-01-01

We have sought evidence for radiative decays of neutralinos produced in proton-antiproton collisions at √s=1.8TeV. Events containing two photons plus large missing transverse energy were investigated. The observed event rate and the missing transverse energy distribution of the two-photon events are consistent with QCD predictions. Inferred limits on squark and gluino masses depend on the supersymmetry model parameters. The particular choices μ=-40GeV/c 2 and tanβ=1.5 lead to 90%-confidence-level asymptotic lower limits of 110 GeV/c 2 and 140 GeV/c 2 for squarks and gluinos, respectively

Technical advances in radiation therapy

International Nuclear Information System (INIS)

Sause, W.T.

1986-01-01

Substantial advances have been made in radiation therapy. Many of these advances can be applied in most radiation therapy departments without expensive improvements in equipment. Changes in radiation fractionation, chemotherapeutic sensitization, intraoperative radiation, and interstitial implants can be performed with experience and improved physician training in most medium-sized departments. Advances that require investments in expensive equipment such as particle radiation and hyperthermia will need to be evaluated at designated treatment centers. 106 references

Radiation therapy sources, equipment and installations

International Nuclear Information System (INIS)

2011-03-01

The safety code for Telegamma Therapy Equipment and Installations, (AERB/SC/MED-1) and safety code for Brachytherapy Sources, Equipment and Installations, (AERB/SC/MED-3) were issued by AERB in 1986 and 1988 respectively. These codes specified mandatory requirements for radiation therapy facilities, covering the entire spectrum of operations ranging from the setting up of a facility to its ultimate decommissioning, including procedures to be followed during emergency situations. The codes also stipulated requirements of personnel and their responsibilities. With the advent of new techniques and equipment such as 3D-conformal radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, treatment planning system, stereotactic radiosurgery, stereotactic radiotherapy, portal imaging, integrated brachytherapy and endovascular brachytherapy during the last two decades, AERB desires that these codes be revised and merged into a single code titled Radiation Therapy Sources, Equipment, and Installations

Radiation Therapy Side Effects

Science.gov (United States)

Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects.

Internal Radiation Therapy for Cancer

Science.gov (United States)

When getting internal radiation therapy, a source of radiation is put inside your body, in either liquid or solid form. It can be used treat different kinds of cancer, including thyroid, head and neck, breast, cervix, prostate, and eye. Learn more about how what to expect when getting internal radiation therapy.

K-shell ionization by antiprotons

International Nuclear Information System (INIS)

Mehler, G.; Mueller, B.; Greiner, W.; Soff, G.

1987-01-01

We present first calculations for the impact parameter dependence of K-shell ionization rates in anti pCu and in anti pAg collisions at various projectile energies. We show that the effect of the attractive Coulomb potential on the Rutherford trajectory and the anti-binding effect caused by the negative charge of the antiproton result in a considerable increase of the ionization probability. Total ionization cross-sections for proton and antiproton projectiles are compared with each other and with experimental ionization cross-sections for protons. (orig.)

Nonsurgical treatment for cancer using radiation therapy

International Nuclear Information System (INIS)

Ogi, Yasuo

2012-01-01

The number of people who are dying from cancer has been increasing in association with population aging. Radiation therapy is now one of the three major cancer treatment methods, along with surgery and chemotherapy. People used to consider radiation therapy only as a ''noninvasive cancer treatment''; however, with the ceaseless effort by medical experts and corporations, different radiation therapy types and techniques including the latest technical advances have come out one after another, and the improvements in radiation therapies have provided treatments that are not only less traumatizing to patients but also as effective and therapeutic as surgery in certain body regions. The importance of radiation therapy has become and will become even greater in the society with more elderly cancer patients who do not have the physical strength to undergo surgery. In this article, the history of radiation therapy, rapidly developed high-precision radiation therapy techniques, and unsolved issues are discussed, and then, ''MHI vero4DRT'', which is the high-precision image-guided radiation therapy equipment developed for solving such issues, is introduced. (author)

Atomic approaches in metastable antiprotonic helium atoms. REPLY to 'analysis of the lifetimes and fractions of antiprotons trapped in metastable antiprotonic-helium states' by I. Shimamura and M. Kimura

International Nuclear Information System (INIS)

Yamazaki, Toshimitsu; Ohtsuki, Kazumasa.

1994-08-01

In the present note the authors clarify the purpose of YO and complement its essential points, thus showing that the criticisms of SK are inappropriate. The paper YO [1] was aimed at discussing some new aspects related to the metastability of hadronic helium atoms which had been discovered when negative kaons [2], negative pions [3] and antiprotons [4] were stopped in liquid helium. The delayed fraction, time spectrum shape and lifetimes were the observables. Further experimental studies are in progress [5], and as of today there is no successful explanation for these interesting phenomena. So, YO tried to give brief and rather qualitative estimates for the observations in an intuitive way, considering only the leading terms. The following problems are discussed in as simple a manner as possible, starting from the exotic-atom viewpoints of Condo [6] and Russell [7]: i)the atomic core polarization effect, ii)the structure and radiative lifetimes, iii)the non-statistical distribution of the angular momentum and an estimate of the delayed fraction, and iv)the isotope effect, though the title represents only i). To respond to the comments of SK, it is important to consider the correspondence between the atomic approach and the molecular approach for the metastable antiprotonic helium atom of Condo-Russell. We therefore begin this note with a discussion of this aspect. (author)

Search for antiproton-nucleus states with (anti p,p) reactions

International Nuclear Information System (INIS)

Garreta, D.; Birien, P.; Bruge, G.; Chaumeaux, A.; Drake, D.M.; Janouin, S.; Legrand, D.; Lemaire, M.C.; Mayer, B.; Pain, J.; Peng, J.C.; Berrada, M.; Bocquet, J.P.; Monnand, E.; Mougey, J.; Perrin, P.

1985-01-01

We have studied (anti p,p) reactions on 12 C, 63 Cu, and 209 Bi to search for possible nuclear states formed by antiprotons and nuclei. The experiments used the 180 MeV antiproton beam from LEAR, and the high-resolution magnetic spectrometer, SPES II, to detect the outgoing protons. No evidence of antiproton-nucleus states was found. The gross features of the proton spectra are reasonably well described by intranuclear cascade model calculations, which consider proton emission following antiproton annihilations in the target nucleus. (orig.)

LEAP: A balloon-borne search for low-energy cosmic ray antiprotons

Science.gov (United States)

Moats, Anne Rosalie Myers

The LEAP (Low Energy Antiproton) experiment is a search for cosmic ray antiprotons in the 120 MeV to 1.2 GeV kinetic energy range. The motivation for this project was the result announced by Buffington et al. (1981) that indicated an anomalously high antiproton flux below 300 MeV; this result has compelled theorists to propose sources of primary antiprotons above the small secondary antiproton flux produced by high energy cosmic ray collisions with nuclei in the interstellar medium. LEAP consisted of the NMSU magnet spectrometer, a time-of-flight system designed at NASA-Goddard, two scintillation detectors, and a Cherenkov counter. Analysis of flight data performed by the high energy astrophysics group at Goddard Space Flight Center revealed no antiproton candidates found in the 120 MeV to 360 MeV range; 3 possible antiproton candidate events were found in the 500 MeV to 1.2 GeV range in an analysis done here at the University of Arizona. However, since it will be necessary to sharpen the calibration on all of the LEAP systems in order to positively identify these events as antiprotons, only an upper limit has been determined at present. Thus, combining the analyses performed at the University of Arizona and NASA-Goddard, 90 percent confidence upper limits of 3.5 x 10-5 in the 120 MeV to 360 MeV range and 2.3 x 10-4 in the 500 MeV to 1.2 GeV range for the antiproton/proton ratio is indicated by the LEAP results. LEAP disagrees sharply with the results of the Buffington group, indicating a low antiproton flux at these energies. Thus, a purely secondary antiproton flux may be adequate at low energies.

Radiation Therapy - Multiple Languages

Science.gov (United States)

... W XYZ List of All Topics All Radiation Therapy - Multiple Languages To use the sharing features on this page, ... Information Translations Vietnamese (Tiếng Việt) Expand Section Radiation Therapy - Tiếng Việt (Vietnamese) ... Health Information Translations Characters not displaying correctly on this page? See language display issues . Return to the MedlinePlus Health Information ...

Large amounts of antiproton production by heavy ion collision

International Nuclear Information System (INIS)

Takahashi, Hiroshi; Powell, J.

1987-01-01

To produce large amounts of antiprotons, on the order of several grams/year, use of machines to produce nuclear collisions are studied. These can be of either proton-proton, proton-nucleus and nucleus-nucleus in nature. To achieve high luminosity colliding beams, on the order of 10 41 m/cm 2 , a self-colliding machine is required, rather than a conventional circular colliding type. The self-colliding machine can produce additional antiprotons through successive collisions of secondary particles, such as spectator nucleons. A key problem is how to collect the produced antiprotons without capture by beam nuclei in the collision zone. Production costs for anti-matter are projected for various energy source options and technology levels. Dedicated facilities using heavy ion collisions could produce antiproton at substantially less than 1 million $/milligram. With co-production of other valuable products, e.g., nuclear fuel for power reactors, antiproton costs could be reduced to even lower values

Modeling of the Near-Earth Low-Energy Antiproton Fluxes

Directory of Open Access Journals (Sweden)

U. B. Jayanthi

2011-01-01

Full Text Available The local interstellar antiproton spectrum is simulated taking into account antineutron decay, (He,p interaction, secondary and tertiary antiproton production, and the solar modulation in the “force field” approximation. Inclusive invariant cross-sections were obtained through a Monte Carlo procedure using the Multistage Dynamical Model code simulating various processes of the particle production. The results of the simulations provided flux values of 4⋅10−3 to 10−2 and 10−2 to 1.7⋅10−2 antiprotons/(2 s sr GeV at energies of 0.2 and 1 GeV, respectively, for the solar maximum and minimum epochs. Simulated flux of the trapped antiprotons in the inner magnetosphere due to galactic cosmic ray (GCR interactions with the atmospheric constituents exceeds the galactic antiproton flux up to several orders. These simulation results considering the assumptions with the attendant limitations are in comprehensive agreement with the experimental data including the PAMELA ones.

Calculated LET spectrum from antiproton beams stopping in water

CERN Document Server

Bassler, Niels

2009-01-01

Antiprotons have been proposed as a potential modality for radiotherapy because the annihilation at the end of range leads to roughly a doubling of physical dose in the Bragg peak region. So far it has been anticipated that the radiobiology of antiproton beams is similar to that of protons in the entry region of the beam, but very different in the annihilation region, due to the expected high-LET components resulting from the annihilation. On closer inspection we find that calculations of dose averaged LET in the entry region may suggest that the RBE of antiprotons in the plateau region could significantly differ from unity, which seems to warrant closer inspection of the radiobiology in this region. Materials and Methods. Monte Carlo simulations using FLUKA were performed for calculating the entire particle spectrum of a beam of 126 MeV antiprotons hitting a water phantom. Results and Discussion. In the plateau region of the simulated antiproton beam we observe a dose-averaged unrestrict...

Large amounts of antiproton production by heavy ion collision

Energy Technology Data Exchange (ETDEWEB)

Takahashi, Hiroshi; Powell, J.

1987-01-01

To produce large amounts of antiprotons, on the order of several grams/year, use of machines to produce nuclear collisions are studied. These can be of either proton-proton, proton-nucleus and nucleus-nucleus in nature. To achieve high luminosity colliding beams, on the order of 10/sup 41/ m/cm/sup 2/, a self-colliding machine is required, rather than a conventional circular colliding type. The self-colliding machine can produce additional antiprotons through successive collisions of secondary particles, such as spectator nucleons. A key problem is how to collect the produced antiprotons without capture by beam nuclei in the collision zone. Production costs for anti-matter are projected for various energy source options and technology levels. Dedicated facilities using heavy ion collisions could produce antiproton at substantially less than 1 million $/milligram. With co-production of other valuable products, e.g., nuclear fuel for power reactors, antiproton costs could be reduced to even lower values.

Atomic Spectroscopy and Collisions Using Slow Antiprotons \\\\ ASACUSA Collaboration

CERN Multimedia

Matsuda, Y; Lodi-rizzini, E; Kuroda, N; Schettino, G; Hori, M; Pirkl, W; Mascagna, V; Leali, M; Malbrunot, C L S; Yamazaki, Y; Eades, J; Simon, M; Massiczek, O; Sauerzopf, C; Nagata, Y; Knudsen, H; Uggerhoj, U I; Mc cullough, R W; Toekesi, K M; Venturelli, L; Widmann, E; Zmeskal, J; Kanai, Y; Kristiansen, H; Todoroki, K; Bartel, M A; Moller, S P; Charlton, M; Diermaier, M; Kolbinger, B

2002-01-01

ASACUSA (\\underline{A}tomic \\underline{S}pectroscopy \\underline{A}nd \\underline{C}ollisions \\underline{U}sing \\underline{S}low \\underline{A}ntiprotons) is a collaboration between a number of Japanese and European research institutions, with the goal of studying bound and continuum states of antiprotons with simple atoms.\\\\ Three phases of experimentation are planned for ASACUSA. In the first phase, we use the direct $\\overline{p}$ beam from AD at 5.3 MeV and concentrate on the laser and microwave spectroscopy of the metastable antiprotonic helium atom, $\\overline{p}$He$^+$, consisting of an electron and antiproton bound by the Coulomb force to the helium nucleus. Samples of these are readily created by bringing AD antiproton beam bunches to rest in helium gas. With the help of techniques developed at LEAR for resonating high precision laser beams with antiproton transitions in these atoms, ASACUSA achieved several of these first-phase objectives during a few short months of AD operation in 2000. Six atomic tr...

Different Approaches in Radiation Therapy

Directory of Open Access Journals (Sweden)

Rolf-Dieter eKortmann

2011-12-01

Full Text Available Radiation therapy is a cornerstone in the therapeutic management of craniopharyngioma. The close proximity to neighbouring eloquent structures pose a particular challenge to radiation therapy. Modern treatment technologies including fractionated 3-d conformal radiotherapy, intensity modulated radiation therapy and recently proton therapy are able to precisely cover the target while preserving surrounding tissue,Tumour controls between 80 and in access of 90 % can be achieved. Alternative treatments consisting of radiosurgery, intracavitary application of isotopes and brachytherapy also offer an acceptable tumour control and might be given in selected cases. More research is needed to establish the role of each treatment modality.

Modern Radiation Therapy for Hodgkin Lymphoma

DEFF Research Database (Denmark)

Specht, Lena; Yahalom, Joachim; Illidge, Tim

2014-01-01

Radiation therapy (RT) is the most effective single modality for local control of Hodgkin lymphoma (HL) and an important component of therapy for many patients. These guidelines have been developed to address the use of RT in HL in the modern era of combined modality treatment. The role of reduced...... on Radiation Units and Measurements concepts of gross tumor volume, clinical target volume, internal target volume, and planning target volume are used for defining the targeted volumes. Newer treatment techniques, including intensity modulated radiation therapy, breath-hold, image guided radiation therapy......, and 4-dimensional imaging, should be implemented when their use is expected to decrease significantly the risk for normal tissue damage while still achieving the primary goal of local tumor control. The highly conformal involved node radiation therapy (INRT), recently introduced for patients for whom...

Radiation therapy for gastric cancer

International Nuclear Information System (INIS)

Dobelbower, R.R.; Bagne, F.; Ajlouni, M.I.; Milligan, A.J.

1988-01-01

Adenocarcinoma of the stomach is a moderately radioresponsive neoplasm. Attempts to treat patients with unresectable disease with external beam radiation therapy alone have generally failed because of problems with tumor localization and adequate dose delivery as well as the inherent radioresponsiveness of the gastric mucosa and the organs intimately related to the stomach. Combining external beam therapy and chemotherapy (acting as a systemic agent and as a radiosensitizer) seems to be of some (albeit limited) benefit in the management of unresectable adenocarcinoma of the stomach. Optimum combinations of radiation therapy, chemotherapy, and radiation sensitizers in this situation remain to be determined. The authors discuss strides which have been made in the treatment of gastric cancer. They also address the unanswered clinical questions which remain regarding the use of radiation therapy in the treatment of this highly lethal disease

Why do patients drop out during radiation therapy?

International Nuclear Information System (INIS)

Huh, Seung Jae; Ahn, Yong Chan; Kim, Dae Yong; Shin, Kyung Hwan; Lee, Kyu Chan; Chong, Won A; Kim, Hyun Joo; Wu, Hong Gyun

1998-01-01

This study is to see how much proportion of the patients receiving radiation therapy drop out during radiation therapy and to analyze the reason for the incomplete treatment. The base population of this study was 1,100 patients with registration numbers 901 through 2,000 at Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea. Authors investigated the incidence of incomplete radiation therapy, which was defined as less than 95% of initially planned radiation dose, and the reasons for incomplete radiation therapy. One hundred and twenty eight patients (12%) did not complete the planned radiation therapy. The performance status of the incompletely treated patients was generally poorer than that of the base population, and the aim of radiation therapy was more commonly palliative. The most common reason for not completing the planned treatment was the patients' refusal of further radiation therapy because of the distrust of radiation therapy and/or the poor economic status. Careful case selection for radiation therapy with consideration of the socioeconomic status of the patients in addition to the clinical indication would be necessary for the reduction of incomplete treatment, especially in the palliative setting

42 CFR 410.35 - X-ray therapy and other radiation therapy services: Scope.

Science.gov (United States)

2010-10-01

... 42 Public Health 2 2010-10-01 2010-10-01 false X-ray therapy and other radiation therapy services... Other Health Services § 410.35 X-ray therapy and other radiation therapy services: Scope. Medicare Part B pays for X-ray therapy and other radiation therapy services, including radium therapy and...

Study of X-Ray and $\\gamma$-Ray Spectra from Antiprotonic Atoms at the Slowly Extracted Antiproton Beam of LEAR

CERN Multimedia

2002-01-01

This experiment will study the X-ray spectra of antiprotonic atoms and the $\\gamma$ spectra of residual nuclei after the antiproton absorption. We intend to begin with measurements on selected isotopically pure targets. Strong interaction effects, the antiproton absorption and the atomic cascade are analysed through the measurement of energies, lineshapes, relative and absolute intensities of all observable lines. The experiments are continued to determine st in resolved fine structure levels and in different isotopes of the same element. Coincidence techniques may be applied. All components of the experimental set-up are already existing from previous experiments and we could begin the measurements with any slowly extracted beam of low energy at LEAR.

Radiation Therapy for Cancer

Science.gov (United States)

Radiation therapy is a type of cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Learn about the types of radiation, why side effects happen, which ones you might have, and more.

Radiation therapy of thoracic and abdominal tumors

International Nuclear Information System (INIS)

LaRue, S.M.; Gillette, S.M.; Poulson, J.M.

1995-01-01

Until recently, radiotherapy of thoracic and abdominal tumors in animals has been limited. However, the availability of computerized tomography and other imaging techniques to aid in determining the extent of tumor, an increase in knowledge of dose tolerance of regional organs, the availability of isocentrically mounted megavoltage machines, and the willingness of patients to pursue more aggressive treatment is making radiation therapy of tumors in these regions far more common. Tumor remission has been reported after radiation therapy of thymomas. Radiation therapy has been used to treat mediastinal lymphoma refractory to chemotherapy, and may be beneficial as part of the initial treatment regimen for this disease. Chemodectomas are responsive to radiation therapy in human patients, and favorable response has also been reported in dogs. Although primary lung tumors in dogs are rare, in some cases radiation therapy could be a useful primary or adjunctive therapy. Lung is the dose-limiting organ in the thorax. Bladder and urethral tumors in dogs have been treated using intraoperative and external-beam radiation therapy combined with chemotherapy. These tumors are difficult to control locally with surgery alone, although the optimal method of combining treatment modalities has not been established. Local control of malignant perianal tumors is also difficult to achieve with surgery alone, and radiation therapy should be used. Intraoperative radiation therapy combined with external-beam radiation therapy has been used for the management of metastatic carcinoma to the sublumbar lymph nodes. Tolerance of retroperitoneal tissues may be decreased by disease or surgical manipulation

On the Utility of Antiprotons as Drivers for Inertial Confinement Fusion

Energy Technology Data Exchange (ETDEWEB)

Perkins, L J; Orth, C D; Tabak, M

2003-10-20

By contrast to the large mass, complexity and recirculating power of conventional drivers for inertial confinement fusion (ICF), antiproton annihilation offers a specific energy of 90MJ/{micro}g and thus a unique form of energy packaging and delivery. In principle, antiproton drivers could provide a profound reduction in system mass for advanced space propulsion by ICF. We examine the physics underlying the use of antiprotons ({bar p}) to drive various classes of high-yield ICF targets by the methods of volumetric ignition, hotspot ignition and fast ignition. The useable fraction of annihilation deposition energy is determined for both {bar p}-driven ablative compression and {bar p}-driven fast ignition, in association with 0-D and 1-D target burn models. Thereby, we deduce scaling laws for the number of injected antiprotons required per capsule, together with timing and focal spot requirements. The kinetic energy of the injected antiproton beam required to penetrate to the desired annihilation point is always small relative to the deposited annihilation energy. We show that heavy metal seeding of the fuel and/or ablator is required to optimize local deposition of annihilation energy and determine that a minimum of {approx}3x10{sup 15} injected antiprotons will be required to achieve high yield (several hundred megajoules) in any target configuration. Target gains - i.e., fusion yields divided by the available p - {bar p} annihilation energy from the injected antiprotons (1.88GeV/{bar p}) - range from {approx}3 for volumetric ignition targets to {approx}600 for fast ignition targets. Antiproton-driven ICF is a speculative concept, and the handling of antiprotons and their required injection precision - temporally and spatially - will present significant technical challenges. The storage and manipulation of low-energy antiprotons, particularly in the form of antihydrogen, is a science in its infancy and a large scale-up of antiproton production over present supply

On the Utility of Antiprotons as Drivers for Inertial Confinement Fusion

International Nuclear Information System (INIS)

Perkins, L J; Orth, C D; Tabak, M

2003-01-01

By contrast to the large mass, complexity and recirculating power of conventional drivers for inertial confinement fusion (ICF), antiproton annihilation offers a specific energy of 90MJ/(micro)g and thus a unique form of energy packaging and delivery. In principle, antiproton drivers could provide a profound reduction in system mass for advanced space propulsion by ICF. We examine the physics underlying the use of antiprotons ((bar p)) to drive various classes of high-yield ICF targets by the methods of volumetric ignition, hotspot ignition and fast ignition. The useable fraction of annihilation deposition energy is determined for both (bar p)-driven ablative compression and (bar p)-driven fast ignition, in association with 0-D and 1-D target burn models. Thereby, we deduce scaling laws for the number of injected antiprotons required per capsule, together with timing and focal spot requirements. The kinetic energy of the injected antiproton beam required to penetrate to the desired annihilation point is always small relative to the deposited annihilation energy. We show that heavy metal seeding of the fuel and/or ablator is required to optimize local deposition of annihilation energy and determine that a minimum of ∼3x10 15 injected antiprotons will be required to achieve high yield (several hundred megajoules) in any target configuration. Target gains - i.e., fusion yields divided by the available p - (bar p) annihilation energy from the injected antiprotons (1.88GeV/(bar p)) - range from ∼3 for volumetric ignition targets to ∼600 for fast ignition targets. Antiproton-driven ICF is a speculative concept, and the handling of antiprotons and their required injection precision - temporally and spatially - will present significant technical challenges. The storage and manipulation of low-energy antiprotons, particularly in the form of antihydrogen, is a science in its infancy and a large scale-up of antiproton production over present supply methods would be

On the utility of antiprotons as drivers for inertial confinement fusion

International Nuclear Information System (INIS)

Perkins, L. John; Orth, Charles D.; Tabak, Max

2004-01-01

In contrast to the large mass, complexity and recirculating power of conventional drivers for inertial confinement fusion (ICF), antiproton annihilation offers a specific energy of 90 MJ μg -1 and thus a unique form of energy packaging and delivery. In principle, antiproton drivers could provide a profound reduction in system mass for advanced space propulsion by ICF. We examine the physics underlying the use of antiprotons (p-bar) to drive various classes of high-yield ICF targets by the methods of volumetric ignition, hotspot ignition and fast ignition. The useable fraction of annihilation deposition energy is determined for both p-bar-driven ablative compression and p-bar-driven fast ignition, in association with zero- and one-dimensional target burn models. Thereby, we deduce scaling laws for the number of injected antiprotons required per capsule, together with timing and focal spot requirements. The kinetic energy of the injected antiproton beam required to penetrate to the desired annihilation point is always small relative to the deposited annihilation energy. We show that heavy metal seeding of the fuel and/or ablator is required to optimize local deposition of annihilation energy and determine that a minimum of ∼3 x 10 15 injected antiprotons will be required to achieve high yield (several hundred megajoules) in any target configuration. Target gains-i.e. fusion yields divided by the available p-p-bar annihilation energy from the injected antiprotons (1.88 GeV/p-bar)-range from ∼3 for volumetric ignition targets to ∼600 for fast ignition targets. Antiproton-driven ICF is a speculative concept, and the handling of antiprotons and their required injection precision - temporally and spatially - will present significant technical challenges. The storage and manipulation of low-energy antiprotons, particularly in the form of antihydrogen, is a science in its infancy and a large scale-up of antiproton production over present supply methods would be

Risk analysis of external radiation therapy

International Nuclear Information System (INIS)

Arvidsson, Marcus

2011-09-01

External radiation therapy is carried out via a complex treatment process in which many different groups of staff work together. Much of the work is dependent on and in collaboration with advanced technical equipment. The purpose of the research task has been to identify a process for external radiation therapy and to identify, test and analyze a suitable method for performing risk analysis of external radiation therapy

Gene expression profiles in cervical cancer with radiation therapy alone and chemo-radiation therapy

International Nuclear Information System (INIS)

Lee, Kyu Chan; Kim, Joo Young; Hwang, You Jin; Kim, Meyoung Kon; Choi, Myung Sun; Kim, Chul Young

2003-01-01

To analyze the gene expression profiles of uterine cervical cancer, and its variation after radiation therapy, with or without concurrent chemotherapy, using a cDNA microarray. Sixteen patients, 8 with squamous cell carcinomas of the uterine cervix, who were treated with radiation alone, and the other 8 treated with concurrent chemo-radiation, were included in the study. Before the starting of the treatment, tumor biopsies were carried out, and the second time biopsies were performed after a radiation dose of 16.2-27 Gy. Three normal cervix tissues were used as a control group. The microarray experiments were performed with 5 groups of the total RNAs extracted individually and then admixed as control, pre-radiation therapy alone, during-radiation therapy alone, pre-chemoradiation therapy, and during chemoradiation therapy. The 33P-labeled cDNAs were synthesized from the total RNAs of each group, by reverse transcription, and then they were hybridized to the cDNA microarray membrane. The gene expression of each microarrays was captured by the intensity of each spot produced by the radioactive isotopes. The pixels per spot were counted with an Arrayguage, and were exported to Microsoft Excel. The data were normalized by the Z transformation, and the comparisons were performed on the Z-ratio values calculated. The expressions of 15 genes, including integrin linked kinase (ILK), CDC28 protein kinase 2, Spry 2, and ERK 3, were increased with the Z-ratio values of over 2.0 for the cervix cancer tissues compared to those for the normal controls. Those genes were involved in cell growth and proliferation, cell cycle control, or signal transduction. The expressions of the other 6 genes, including G protein coupled receptor kinase 6, were decreased with the Z-ratio values of below -2.0. After the radiation therapy, most of the genes, with a previously increase expressions, represented the decreased expression profiles, and the genes, with the Z-ratio values of over 2.0, were

Physics with ultra-low energy antiprotons

International Nuclear Information System (INIS)

Holtkamp, D.B.; Holzscheiter, M.H.; Hughes, R.J.

1989-01-01

The experimental observation that all forms of matter experience the same gravitational acceleration is embodied in the weak equivalence principle of gravitational physics. However no experiment has tested this principle for particles of antimatter such as the antiproton or the antihydrogen atom. Clearly the question of whether antimatter is in compliance with weak equivalence is a fundamental experimental issue, which can best be addressed at an ultra-low energy antiproton facility. This paper addresses the issue. 20 refs

Three-dimensional conformal radiation therapy: the tomo-therapy approach

International Nuclear Information System (INIS)

Linthout, N.; Verellen, D.; Coninck, P. de; Bel, A.; Storme, G.

2000-01-01

Conformal radiation therapy allows the possibility of delivering high doses at the tumor volume whilst limiting the dose to the surrounding tissues and diminishing the secondary effects. With the example of the conformal radiation therapy used at the AZ VU8 (3DCRT and tomo-therapy), two treatment plans of a left ethmoid carcinoma will be evaluated and discussed in detail. The treatment of ethmoid cancer is technically difficult for both radiation therapy and surgery because of the anatomic constraints and patterns of local spread. A radiation therapy is scheduled to be delivered after surgical resection of the tumor. The treatment plan for the radiation therapy was calculated on a three-dimensional (3D) treatment planning system based on virtual simulation with a beam's eye view: George Sherouse's Gratis. An effort was made to make the plan as conformal and as homogeneous as possible to deliver a dose of 66 Gy in 33 fractions at the tumor bed with a maximum dose of 56 Gy to the right optic nerve and the chiasma. To establish the clinical utility and potential advantages of tomo-therapy over 3DCRT for ethmoid carcinoma, the treatment of this patient was also planned with Peacock Plant. For both treatment plans the isodose distributions and cumulative dose volume histograms (CDVH) were computed. Superimposing the CDVHs yielded similar curves for the target and an obvious improvement for organs at risk such as the chiasma, brainstem and the left eye when applying tomo-therapy. These results have also been reflected in the tumor control probabilities (equal for both plans) and the normal tissue complication probabilities (NTCP), yielding significant reductions in NTCP for tomo-therapy. The probability of uncomplicated tumor control was 52.7% for tomo-therapy against 38.3% for 3DCRT. (authors)

Antiproton collisions with molecular hydrogen

DEFF Research Database (Denmark)

Lühr, Armin Christian; Saenz, Alejandro

2008-01-01

Theoretical antiproton and proton cross sections for ionization and excitation of hydrogen molecules as well as energy spectra of the ionized electrons were calculated in the impact-energy range from 8  to  4000  keV. The cross sections were computed with the close-coupling formulation of the sem......Theoretical antiproton and proton cross sections for ionization and excitation of hydrogen molecules as well as energy spectra of the ionized electrons were calculated in the impact-energy range from 8  to  4000  keV. The cross sections were computed with the close-coupling formulation...

A new approach to experiments with non-relativistic antiprotons

International Nuclear Information System (INIS)

Poth, H.

1990-05-01

Is low-energy antiproton physics phasing out with the present round of experiments or are there good reasons to continue at an improved slow antiproton facility which could be located at a high intensity hadron accelerator? We point out, that there are four frontiers where substantial advances could be made. In particular, we discuss the low-energy frontier and emphasize that experiments with no-relativistic antiprotons would increase drastically the sensitivity and would reveal new effects. (orig.)

Protection of the patient in radiation therapy

International Nuclear Information System (INIS)

1991-01-01

In the ICRP report (ICRP-Pub-44) a broad picture of radiotheraphy is presented useful to all involved in the care of cancer patients, for instance to physicians, including medical oncologists, and to medical physicists, radiographers, dosimetrists, and administrators. Information is given on the general principles of radiation therapy including external beam therapy and brachytherapy; the accuracy of radiation delivery and quality assurance; the biological radiation response; the expected risk to specific organs or tissues from therapeutic irradiation; the absorbed dose to tissues inside and outside the useful radiation beams; the organization and planning of radiation oncology services; radiation therapy staff education, training and duties; and finally medical research involving the use of radiation therapy. (orig./HP) [de

Radiation biology and radiation therapy

International Nuclear Information System (INIS)

Wideroee, R.

1975-01-01

Radiation biology and radiation therapy can be compared with investigations in different layers of earth. Radiation biology works upwards from the elementary foundations, therapy works downwards with roots to secure and improve the clinical 'surface work'. The Ellis formula (Strandquist), which is a collection of clinical experience, is suited to form connections with radiobiology in the middle layers, and cooperation can give impulses for research. The structure and conditions of tumours and the complicated problems met with are discussed, based on the Carmel symposium of 1969. The oxygen problem in anoxic tumours is not yet solved. Experimental investigations of the effect itself give partly contradictory results. From a clinical viewpoint reoxygenation is of the utmost significance for obtaining control over the primary tumour, and advanced irradiation programmes will here give better results than the traditional ones. New chemicals, e.g. R 0 -07-0582, appear to reduce the OER value to 1.5, thereby making neutron therapy superfluous. Finally a problem from fundamental research is dealt with, wherein two hypotheses explaining the β-effect are described. The repair hypothesis gives a simple explanation but leaves many questions unanswered. The other hypothesis explains the β-effect as two neighbouring single breaks of the DNA molecule. It still presents difficulties, and is scarcely the correct explanation. (JIW)

A novel antiproton radial diagnostic based on octupole induced ballistic loss

International Nuclear Information System (INIS)

Andresen, G. B.; Bowe, P. D.; Hangst, J. S.; Bertsche, W.; Butler, E.; Charlton, M.; Humphries, A. J.; Jenkins, M. J.; Joergensen, L. V.; Madsen, N.; Werf, D. P. van der; Bray, C. C.; Chapman, S.; Fajans, J.; Povilus, A.; Wurtele, J. S.; Cesar, C. L.; Lambo, R.; Silveira, D. M.; Fujiwara, M. C.

2008-01-01

We report results from a novel diagnostic that probes the outer radial profile of trapped antiproton clouds. The diagnostic allows us to determine the profile by monitoring the time history of antiproton losses that occur as an octupole field in the antiproton confinement region is increased. We show several examples of how this diagnostic helps us to understand the radial dynamics of antiprotons in normal and nested Penning-Malmberg traps. Better understanding of these dynamics may aid current attempts to trap antihydrogen atoms

A novel antiproton radial diagnostic based on octupole induced ballistic loss

CERN Document Server

Andresen, G.B.; Bowe, P.D.; Bray, C.C.; Butler, E.; Cesar, C.L.; Chapman, S.; Charlton, M.; Fajans, J.; Fujiwara, M.C.; Funakoshi, R.; Gill, D.R.; Hangst, J.S.; Hardy, W.N.; Hayano, R.S.; Hayden, M.E.; Humphries, A.J.; Hydomako, R.; Jenkins, M.J.; Jorgensen, L.V.; Kurchaninov, L.; Lambo, R.; Madsen, N.; Nolan, P.; Olchanski, K.; Olin, A.; Page, R.D.; Povilus, A.; Pusa, P.; Robicheaux, F.; Sarid, E.; Seif El Nasr, S.; Silveira, D.M.; Storey, J.W.; Thompson, R.I.; van der Werf, D.P.; Wurtele, J.S.; Yamazaki, Y.

2008-01-01

We report results from a novel diagnostic that probes the outer radial profile of trapped antiproton clouds. The diagnostic allows us to determine the profile by monitoring the time-history of antiproton losses that occur as an octupole field in the antiproton confinement region is increased. We show several examples of how this diagnostic helps us to understand the radial dynamics of antiprotons in normal and nested Penning-Malmberg traps. Better understanding of these dynamics may aid current attempts to trap antihydrogen atoms.

External Beam Radiation Therapy for Cancer

Science.gov (United States)

External beam radiation therapy is used to treat many types of cancer. it is a local treatment, where a machine aims radiation at your cancer. Learn more about different types of external beam radiation therapy, and what to expect if you're receiving treatment.

The ASACUSA experiment at CERN's AD antiproton decelerator catches antiprotons in helium, where the antiprotons replace electrons, giving exotics atoms.

CERN Multimedia

Loïez, P

2000-01-01

Photo 03: Laser beams are prepared for shooting at antiprotonic helium atoms. Left to right: Masaki Hori (Tokyo University) and John Eades (CERN). Photo 01: Dye laser triggered by "YAG" laser. Photo 02: Masaki Hori adjusting optical system of laser beams.

Problems in the phenomenological analysis of cross-section difference sigmasub(pp)-sigmasub(pn) and sigmasub(antiproton proton)-sigmasub(antiproton neutron)

International Nuclear Information System (INIS)

Bouquet, A.; Diu, B.; Leader, E.; Nicolescu, B.

1976-01-01

It is shown that uncertainties in the exact value of the Glauber correction make it virtually impossible to deduce any significant conclusions about the asymptotic behaviour of the sigmasub(pp)-sigmasub(pn) and sigma sub(antiproton proton)-sigmasub(antiproton neutron) cross-section differences, if only data on pp, pd, antiproton proton and antiprotond collisions are used. Nevertheless it can be demonstrated that the imaginary part of the rho exchange amplitude is basically Regge behaved. If, on the other hand, neutron beam data on sigmasub(np) are used, it can be shown that the imaginary part of the A 2 exchange amplitude contains a non-Regge, growing, asymptotic component, reminiscent of that found in the I=) symmetric amplitude

Comparison of dose-volume histograms for Tomo therapy, linear accelerator-based 3D conformal radiation therapy, and intensity-modulated radiation therapy

International Nuclear Information System (INIS)

Ji, Youn-Sang; Dong, Kyung-Rae; Kim, Chang-Bok; Choi, Seong-Kwan; Chung, Woon-Kwan; Lee, Jong-Woong

2011-01-01

Highlights: → Evaluation of DVH from 3D CRT, IMRT and Tomo therapy was conducted for tumor therapy. → The doses of GTV and CTV were compared using DVHs from 3D CRT, IMRT and Tomo therapy. → The GTV was higher when Tomo therapy was used, while the doses of critical organ were low. → They said that Tomo therapy satisfied the goal of radiation therapy more than the others. - Abstract: Evaluation of dose-volume histograms from three-dimensional conformal radiation therapy (3D CRT), intensity-modulated radiation therapy (IMRT), and Tomo therapy was conducted. These three modalities are among the diverse treatment systems available for tumor therapy. Three patients who received tumor therapy for a malignant oligodendroglioma in the cranium, nasopharyngeal carcinoma in the cervical neck, and prostate cancer in the pelvis were selected as study subjects. Therapy plans were made for the three patients before dose-volume histograms were obtained. The doses of the gross tumor volume (GTV) and the clinical target volume (CTV) were compared using the dose-volume histograms obtained from the LINAC-based 3D CRT, IMRT planning station (Varian Eclipse-Varian, version 8.1), and Tomo therapy planning station. In addition, the doses of critical organs in the cranium, cervix, and pelvis that should be protected were compared. The GTV was higher when Tomo therapy was used compared to 3D CRT and the LINAC-based IMRT, while the doses of critical organ tissues that required protection were low. These results demonstrated that Tomo therapy satisfied the ultimate goal of radiation therapy more than the other therapies.

The antiproton depth–dose curve measured with alanine detectors

CERN Document Server

Bassler, Niels; Palmans, Hugo; Holzscheiter, Michael H; Kovacevic, Sandra

2008-01-01

n this paper we report on the measurement of the antiproton depth–dose curve, with alanine detectors. The results are compared with simulations using the particle energy spectrum calculated by FLUKA, and using the track structure model of Hansen and Olsen for conversion of calculated dose into response. A good agreement is observed between the measured and calculated relative effectiveness although an underestimation of the measured values beyond the Bragg-peak remains unexplained. The model prediction of response of alanine towards heavy charged particles encourages future use of the alanine detectors for dosimetry of mixed radiation fields.

The Antiproton Depth Dose Curve Measured with Alanine Detectors

DEFF Research Database (Denmark)

Bassler, Niels; Hansen, Johnny Witterseh; Palmans, Hugo

2008-01-01

In this paper we report on the measurement of the antiproton depth dose curve, with alanine detectors. The results are compared with simulations using the particle energy spectrum calculated by FLUKA, and using the track structure model of Hansen et Olsen for conversion of calculated dose...... into response. A good agreement was observed between the measured and calculated relative effectiveness although a slight underestimation of the calculated values in the Bragg peak remains unexplained. The model prediction of response of alanine towards heavy charged particles encourages future use...... of the alanine detectors for dosimetry of mixed radiation fields....

Radiation therapy for metastatic spinal tumors

International Nuclear Information System (INIS)

Kida, Akio; Fukuda, Haruyuki; Taniguchi, Shuji; Sakai, Kazuaki

2000-01-01

The results of radiation therapy for metastatic spinal tumors were evaluated in terms of pain relief, improvement of neurological impairment, and survival. Between 1986 and 1995, 52 symptomatic patients with metastatic spinal tumors treated with radiation therapy were evaluated. The patients all received irradiation of megavoltage energy. Therapeutic efficacy was evaluated in terms of pain relief and improvement of neurological impairment. Pain relief was observed in 29 (61.7%) of 47 patients with pain. Therapy was effective for 17 (70.8%) of 24 patients without neurological impairment, and efficacy was detected in 12 (52.2%) of 23 patients with neurological impairment. Improvement of neurological symptoms was obtained in seven (25.0%) of 28 patients with neurological impairment. Radiation therapy was effective for pain relief in patients with metastatic spinal tumors. In patients with neurological impairment, less pain relief was observed than in those without impairment. Improvement of neurological impairment was restricted, but radiation therapy was thought to be effective in some cases in the early stage of neurological deterioration. Radiation therapy for metastatic spinal tumors contraindicated for surgery was considered effective for improvement of patients' activities of daily living. (author)

Radiation therapy in the treatment of hilar cholangiocarcinoma

International Nuclear Information System (INIS)

Jing Jin; Zhai Renyou

2007-01-01

The incidence of hilar cholangiocarcinoma is very rare worldwide. Radical resection is the only prognostic factor for long survival in patients with hilar cholangiocarcinoma. Postoperative radiation therapy can improve local control and survival rates for patients with palliative resection, but it remains controversial in patients with radical resection. Biliary drainage can effectively release bile duct obstruction for the majority of patients with locally advanced disease, and may even prolong survival when combined with radiation therapy. Radiation therapy includes extrernal beam therapy alone, external beam therapy with intraluminal brachytheapy and new radiation technique, such as three dimentional conformal therapy and intensity modulated radiation therapy. The propective randomized clinical study is needed for further investigation in the role of combined modality therapy especially for hilar cholangiocarcinoma. (authors)

The Floor's the Limit (Antiproton energies to hit new low)

CERN Multimedia

2000-01-01

Celebrating the success of the RFQ in Aarhus. Left to right: Alessanda Lombardi (CERN), Iouri Bylinskii (CERN), Alex Csete (Aarhus), Ulrik Uggerhøj (Aarhus), Ryu Hayano (Tokyo, spokesman ASACUSA), Helge Knudsen (Aarhus), Werner Pirkl (CERN), Ryan Thompson (Aarhus), Søren P. Møller (Aarhus). Although in particle physics we are accustomed to strive for higher and higher energies, this is not always the most interesting thing to do with antiprotons. Indeed, as recent issues of the Bulletin have suggested, the signpost on the road to a closer look at the antiproton points towards ever-lower energies. The CERN Antiproton Decelerator decelerates antipro-tons emerging from a target placed in the path of a 26 GeV/c proton beam from 90 % of to about 10 % of the speed of light. However, even this is far too fast for many of the most interesting experiments on antiprotons planned by Danish and Japanese members of the ASACUSA collaboration. Tokyo University has therefore financed the con...

Antiproton tagging and vertex fitting in a Timepix3 detector

CERN Document Server

Aghion, S.; The AEGIS collaboration; Antonello, M.; Belov, A.; Bonomi, G.; Brusah, R. S.; Caccia, M.; Camper, A.; Caravita, R.; Castelli, F.; Cerchiari, G.; Comparat, D.; Consolati, G.; Demetrio, A.; Di Noto, L.; Doser, M.; Evans, C.; Fanì, M.; Ferragut, R.; Fesel, J.; Fontana, A.; Gerber, S.; Giammarchi, M.; Gligorova, A.; Guatieri, F.; Hackstock, P.; Haider, S.; Hinterberger, A.; Holmestad, H.; Kellerbauer, A.; Khalidova, O.; Krasnický, D.; Lagomarsino, V.; Lansonneur, P.; Lebrun, P.; Malbrunot, C.; Mariazzi, S.; Marton, J.; Matveev, V.; Müller, S. R.; Nebbia, G.; Nedelec, P.; Oberthaler, M.; Pacifico, N.; Pagano, D.; Penasa, L.; Petracek, V.; Prelz, F.; Prevedelli, M.; Rienaecker, B.; Robert, J.; Røhne, O. M.; Rotondi, A.; Sandaker, H.; Santoro, R.; Smestad, L.; Sorrentino, F.; Testera, G.; Tietje, I. C.; Widmann, E.; Yzombard, P.; Zimmer, C.; Zmeskal, J.; Zurlo, N.

2018-01-01

Studies of antimatter are important for understanding our universe at a fundamental level. There are still unsolved problems, such as the matter-antimatter asymmetry in the universe. The AEgIS experiment at CERN aims at measuring the gravitational fall of antihydrogen in order to determine the gravitational force on antimatter. The proposed method will make use of a position-sensitive detector to measure the annihilation point of antihydrogen. Such a detector must be able to tag the antiproton, measure its time of arrival and reconstruct its annihilation point with high precision in the vertical direction. This work explores a new method for tagging antiprotons and reconstructing their annihilation point. Antiprotons from the Antiproton Decelerator at CERN was used to obtain data on direct annihilations on the surface of a silicon pixel sensor with Timepix3 readout. These data were used to develop and verify a detector response model for annihilation of antiprotons in this detector. Using this model and the a...

A measurement of the gravitational acceleration of the antiproton

International Nuclear Information System (INIS)

Holzscheiter, M.H.

1990-01-01

A fundamental experiment in gravity proposed by us, is the measurement of the gravitational force on antimatter. This measurement would constitute the first direct test of the Weak Equivalence Principle (WEP) for antimatter. The availability of low-energy antiprotons at CERN has made such an experiment feasible, and a proposal to carry out such a measurement has been accepted by the CERN Program Committee. We plan to use a time-of-flight technique similar to that pioneered by Fairbank and Witteborn in their measurement of the gravitational force on an electron. Very slow particles are launched into a vertical drift tube and the time-of-flight spectrum of these particles is recorded. This spectrum will exhibit a cut-off point directly related to the gravitational acceleration of the particles. Obtaining very slow antiprotons involves several stages of deceleration. Antiprotons from LEAR will be initially decelerated from 2 MeV to tens of kilovolts by passing them through a thin foil. After capture and cooling in a series of ion traps, the antiprotons will be in a thermal distribution with a temperature of a few degrees Kelvin. These ultra-cold antiprotons will then be released a few at a time into the drift tube. A detector will measure the arrival time of the particles at the exit of the drift tube. H - -ion, which have almost identical electromagnetic properties to the antiprotons, will be used for comparison and as a calibration standard. 7 refs., 1 fig

Antiproton impact ionization of atomic hydrogen and helium

Energy Technology Data Exchange (ETDEWEB)

McGovern, M; Walters, H R J [Department of Applied Mathematics and Theoretical Physics, Queen' s University, Belfast BT7 INN (United Kingdom); Assafrao, D; Mohallem, J R [Laboratorio de Atomos e Moleculas Especiais, Departamento de Fisica, ICEx, Universidade Federal de Minas Gerais, P.O Box 702, 30123-970 Belo Horizonte, MG (Brazil); Whelan, Colm T, E-mail: mmcgovern06@qub.ac.u [Department of Physics, Old Dominion University, Norfolk, VA 23529-0116 (United States)

2009-11-01

We shall present results for antiproton ionization of H and He ranging from fully differential cross sections to total ionization. The calculations have been made in a coupled pseudostate impact parameter approximation. It will be shown that the interaction between the antiproton and the target nucleus is very important at low energies.

Slowing down of 100 keV antiprotons in Al foils

Science.gov (United States)

Nordlund, K.

2018-03-01

Using energy degrading foils to slow down antiprotons is of interest for producing antihydrogen atoms. I consider here the slowing down of 100 keV antiprotons, that will be produced in the ELENA storage ring under construction at CERN, to energies below 10 keV. At these low energies, they are suitable for efficient antihydrogen production. I simulate the antihydrogen motion and slowing down in Al foils using a recently developed molecular dynamics approach. The results show that the optimal Al foil thickness for slowing down the antiprotons to below 5 keV is 910 nm, and to below 10 keV is 840 nm. Also the lateral spreading of the transmitted antiprotons is reported and the uncertainties discussed.

Clinical experience of radiation therapy for Graves` ophthalmopathy

Energy Technology Data Exchange (ETDEWEB)

Takahashi, Takeo; Mitsuhashi, Norio; Nagashima, Hisako; Sakurai, Hideyuki; Murata, Osamu; Ishizeki, Kei; Shimaya, Sanae; Hayakawa, Kazushige; Niibe, Hideo [Gunma Univ., Maebashi (Japan). School of Medicine

1996-11-01

The effect of radiation therapy for Graves` ophthalmopathy was evaluated. Ten patients with Graves` ophthalmopathy were treated with radiation therapy between 1992 and 1993 in Gunma University Hospital. All patients had a past history of hyperthyroidism and received 2,000 cGy to the retrobulbar tissues in 20 fractions. Nine of ten patients were treated with radiation therapy after the failure of corticosteroids. Six patients (60%) showed good or excellent responses. The exophthalmos type was more responsive to radiation therapy than the double vision type in this series. Two of five patients with the exophthalmos type demonstrated excellent responses, and their symptoms disappeared almost completely. The improvement of symptoms appeared within 3-6 months, and obvious clinical effects were demonstrated after 6 months of radiotherapy. Radiation therapy was well tolerated, and we have not observed any side effects of radiation therapy. In conclusion, radiation therapy is effective treatment for Graves` ophthalmopathy. (author)

Clinical experience of radiation therapy for Graves' ophthalmopathy

International Nuclear Information System (INIS)

Takahashi, Takeo; Mitsuhashi, Norio; Nagashima, Hisako; Sakurai, Hideyuki; Murata, Osamu; Ishizeki, Kei; Shimaya, Sanae; Hayakawa, Kazushige; Niibe, Hideo

1996-01-01

The effect of radiation therapy for Graves' ophthalmopathy was evaluated. Ten patients with Graves' ophthalmopathy were treated with radiation therapy between 1992 and 1993 in Gunma University Hospital. All patients had a past history of hyperthyroidism and received 2,000 cGy to the retrobulbar tissues in 20 fractions. Nine of ten patients were treated with radiation therapy after the failure of corticosteroids. Six patients (60%) showed good or excellent responses. The exophthalmos type was more responsive to radiation therapy than the double vision type in this series. Two of five patients with the exophthalmos type demonstrated excellent responses, and their symptoms disappeared almost completely. The improvement of symptoms appeared within 3-6 months, and obvious clinical effects were demonstrated after 6 months of radiotherapy. Radiation therapy was well tolerated, and we have not observed any side effects of radiation therapy. In conclusion, radiation therapy is effective treatment for Graves' ophthalmopathy. (author)

Radiation therapy for carcinoma of the endometrium

International Nuclear Information System (INIS)

Potish, R.A.

1987-01-01

Carcinoma of the endometrium is the most common malignant tumor in the female genital tract. Radiation therapy continues to play a major role in the management of endometrial carcinoma, both as primary therapy and as adjuvant treatment. The utility of pelvic external beam therapy and intracavitary therapy is long established. However, the modern era of surgical staging has lead to an appreciation of the role of radiation therapy beyond the pelvis. Radiation therapy has been shown to be of particular benefit in peritoneal and nodal spread. The classic management of endometrial cancer is reviewed and relatively new and somewhat controversial topics, such as preoperative intracavitary therapy followed by external beam therapy are discussed

Slowing down of 100 keV antiprotons in Al foils

Directory of Open Access Journals (Sweden)

K. Nordlund

2018-03-01

Full Text Available Using energy degrading foils to slow down antiprotons is of interest for producing antihydrogen atoms. I consider here the slowing down of 100 keV antiprotons, that will be produced in the ELENA storage ring under construction at CERN, to energies below 10 keV. At these low energies, they are suitable for efficient antihydrogen production. I simulate the antihydrogen motion and slowing down in Al foils using a recently developed molecular dynamics approach. The results show that the optimal Al foil thickness for slowing down the antiprotons to below 5 keV is 910 nm, and to below 10 keV is 840 nm. Also the lateral spreading of the transmitted antiprotons is reported and the uncertainties discussed. Keywords: Antiprotons, Stopping power, Slowing down, Molecular dynamics

Operational experience with bunch rotation momentum reduction in the Fermilab antiproton source

International Nuclear Information System (INIS)

Bharadwaj, V.; Griffin, J.E.; MacLachlan, J.A.; Martin, P.S.; Meisner, K.G.; Wildman, D.

1987-01-01

In the Fermilab antiproton accumulation system antiprotons are produced by the delivery of trains of 120 GeV proton bunches to a production target from which antiprotons are collected with mean energy 8 GeV (kinetic) and momentum spread Δrho/rho > 3%. The antiproton beam has the time structure of the incident protons. The proton bunch spacing-to-length ratio is made as large as possible (> 20:1) so that the resulting antiproton momentum spread may be reduced by ''bunch rotation'' in a ''debunching'' ring where time spread is exchanged for momentum spread. Details of these procedures are described elsewhere; in this paper the authors report on the efficacy of these procedures during routine operation

DNA repair related to radiation therapy

International Nuclear Information System (INIS)

Klein, W.

1979-01-01

The DNA excision repair capacity of peripheral human lymphocytes after radiation therapy has been analyzed. Different forms of application of the radiation during the therapy have been taken into account. No inhibition of repair was found if cells were allowed a certain amount of accomodation to radiation, either by using lower doses or longer application times. (G.G.)

Radiation therapy facilities in the United States

International Nuclear Information System (INIS)

Ballas, Leslie K.; Elkin, Elena B.; Schrag, Deborah; Minsky, Bruce D.; Bach, Peter B.

2006-01-01

Purpose: About half of all cancer patients in the United States receive radiation therapy as a part of their cancer treatment. Little is known, however, about the facilities that currently deliver external beam radiation. Our goal was to construct a comprehensive database of all radiation therapy facilities in the United States that can be used for future health services research in radiation oncology. Methods and Materials: From each state's health department we obtained a list of all facilities that have a linear accelerator or provide radiation therapy. We merged these state lists with information from the American Hospital Association (AHA), as well as 2 organizations that audit the accuracy of radiation machines: the Radiologic Physics Center (RPC) and Radiation Dosimetry Services (RDS). The comprehensive database included all unique facilities listed in 1 or more of the 4 sources. Results: We identified 2,246 radiation therapy facilities operating in the United States as of 2004-2005. Of these, 448 (20%) facilities were identified through state health department records alone and were not listed in any other data source. Conclusions: Determining the location of the 2,246 radiation facilities in the United States is a first step in providing important information to radiation oncologists and policymakers concerned with access to radiation therapy services, the distribution of health care resources, and the quality of cancer care

Compression of a mixed antiproton and electron non-neutral plasma to high densities

Science.gov (United States)

Aghion, Stefano; Amsler, Claude; Bonomi, Germano; Brusa, Roberto S.; Caccia, Massimo; Caravita, Ruggero; Castelli, Fabrizio; Cerchiari, Giovanni; Comparat, Daniel; Consolati, Giovanni; Demetrio, Andrea; Di Noto, Lea; Doser, Michael; Evans, Craig; Fanì, Mattia; Ferragut, Rafael; Fesel, Julian; Fontana, Andrea; Gerber, Sebastian; Giammarchi, Marco; Gligorova, Angela; Guatieri, Francesco; Haider, Stefan; Hinterberger, Alexander; Holmestad, Helga; Kellerbauer, Alban; Khalidova, Olga; Krasnický, Daniel; Lagomarsino, Vittorio; Lansonneur, Pierre; Lebrun, Patrice; Malbrunot, Chloé; Mariazzi, Sebastiano; Marton, Johann; Matveev, Victor; Mazzotta, Zeudi; Müller, Simon R.; Nebbia, Giancarlo; Nedelec, Patrick; Oberthaler, Markus; Pacifico, Nicola; Pagano, Davide; Penasa, Luca; Petracek, Vojtech; Prelz, Francesco; Prevedelli, Marco; Rienaecker, Benjamin; Robert, Jacques; Røhne, Ole M.; Rotondi, Alberto; Sandaker, Heidi; Santoro, Romualdo; Smestad, Lillian; Sorrentino, Fiodor; Testera, Gemma; Tietje, Ingmari C.; Widmann, Eberhard; Yzombard, Pauline; Zimmer, Christian; Zmeskal, Johann; Zurlo, Nicola; Antonello, Massimiliano

2018-04-01

We describe a multi-step "rotating wall" compression of a mixed cold antiproton-electron non-neutral plasma in a 4.46 T Penning-Malmberg trap developed in the context of the AEḡIS experiment at CERN. Such traps are routinely used for the preparation of cold antiprotons suitable for antihydrogen production. A tenfold antiproton radius compression has been achieved, with a minimum antiproton radius of only 0.17 mm. We describe the experimental conditions necessary to perform such a compression: minimizing the tails of the electron density distribution is paramount to ensure that the antiproton density distribution follows that of the electrons. Such electron density tails are remnants of rotating wall compression and in many cases can remain unnoticed. We observe that the compression dynamics for a pure electron plasma behaves the same way as that of a mixed antiproton and electron plasma. Thanks to this optimized compression method and the high single shot antiproton catching efficiency, we observe for the first time cold and dense non-neutral antiproton plasmas with particle densities n ≥ 1013 m-3, which pave the way for an efficient pulsed antihydrogen production in AEḡIS.

Involved Node Radiation Therapy

DEFF Research Database (Denmark)

Maraldo, Maja V; Aznar, Marianne C; Vogelius, Ivan R

2012-01-01

PURPOSE: The involved node radiation therapy (INRT) strategy was introduced for patients with Hodgkin lymphoma (HL) to reduce the risk of late effects. With INRT, only the originally involved lymph nodes are irradiated. We present treatment outcome in a retrospective analysis using this strategy...... to 36 Gy). Patients attended regular follow-up visits until 5 years after therapy. RESULTS: The 4-year freedom from disease progression was 96.4% (95% confidence interval: 92.4%-100.4%), median follow-up of 50 months (range: 4-71 months). Three relapses occurred: 2 within the previous radiation field......, and 1 in a previously uninvolved region. The 4-year overall survival was 94% (95% confidence interval: 88.8%-99.1%), median follow-up of 58 months (range: 4-91 months). Early radiation therapy toxicity was limited to grade 1 (23.4%) and grade 2 (13.8%). During follow-up, 8 patients died, none from HL, 7...

Whole-brain hippocampal sparing radiation therapy: Volume-modulated arc therapy vs intensity-modulated radiation therapy case study

Energy Technology Data Exchange (ETDEWEB)

Lee, Katrina, E-mail: Trinabena23@gmail.com; Lenards, Nishele; Holson, Janice

2016-04-01

The hippocampus is responsible for memory and cognitive function. An ongoing phase II clinical trial suggests that sparing dose to the hippocampus during whole-brain radiation therapy can help preserve a patient's neurocognitive function. Progressive research and advancements in treatment techniques have made treatment planning more sophisticated but beneficial for patients undergoing treatment. The aim of this study is to evaluate and compare hippocampal sparing whole-brain (HS-WB) radiation therapy treatment planning techniques using volume-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). We randomly selected 3 patients to compare different treatment techniques that could be used for reducing dose to the hippocampal region. We created 2 treatment plans, a VMAT and an IMRT, from each patient's data set and planned on the Eclipse 11.0 treatment planning system (TPS). A total of 6 plans (3 IMRT and 3 VMAT) were created and evaluated for this case study. The physician contoured the hippocampus as per the Radiation Therapy Oncology Group (RTOG) 0933 protocol atlas. The organs at risk (OR) were contoured and evaluated for the plan comparison, which included the spinal cord, optic chiasm, the right and left eyes, lenses, and optic nerves. Both treatment plans produced adequate coverage on the planning target volume (PTV) while significantly reducing dose to the hippocampal region. The VMAT treatment plans produced a more homogenous dose distribution throughout the PTV while decreasing the maximum point dose to the target. However, both treatment techniques demonstrated hippocampal sparing when irradiating the whole brain.

Whole-brain hippocampal sparing radiation therapy: Volume-modulated arc therapy vs intensity-modulated radiation therapy case study

International Nuclear Information System (INIS)

Lee, Katrina; Lenards, Nishele; Holson, Janice

2016-01-01

The hippocampus is responsible for memory and cognitive function. An ongoing phase II clinical trial suggests that sparing dose to the hippocampus during whole-brain radiation therapy can help preserve a patient's neurocognitive function. Progressive research and advancements in treatment techniques have made treatment planning more sophisticated but beneficial for patients undergoing treatment. The aim of this study is to evaluate and compare hippocampal sparing whole-brain (HS-WB) radiation therapy treatment planning techniques using volume-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). We randomly selected 3 patients to compare different treatment techniques that could be used for reducing dose to the hippocampal region. We created 2 treatment plans, a VMAT and an IMRT, from each patient's data set and planned on the Eclipse 11.0 treatment planning system (TPS). A total of 6 plans (3 IMRT and 3 VMAT) were created and evaluated for this case study. The physician contoured the hippocampus as per the Radiation Therapy Oncology Group (RTOG) 0933 protocol atlas. The organs at risk (OR) were contoured and evaluated for the plan comparison, which included the spinal cord, optic chiasm, the right and left eyes, lenses, and optic nerves. Both treatment plans produced adequate coverage on the planning target volume (PTV) while significantly reducing dose to the hippocampal region. The VMAT treatment plans produced a more homogenous dose distribution throughout the PTV while decreasing the maximum point dose to the target. However, both treatment techniques demonstrated hippocampal sparing when irradiating the whole brain.

External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy

International Nuclear Information System (INIS)

Takada, Chitose; Ito, Koushiro; Nishi, Junko; Yamamoto, Toshihiro; Hatanaka, Yoshimi; Baba, Yuji; Takahashi, Mutsumasa.

1995-01-01

From 1980 to 1990, a total of 54 patients with prostatic carcinoma were treated with external radiation therapy at the Kumamoto National Hospital. Ten patients were classified as Stage B, 22 as Stage C, and another 22 as Stage D according to the American Urological Association Clinical Staging System. The 5-year survival for all 54 patients was 30%. The 5-year disease-specific survival was 67% for Stage B, 47% for Stage C, and 26% for Stage D. The 5-year survival was 43% for patients in whom radiation therapy was initiated immediately after the first diagnosis or with less than one year of hormonal therapy, while it was 0% for patients in whom radiation therapy was initiated after more than one year of hormonal therapy (p=0.01). The cause of intercurrent death was acute myocardial infarction in four patients and acute cardiac failure in one. Four of these patients received hormonal therapy for more than one year. The incidence of radiation-induced proctitis was not severe. This study suggests that long-term hormonal therapy prior to radiation therapy worsens the prognosis of patients with prostatic carcinoma. (author)

Low-energy antiprotons physics and the FLAIR facility

International Nuclear Information System (INIS)

Widmann, E

2015-01-01

FLAIR, the Facility for low-energy antiproton and ion research has been proposed in 2004 as an extension of the planned FAIR facility at Darmstadt, Germany. FLAIR was not included into the modularized start version of FAIR, but the recent installation of the CRYRING storage ring at GSI Darmstadt has opened new perspectives for physics with low-energy antiprotons at FAIR. (paper)

Measurement of strong interaction effects in antiprotonic helium atoms

International Nuclear Information System (INIS)

Davies, J.D.; Gorringe, T.P.; Lowe, J.; Nelson, J.M.; Playfer, S.M.; Pyle, G.J.; Squier, G.T.A.

1984-01-01

The strong interaction shift and width for the 2 p level and the width for the 3d level have been measured for antiprotonic helium atoms. The results are compared with optical model calculations. The possible existence of strongly bound antiproton states in nuclei is discussed. (orig.)

Improved Study of the Antiprotonic Helium Hyperfine Structure

CERN Document Server

Pask, T.; Dax, A.; Hayano, R.S.; Hori, M.; Horvath, D.; Juhasz, B.; Malbrunot, C.; Marton, J.; Ono, N.; Suzuki, K.; Zmeskal, J.; Widmann, E.

2008-01-01

We report the initial results from a systematic study of the hyperfine (HF) structure of antiprotonic helium (n,l) = (37,~35) carried out at the Antiproton Decelerator (AD) at CERN. We performed a laser-microwave-laser resonance spectroscopy using a continuous wave (cw) pulse-amplified laser system and microwave cavity to measure the HF transition frequencies. Improvements in the spectral linewidth and stability of our laser system have increased the precision of these measurements by a factor of five and reduced the line width by a factor of three compared to our previous results. A comparison of the experimentally measured transition frequencies with three body QED calculations can be used to determine the antiproton spin magnetic moment, leading towards a test of CPT invariance.

Communication skills training for radiation therapists: preparing patients for radiation therapy.

Science.gov (United States)

Halkett, Georgia; O'Connor, Moira; Aranda, Sanchia; Jefford, Michael; Merchant, Susan; York, Debra; Miller, Lisa; Schofield, Penelope

2016-12-01

Patients sometimes present for radiation therapy with high levels of anxiety. Communication skills training may assist radiation therapists to conduct more effective consultations with patients prior to treatment planning and treatment commencement. The overall aim of our research is to examine the effectiveness of a preparatory programme 'RT Prepare' delivered by radiation therapists to reduce patient psychological distress. The purpose of this manuscript was to describe the communication skills workshops developed for radiation therapists and evaluate participants' feedback. Radiation therapists were invited to participate in two communication skills workshops run on the same day: (1) Consultation skills in radiation therapy and (2) Eliciting and responding to patients' emotional cues. Evaluation forms were completed. Radiation therapists' consultations with patients were then audio-recorded and evaluated prior to providing a follow-up workshop with participants. Nine full day workshops were held. Sixty radiation therapists participated. Positive feedback was received for both workshops with 88% or more participants agreeing or strongly agreeing with all the statements about the different components of the two workshops. Radiation therapists highlighted participating in role play with an actor, discussing issues; receiving feedback; acquiring new skills and knowledge; watching others role play and practicing with checklist were their favourite aspects of the initial workshop. The follow-up workshops provided radiation therapists with feedback on how they identified and addressed patients' psychological concerns; time spent with patients during consultations and the importance of finding private space for consultations. Communication skills training consisting of preparing patients for radiation therapy and eliciting and responding to emotional cues with follow-up workshops has the potential to improve radiation therapists' interactions with patients undergoing

New modalities in radiation therapy for treatment of cancer

International Nuclear Information System (INIS)

Kumar, Deepak

2013-01-01

Cancer is a generic term for a large group of diseases characterized by rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs. Cancer mortality is the second and most common cause of death in the USA and in most European countries. In India, it is the fourth leading disease and the major cause of death. Cancer remains one of the most dreadful disease and approximately ten million cases of cancer occur in the world every year. The course of cancer treatment depends on the type of cancer, its location, and its state of advancement. Cancer is treated with surgery, chemotherapy, radiation therapy, hormone therapy, biological therapy and targeted therapy. Radiation therapy is an important an affordable modality for cancer treatment with minimal side effects. Radiation kills cancer cells with high-energy rays targeted directly to the tumor. Radiation therapy works by damaging the DNA and preventing its replication: therefore, it preferentially kills cancer cells, which rapidly divides. Radiation therapy is used for cure, control, and palliation of cancers in more than 60% of cancer patients. The goal of radiotherapy is to treat the cancer and spare the normal tissue as much as possible. Advances have been made in radiotherapy that allow delivery of higher doses of radiation to the tumor while sparing a greater amount of surrounding tissue, thus achieving more cures and fewer acute and long-term side effects. Technological advances and research are being continued to result in improvements in the field. Several new devices and techniques are used these days in radiotherapy for accurate treatment of cancer. Teletherapy (external radiation therapy) used focused radiation beams targeting well defined tumor through extremely detailed imaging scans. Conventional external beam radiation therapy (2DXRT) is delivered via two-dimensional beams using linear accelerator machines (X

Music therapy CD creation for initial pediatric radiation therapy: a mixed methods analysis.

Science.gov (United States)

Barry, Philippa; O'Callaghan, Clare; Wheeler, Greg; Grocke, Denise

2010-01-01

A mixed methods research design was used to investigate the effects of a music therapy CD (MTCD) creation intervention on pediatric oncology patients' distress and coping during their first radiation therapy treatment. The music therapy method involved children creating a music CD using interactive computer-based music software, which was "remixed" by the music therapist-researcher to extend the musical material. Eleven pediatric radiation therapy outpatients aged 6 to 13 years were randomly assigned to either an experimental group, in which they could create a music CD prior to their initial treatment to listen to during radiation therapy, or to a standard care group. Quantitative and qualitative analyses generated multiple perceptions from the pediatric patients, parents, radiation therapy staff, and music therapist-researcher. Ratings of distress during initial radiation therapy treatment were low for all children. The comparison between the two groups found that 67% of the children in the standard care group used social withdrawal as a coping strategy, compared to 0% of the children in the music therapy group; this trend approached significance (p = 0.076). MTCD creation was a fun, engaging, and developmentally appropriate intervention for pediatric patients, which offered a positive experience and aided their use of effective coping strategies to meet the demands of their initial radiation therapy treatment.

Segmented scintillation detectors with silicon photomultiplier readout for measuring antiproton annihilations

CERN Document Server

Sótér, A.; Kobayashi, T.; Barna, D.; Horváth, D.; Hori, M.

2014-01-01

The Atomic Spectroscopy and Collisions Using Slow Antiprotons (ASACUSA) experiment at the Antiproton Decelerator (AD) facility of CERN constructed segmented scintillators to detect and track the charged pions which emerge from antiproton annihilations in a future superconducting radiofrequency Paul trap for antiprotons. A system of 541 cast and extruded scintillator bars were arranged in 11 detector modules which provided a spatial resolution of 17 mm. Green wavelength-shifting fibers were embedded in the scintillators, and read out by silicon photomultipliers which had a sensitive area of 1 x 1 mm^2. The photoelectron yields of various scintillator configurations were measured using a negative pion beam of momentum p ~ 1 GeV/c. Various fibers and silicon photomultipliers, fiber end terminations, and couplings between the fibers and scintillators were compared. The detectors were also tested using the antiproton beam of the AD. Nonlinear effects due to the saturation of the silicon photomultiplier were seen a...

Commissioning of Fermilab's Electron Cooling System for 8-GeV Antiprotons

CERN Document Server

Nagaitsev, Sergei; Burov, Alexey; Carlson, Kermit; Gai, Wei; Gattuso, Consolato; Hu, Martin; Kazakevich, Grigory; Kramper, Brian J; Kroc, Thomas K; Leibfritz, Jerry; Prost, Lionel; Pruss, Stanley M; Saewert, Greg W; Schmidt, Chuck; Seletsky, Sergey; Shemyakin, Alexander V; Sutherland, Mary; Tupikov, Vitali; Warner, Arden

2005-01-01

A 4.3-MeV electron cooling system has been installed at Fermilab in the Recycler antiproton storage ring and is being currently commissioned. The cooling system is designed to assist accumulation of 8.9-GeV/c antiprotons for the Tevatron collider operations. This paper will report on the progress of the electron beam commissioning effort as well as on detailed plans of demonstrating the cooling of antiprotons.

Muon, positron and antiproton interactions with atoms and molecules

Energy Technology Data Exchange (ETDEWEB)

Armour, Edward A G, E-mail: edward.armour@nottingham.ac.u [School of Mathematical Sciences, University of Nottingham, Nottingham NG7 2RD (United Kingdom)

2010-04-01

In this paper, a description is given of some interesting processes involving the interaction of a muon, a positron, or an antiproton with atoms and molecules. The process involving a muon is the resonant formation of the muonic molecular ion, dt{mu}, in the muon catalyzed fusion cycle. In the case of a positron, the process considered is positron annihilation in low-energy positron scattering by the hydrogen molecule. The antiproton is considered as the nucleus of an antihydrogen atom interacting with simple atoms. Attention is given to antiproton annihilation through the strong interaction. An outline is given of proposed tests of fundamental physics to be carried out using antihydrogen.

Pediatric radiation therapy. A Japanese nationwide survey

International Nuclear Information System (INIS)

Nemoto, Kenji; Nagata, Yasushi; Hirokawa, Yutaka

2006-01-01

A national survey on the current status of pediatric radiation therapy was performed in October 2004. We sent questionnaires to 638 radiotherapy facilities in Japan (except for Kansai area) and 245 responses were analyzed. According to the database of committee of Japanese Society of Therapeutic Radiology and Oncology (JASTRO), the number of pediatric patients who received radiation therapy during 2003 in Japan was 1,101. The most frequent pediatric malignancy was brain tumor, followed by leukemia and lymphoma. The total effort of radiation therapy for children was two to six times larger than that for adult patients. An additional fee seems to be necessary for the highly technical and laborious radiation therapy required for children. (author)

Antiproton acceleration in the Fermilab Main Ring and Tevatron

International Nuclear Information System (INIS)

Martin, P.; Dinkel, J.; Ducar, R.

1987-01-01

The operation of the Fermilab Main Ring and Tevatron rf systems for colliding beams physics is discussed. The changes in the rf feedback system required for acceleration of antiprotons, and the methods for achieving proper transfer of both protons and antiprotons are described. Data on acceleration and transfer efficiencies are presented

Whole-brain hippocampal sparing radiation therapy: Volume-modulated arc therapy vs intensity-modulated radiation therapy case study.

Science.gov (United States)

Lee, Katrina; Lenards, Nishele; Holson, Janice

2016-01-01

The hippocampus is responsible for memory and cognitive function. An ongoing phase II clinical trial suggests that sparing dose to the hippocampus during whole-brain radiation therapy can help preserve a patient׳s neurocognitive function. Progressive research and advancements in treatment techniques have made treatment planning more sophisticated but beneficial for patients undergoing treatment. The aim of this study is to evaluate and compare hippocampal sparing whole-brain (HS-WB) radiation therapy treatment planning techniques using volume-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). We randomly selected 3 patients to compare different treatment techniques that could be used for reducing dose to the hippocampal region. We created 2 treatment plans, a VMAT and an IMRT, from each patient׳s data set and planned on the Eclipse 11.0 treatment planning system (TPS). A total of 6 plans (3 IMRT and 3 VMAT) were created and evaluated for this case study. The physician contoured the hippocampus as per the Radiation Therapy Oncology Group (RTOG) 0933 protocol atlas. The organs at risk (OR) were contoured and evaluated for the plan comparison, which included the spinal cord, optic chiasm, the right and left eyes, lenses, and optic nerves. Both treatment plans produced adequate coverage on the planning target volume (PTV) while significantly reducing dose to the hippocampal region. The VMAT treatment plans produced a more homogenous dose distribution throughout the PTV while decreasing the maximum point dose to the target. However, both treatment techniques demonstrated hippocampal sparing when irradiating the whole brain. Copyright © 2016 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Antiproton Production beam and Reverse Injection System

Energy Technology Data Exchange (ETDEWEB)

Chadwick, G.

1981-08-16

The objectives of this project are two fold: (1) To extract high energy protons from the Main Ring (MR) and target them to produce antiprotons which are subsequently captured in the existing Booster accelerator; and (2) to provide a channel for injecting either protons or antiprotons into the MR from the booster in a direction opposite to that of the normal proton acceleration as colliding beams can be created. The present design, therefore, is in support of two separate larger projects, viz., the collisions of protons in the Tevatron (normal circulation direction) with 'reverse injected' protons in the MR, and the collision of normal direction protons with reverse injected antiprotons either in the MR or in the Tevatron. Figure 1 shows the layout of the project area. It spans the shortest distance between possible injection/ejection points in the existing accelerator structures, hence minimizing costs. The tunnel will lie underground at the level of the MR and booster.

Spectroscopy of antiprotonic helium atoms and its contribution to the fundamental physical constants

CERN Document Server

Hayano, R S

2010-01-01

Antiprotonic helium atom, a metastable neutral system consisting of an antiproton, an electron and a helium nucleus, was serendipitously discovered, and has been studied at CERN’s antiproton decelerator facility. Its transition frequencies have recently been measured to nine digits of precision by laser spectroscopy. By comparing these experimental results with three-body QED calculations, the antiproton-to-electron massratio was determined as 1836.152674(5). This result contributed to the CODATA recommended values of the fundamental physical constants.

Physics with antiprotons: from antihydrogen to the top-quark

International Nuclear Information System (INIS)

Koch, H.

2001-01-01

The talk gives a survey on experiments performed with antiprotons of different energies. The emphasis will be on results obtained at LEAR/CERN, but the exciting investigations with higher energy antiprotons, leading to the discovery of the intermediate bosons W + , W - , Z 0 and the top quark t, will also be discussed. (orig.)

Better Efficacy of Synchrotron Spatially Microfractionated Radiation Therapy Than Uniform Radiation Therapy on Glioma

International Nuclear Information System (INIS)

Bouchet, Audrey; Bräuer-Krisch, Elke; Prezado, Yolanda; El Atifi, Michèle; Rogalev, Léonid; Le Clec'h, Céline; Laissue, Jean Albert; Pelletier, Laurent; Le Duc, Géraldine

2016-01-01

Purpose: Synchrotron microbeam radiation therapy (MRT) is based on the spatial fractionation of the incident, highly focused synchrotron beam into arrays of parallel microbeams, typically a few tens of microns wide and depositing several hundred grays. This irradiation modality was shown to have a high therapeutic impact on tumors, especially in intracranial locations. However, mechanisms responsible for such a property are not fully understood. Methods and Materials: Thanks to recent progress in dosimetry, we compared the effect of MRT and synchrotron broad beam (BB) radiation therapy delivered at comparable doses (equivalent to MRT valley dose) on tumor growth control and on classical radiobiological functions by histologic evaluation and/or transcriptomic analysis. Results: MRT significantly improved survival of rats bearing 9L intracranial glioma compared with BB radiation therapy delivered at a comparable dose (P<.001); the efficacy of MRT and BB radiation therapy was similar when the MRT dose was half that of BB. The greater efficacy of MRT was not correlated with a difference in cell proliferation (Mki67 and proliferating cell nuclear antigen) or in transcriptomic stimulation of angiogenesis (vascular endothelial growth factor A or tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 2) but was correlated with a higher cell death rate (factor for apoptosis signals) and higher recruitment of macrophages (tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 1 and CD68 transcripts) a few days after MRT. Conclusions: These results show the superiority of MRT over BB radiation therapy when applied at comparable doses, suggesting that spatial fractionation is responsible for a specific and particularly efficient tissue response. The higher induction of cell death and immune cell activation in brain tumors treated by MRT may be involved in such responses.

Better Efficacy of Synchrotron Spatially Microfractionated Radiation Therapy Than Uniform Radiation Therapy on Glioma

Energy Technology Data Exchange (ETDEWEB)

Bouchet, Audrey, E-mail: audrey.m.bouchet@gmail.com [Université Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble (France); Biomedical Beamline, European Synchrotron Radiation Facility, Grenoble (France); Bräuer-Krisch, Elke; Prezado, Yolanda [Biomedical Beamline, European Synchrotron Radiation Facility, Grenoble (France); El Atifi, Michèle [Université Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble (France); Grenoble University Hospital, Grenoble (France); Rogalev, Léonid; Le Clec' h, Céline [Biomedical Beamline, European Synchrotron Radiation Facility, Grenoble (France); Laissue, Jean Albert [University of Bern, Bern (Switzerland); Pelletier, Laurent, E-mail: laurent.pelletier@ujf-grenoble.fr [Université Grenoble Alpes, Grenoble Institut des Neurosciences, Grenoble (France); Grenoble University Hospital, Grenoble (France); Le Duc, Géraldine [Biomedical Beamline, European Synchrotron Radiation Facility, Grenoble (France)

2016-08-01

Purpose: Synchrotron microbeam radiation therapy (MRT) is based on the spatial fractionation of the incident, highly focused synchrotron beam into arrays of parallel microbeams, typically a few tens of microns wide and depositing several hundred grays. This irradiation modality was shown to have a high therapeutic impact on tumors, especially in intracranial locations. However, mechanisms responsible for such a property are not fully understood. Methods and Materials: Thanks to recent progress in dosimetry, we compared the effect of MRT and synchrotron broad beam (BB) radiation therapy delivered at comparable doses (equivalent to MRT valley dose) on tumor growth control and on classical radiobiological functions by histologic evaluation and/or transcriptomic analysis. Results: MRT significantly improved survival of rats bearing 9L intracranial glioma compared with BB radiation therapy delivered at a comparable dose (P<.001); the efficacy of MRT and BB radiation therapy was similar when the MRT dose was half that of BB. The greater efficacy of MRT was not correlated with a difference in cell proliferation (Mki67 and proliferating cell nuclear antigen) or in transcriptomic stimulation of angiogenesis (vascular endothelial growth factor A or tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 2) but was correlated with a higher cell death rate (factor for apoptosis signals) and higher recruitment of macrophages (tyrosine kinase with immunoglobulin-like and epidermal growth factor-like domains 1 and CD68 transcripts) a few days after MRT. Conclusions: These results show the superiority of MRT over BB radiation therapy when applied at comparable doses, suggesting that spatial fractionation is responsible for a specific and particularly efficient tissue response. The higher induction of cell death and immune cell activation in brain tumors treated by MRT may be involved in such responses.

Influence of radiation therapy on T-lymphocyte subpopulations

International Nuclear Information System (INIS)

Job, G.

1984-01-01

The author claims this to be the first time where monoclonal antibodies are used in a long-term study in order to determine the influence of radiation therapy on T-lymphozyte-subpopulations in patients suffering from malignant growths. The influence of radiation therapy on B-cells, T-cells and macrophages was also checked. Two groups of patients were given two different radiation doses, and examined separately in order to discover possible effects of the dosage. Radiation therapy reduced B- and T-lymphocytes to the same degree as the total lymphozyte population so that their shares in percent remained unchanged. The same was also found for macrophages. Determination of clones and suppressor T-lymphozytes before, during and after radiation showed T-lymphozytes to have a higher resistance against the influence of radiation than clones. Suppressor cells also regenerated more quickly than clones after the end of the therapy. While radiation therapy was applied the clone/suppressor cell ratio dropped to values lower than those of the healthy reference group. After the end of the therapy this quotient dropped even further in some cases while in others it began to rise slowly, but even 6 months after the end of the therapy it was still lower than normal. As a number of diseases show an increased 'immunoregulatory quotient' it would be conceivable to influence this quotient with radiation therapy in order to achieve a therapeutic effect. (orig./MG) [de

Buffer-gas cooling of antiprotonic helium to 1.5 to 1.7 K, and antiproton-to–electron mass ratio

CERN Document Server

Hori, Masaki; Sótér, Anna; Barna, Daniel; Dax, Andreas; Hayano, Ryugo; Kobayashi, Takumi; Murakami, Yohei; Todoroki, Koichi; Yamada, Hiroyuki; Horváth, Dezső; Venturelli, Luca

2016-01-01

Charge, parity, and time reversal (CPT) symmetry implies that a particle and its antiparticle have the same mass. The antiproton-to-electron mass ratio Embedded Image can be precisely determined from the single-photon transition frequencies of antiprotonic helium. We measured 13 such frequencies with laser spectroscopy to a fractional precision of 2.5 × 10−9 to 16 × 10−9. About 2 × 109 antiprotonic helium atoms were cooled to temperatures between 1.5 and 1.7 kelvin by using buffer-gas cooling in cryogenic low-pressure helium gas; the narrow thermal distribution led to the observation of sharp spectral lines of small thermal Doppler width. The deviation between the experimental frequencies and the results of three-body quantum electrodynamics calculations was reduced by a factor of 1.4 to 10 compared with previous single-photon experiments. From this, Embedded Image was determined as 1836.1526734(15), which agrees with a recent proton-to-electron experimental value within 8 × 10−10.

External and internal radiation therapy: Past and future directions

Directory of Open Access Journals (Sweden)

Sadeghi Mahdi

2010-01-01

Full Text Available Cancer is a leading cause of morbidity and mortality in the modern world. Treatment modalities comprise radiation therapy, surgery, chemotherapy and hormonal therapy. Radiation therapy can be performed by using external or internal radiation therapy. However, each method has its unique properties which undertakes special role in cancer treatment, this question is brought up that: For cancer treatment, whether external radiation therapy is more efficient or internal radiation therapy one? To answer this question, we need to consider principles and structure of individual methods. In this review, principles and application of each method are considered and finally these two methods are compared with each other.

Evaporative Cooling of Antiprotons to Cryogenic Temperatures

CERN Document Server

Andresen, G B; Baquero-Ruiz, M; Bertsche, W; Bowe, P D; Butler, E; Cesar, C L; Chapman, S; Charlton, M; Fajans, J; Friesen, T; Fujiwara, M C; Gill, D R; Hangst, J S; Hardy, W N; Hayano, R S; Hayden, M E; Humphries, A; Hydomako, R; Jonsell, S; Kurchaninov, L; Lambo, R; Madsen, N; Menary, S; Nolan, P; Olchanski, K; Olin, A; Povilus, A; Pusa, P; Robicheaux, F; Sarid, E; Silveira, D M; So, C; Storey, J W; Thompson, R I; van der Werf, D P; Wilding, D; Wurtele, J S; Yamazaki, Y

2010-01-01

We report the application of evaporative cooling to clouds of trapped antiprotons, resulting in plasmas with measured temperature as low as 9~K. We have modeled the evaporation process for charged particles using appropriate rate equations. Good agreement between experiment and theory is observed, permitting prediction of cooling efficiency in future experiments. The technique opens up new possibilities for cooling of trapped ions and is of particular interest in antiproton physics, where a precise CPT test on trapped antihydrogen is a long-standing goal.

Progress in antiproton physics

International Nuclear Information System (INIS)

Miettinen, H.I.

1976-09-01

Some recent results on proton-antiproton collisions are reviewed. The duality structure of processes where baryon number or strangeness may be annihilated receives particular attention. Attempts to obtain experimental information on the impact parameter space structure of multiparticle processes are discussed. Suggestions for future research are made

Coincidence studies with antiprotons

Energy Technology Data Exchange (ETDEWEB)

McGovern, M; Walters, H R J [Department of Applied Mathematics and Theoretical Physics, Queen' s University, Belfast BT7 1NN (United Kingdom); Assafrao, D; Mohallem, J R [Laboratorio de Atomos e Moleculas Especiais, Departamento de Fisica, ICEx, Universidade Federal de Minas Gerais, P.O Box 702, 30123-970 Belo Horizonte, MG (Brazil); Whelan, Colm T, E-mail: mmcgovern06@qub.ac.u [Department of Physics, Old Dominion University, Norfolk, VA 23529-0116 (United States)

2010-02-01

We present a short overview of a new method for calculating fully differential cross sections that is able to describe any aspect of coincidence measurements involving heavy projectiles. The method is based upon impact parameter close coupling with pseudostates. Examples from antiproton impact ionization are shown.

Spectroscopy of antiprotonic helium atoms and its contribution to the fundamental physical constants

Science.gov (United States)

Hayano, Ryugo S.

2010-01-01

Antiprotonic helium atom, a metastable neutral system consisting of an antiproton, an electron and a helium nucleus, was serendipitously discovered, and has been studied at CERN’s antiproton decelerator facility. Its transition frequencies have recently been measured to nine digits of precision by laser spectroscopy. By comparing these experimental results with three-body QED calculations, the antiproton-to-electron massratio was determined as 1836.152674(5). This result contributed to the CODATA recommended values of the fundamental physical constants. PMID:20075605

Modern radiation therapy for extranodal lymphomas

DEFF Research Database (Denmark)

Yahalom, Joachim; Illidge, Tim; Specht, Lena

2015-01-01

Extranodal lymphomas (ENLs) comprise about a third of all non-Hodgkin lymphomas (NHL). Radiation therapy (RT) is frequently used as either primary therapy (particularly for indolent ENL), consolidation after systemic therapy, salvage treatment, or palliation. The wide range of presentations of ENL...... and treatment planning for the most frequently involved organs. Specifically, detailed recommendations for RT volumes are provided. We have applied the same modern principles of involved site radiation therapy as previously developed and published as guidelines for Hodgkin lymphoma and nodal NHL. We have...... there is a lack of guidelines for the use of RT in the management of ENL. This report presents an effort by the International Lymphoma Radiation Oncology Group (ILROG) to harmonize and standardize the principles of treatment of ENL, and to address the technical challenges of simulation, volume definition...

Radiation Therapy for Cancer

Science.gov (United States)

... can cause pain. Radiation given to shrink a tumor near the esophagus , which can interfere with a patient’s ability to eat and drink. How is radiation therapy planned for an individual ... show the location of a patient’s tumor and the normal areas around it. These scans ...

Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy

International Nuclear Information System (INIS)

Liu Hui; Zhang Xu; Vinogradskiy, Yevgeniy Y.; Swisher, Stephen G.; Komaki, Ritsuko; Chang, Joe Y.

2012-01-01

Purpose: To determine the incidence of and risk factors for radiation pneumonitis (RP) after stereotactic ablative radiation therapy (SABR) to the lung in patients who had previously undergone conventional thoracic radiation therapy. Methods and Materials: Seventy-two patients who had previously received conventionally fractionated radiation therapy to the thorax were treated with SABR (50 Gy in 4 fractions) for recurrent disease or secondary parenchymal lung cancer (T 10 and mean lung dose (MLD) of the previous plan and the V 10 -V 40 and MLD of the composite plan were also related to RP. Multivariate analysis revealed that ECOG PS scores of 2-3 before SABR (P=.009), FEV1 ≤65% before SABR (P=.012), V 20 ≥30% of the composite plan (P=.021), and an initial PTV in the bilateral mediastinum (P=.025) were all associated with RP. Conclusions: We found that severe RP was relatively common, occurring in 20.8% of patients, and could be predicted by an ECOG PS score of 2-3, an FEV1 ≤65%, a previous PTV spanning the bilateral mediastinum, and V 20 ≥30% on composite (previous RT+SABR) plans. Prospective studies are needed to validate these predictors and the scoring system on which they are based.

TH-F-202-00: MRI for Radiation Therapy

International Nuclear Information System (INIS)

2016-01-01

MRI has excellent soft tissue contrast and can provide both anatomical and physiological information. It is becoming increasingly important in radiation therapy for treatment planning, image-guided radiation therapy, and treatment assessment. It is critically important at this time point to educate and update our medical physicists about MRI to prepare for the upcoming surge of MRI applications in radiation therapy. This session will review important basics of MR physics, pulse sequence designs, and current radiotherapy application, as well as showcase exciting new developments in MRI that can be potentially useful in radiation therapy. Learning Objectives: To learn basics of MR physics and understand the differences between various pulse sequences To review current applications of MRI in radiation therapy.To discuss recent MRI advances for future MRI guided radiation therapy Partly supported by NIH (1R21CA165384).; W. Miller, Research supported in part by Siemens Healthcare; G. Li, My clinical research is in part supported by NIH U54CA137788. I have a collaborative research project with Philips Healthcare.; J. Cai, jing cai

TH-F-202-00: MRI for Radiation Therapy

Energy Technology Data Exchange (ETDEWEB)

NONE

2016-06-15

MRI has excellent soft tissue contrast and can provide both anatomical and physiological information. It is becoming increasingly important in radiation therapy for treatment planning, image-guided radiation therapy, and treatment assessment. It is critically important at this time point to educate and update our medical physicists about MRI to prepare for the upcoming surge of MRI applications in radiation therapy. This session will review important basics of MR physics, pulse sequence designs, and current radiotherapy application, as well as showcase exciting new developments in MRI that can be potentially useful in radiation therapy. Learning Objectives: To learn basics of MR physics and understand the differences between various pulse sequences To review current applications of MRI in radiation therapy.To discuss recent MRI advances for future MRI guided radiation therapy Partly supported by NIH (1R21CA165384).; W. Miller, Research supported in part by Siemens Healthcare; G. Li, My clinical research is in part supported by NIH U54CA137788. I have a collaborative research project with Philips Healthcare.; J. Cai, jing cai.

Antiproton source beam position system

International Nuclear Information System (INIS)

Bagwell, T.; Holmes, S.; McCarthy, J.; Webber, R.

1984-05-01

The TeV I Beam Position Monitor (BPM) system is designed to provide a useful diagnostic tool during the commissioning and operational phases of the antiproton source. Simply stated the design goal is to provide single turn position information for intensities of > 1x10 9 particles, and multi-turn (clocked orbit) information for beam intensities of > 1x10 7 particles, both with sub-millimeter resolution. It is anticipated that the system will be used during commissioning for establishing the first turn through the Debuncher and Accumulator, for aligning injection orbits, for providing information necessary to correct closed orbits, and for measuring various machine parameters (e.g. tunes, dispersion, aperture, chromaticity). During normal antiproton operation the system will be used to monitor the beam position throughout the accumulation process

Experiment to measure the gravitational force on the antiproton

International Nuclear Information System (INIS)

Brown, R.E.

1985-01-01

A collaboration has been formed to measure the acceleration of antiprotons in the earth's gravitational field. The technique is to produce, decelerate, and trap quantities of antiprotons, to cool them to untralow energy, and to measure their acceleration in a time-of-flight experiment. Present plans and the results of initial efforts toward this end are presented

Exploration of a High Luminosity 100 TeV Proton Antiproton Collider

Energy Technology Data Exchange (ETDEWEB)

Oliveros, Sandra J. [Univ. of Mississippi, Oxford, MS (United States); Summers, Don [Univ. of Mississippi, Oxford, MS (United States); Cremaldi, Lucien [Univ. of Mississippi, Oxford, MS (United States); Acosta, John [Univ. of Mississippi, Oxford, MS (United States); Neuffer, David [Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States)

2017-04-12

New physics is being explored with the Large Hadron Collider at CERN and with Intensity Frontier programs at Fermilab and KEK. The energy scale for new physics is known to be in the multi-TeV range, signaling the need for a future collider which well surpasses this energy scale. We explore a 10$^{\\,34}$ cm$^{-2}$ s$^{-1}$ luminosity, 100 TeV $p\\bar{p}$ collider with 7$\\times$ the energy of the LHC but only 2$\\times$ as much NbTi superconductor, motivating the choice of 4.5 T single bore dipoles. The cross section for many high mass states is 10 times higher in $p\\bar{p}$ than $pp$ collisions. Antiquarks for production can come directly from an antiproton rather than indirectly from gluon splitting. The higher cross sections reduce the synchrotron radiation in superconducting magnets and the number of events per beam crossing, because lower beam currents can produce the same rare event rates. Events are more centrally produced, allowing a more compact detector with less space between quadrupole triplets and a smaller $\\beta^{*}$ for higher luminosity. A Fermilab-like $\\bar p$ source would disperse the beam into 12 momentum channels to capture more antiprotons. Because stochastic cooling time scales as the number of particles, 12 cooling ring sets would be used. Each set would include phase rotation to lower momentum spreads, equalize all momentum channels, and stochastically cool. One electron cooling ring would follow the stochastic cooling rings. Finally antiprotons would be recycled during runs without leaving the collider ring by joining them to new bunches with synchrotron damping.

Care of the patient receiving radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Yasko, J.M.

1982-12-01

External radiation therapy, or teletherapy, is the use of ionizing radiation to destroy cancer cells. Clinical use of ionizing radiation as treatment for cancer began with the discovery of x-rays in 1895, the identification of natural radioactivity (radium) in 1896, and the first reported cure of cancer, a basal cell epithelioma, induced by radiation in 1899. Initially, radiation was administered as a single large dose and produced severe, life-threatening side effects. The basis for the use of ionizing radiation in daily increments for a period of weeks was provided by Regaud in 1922; ten years later, Coutard clinically developed the method of dose fractionation, which remains in use today. Although the use of ionizing radiation as a treatment is over eighty years old, only in recent years have advancements in its clinical application been based on research related to the biologic effect of radiation on human cells. To effectively care for the patient prior to, during, and at the completion of external radiation therapy, the nurse must know the physical and biologic basis of external radiation therapy and its clinical application.

Care of the patient receiving radiation therapy

International Nuclear Information System (INIS)

Yasko, J.M.

1982-01-01

External radiation therapy, or teletherapy, is the use of ionizing radiation to destroy cancer cells. Clinical use of ionizing radiation as treatment for cancer began with the discovery of x-rays in 1895, the identification of natural radioactivity (radium) in 1896, and the first reported cure of cancer, a basal cell epithelioma, induced by radiation in 1899. Initially, radiation was administered as a single large dose and produced severe, life-threatening side effects. The basis for the use of ionizing radiation in daily increments for a period of weeks was provided by Regaud in 1922; ten years later, Coutard clinically developed the method of dose fractionation, which remains in use today. Although the use of ionizing radiation as a treatment is over eighty years old, only in recent years have advancements in its clinical application been based on research related to the biologic effect of radiation on human cells. To effectively care for the patient prior to, during, and at the completion of external radiation therapy, the nurse must know the physical and biologic basis of external radiation therapy and its clinical application

RADIATION THERAPY COMMUNICATION-REIRRADIATION OF A NASAL TUMOR IN A BRACHYCEPHALIC DOG USING INTENSITY MODULATED RADIATION THERAPY.

Science.gov (United States)

Rancilio, Nicholas J; Custead, Michelle R; Poulson, Jean M

2016-09-01

A 5-year-old spayed female Shih Tzu was referred for evaluation of a nasal transitional carcinoma. A total lifetime dose of 117 Gy was delivered to the intranasal mass in three courses over nearly 2 years using fractionated intensity modulated radiation therapy (IMRT) to spare normal tissues. Clinically significant late normal tissue side effects were limited to bilaterally diminished tear production. The patient died of metastatic disease progression 694 days after completion of radiation therapy course 1. This case demonstrates that retreatment with radiation therapy to high lifetime doses for recurrent local disease may be well tolerated with IMRT. © 2016 American College of Veterinary Radiology.

Experimental determination of the complete spin structure for anti-proton + proton -> anti-\\Lambda + \\Lambda at anti-proton beam momentum of 1.637 GeV/c

CERN Document Server

Paschke, K.D.; Berdoz, A.; Franklin, G.B.; Khaustov, P.; Meyer, C.A.; Bradtke, C.; Gehring, R.; Goertz, S.; Harmsen, J.; Meier, A.; Meyer, W.; Radtke, E.; Reicherz, G.; Dutz, H.; Pluckthun, M.; Schoch, B.; Dennert, H.; Eyrich, W.; Hauffe, J.; Metzger, A.; Moosburger, M.; Stinzing, F.; Wirth, St.; Fischer, H.; Franz, J.; Heinsius, F.H.; Kriegler, E.; Schmitt, H.; Bunker, B.; Hertzog, D.; Jones, T.; Tayloe, R.; Broders, R.; Geyer, R.; Kilian, K.; Oelert, W.; Rohrich, K.; Sachs, K.; Sefzick, T.; Bassalleck, B.; Eilerts, S.; Fields, D.E.; Kingsberry, P.; Lowe, J.; Stotzer, R.; Johansson, T.; Pomp, S.; Wirth, St.

2006-01-01

The reaction anti-proton + proton -> anti-\\Lambda + \\Lambda -> anti-proton + \\pi^+ + proton + \\pi^- has been measured with high statistics at anti-proton beam momentum of 1.637 GeV/c. The use of a transversely-polarized frozen-spin target combined with the self-analyzing property of \\Lambda/anti-\\Lambda decay allows access to unprecedented information on the spin structure of the interaction. The most general spin-scattering matrix can be written in terms of eleven real parameters for each bin of scattering angle, each of these parameters is determined with reasonable precision. From these results all conceivable spin-correlations are determined with inherent self-consistency. Good agreement is found with the few previously existing measurements of spin observables in anti-proton + proton -> anti-\\Lambda + \\Lambda near this energy. Existing theoretical models do not give good predictions for those spin-observables that had not been previously measured.

Discriminating between antihydrogen and mirror-trapped antiprotons in a minimum-B trap

CERN Document Server

Amole, C; Ashkezari, M D; Baquero-Ruiz, M; Bertsche, W; Butler, E; Cesar, C L; Chapman, S; Charlton, M; Deller, A; Eriksson, S; Fajans, J; Friesen, T; Fujiwara, M C; Gill, D R; Gutierrez, A; Hangst, J S; Hardy, W N; Hayden, M E; Humphries, A J; Hydomako, R; Kurchaninov, L; Jonsell, S; Madsen, N; Menary, S; Nolan, P; Olchanski, K; Olin, A; Povilus, A; Pusa, P; Robicheaux, F; Sarid, E; Silveira, D M; So, C; Storey, J W; Thompson, R I; van der Werf, D P; Wurtele, J S

2012-01-01

Recently, antihydrogen atoms were trapped at CERN in a magnetic minimum (minimum-B) trap formed by superconducting octupole and mirror magnet coils. The trapped antiatoms were detected by rapidly turning off these magnets, thereby eliminating the magnetic minimum and releasing any antiatoms contained in the trap. Once released, these antiatoms quickly hit the trap wall, whereupon the positrons and antiprotons in the antiatoms annihilated. The antiproton annihilations produce easily detected signals; we used these signals to prove that we trapped antihydrogen. However, our technique could be confounded by mirror-trapped antiprotons, which would produce seemingly-identical annihilation signals upon hitting the trap wall. In this paper, we discuss possible sources of mirror-trapped antiprotons and show that antihydrogen and antiprotons can be readily distinguished, often with the aid of applied electric fields, by analyzing the annihilation locations and times. We further discuss the general properties of antipr...

Clinical applications of continuous infusion chemotherapy ahd concomitant radiation therapy

International Nuclear Information System (INIS)

Rosenthal, C.J.; Rotman, M.

1986-01-01

This book presents information on the following topics: theoretical basis and clinical applications of 5-FU as a radiosensitizer; treatment of hepatic metastases from gastro intestingal primaries with split course radiation therapy; combined modality therapy with 5-FU, Mitomycin-C and radiation therapy for sqamous cell cancers; treatment of bladder carcinoma with concomitant infusion chemotherapy and irradiation; a treatment of invasiv bladder cancer by the XRT/5FU protocol; concomitant radiation therapy and doxorubicin by continuous infusion in advanced malignancies; cis platin by continuous infusion with concurrent radiation therapy in malignant tumors; combination of radiation with concomitant continuous adriamycin infusion in a patient with partially excised pleomorphic soft tissue sarcoma of the lower extremeity; treatment of recurrent carcinoma of the paranasal sinuses using concomitant infusion cis-platinum and radiation therapy; hepatic artery infusion for hepatic metastases in combination with hepatic resection and hepatic radiation; study of simultaneous radiation therapy, continuous infusion, 5FU and bolus mitomycin-C; cancer of the esophagus; continuous infusion VP-16, bolus cis-platinum and simultaneous radiation therapy as salvage therapy in small cell bronchogenic carcinoma; and concomitant radiation, mitomycin-C and 5-FU infusion in gastro intestinal cancer

Effect of radiation therapy against intracranial hemangiopericytoma

Energy Technology Data Exchange (ETDEWEB)

Uemura, Shozaburo; Kuratsu, Jun-ichi; Hamada, Jun-ichiro; Yoshioka, Susumu; Kochi, Masato; Ushio, Yukitaka [Kumamoto Univ. (Japan). School of Medicine; Nakahara, Tadashi; Kishida, Katsuaki

1992-06-01

Seven cases of intracranial hemangiopericytoma were studied retrospectively to investigate the efficacy of radiation therapy. Tumor response evaluated by computed tomography and magnetic resonance imaging was obvious after 20-30 Gy irradiation. The total reduction rate was 80-90% and continued as long as 5-7 months after treatment. In five patients receiving radiation therapy before radical removal, the tumors were easily removed without massive hemorrhage. Histological inspection of specimens after irradiation showed a significant disappearance of tumor cells. Pyknosis frequently occurred in endothelial cells, and proliferating vessels with hyalinoid degeneration were also seen. Reticulin fibers between tumor cells were fewer, split, or absent. Preoperative radiation therapy is useful in the treatment of hemangiopericytoma involving considerable surgical risk. Postoperative radiation therapy should be given even if removal is complete. (author).

Effect of radiation therapy against intracranial hemangiopericytoma

International Nuclear Information System (INIS)

Uemura, Shozaburo; Kuratsu, Jun-ichi; Hamada, Jun-ichiro; Yoshioka, Susumu; Kochi, Masato; Ushio, Yukitaka; Nakahara, Tadashi; Kishida, Katsuaki.

1992-01-01

Seven cases of intracranial hemangiopericytoma were studied retrospectively to investigate the efficacy of radiation therapy. Tumor response evaluated by computed tomography and magnetic resonance imaging was obvious after 20-30 Gy irradiation. The total reduction rate was 80-90% and continued as long as 5-7 months after treatment. In five patients receiving radiation therapy before radical removal, the tumors were easily removed without massive hemorrhage. Histological inspection of specimens after irradiation showed a significant disappearance of tumor cells. Pyknosis frequently occurred in endothelial cells, and proliferating vessels with hyalinoid degeneration were also seen. Reticulin fibers between tumor cells were fewer, split, or absent. Preoperative radiation therapy is useful in the treatment of hemangiopericytoma involving considerable surgical risk. Postoperative radiation therapy should be given even if removal is complete. (author)

Measurement of cosmic ray antiprotons from 3.7 to 19 GeV

International Nuclear Information System (INIS)

Hof, M.; Pfeifer, C.; Menn, W.; Simon, M.; Golden, R.L.; Stochaj, S.J.; Basini, G.; Ricci, M.

1996-02-01

The antiproton to proton ratio in the cosmic rays has been measured in the energy range from 3.7 to 19 GeV. This measurement was carried out using a balloon-borne superconducting magnetic spectrometer along with a gas Cherenkov counter, an imaging calorimeter and a time of flight scintillator system. The measured antiproton to proton ratio was determined to be 1.24 (+0.68, -0.51)X 10 -4 . The present result along with other recent observations show that the observed abundances of antiprotons are consistent with models, in which antiprotons are produced as secondaries during the propagation of cosmic rays in the galaxy

Radiation therapy physics

CERN Document Server

1995-01-01

The aim of this book is to provide a uniquely comprehensive source of information on the entire field of radiation therapy physics. The very significant advances in imaging, computational, and accelerator technologies receive full consideration, as do such topics as the dosimetry of radiolabeled antibodies and dose calculation models. The scope of the book and the expertise of the authors make it essential reading for interested physicians and physicists and for radiation dosimetrists.

Modern radiation therapy for primary cutaneous lymphomas

DEFF Research Database (Denmark)

Specht, Lena; Dabaja, Bouthaina; Illidge, Tim

2015-01-01

Primary cutaneous lymphomas are a heterogeneous group of diseases. They often remain localized, and they generally have a more indolent course and a better prognosis than lymphomas in other locations. They are highly radiosensitive, and radiation therapy is an important part of the treatment......, either as the sole treatment or as part of a multimodality approach. Radiation therapy of primary cutaneous lymphomas requires the use of special techniques that form the focus of these guidelines. The International Lymphoma Radiation Oncology Group has developed these guidelines after multinational...... meetings and analysis of available evidence. The guidelines represent an agreed consensus view of the International Lymphoma Radiation Oncology Group steering committee on the use of radiation therapy in primary cutaneous lymphomas in the modern era....

Antiproton Powered Gas Core Fission Rocket

International Nuclear Information System (INIS)

Kammash, Terry

2005-01-01

Extensive research in recent years has demonstrated that 'at rest' annihilation of antiprotons in the uranium isotope U238 leads to fission at nearly 100% efficiency. The resulting highly-ionizing, energetic fission fragments can heat a suitable medium to very high temperatures, making such a process particularly suitable for space propulsion applications. Such an ionized medium, which would serve as a propellant, can be confined by a magnetic field during the heating process, and subsequently ejected through a magnetic nozzle to generate thrust. The gasdynamic mirror (GDM) magnetic configuration is especially suited for this application since the underlying confinement principle is that the plasma be of such density and temperature as to make the ion-ion collision mean free path shorter than the plasma length. Under these conditions the plasma behaves like a fluid, and its escape from the system is analogous to the flow of a gas into vacuum from a vessel with a hole. For the system we propose we envisage radially injecting atomic or U238 plasma beam at a pre-determined position and axially pulsing an antiproton beam which upon interaction with the uranium target gives rise to near isotropic ejection of fission fragments with a total mass of 212 amu and total energy of about 160 MeV. These particles, along with the annihilation products (i.e. pions and muons) will heat the background U238 gas - inserted into the chamber just prior to the release of the antiproton - to one keV temperature. Preliminary analysis reveals that such a propulsion system can produce a specific impulse of about 3000 seconds at a thrust of about 50 kN. When applied to a round trip Mars mission, we find that such a journey can be accomplished in about 142 days with 2 days of thrusting and requiring only one gram of antiprotons to achieve it

Physics fundamentals and biological effects of synchrotron radiation therapy

International Nuclear Information System (INIS)

Prezado, Y.

2010-01-01

The main goal of radiation therapy is to deposit a curative dose in the tumor without exceeding the tolerances in the nearby healthy tissues. For some radioresistant tumors, like gliomas, requiring high doses for complete sterilization, the major obstacle for curative treatment with ionizing radiation remains the limited tolerance of the surrounding healthy tissue. This limitation is particularly severe for brain tumors and, especially important in children, due to the high risk of complications in the development of the central nervous system. In addition, the treatment of tumors close to an organ at risk, like the spinal cord, is also restricted. One possible solution is the development of new radiation therapy techniques exploiting radically different irradiation modes and modifying, in this way, the biological equivalent doses. This is the case of synchrotron radiation therapy (SRT). In this work the three new radiation therapy techniques under development at the European Synchrotron Radiation Facility (ESRF), in Grenoble (France) will be described, namely: synchrotron stereotactic radiation therapy (SSRT), microbeam radiation therapy (MRT) and minibeam radiation therapy. The promising results in the treatment of the high grade brain tumors obtained in preclinical studies have paved the way to the clinical trials. The first patients are expected in the fall of 2010. (Author).

Galactic diffusion and the antiproton signal of supersymmetric dark matter

CERN Document Server

Chardonnet, P; Salati, Pierre; Taillet, R

1996-01-01

The leaky box model is now ruled out by measurements of a cosmic ray gradient throughout the galactic disk. It needs to be replaced by a more refined treatment which takes into account the diffusion of cosmic rays in the magnetic fields of the Galaxy. We have estimated the flux of antiprotons on the Earth in the framework of a two-zone diffusion model. Those species are created by the spallation reactions of high-energy nuclei with the interstellar gas. Another potential source of antiprotons is the annihilation of supersymmetric particles in the dark halo that surrounds our Galaxy. In this letter, we investigate both processes. Special emphasis is given to the antiproton signature of supersymmetric dark matter. The corresponding signal exceeds the conventional spallation flux below 300 MeV, a domain that will be thoroughly explored by the Antimatter Spectrometer experiment. The propagation of the antiprotons produced in the remote regions of the halo back to the Earth plays a crucial role. Depending on the e...

Radiation therapy and late reactions in normal tissues

International Nuclear Information System (INIS)

Aoyama, Takashi; Kuroda, Yasumasa

1998-01-01

Recent developments in cancer therapy have made us increasingly aware that the quality of life of a patient is as valuable as other benefits received from therapy. This awareness leads to an emphasis on organ and/or function preservation in the course of therapy. In line with this new thinking, greater consideration is placed on radiation therapy as an appropriate modality of cancer therapy. Possible complications in normal tissues, especially those of late reaction type after the therapy must be overcome. This review, therefore, focuses on recent progress of studies on mechanisms of the complications of the late reaction type. An observation of a clinical case concerning a late reaction of spinal cord (radiation myelopathy) and surveys of experimental studies on the mechanisms of late reactions (including radiation pneumonitis and lung fibrosis, and radiation response of vascular endothelial cells) provide a hypothesis that apoptosis through the pathway starting with radiation-induced sphingomyelin hydrolysis may play an important role in causing a variety of late reactions. This insight is based on the fact that radiation also activates protein kinase C which appears to block apoptosis. The mechanisms of late reactions, therefore, may involve a balance between radiation-induced apoptotic death and its down regulation by suppressor mechanisms through protein kinase C. (author)

Serach for polarization effects in the antiproton production process

CERN Multimedia

It is proposed to study polarization effects in the production of antiprotons at the PS test beam line T11 at 3.5 GeV/c momentum. A polarization in the production process has never been studied but if existing it would allow for a rather simple and cheap way to generate a polarized antiproton beam with the existing facilities at CERN.

Selective use of adjuvant radiation therapy in resectable colorectal adenocarcinoma

International Nuclear Information System (INIS)

Cohen, A.M.; Gunderson, L.L.; Welch, C.E.

1981-01-01

Colorectal cancer recurs within the operative field in 10-20 per cent of patients undergoing potentially curative surgery. In certain subgroups, the recurrence rate is 20-50 per cent. There are some data to suggest either preoperative or postoperative radiation therapy as an adjuvant to potentially curative surgery can reduce the local operative failure rate. However, since radiation therapy has significant side effects, patient selection to maximize the therapeutic ratio is important. This report defines the criteria at the Massachusetts General Hospital for selection of patients with colorectal cancer for adjuvant radiation therapy, defines radiation therapy-surgery sequencing alternatives used, and describes techniques to reduce radiation side effects. Over a period of three and a half years, 196 patients received adjuvant radiation therapy: 51 patients received either moderate or low dose preoperative radiation therapy to rectal or rectosigmoid cancers, and 161 patients received postoperative radiation therapy to the pelvis or extrapelvic colonic tumor-lymph node beds. Some patients who received low-dose preoperative radiation therapy also received moderate-dose postoperative radiation therapy. We prefer moderate-dose postoperative radiation therapy as the approach most likely to decrease the local recurrence rate with minimal interference with surgical procedures and late small-bowel complications. Patients who received postoperative radiation therapy were those without distant metastases, whose primary tumor pathology revealed macroscopic or extensive microscopic transmural tumor penetration into extraperitoneal tissues. Careful case selection, multiple field techniques, the use of reperitonealization, omental flaps, and retroversion of the uterus into the pelvis were combined with postoperative small-bowel x-rays, bladder distention, and lateral portals to minimize radiation damage to normal structures

Measurement of antiproton annihilation on Cu, Ag and Au with emulsion films

International Nuclear Information System (INIS)

Aghion, S.; Consolati, G.; Evans, C.; Ferragut, R.; Amsler, C.; Ariga, A.; Ariga, T.; Ereditato, A.; Bonomi, G.; Bräunig, P.; Demetrio, A.; Brusa, R.S.; Cabaret, L.; Comparat, D.; Caccia, M.; Castelli, F.; Caravita, R.; Noto, L. Di; Cerchiari, G.; Doser, M.

2017-01-01

The characteristics of low energy antiproton annihilations on nuclei (e.g. hadronization and product multiplicities) are not well known, and Monte Carlo simulation packages that use different models provide different descriptions of the annihilation events. In this study, we measured the particle multiplicities resulting from antiproton annihilations on nuclei. The results were compared with predictions obtained using different models in the simulation tools GEANT4 and FLUKA. For this study, we exposed thin targets (Cu, Ag and Au) to a very low energy antiproton beam from CERN's Antiproton Decelerator, exploiting the secondary beamline available in the AEgIS experimental zone. The antiproton annihilation products were detected using emulsion films developed at the Laboratory of High Energy Physics in Bern, where they were analysed at the automatic microscope facility. The fragment multiplicity measured in this study is in good agreement with results obtained with FLUKA simulations for both minimally and heavily ionizing particles.

Measurement of antiproton annihilation on Cu, Ag and Au with emulsion films

Science.gov (United States)

Aghion, S.; Amsler, C.; Ariga, A.; Ariga, T.; Bonomi, G.; Bräunig, P.; Brusa, R. S.; Cabaret, L.; Caccia, M.; Caravita, R.; Castelli, F.; Cerchiari, G.; Comparat, D.; Consolati, G.; Demetrio, A.; Di Noto, L.; Doser, M.; Ereditato, A.; Evans, C.; Ferragut, R.; Fesel, J.; Fontana, A.; Gerber, S.; Giammarchi, M.; Gligorova, A.; Guatieri, F.; Haider, S.; Hinterberger, A.; Holmestad, H.; Huse, T.; Kawada, J.; Kellerbauer, A.; Kimura, M.; Krasnický, D.; Lagomarsino, V.; Lansonneur, P.; Lebrun, P.; Malbrunot, C.; Mariazzi, S.; Matveev, V.; Mazzotta, Z.; Müller, S. R.; Nebbia, G.; Nedelec, P.; Oberthaler, M.; Pacifico, N.; Pagano, D.; Penasa, L.; Petracek, V.; Pistillo, C.; Prelz, F.; Prevedelli, M.; Ravelli, L.; Rienaecker, B.; RØhne, O. M.; Rotondi, A.; Sacerdoti, M.; Sandaker, H.; Santoro, R.; Scampoli, P.; Simon, M.; Smestad, L.; Sorrentino, F.; Testera, G.; Tietje, I. C.; Vamosi, S.; Vladymyrov, M.; Widmann, E.; Yzombard, P.; Zimmer, C.; Zmeskal, J.; Zurlo, N.

2017-04-01

The characteristics of low energy antiproton annihilations on nuclei (e.g. hadronization and product multiplicities) are not well known, and Monte Carlo simulation packages that use different models provide different descriptions of the annihilation events. In this study, we measured the particle multiplicities resulting from antiproton annihilations on nuclei. The results were compared with predictions obtained using different models in the simulation tools GEANT4 and FLUKA. For this study, we exposed thin targets (Cu, Ag and Au) to a very low energy antiproton beam from CERN's Antiproton Decelerator, exploiting the secondary beamline available in the AEgIS experimental zone. The antiproton annihilation products were detected using emulsion films developed at the Laboratory of High Energy Physics in Bern, where they were analysed at the automatic microscope facility. The fragment multiplicity measured in this study is in good agreement with results obtained with FLUKA simulations for both minimally and heavily ionizing particles.

Antiproton-decelerating Radio-Frequency Quadrupole (RFQD), inner structure.

CERN Multimedia

Laurent Guiraud

1999-01-01

The inner structure of the RFQD, withdrawn from its tank. In picture _06, the upstream end is in the back and the view is on the downstream exit. The RFQD has a length of 3.5 m and operates at a frequency of 202.4 MHz. It further decelerates antiprotons from the Antiproton Decelerator (3.5 MeV/c to 100 MeV/c, or 5.3 MeV) to very low energies around 50 keV.

Extramammary Paget's disease: role of radiation therapy

International Nuclear Information System (INIS)

Guerrieri, M.; Back, M.F.

2002-01-01

Extra mammary Paget's disease (EMPD) is an uncommon premalignant skin condition that has been traditionally managed with surgery. A report of long-standing Paget's disease with transformation to invasive adenocarcinoma definitively managed with radiation therapy is presented. A review of cases of extramammary Paget's disease treated with radiation therapy is discussed. The use of radiation therapy should be considered in selected cases, as these studies demonstrate acceptable rates of local control when used as an adjunct to surgery, or as a definitive treatment modality. Copyright (2002) Blackwell Science Pty Ltd

Scalp Dose Evaluation According Radiation Therapy Technique of Whole Brain Radiation Therapy

International Nuclear Information System (INIS)

Jang, Joon Yung; Park, Soo Yun; Kim, Jong Sik; Choi, Byeong Gi; Song, Gi Won

2011-01-01

Opposing portal irradiation with helmet field shape that has been given to a patient with brain metastasis can cause excess dose in patient's scalp, resulting in hair loss. For this reason, this study is to quantitatively analyze scalp dose for effective prevention of hair loss by comparing opposing portal irradiation with scalp-shielding shape and tomotherapy designed to protect patient's scalp with conventional radiation therapy. Scalp dose was measured by using three therapies (HELMET, MLC, TOMO) after five thermo-luminescence dosimeters were positioned along center line of frontal lobe by using RANDO Phantom. Scalp dose and change in dose distribution were compared and analyzed with DVH after radiation therapy plan was made by using Radiation Treatment Planning System (Pinnacle3, Philips Medical System, USA) and 6 MV X-ray (Clinac 6EX, VARIAN, USA). When surface dose of scalp by using thermo-luminescence dosimeters was measured, it was revealed that scalp dose decreased by average 87.44% at each point in MLC technique and that scalp dose decreased by average 88.03% at each point in TOMO compared with HELMET field therapy. In addition, when percentage of volume (V95%, V100%, V105% of prescribed dose) was calculated by using Dose Volume Histogram (DVH) in order to evaluate the existence or nonexistence of hotspot in scalp as to three therapies (HELMET, MLC, TOMO), it was revealed that MLC technique and TOMO plan had good dose coverage and did not have hot spot. Reducing hair loss of a patient who receives whole brain radiotherapy treatment can make a contribution to improve life quality of the patient. It is expected that making good use of opposing portal irradiation with scalp-shielding shape and tomotherapy to protect scalp of a patient based on this study will reduce hair loss of a patient.

Scalp Dose Evaluation According Radiation Therapy Technique of Whole Brain Radiation Therapy

Energy Technology Data Exchange (ETDEWEB)

Jang, Joon Yung; Park, Soo Yun; Kim, Jong Sik; Choi, Byeong Gi; Song, Gi Won [Dept. of Radiation Oncology, Samsung Medical Center, Seoul (Korea, Republic of)

2011-09-15

Opposing portal irradiation with helmet field shape that has been given to a patient with brain metastasis can cause excess dose in patient's scalp, resulting in hair loss. For this reason, this study is to quantitatively analyze scalp dose for effective prevention of hair loss by comparing opposing portal irradiation with scalp-shielding shape and tomotherapy designed to protect patient's scalp with conventional radiation therapy. Scalp dose was measured by using three therapies (HELMET, MLC, TOMO) after five thermo-luminescence dosimeters were positioned along center line of frontal lobe by using RANDO Phantom. Scalp dose and change in dose distribution were compared and analyzed with DVH after radiation therapy plan was made by using Radiation Treatment Planning System (Pinnacle3, Philips Medical System, USA) and 6 MV X-ray (Clinac 6EX, VARIAN, USA). When surface dose of scalp by using thermo-luminescence dosimeters was measured, it was revealed that scalp dose decreased by average 87.44% at each point in MLC technique and that scalp dose decreased by average 88.03% at each point in TOMO compared with HELMET field therapy. In addition, when percentage of volume (V95%, V100%, V105% of prescribed dose) was calculated by using Dose Volume Histogram (DVH) in order to evaluate the existence or nonexistence of hotspot in scalp as to three therapies (HELMET, MLC, TOMO), it was revealed that MLC technique and TOMO plan had good dose coverage and did not have hot spot. Reducing hair loss of a patient who receives whole brain radiotherapy treatment can make a contribution to improve life quality of the patient. It is expected that making good use of opposing portal irradiation with scalp-shielding shape and tomotherapy to protect scalp of a patient based on this study will reduce hair loss of a patient.

Evidence for the Stochastic Acceleration of Secondary Antiprotons by Supernova Remnants

Energy Technology Data Exchange (ETDEWEB)

Cholis, Ilias [Johns Hopkins U.; Hooper, Dan [Chicago U., KICP; Linden, Tim [Ohio State U.

2017-01-16

The antiproton-to-proton ratio in the cosmic-ray spectrum is a sensitive probe of new physics. Using recent measurements of the cosmic-ray antiproton and proton fluxes in the energy range of 1-1000 GeV, we study the contribution to the $\\bar{p}/p$ ratio from secondary antiprotons that are produced and subsequently accelerated within individual supernova remnants. We consider several well-motivated models for cosmic-ray propagation in the interstellar medium and marginalize our results over the uncertainties related to the antiproton production cross section and the time-, charge-, and energy-dependent effects of solar modulation. We find that the increase in the $\\bar{p}/p$ ratio observed at rigidities above $\\sim$ 100 GV cannot be accounted for within the context of conventional cosmic-ray propagation models, but is consistent with scenarios in which cosmic-ray antiprotons are produced and subsequently accelerated by shocks within a given supernova remnant. In light of this, the acceleration of secondary cosmic rays in supernova remnants is predicted to substantially contribute to the cosmic-ray positron spectrum, accounting for a significant fraction of the observed positron excess.

Cancer of the larynx: radiation therapy. III

International Nuclear Information System (INIS)

Wang, C.C.

1976-01-01

Radiation therapy is the treatment of choice for a T1 and T2 tumor with normal cord mobility and/or an exophytic lesion. It not only provides excellent control of the disease, but also preserves a good, useful voice in approximately 90 percent of the irradiated patients. For a T2 lesion with impaired cord mobility and/or moderate ulceration, a trial course of radiotherapy is initially given. If the tumor shows good regression and/or a return of normal cord mobility after a dose of 4000 rads, radiation therapy may be continued to a curative dose level, about 6500 rads. Surgery is reserved for treating residual disease six to eight weeks after radiation therapy or for recurrence. A T3 lesion with complete cord fixation and/or deep ulceration with nodes does not respond favorably to radiation therapy, and a planned combination of irradiation and laryngectomy is advised. Disease that extends beyond the larynx, T4, is rarely curable by radiation therapy alone. If the lesion is still operable, a combined approach of radiation and surgery is preferred; if not, palliative radiation therapy is given. Lymph node metastases from laryngeal carcinoma indicate advanced disease and is managed by preoperative irradiation and radical neck dissection. Under a program of therapeutic individualization, two-thirds to three-quarters of patients with cancer of the larynx can be cured by irradiation with preservation of a good, useful voice. In the remainder, the larynx must be sacrificed to save the patient's life. The ultimate control of laryngeal cancer lies in eradicating the extensive primary lesion and metastatic nodes, a common problem in the management of squamous cell carcinoma elsewhere in the body

The Antiproton and How It Was Discovered

International Nuclear Information System (INIS)

Eades, John

2005-01-01

The antiproton celebrates its 50th birthday this year. Although its existence had been suspected since the discovery of the positron in 1932, there was still doubt in some quarters that such a companion particle to the proton could exist. I will try to trace the scientific history of the antiproton from that time to the publication of the definitive paper by Chamberlain, Segre, Wiegand and Ypsilantis in November 1955, with a brief look at what happened next. The narrative will be supplemented with thoughts and opinions of some of the main actors, both at the time and in retrospect

Collisions involving antiprotons and antihydrogen: an overview

Science.gov (United States)

Jonsell, S.

2018-03-01

I give an overview of experimental and theoretical results for antiproton and antihydrogen scattering with atoms and molecules (in particular H, He). At low energies (>1 keV) there are practically no experimental data available. Instead I compare the results from different theoretical calculations, of various degrees of sophistication. At energies up to a few tens of eV, I focus on simple approximations that give reasonably accurate results, as these allow quick estimates of collision rates without embarking on a research project. This article is part of the Theo Murphy meeting issue `Antiproton physics in the ELENA era'.

Whole-brain radiation therapy for brain metastases: detrimental or beneficial?

International Nuclear Information System (INIS)

Gemici, Cengiz; Yaprak, Gokhan

2015-01-01

Stereotactic radiosurgery is frequently used, either alone or together with whole-brain radiation therapy to treat brain metastases from solid tumors. Certain experts and radiation oncology groups have proposed replacing whole-brain radiation therapy with stereotactic radiosurgery alone for the management of brain metastases. Although randomized trials have favored adding whole-brain radiation therapy to stereotactic radiosurgery for most end points, a recent meta-analysis demonstrated a survival disadvantage for patients treated with whole-brain radiation therapy and stereotactic radiosurgery compared with patients treated with stereotactic radiosurgery alone. However the apparent detrimental effect of adding whole-brain radiation therapy to stereotactic radiosurgery reported in this meta-analysis may be the result of inhomogeneous distribution of the patients with respect to tumor histologies, molecular histologic subtypes, and extracranial tumor stages between the groups rather than a real effect. Unfortunately, soon after this meta-analysis was published, even as an abstract, use of whole-brain radiation therapy in managing brain metastases has become controversial among radiation oncologists. The American Society of Radiation Oncology recently recommended, in their “Choose Wisely” campaign, against routinely adding whole-brain radiation therapy to stereotactic radiosurgery to treat brain metastases. However, this situation creates conflict for radiation oncologists who believe that there are enough high level of evidence for the effectiveness of whole-brain radiation therapy in the treatment of brain metastases

New results on strong-interaction effects in antiprotonic hydrogen

International Nuclear Information System (INIS)

Anagnostopoulos, D. F.; Augsburger, M.; Borchert, G.; Castelli, C.; Chatellard, D.; El-Khoury, P.; Egger, J.-P.; Gorke, H.; Gotta, D.; Hauser, P.; Indelicato, P.; Kirch, K.; Lenz, S.; Nelms, N.; Rashid, K.; Schult, O. W. B.; Siems, Th.; Simons, L. M.

1999-01-01

Lyman and Balmer transitions of antiprotonic hydrogen and deuterium have been measured at the Low-Energy Antiproton Ring LEAR at CERN in order to determine the strong interaction effects. The X-rays were detected using Charge-Coupled Devices (CCDs) and a reflection type crystal spectrometer. The results of the measurements support the meson-exchange models describing the medium and long range part of the nucleon-antinucleon interaction

Multilepton production in neutrino interactions and proton-antiproton collisions

International Nuclear Information System (INIS)

Valenzuela, G.N.

1985-01-01

In part I, we consider the class of events containing 2 or 3 leptons in (anti-neutrino deep inelastic scattering and in proton-antiproton collisions. Understanding the characteristics and rate of production of this type of event has often proven to be a theoretical challenge. We show that a cluster model involving associated-charm production not only accounts for certain dimuon events, but also affords better agreement with experiment regarding trimuons produced in neutrino interactions. We also investigate correlations between D-meson and dimuon production in p anti p collisions in the context of a cluster model which includes the possibility of finding b anti b pairs in jets. Part II consists of a study of radiation zeros in the reaction p anti p → l anti nuγX. It has been proposed that the radiation zero phenomenon could be observed in processes involving the radiative decay of the W-boson. These processes might allow the measurement of the W anomalous magnetic moment. We calculate the effect on this measurement of the decay width and the non-zero transverse momentum of the W. We find that although the radiation zero is filled in to some extent, it might still be possible to estimate the magnetic moment of the W in future experiments

Insufficiency fractures following radiation therapy for gynecologic malignancies

Energy Technology Data Exchange (ETDEWEB)

Ikushima, Hitoshi; Takegawa, Yoshihiro; Matsuki, Hirokazu; Yasuda, Hiroaki; Kawanaka, Takashi; Shiba, Atsushi; Kishida, Yoshiomi; Iwamoto, Seiji; Nishitani, Hiromu [Tokushima Univ. (Japan). School of Medicine

2002-12-01

The purpose of this study was to investigate the incidence, clinical and radiological findings of insufficiency fractures (IF) of the female pelvis following radiation therapy. We retrospectively reviewed the radiation oncology records of 108 patients with gynecologic malignancies who underwent external beam radiation therapy of the whole pelvis. All patients underwent conventional radiography and computed tomography (CT) scan every 6 months in follow-up after radiation therapy and magnetic resonance imaging (MRI) and radionuclide bone scan were added when the patients complained of pelvic pain. Thirteen of 108 patients (12%) developed IF in the irradiated field with a median interval of 6 months (range 3-51) from the completion of external beam radiation therapy. All patients who developed IF were postmenopausal women. Age of the patients who developed IF was significantly higher than that of the other patients. The parts of IF were sacroiliac joints, pubis, sacral body and 5th lumbar vertebra and six of 14 patients had multiple lesions. Treatment with rest and nonsteroidal anti-inflammatory drugs lead to symptomatic relief in all patients, although symptoms lasted from 3 to 20 months. Radiation-induced pelvic IF following radiation therapy for gynecologic malignancies were frequently observed in the post-menopausal patients within 1 year after external beam radiation therapy. Symmetrical fractures of the bilateral sacroiliac joint and pubis were the characteristic pattern of pelvic IF. All patients healed with conservative treatment, and nobody became non-ambulant. (author)

Antiprotons from spallation of cosmic rays on ISM

CERN Document Server

Donato, F

2002-01-01

We provide the first evaluation of the secondary interstellar cosmic antiproton flux that is fully consistent with cosmic ray nuclei in the framework of a two-zone diffusion model. We also study and conservatively quantify all possible sources of uncertainty that may affect that antiproton flux. Uncertainties related to propagation are shown to range between 10% and 25%, depending on which part of the spectrum is considered, while the ones related to nuclear physics stand around 22-25 % over all the energy spectrum.

Radiation Belts of Antiparticles in Planetary Magnetospheres

Science.gov (United States)

Pugacheva, G. I.; Gusev, A. A.; Jayanthi, U. B.; Martin, I. M.; Spjeldvik, W. N.

2007-05-01

The Earth's radiation belts could be populated, besides with electrons and protons, also by antiparticles, such as positrons (Basilova et al., 1982) and antiprotons (pbar). Positrons are born in the decay of pions that are directly produced in nuclear reactions of trapped relativistic inner zone protons with the residual atmosphere at altitudes in the range of about 500 to 3000 km over the Earth's surface. Antiprotons are born by high energy (E > 6 GeV) cosmic rays in p+p - p+p+p+ pbar and in p+p - p+p+n+nbar reactions. The trapping and storage of these charged anti-particles in the magnetosphere result in radiation belts similar to the classical Van Allen belts of protons and electrons. We describe the mathematical techniques used for numerical simulation of the trapped positron and antiproton belt fluxes. The pion and antiproton yields were simulated on the basis of the Russian nuclear reaction computer code MSDM, a Multy Stage Dynamical Model, Monte Carlo code, (i.e., Dementyev and Sobolevsky, 1999). For estimates of positron flux there we have accounted for ionisation, bremsstrahlung, and synchrotron energy losses. The resulting numerical estimates show that the positron flux with energy >100 MeV trapped into the radiation belt at L=1.2 is of the order ~1000 m-2 s-1 sr-1, and that it is very sensitive to the shape of the trapped proton spectrum. This confined positron flux is found to be greater than that albedo, not trapped, mixed electron/positron flux of about 50 m-2 s-1 sr-1 produced by CR in the same region at the top of the geomagnetic field line at L=1.2. As we show in report, this albedo flux also consists mostly of positrons. The trapped antiproton fluxes produced by CR in the Earth's upper rarified atmosphere were calculated in the energy range from 10 MeV to several GeV. In the simulations we included a mathematic consideration of the radial diffusion process, both an inner and an outer antiproton source, losses of particles due to ionization process

Intensity-modulated radiation therapy: dynamic MLC (DMLC) therapy, multisegment therapy and tomotherapy. An example of QA in DMLC therapy

International Nuclear Information System (INIS)

Webb, S.

1998-01-01

Intensity-modulated radiation therapy will make a quantum leap in tumor control. It is the new radiation therapy for the new millennium. The major methods to achieve IMRT are: 1. Dynamic multileaf collimator (DMLC) therapy, 2. multisegment therapy, and 3. tomotherapy. The principles of these 3 techniques are briefly reviewed. Each technique presents unique QA issues which are outlined. As an example this paper will present the results of a recent new study of an important QA concern in DMLC therapy. (orig.) [de

Radiation therapy of Graves' ophthalmopathy. 2; Therapy started time

Energy Technology Data Exchange (ETDEWEB)

Kawamura, Toshinori; Koga, Sukehiko (Fujita Health Univ., Toyoake, Aichi (Japan). School of Medicine)

1994-04-01

The difference in the improvement of exophthalmos according to the period of starting radiation therapy was investigated for 26 patients of thyroid ophthalmopathy, also taking thyroidism during radiation into consideration. A 4 MV X-ray was used to a total dose of 20 Gy per 2 weeks. The treatment value tended to be better for the patients in whom the period from the appearance of exophthalmos in an euthyroid condition to the start of radiation was less than 12 months; those of a longer period showed poorer improvement. Radiation treatment of a hyperthyroid condition also showed poor results and it was thought it was not an adequately long enough period for the radiation to take effect. As a result, it was considered that the radiation therapy shall be advantageous if started within 12 months after the appearance of exophthalmos in an euthyroid condition. (author).

Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki

International Nuclear Information System (INIS)

Pinkston, J.A.; Antoku, Shigetoshi; Russell, W.J.

1980-10-01

In the continuing evaluations of atomic bomb survivors for late radiation effects, not only doses from the A-bombs but those from other radiation sources must be considered, for the latter may be concomitantly acting factors causing bias among these investigations. In the present study, among 73 Hiroshima and 22 Nagasaki Adult Health Study (AHS) subjects who reported receiving radiation therapy, from 1970 through 1979, the medical records of 72 and 20, respectively, were reviewed, and 41 Hiroshima and 14 Nagasaki subjects were confirmed to have received radiation therapy. The data obtained in the present study were pooled with those of the previous investigation on radiation therapy exposures of AHS subjects prior to 1970. A total of 190 subjects have been documented as receiving radiation therapy and their doses were estimated. Energies used in treatments and diseases treated are discussed. Malignancies developed subsequent to radiation therapy in seven cases; five after treatment for malignancies and two after treatment for benign diseases. Neoplasms of 12 AHS subjects may have been induced by earlier radiation therapy; 5 in the earlier study and 7 in the present one. These investigations underscore the need for continued documentation of exposures to ionizing radiation for medical reasons, especially from sources incurring relatively high doses. Bias in assessments of late radiation effects among A-bomb survivors can thus be avoided. (author)

Measurement of strong interaction parameters in antiprotonic hydrogen and deuterium

CERN Document Server

Augsburger, M A; Borchert, G L; Chatellard, D; Egger, J P; El-Khoury, P; Gorke, H; Gotta, D; Hauser, P R; Indelicato, P J; Kirch, K; Lenz, S; Siems, T; Simons, L M

1999-01-01

In the PS207 experiment at CERN, X-rays from antiprotonic hydrogen and deuterium have been measured at low pressure. The strong interaction shift and the broadening of the K/sub alpha / transition in antiprotonic hydrogen were $9 determined. Evidence was found for the individual hyperfine components of the protonium ground state. (7 refs).

New results on strong-interaction effects in antiprotonic hydrogen

CERN Document Server

Gotta, D; Augsburger, M A; Borchert, G L; Castelli, C M; Chatellard, D; El-Khoury, P; Egger, J P; Gorke, H; Hauser, P R; Indelicato, P J; Kirch, K; Lenz, S; Nelms, N; Rashid, K; Schult, O W B; Siems, T; Simons, L M

1999-01-01

Lyman and Balmer transitions of antiprotonic hydrogen and deuterium have been measured at the low-energy antiproton ring LEAR at CERN in order to determine the strong interaction effects. The X-rays were detected using charge-coupled devices (CCDs) and a reflection type crystal spectrometer. The results of the measurements support the meson-exchange models describing the medium and long range part of the nucleon-antinucleon interaction. (33 refs).

Detoxication and antiproteolytic therapy of radiation complications

International Nuclear Information System (INIS)

Yakhontov, N.E.; Klimov, I.A.; Lavrikova, L.P.; Martynov, A.D.; Provorova, T.P.; Serdyukov, A.S.; Shestakov, A.F.

1984-01-01

49 patients with uterine cervix and ovarian carcinomas were treated with detoxication and antiproteolytic therapy of radiation-induced side-effects. The therapy permits to complete without interruption the remote gamma-therapy course and to reduce patients in-hospital periods by 10+- 1 days. The prescription of hemoder intravenous injection in a dose of 450 ml and contrical intramuscular injection (10000 AtrE) in cases of pronounced manifestations of radiation-induced side-effects (asthenia, leukopenia, enterocolitis) for 3 days should be considered an efficient therapy

Radiation therapy in patients with hematologic diseases

International Nuclear Information System (INIS)

Hennequin, C.; Maylin, C.

1995-01-01

Radiation therapy has a significant place in the treatment of hematologic diseases. Irradiation is a key component of the treatment strategy for Hodgkin's disease and has benefited from clinical studies aimed at improving its therapeutic index. There have been many recent improvements, in particular with regard to accuracy of techniques, imagery, dosimetry, and implementation of quality-control procedures. In localized non-Hodgkin's lymphoma, the gold-standard treatment is radiation therapy coupled with a short course of chemotherapy. In contrast, the place of irradiation in disseminated lymphomas remains to be defined. Prophylactic irradiation of the brain is still used in patients with acute lymphoblastic leukemia. Radiation therapy is of value as palliative treatment of bone lesions of myeloma, in chemo-resistant lymphomas, and in relapses of leukemia. Total body irradiation is a cumbersome but irreplaceable method, which has also benefited from recent clinical and biological studies. Optimal radiation therapy with the best possible therapeutic index requires adequate technological and human resources. (authors). 30 refs., 1 tab

Measurements of cascade times of antiprotons in molecular hydrogen and helium

CERN Document Server

Bianconi, A; Corradini, M; Donzella, A; Gómez, G; Lodi-Rizzini, E; Venturelli, L; Vilar, R; Zenoni, A; Bertin, A; Bruschi, M; Capponi, M; De Castro, S; Donà, R; Galli, D; Giacobbe, B; Marconi, U; Massa, I; Piccinini, M; Semprini-Cesari, N; Spighi, R; Vagnoni, V M; Vecchi, S; Villa, M; Vitale, A; Zoccoli, A; Cicalò, C; De Falco, A; Masoni, A; Puddu, G; Serci, S; Usai, G L; Gorchakov, O E; Prakhov, S N; Rozhdestvensky, A M; Tretyak, V I; Poli, M; Gianotti, P; Guaraldo, C; Lanaro, A; Lucherini, V; Petrascu, C; Ableev, V G; Ricci, R A; Vannucci, Luigi; Filippini, V; Fontana, A; Montagna, P; Rotondi, A; Salvini, P; Mirfakhraee, N; Bussa, M P; Busso, L; Cerello, P G; Denisov, O Yu; Ferrero, L; Garfagnini, R; Grasso, A; Maggiora, A; Panzarasa, A; Panzieri, D; Tosello, F; Botta, E; Bressani, Tullio; Calvo, D; Costa, S; D'Isep, F; Feliciello, A; Filippi, A; Marcello, S; Agnello, M; Iazzi, F; Minetti, B; Tessaro, S; Santi, L

2000-01-01

The OBELIX experiment at CERN collected samples of antiproton annihilations at rest in different gaseous targets, such as hydrogen, deuterium and helium. We analyze a set of the Obelix data using a new technique for measuring, for the first time, the cascade times independent of the capture energy and of the antiproton stopping power. We report on measurements of the cascade times for hydrogen at 3.4, 5.8, 9.8 and 150 mbar and for helium at 8.2, 50 and 150 mbar pressure. An estimate of the antiproton capture energy in hydrogen is also presented. (12 refs).

Impact of radiation therapy on sexual life

International Nuclear Information System (INIS)

Leroy, T.; Gabelle Flandin, I.; Habold, D.; Hannoun-Levi, J.M.

2012-01-01

The aim of this study was to evaluate the impact of radiation therapy on sexual life. The analysis was based on a Pubmed literature review. The keywords used for this research were 'sexual, radiation, oncology, and cancer'. After a brief reminder on the anatomy and physiology, we explained the main complications of radiation oncology and their impact on sexual life. Preventive measures and therapeutic possibilities were discussed. Radiation therapy entails local, systematic and psychological after-effects. For women, vaginal stenosis and dyspareunia represent the most frequent side effects. For men, radiation therapy leads to erectile disorders for 25 to 75% of the patients. These complications have an echo often mattering on the patient quality of life of and on their sexual life post-treatment reconstruction. The knowledge of the indications and the various techniques of irradiation allow reducing its potential sexual morbidity. The information and the education of patients are essential, although often neglected. In conclusion, radiation therapy impacts in variable degrees on the sexual life of the patients. Currently, there are not enough preventive and therapeutic means. Patient information and the early screening of the sexual complications are at stake in the support of patients in the reconstruction of their sexual life. (authors)

Calculated LET-Spectrum of Antiprotons

DEFF Research Database (Denmark)

Bassler, Niels

-LET components resulting from the annihilation. Though, the calculations of dose-averaged LET in the entry region may suggest that the RBE of antiprotons in the plateau region could significantly differ from unity. Materials and Methods Monte Carlo simulations using FLUKA were performed for calculating...

Enhancing trappable antiproton populations through deceleration and frictional cooling

Energy Technology Data Exchange (ETDEWEB)

Zolotorev, M.; Sessler, A.; Penn, G.; Wurtele, J. S.; Charman, A. E.

2012-03-01

CERN currently delivers antiprotons for trapping experiments with the Antiproton Decelerator (AD), which slows the antiprotons down to about 5 MeV.This energy is currently too high for direct trapping, and thick foils are used to slow down the beam to energies which can be trapped.To allow further deceleration to $\\sim 100 \\;\\mbox{keV}$, CERN is initiating the construction of ELENA,consisting of a ring which will combine RF deceleration and electron cooling capabilities. We describe a simple frictionalcooling scheme that can serve to provide significantly improved trapping efficiency, either directly from the AD or first usinga standard deceleration mechanism (induction linac or RFQ). This scheme could be implemented in a short time.The device itself is short in length, uses accessible voltages, and at reasonable cost could serve in the interim beforeELENA becomes operational, or possibly in lieu of ELENA for some experiments. Simple theory and simulations provide a preliminary assessment of theconcept and its strengths and limitations, and highlight important areas for experimental studies, in particular to pin down the level of multiplescattering for low-energy antiprotons. We show that the frictional cooling scheme can provide a similar energy spectrum to that of ELENA,but with higher transverse emittances.

Interaction of antiprotons with Rb atoms and a comparison of antiproton stopping powers of the atoms H, Li, Na, K, and Rb

DEFF Research Database (Denmark)

Lühr, Armin Christian; Fischer, Nicolas; Saenz, Alejandro

2009-01-01

Ionization and excitation cross sections as well as electron-energy spectra and stopping powers of the alkali metal atoms Li, Na, K, and Rb colliding with antiprotons were calculated using a time-dependent channel-coupling approach. An impact-energy range from 0.25 to 4000 keV was considered....... The target atoms are treated as effective one-electron systems using a model potential. The results are compared with calculated cross sections for antiproton-hydrogen atom collisions....

Once-Daily Radiation Therapy for Inflammatory Breast Cancer

International Nuclear Information System (INIS)

Brown, Lindsay; Harmsen, William; Blanchard, Miran; Goetz, Matthew; Jakub, James; Mutter, Robert; Petersen, Ivy; Rooney, Jessica; Stauder, Michael; Yan, Elizabeth; Laack, Nadia

2014-01-01

Purpose: Inflammatory breast cancer (IBC) is a rare and aggressive breast cancer variant treated with multimodality therapy. A variety of approaches intended to escalate the intensity and efficacy of radiation therapy have been reported, including twice-daily radiation therapy, dose escalation, and aggressive use of bolus. Herein, we examine our outcomes for patients treated with once-daily radiation therapy with aggressive bolus utilization, focusing on treatment technique. Methods and Materials: A retrospective review of patients with nonmetastatic IBC treated from January 1, 2000, through December 31, 2010, was performed. Locoregional control (LRC), disease-free survival (DFS), overall survival (OS) and predictors thereof were assessed. Results: Fifty-two women with IBC were identified, 49 (94%) of whom were treated with neoadjuvant chemotherapy. All underwent mastectomy followed by adjuvant radiation therapy. Radiation was delivered in once-daily fractions of 1.8 to 2.25 Gy (median, 2 Gy). Patients were typically treated with daily 1-cm bolus throughout treatment, and 33 (63%) received a subsequent boost to the mastectomy scar. Five-year Kaplan Meier survival estimates for LRC, DFS, and OS were 81%, 56%, and 64%, respectively. Locoregional recurrence was associated with poorer OS (P<.001; hazard ratio [HR], 4.1). Extracapsular extension was associated with worse LRC (P=.02), DFS (P=.007), and OS (P=.002). Age greater than 50 years was associated with better DFS (P=.03). Pathologic complete response was associated with a trend toward improved LRC (P=.06). Conclusions: Once-daily radiation therapy with aggressive use of bolus for IBC results in outcomes consistent with previous reports using various intensified radiation therapy regimens. LRC remains a challenge despite modern systemic therapy. Extracapsular extension, age ≤50 years, and lack of complete response to chemotherapy appear to be associated with worse outcomes. Novel strategies are needed in IBC

Targeted Radiation Therapy for Cancer Initiative

Science.gov (United States)

2017-11-01

AWARD NUMBER: W81XWH-08-2-0174 TITLE: Targeted Radiation Therapy for Cancer Initiative PRINCIPAL INVESTIGATOR: Dusten Macdonald, MD...for Cancer Initiative 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Dusten Macdonald, MD 5d. PROJECT NUMBER...Cancer Initiative Final Report INTRODUCTION: The full potential of radiation therapy has not been realized due to the inability to locate and

Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer

DEFF Research Database (Denmark)

Jeppesen, Stefan Starup; Schytte, Tine; Jensen, Henrik R

2013-01-01

Abstract Introduction. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) is now an accepted and patient friendly treatment, but still controversy exists about its comparability to conventional radiation therapy (RT). The purpose of this single...... and SBRT predicted improved prognosis. However, staging procedure, confirmation procedure of recurrence and technical improvements of radiation treatment is likely to influence outcomes. However, SBRT seems to be as efficient as conventional RT and is a more convenient treatment for the patients....

Intensity-modulated radiation therapy.

Science.gov (United States)

Goffman, Thomas E; Glatstein, Eli

2002-07-01

Intensity-modulated radiation therapy (IMRT) is an increasingly popular technical means of tightly focusing the radiation dose around a cancer. As with stereotactic radiotherapy, IMRT uses multiple fields and angles to converge on the target. The potential for total dose escalation and for escalation of daily fraction size to the gross cancer is exciting. The excitement, however, has greatly overshadowed a range of radiobiological and clinical concerns.

Relativistic hydrodynamics, heavy ion reactions and antiproton annihilation

International Nuclear Information System (INIS)

Strottman, D.

1985-01-01

The application of relativistic hydrodynamics to relativistic heavy ions and antiproton annihilation is summarized. Conditions for validity of hydrodynamics are presented. Theoretical results for inclusive particle spectra, pion production and flow analysis are given for medium energy heavy ions. The two-fluid model is introduced and results presented for reactions from 800 MeV per nucleon to 15 GeV on 15 GeV per nucleon. Temperatures and densities attained in antiproton annihilation are given. Finally, signals which might indicate the presence of a quark-gluon plasma are briefly surveyed

Modern role and issues of radiation therapy for benign diseases

International Nuclear Information System (INIS)

Miyashita, Tsuguhiro; Tateno, Atsushi; Kumazaki, Tatsuo

1999-01-01

Cases of radiation therapy for benign diseases have diminished in number because of recent alternative methods and knowledge about radiation carcinogenesis. In contrast to this tendency, our cases of benign diseases have recently increased. The facts made us reconsider today's radiation therapy of benign diseases. We reviewed 349 patients who were diagnosed as having benign tumors or non-neoplastic conditions and treated by radiation therapy in the past sixteen years. Analyzed items were the annual transition of treatment number, sorts of diseases, patients' age and sex, and the goal of therapy. Of all radiation therapy patients, benign diseases account for 9.26%. The annual percentages were 0.5%, 6.0%, 11.2% and 13.7% at intervals of five years since 1982. The majority was 246 post-operative irradiation for keloids (71%) and 41 pituitary adenomas (12%). Compared with malignant tumors, benign disease patients were statistically younger and female-dominant. Applications of radiation therapy in keloids and pituitary adenomas had definite goals, but were unclear in other rare diseases. Benign diseases should be treated by radiation therapy as the second or third option, provided the patients have serious symptoms and their diseases do not respond to other modalities. It seems to be widely accepted that favorite cases such as keloids and pituitary adenomas are treated by radiation therapy. But, optimal radiation therapies for other rare benign diseases have not been established. Therefore, the building of databases on radiation therapy on benign diseases should be pursued. Since benign disease patients were young and female-dominant and had many remaining years, their carcinogenicity potential should be considered. (author)

Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring; Limited chemotherapy and radiation therapy versus radiation therapy alone

Energy Technology Data Exchange (ETDEWEB)

Uematsu, Minoru (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology Dept. of Radiology, National Defense Medical College, Saitama (Japan)); Kondo, Makoto (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology); Hiramatsu, Hideko (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology); Ikeda, Yasuo (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Hematology); Mikata, Sumio (Chiba Univ. (Japan). School of Medicine); Katayama, Michiaki (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology); Ito, Hisao (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology); Kusano, Shoichi (Dept. of Radiology, National Defense Medical College, Saitama (Japan)); Kubo, Asuchishi (Keio Univ. School of Medicine, Tokyo (Japan). Dept. of Radiology)

1993-01-01

Seventeen patients with stage IA non-Hodgkin's lymphoma of the Waldeyer's ring were treated with radiation therapy with or without chemotherapy. All lesions were judged as having intermediate grade malignancy in the Working Formulation. Eight patients received combined treatment with three cycles of cylcophosphamide, doxorubicin, vincristine and prednison (CHOP) and radiation therapy with 30 to 40 Gy. Another 9 patients were treated with radiation therapy 40 to 60 Gy alone. After a median follow-up of 69 months, all 8 patients, treated with combined modality were alive and relapse-free whereas 4 of the 9 treated with irradiation alone had relapsed. All relapses occurred transdiaphragmatically. Two of the 4 relapsing patients were saved, but the other two died of the disease. The 5-year relapse-free and cause-specific survival rates were 100% and 100% in the combined modality group, and 56% and 76% in the radiation therapy alone group (relapse-free: p=0.04, cause-specific: p=0.16). There were no serious complications related to treatment, although most patients complained of mouth dryness and most patients given CHOP had paresthesia. Our opinion was that the total impact of these two side-effects on quality of life was less pronounced after combined modality than after radiation therapy alone. Limited chemotherapy and radiation therapy seemed to be more beneficial than radiation therapy alone not only in relapse-free survival but also in quality of life after treatment. (orig.).

CT follow-up after radiation therapy for pituitary adenomas

International Nuclear Information System (INIS)

Rush, S.C.; Newall, J.

1988-01-01

Between 1973 and 1985, 105 patients received radiation therapy as all or part of their treatment for pituitary tumor at the New York University Medical Center. Of these, 48 patients underwent computed tomography (CT) at a minimum of 2 years following treatment, with detailed reports available for analysis of tumor regression. There were 28 men with a median age of 46 years (range, 18-71 years) and 20 women with a median age of 53 years (range, 28-80 years). Tumors were classified as secretory in 23 patients, nonsecretory in 21, and undetermined in four. Sixteen patients were treated with radiation therapy alone, 23 patients with surgery and radiation therapy, and the other with bromocriptine and radiation therapy, with or without surgery. With a median follow-up of 5 years (range, 2-14 years), 16 patients developed an empty sella, 25 patients had residual sellar mass, and seven patients had persistent extrasellar components or no change in their intrasellar mass. Among patients who did not have hypopituitarism at the inception of radiation therapy, five of 13 with empty sellas and 12 of 22 with residual mass subsequently required therapy. The authors conclude that residual mass is commonly found in long-term follow-up after radiation therapy, that isolated imaging studies revealing such findings after treatment in no way herald a diagnosis of recurrence, and that hypopituitarism following pituitary radiation therapy does not correlate with the ablation or persistence of tissue within the sella

Radiation therapy for hypopharyngeal carcinoma. Impact of fractionation on treatment outcome

International Nuclear Information System (INIS)

Niibe, Yuzuru; Karasawa, Katsuyuki; Igaki, Hiroshi; Miyashita, Hisao; Tanaka, Yoshiaki

2003-01-01

The purpose of the current study was to evaluate the impact of fractionation on the treatment outcome of radiation therapy for hypopharyngeal carcinoma. Thirty-six inoperable or operation-refused hypopharyngeal patients were treated with curative-intended radiation therapy between 1976 and May 2001. Seventeen patients were treated with conventional radiation therapy, 1.8-2.0 Gy per fraction, totaling 64.0 Gy (conventional fractionation (CF) group), and 19 were treated with hyperfractionated radiation therapy, 1.2 Gy per fraction, totaling 74.4 Gy (hyperfractionation (HF) group). The radiation response of the two groups at the end of radiation therapy was almost the same. However, the 2-year local control rates of the HF and CF groups were 59.0% and 26.1% (p=0.012), respectively, a statistically significant differences. Moreover, multivariate analysis showed that HF was an independent prognostic factor for local control. Hyperfractionated radiation therapy was superior to conventional radiation therapy for local control. Local control of hypopharyngeal carcinoma correlated with laryngeal preservation, suggesting that hyperfractionated radiation therapy for hypopharyngeal carcinoma could be beneficial for patient quality of life (QOL). (author)

Measurement of interaction between antiprotons

Czech Academy of Sciences Publication Activity Database

Adamczyk, L.; Bielčík, J.; Bielčíková, Jana; Federič, Pavol; Chaloupka, P.; Rusňák, Jan; Rusňáková, O.; Šimko, Miroslav; Šumbera, Michal; Tlustý, David; Trzeciak, B. A.; Vértési, Robert

2015-01-01

Roč. 527, č. 7578 (2015), s. 345-348 ISSN 0028-0836 R&D Projects: GA ČR GA13-20841S Institutional support: RVO:61389005 Keywords : STAR collaboration * antiprotons * protons Subject RIV: BG - Nuclear, Atomic and Molecular Physics, Colliders Impact factor: 38.138, year: 2015

State of the art of radiation therapy for esophageal cancer

International Nuclear Information System (INIS)

Itasaka, Satoshi

2014-01-01

Radiation therapy has a critical role in the treatment of esophageal cancer. To improve the treatment outcome of radiotherapy, not only strengthening the treatment intensity but also decreasing the long term toxicity is needed. To reduce the long term cardiopulmonary toxicity of chemoradiation, JCOG is now running a clinical trial which combines three dimensional conformal radiation therapy (3D-CRT) and mild irradiation dose. New techniques of radiation therapy, such as intensity modulated radiation therapy (IMRT) or particle therapy are also promising in both treatment intensity and decreased toxicity. (author)

Nursing care update: Internal radiation therapy

International Nuclear Information System (INIS)

Lowdermilk, D.L.

1990-01-01

Internal radiation therapy has been used in treating gynecological cancers for over 100 years. A variety of radioactive sources are currently used alone and in combination with other cancer treatments. Nurses need to be able to provide safe, comprehensive care to patients receiving internal radiation therapy while using precautions to keep the risks of exposure to a minimum. This article discusses current trends and issues related to such treatment for gynecological cancers.20 references

The role of radiation therapy in the multidisciplinary treatment of patients with malignant tumors. Radiation pathological stand point

International Nuclear Information System (INIS)

Niibe, Hideo

1998-01-01

Estimations suggest that about 60% of all cancer patients will require some form of radiation therapy during their lifetime. Although 40 to 50% of cancer patients in Europe and the United States receive radiation therapy, only about 20% of patients with cancer in Japan undergo such treatment. This is largely due to the lack of understanding of the role of radiation therapy by many medical personnel in Japan, as well as to ''''radiation allergy'''' among many of the general population in Japan, a country that has been undergone atomic bombing. From our perspective as specialists in radiation therapy, the chronic shortage of radiation oncologist also poses a serious problem. Although there are approximately 700 hospitals throughout Japan where radiation therapy is available, no more than half this number of medical facilities have a full-time radiation oncologist. Perhaps the reason for this is that radiation therapy is perceived as unnecessary in Japan. However, it is absolutely essential. In our experience, the 5-year relative survival rate of patients with malignant tumors who have undergone radiation therapy in our clinic is 65 percent. Thus, radiation therapy has proven very useful in the treatment of malignant tumors. Moreover, better estimates of prognosis of cancer patients treated with radiation therapy are becoming possible. This article discusses the role of radiation therapy, from a radiation pathological perspective, in a multidisciplinary approach to treatment of cancer patients. I also emphasize the critical importance of training radiation oncologists who can function as part of multidisciplinary teams that care for patients with malignant tumors. (author). 50 refs

Auger radiation targeted into DNA: a therapy perspective

Energy Technology Data Exchange (ETDEWEB)

Buchegger, Franz [University Hospital of Lausanne CHUV, Service of Nuclear Medicine, Lausanne (Switzerland); University Hospital of Lausanne, Service of Nuclear Medicine, Lausanne (Switzerland); Perillo-Adamer, Florence; Bischof Delaloye, Angelika [University Hospital of Lausanne CHUV, Service of Nuclear Medicine, Lausanne (Switzerland); Dupertuis, Yves M. [University Hospital of Geneva, Service of Nutrition, Geneva (Switzerland)

2006-11-15

Auger electron emitters that can be targeted into DNA of tumour cells represent an attractive systemic radiation therapy goal. In the situation of DNA-associated decay, the high linear energy transfer (LET) of Auger electrons gives a high relative biological efficacy similar to that of {alpha} particles. In contrast to {alpha} radiation, however, Auger radiation is of low toxicity when decaying outside the cell nucleus, as in cytoplasm or outside cells during blood transport. The challenge for such therapies is the requirement to target a high percentage of all cancer cells. An overview of Auger radiation therapy approaches of the past decade shows several research directions and various targeting vehicles. The latter include hormones, peptides, halogenated nucleotides, oligonucleotides and internalising antibodies. Here, we will discuss the basic principles of Auger electron therapy as compared with vector-guided {alpha} and {beta} radiation. We also review some radioprotection issues and briefly present the main advantages and disadvantages of the different targeting modalities that are under investigation. (orig.)

Auger radiation targeted into DNA: a therapy perspective

International Nuclear Information System (INIS)

Buchegger, Franz; Perillo-Adamer, Florence; Bischof Delaloye, Angelika; Dupertuis, Yves M.

2006-01-01

Auger electron emitters that can be targeted into DNA of tumour cells represent an attractive systemic radiation therapy goal. In the situation of DNA-associated decay, the high linear energy transfer (LET) of Auger electrons gives a high relative biological efficacy similar to that of α particles. In contrast to α radiation, however, Auger radiation is of low toxicity when decaying outside the cell nucleus, as in cytoplasm or outside cells during blood transport. The challenge for such therapies is the requirement to target a high percentage of all cancer cells. An overview of Auger radiation therapy approaches of the past decade shows several research directions and various targeting vehicles. The latter include hormones, peptides, halogenated nucleotides, oligonucleotides and internalising antibodies. Here, we will discuss the basic principles of Auger electron therapy as compared with vector-guided α and β radiation. We also review some radioprotection issues and briefly present the main advantages and disadvantages of the different targeting modalities that are under investigation. (orig.)

Breast conservation therapy for breast cancer. Radiation oncologist's point of view

International Nuclear Information System (INIS)

Hiraoka, Masahiro; Mitsumori, Michihide; Kokubo, Masaki; Fujishiro, Satsuki

1998-01-01

The roles and problems of radiation therapy in breast conserving therapy for breast cancer were presented. The roles of radiation therapy include decrease in breast recurrence, an alternative to axillary dissection for N0 cases, and neo-adjuvant radiation therapy. On the other hand, problems associated with radiation therapy are question of using radiation therapy for all cases, complications and worsening of cosmetics, and relatively high breast recurrence rates for margin-positive cases. The concept of breast conserving therapy is to improve QOL without decreasing treatment outcomes. It is considered that we should be more concentrated on the aspects of QOL because treatment outcomes of breast conserving therapy in Japan demonstrated sofar appear excellent. (author)

Missed Radiation Therapy and Cancer Recurrence

Science.gov (United States)

Patients who miss radiation therapy sessions during cancer treatment have an increased risk of their disease returning, even if they eventually complete their course of radiation treatment, according to a new study.

21 CFR 892.5050 - Medical charged-particle radiation therapy system.

Science.gov (United States)

2010-04-01

...-particle radiation therapy system. (a) Identification. A medical charged-particle radiation therapy system... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical charged-particle radiation therapy system... equipment, patient and equipment supports, treatment planning computer programs, component parts, and...

Possibility of resonant capture of antiprotons by highly charged hydrogenlike ions

International Nuclear Information System (INIS)

Genkin, M.; Lindroth, E.

2009-01-01

Recently, an experimental setup was proposed by Lapierre et al. which would allow antiprotons and highly charged ions to collide repeatedly in an electron beam ion trap (EBIT) due to a nested trap configuration. As mentioned by the authors, such a setup may open the possibility to study antiproton capture into well-defined states through a resonant process which involves simultaneous electron excitation. In the present work, we give some theoretical estimations of the feasibility of that process. It appears that the exotic dielectronic-like process of resonant anti-proton capture in highly charged ions does not seem to be completely out of reach

Constraints on particle dark matter from cosmic-ray antiprotons

International Nuclear Information System (INIS)

Fornengo, N.; Vittino, A.; Maccione, L.

2014-01-01

Cosmic-ray antiprotons represent an important channel for dark matter indirect-detection studies. Current measurements of the antiproton flux at the top of the atmosphere and theoretical determinations of the secondary antiproton production in the Galaxy are in good agreement, with no manifest deviation which could point to an exotic contribution in this channel. Therefore, antiprotons can be used as a powerful tool for constraining particle dark matter properties. By using the spectrum of PAMELA data from 50 MV to 180 GV in rigidity, we derive bounds on the dark matter annihilation cross section (or decay rate, for decaying dark matter) for the whole spectrum of dark matter annihilation (decay) channels and under different hypotheses of cosmic-rays transport in the Galaxy and in the heliosphere. For typical models of galactic propagation, the constraints are strong, setting a lower bound on the dark matter mass of a ''thermal'' relic at about 40–80 GeV for hadronic annihilation channels. These bounds are enhanced to about 150 GeV on the dark matter mass, when large cosmic-rays confinement volumes in the Galaxy are considered, and are reduced to 3–4 GeV for annihilation to light quarks (no bound for heavy-quark production) when the confinement volume is small. Bounds for dark matter lighter than few tens of GeV are due to the low energy part of the PAMELA spectrum, an energy region where solar modulation is relevant: to this aim, we have implemented a detailed solution of the transport equation in the heliosphere, which allowed us not only to extend bounds to light dark matter, but also to determine the uncertainty on the constraints arising from solar modulation modelling. Finally, we estimate the impact of soon-to-come AMS-02 data on the antiproton constraints

Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines

Energy Technology Data Exchange (ETDEWEB)

Valicenti, Richard K., E-mail: Richard.valicenti@ucdmc.ucdavis.edu [Department of Radiation Oncology, University of California, Davis School of Medicine, Davis, California (United States); Thompson, Ian [Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas (United States); Albertsen, Peter [Division of Urology, University of Connecticut Health Center, Farmington, Connecticut (United States); Davis, Brian J. [Department of Radiation Oncology, Mayo Medical School, Rochester, Minnesota (United States); Goldenberg, S. Larry [Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia (Canada); Wolf, J. Stuart [Department of Urology, University of Michigan, Ann Arbor, Michigan (United States); Sartor, Oliver [Department of Medicine and Urology, Tulane Medical School, New Orleans, Louisiana (United States); Klein, Eric [Glickman Urological Kidney Institute, Cleveland Clinic, Cleveland, Ohio (United States); Hahn, Carol [Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina (United States); Michalski, Jeff [Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri (United States); Roach, Mack [Department of Radiation Oncology, University of California, San Francisco, San Francisco, California (United States); Faraday, Martha M. [Four Oaks, Inc (United States)

2013-08-01

Purpose: The purpose of this guideline was to provide a clinical framework for the use of radiation therapy after radical prostatectomy as adjuvant or salvage therapy. Methods and Materials: A systematic literature review using PubMed, Embase, and Cochrane database was conducted to identify peer-reviewed publications relevant to the use of radiation therapy after prostatectomy. The review yielded 294 articles; these publications were used to create the evidence-based guideline statements. Additional guidance is provided as Clinical Principles when insufficient evidence existed. Results: Guideline statements are provided for patient counseling, use of radiation therapy in the adjuvant and salvage contexts, defining biochemical recurrence, and conducting a restaging evaluation. Conclusions: Physicians should offer adjuvant radiation therapy to patients with adverse pathologic findings at prostatectomy (ie, seminal vesicle invastion, positive surgical margins, extraprostatic extension) and salvage radiation therapy to patients with prostate-specific antigen (PSA) or local recurrence after prostatectomy in whom there is no evidence of distant metastatic disease. The offer of radiation therapy should be made in the context of a thoughtful discussion of possible short- and long-term side effects of radiation therapy as well as the potential benefits of preventing recurrence. The decision to administer radiation therapy should be made by the patient and the multidisciplinary treatment team with full consideration of the patient's history, values, preferences, quality of life, and functional status. The American Society for Radiation Oncology and American Urological Association websites show this guideline in its entirety, including the full literature review.

Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines

International Nuclear Information System (INIS)

Valicenti, Richard K.; Thompson, Ian; Albertsen, Peter; Davis, Brian J.; Goldenberg, S. Larry; Wolf, J. Stuart; Sartor, Oliver; Klein, Eric; Hahn, Carol; Michalski, Jeff; Roach, Mack; Faraday, Martha M.

2013-01-01

Purpose: The purpose of this guideline was to provide a clinical framework for the use of radiation therapy after radical prostatectomy as adjuvant or salvage therapy. Methods and Materials: A systematic literature review using PubMed, Embase, and Cochrane database was conducted to identify peer-reviewed publications relevant to the use of radiation therapy after prostatectomy. The review yielded 294 articles; these publications were used to create the evidence-based guideline statements. Additional guidance is provided as Clinical Principles when insufficient evidence existed. Results: Guideline statements are provided for patient counseling, use of radiation therapy in the adjuvant and salvage contexts, defining biochemical recurrence, and conducting a restaging evaluation. Conclusions: Physicians should offer adjuvant radiation therapy to patients with adverse pathologic findings at prostatectomy (ie, seminal vesicle invastion, positive surgical margins, extraprostatic extension) and salvage radiation therapy to patients with prostate-specific antigen (PSA) or local recurrence after prostatectomy in whom there is no evidence of distant metastatic disease. The offer of radiation therapy should be made in the context of a thoughtful discussion of possible short- and long-term side effects of radiation therapy as well as the potential benefits of preventing recurrence. The decision to administer radiation therapy should be made by the patient and the multidisciplinary treatment team with full consideration of the patient's history, values, preferences, quality of life, and functional status. The American Society for Radiation Oncology and American Urological Association websites show this guideline in its entirety, including the full literature review

Metastable states in antiprotonic helium atoms an island stability in a sea of continuum

CERN Document Server

Korobov, V I

2002-01-01

In this contribution we consider a phenomenon of metastable states in antiprotonic helium atoms, precise spectroscopy of these states and a present-day study of the electromagnetic properties of antiprotons. Calculation of nonrelativistic energies, relativistic and QED corrections as well as the fine and hyperfine structure and the magnetic moment of an antiproton are the main parts of this study. Refs. 22 (nevyjel)

Thyroid dysfunction after radiation therapy to the neck

International Nuclear Information System (INIS)

Soejima, Toshinori; Hirota, Saeko; Obayashi, Kayoko; Takada, Yoshiki; Kimura, Shuji; Yoshida, Shoji.

1993-01-01

The effects of radiation on the thyroid were investigated in 102 patients treated by radiation therapy to the neck. All patients had radiation ports which included the thyroid gland. Serum thyroid stimulating hormone (TSH) levels were elevated in 41 cases and the cumulative elevation rate was 52.1% in 5 years. The high frequency of elevated serum TSH levels observed in patients whose thyroid glands were included within the radiation fields (74.1%) was statistically significant compared to those whose thyroid glands were only partially included (23.4%). Among the patients whose entire thyroid glands were included within the radiation field, combination with chemotherapy increased the frequency of elevated serum TSH levels, but the increase was not statistically significant. Among 36 laryngeal cancer patients treated by only radiation therapy through a portal encompassing part of the thyroid, 4 (14%) were found to have elevated serum TSH levels. We advocate routine monitoring of thyroid functions after radiation therapy to the neck. (author)

Impaired skin integrity related to radiation therapy

International Nuclear Information System (INIS)

Ratliff, C.

1990-01-01

Skin reactions associated with radiation therapy require frequent nursing assessment and intervention. Preventive interventions and early management can minimize the severity of the skin reaction. With the understanding of the pathogenesis of radiation skin reactions, the ET nurse can determine who is at risk and then implement preventive measures. Because radiation treatment is fractionated, skin reactions do not usually occur until midway through the course of therapy and will subside within a few weeks after completion of radiation. Many patients and their families still fear that radiation causes severe burns. Teaching and anticipatory guidance by the ET nurse is needed to assist patients and their families to overcome this fear, and to educate them on preventive skin care regimens

Technological progress in radiation therapy for brain tumors

LENUS (Irish Health Repository)

Vernimmen, Frederik Jozef

2014-01-01

To achieve a good therapeutic ratio the radiation dose to the tumor should be as high as possible with the lowest possible dose to the surrounding normal tissue. This is especially the case for brain tumors. Technological ad- vancements in diagnostic imaging, dose calculations, and radiation delivery systems, combined with a better un- derstanding of the pathophysiology of brain tumors have led to improvements in the therapeutic results. The widely used technology of delivering 3-D conformal therapy with photon beams (gamma rays) produced by Li-near Accelerators has progressed into the use of Intensity modulated radiation therapy (IMRT). Particle beams have been used for several decades for radiotherapy because of their favorable depth dose characteristics. The introduction of clinically dedicated proton beam therapy facilities has improved the access for cancer patients to this treatment. Proton therapy is of particular interest for pediatric malignancies. These technical improvements are further enhanced by the evolution in tumor physiology imaging which allows for improved delineation of the tumor. This in turn opens the potential to adjust the radiation dose to maximize the radiobiological effects. The advances in both imaging and radiation therapy delivery will be discussed.

Prostate Cancer (Radiation Therapy)

Science.gov (United States)

... be considered carefully, balancing the advantages against the disadvantages as they relate to the individual man's age, ... therapy with photon or x-rays: Uses advanced technology to tailor the x-ray or photon radiation ...

Trapping of antiprotons -- a first step on the way to antihydrogen

International Nuclear Information System (INIS)

Holzscheiter, M.H.

1993-01-01

A first step towards producing and effectively utilizing antihydrogen atoms consists of trapping antiprotons. The immediate next step must then be to control, i.e. trap the produced antihydrogen. The current state of the art in trapping antiprotons and positrons is reviewed, and the challenges in trapping the resulting neutral particles are discussed

Radiation therapy among A-bomb survivors, Hiroshima and Nagasaki

Energy Technology Data Exchange (ETDEWEB)

Russell, W J; Antoku, S

1971-01-01

The hospitals and clinics responsible for radiation therapy reported by ABCC-JNIH Adult Health Study subjects were surveyed to confirm treatment and estimate doses they received. Of 426 cases, 137 were documented by hospital records. Their ABCC medical records were also reviewed for pertinent clinical information. Excluding the cases not verified because of unavailability of records, confirmation rates were 0.46 in Hiroshima and 0.67 in Nagasaki. Radiation therapy doses according to date of treatment, diagnosis, body site, and source of exposure are included. These data are recorded routinely for future reference, along with doses from diagnostic roentgenology for evaluating overall ionizing radiation exposure of A-bomb survivors and their comparison subjects. Radiation therapy by source and by lesion treated is included. There were three cases with malignancies possibly related to their earlier radiation therapy. One was an A-bomb survivor with lung cancer previously reported as due to ionizing radiation from the A-bomb. Radiation therapy she received for breast cancer 11 years earlier was more likely the cause of the lung lesion than was her relatively small A-bomb dose. The importance of recording all diagnostic and therapeutic radiation, especially that received by those under continuing surveillance for late A-bomb effects, is stressed. (auth)

Planning guide for radiologic installations. fascicle 1 -- radiation therapy installations

International Nuclear Information System (INIS)

Tuddenham, W.J.

1976-01-01

Five articles dealing with the development and operation of radiation therapy facilities present recommendations for the design of various types of radiation therapy facilities, including the university center, the free-standing private oncology center, and the community hospital radiation therapy department. Different concepts of department design are represented. In one article, the planning room is conceived to be the central feature of a facility; in another article, radiation therapy is designed around examination rooms. Shielding requirements are also discussed, as are the advantages and space and licensing requirements of various types of equipment. There is a need for planning appropriate computer facilities in conjunction with other equipment plans, and a critique of one radiation therapy unit is provided. The concept of a regional network for the delivery of radiation therapy services is then explored. The volume contains extensive illustrations in the form of floor plans, drawings, figures, and tables. Many of the articles include a bibliography. This is the first in a series of publications on radiation department design which will be useful to architects, engineers, and hospital planners

Molecular image guided radiation therapy-MIGRT in radiobioluminescence and nanoradioguidance

International Nuclear Information System (INIS)

Rao, V.L. Papineni

2014-01-01

Accurate dose delivery to malignant tissue in radiotherapy is essential for enhancing the treatment efficacy while minimizing morbidity of surrounding normal tissues. Advances in therapeutic strategies and diagnosis technologies along with our understanding of the biology of tumor response to radiation therapy have paved way to allow nearly 60% of current cancer patients to be treated with Radiation Therapy. The confluence of molecular imaging and nanotechnology fields are bridging physics and medicine and are quickly making strides in opening new avenues and therapeutic strategies that complement radiation therapy - with a distinct footprint in immunotherapy, adoptive cell therapy, and targeted chemotherapy. Incorporating optical imaging in radiation therapy in my laboratory, endogenous bioluminescence resulting from whole body irradiation in different organs, and in different animals, which is distinct from the Cherenkov radiation. The endogenous bioluminescence in response to irradiation is coined recently as radiobioluminescence. Thus with the necessity, the design, construction, and validation of Molecular Image Guided Radiation Therapy (MIGRT) instrumentation for preclinical theragnostics is carried out

Energy and energy width measurement in the FNAL antiproton accumulator

International Nuclear Information System (INIS)

Church, M.; Hsueh, S.; Rapidis, P.; Werkema, S.

1991-10-01

The Fermilab Antiproton Accumulator has recently been used to produce Charmonium resonances (charm quark, anti-charm quark bound states) in proton-antiproton annihilations using an internal H 2 gas jet target. A measurement of the resonance mass and width may be obtained from a precise knowledge of the antiproton beam energy and energy spread. The beam energy is measured to an accuracy of 1 part in 10 4 in the range 6.3 Gev to 4.1 Gev by measuring the orbit length and revolution frequency of the beam. The beam momentum spread is measured to an accuracy of 10% by measuring the beam frequency spread and the parameter η = (P beam /F rev )·(dF rev /dP beam ). These two measurement techniques are described in this report

Advanced Small Animal Conformal Radiation Therapy Device.

Science.gov (United States)

Sharma, Sunil; Narayanasamy, Ganesh; Przybyla, Beata; Webber, Jessica; Boerma, Marjan; Clarkson, Richard; Moros, Eduardo G; Corry, Peter M; Griffin, Robert J

2017-02-01

We have developed a small animal conformal radiation therapy device that provides a degree of geometrical/anatomical targeting comparable to what is achievable in a commercial animal irradiator. small animal conformal radiation therapy device is capable of producing precise and accurate conformal delivery of radiation to target as well as for imaging small animals. The small animal conformal radiation therapy device uses an X-ray tube, a robotic animal position system, and a digital imager. The system is in a steel enclosure with adequate lead shielding following National Council on Radiation Protection and Measurements 49 guidelines and verified with Geiger-Mueller survey meter. The X-ray source is calibrated following AAPM TG-61 specifications and mounted at 101.6 cm from the floor, which is a primary barrier. The X-ray tube is mounted on a custom-made "gantry" and has a special collimating assembly system that allows field size between 0.5 mm and 20 cm at isocenter. Three-dimensional imaging can be performed to aid target localization using the same X-ray source at custom settings and an in-house reconstruction software. The small animal conformal radiation therapy device thus provides an excellent integrated system to promote translational research in radiation oncology in an academic laboratory. The purpose of this article is to review shielding and dosimetric measurement and highlight a few successful studies that have been performed to date with our system. In addition, an example of new data from an in vivo rat model of breast cancer is presented in which spatially fractionated radiation alone and in combination with thermal ablation was applied and the therapeutic benefit examined.

Combined use of Dexa-Scheroson and Primobolan-Depot in radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Nagai, J [Shizuoka Rosai Hospital (Japan)

1976-05-01

Dexa-Scheroson and Primobolan-Depot were used together with radiation therapy (Linac therapy) required in 13 cases. The following results were obtained. The decrease in white cell counts, which often occurs in radiation therapy, was inhibited by the drugs. There was no case in which radiation therapy should necessarily withdraw because the number of leuckocytes was decreased to less than 3,000. The patients whose liver function was poor should be treated with both drugs at the beginning of radiation therapy. It was found that the combined use of the drugs is effective in the prevention and the treatment of cerebral edema in radiation therapy of intracranial lesion.

Treatment of Recurrent Chordomas by Percutaneous Ethanol Injection Therapy and Radiation Therapy

International Nuclear Information System (INIS)

Nakajo, M.; Ohkubo, K.; Fukukura, Y.; Nandate, T.; Nakajo, M.

2006-01-01

We report a case of recurrent sacral chordomas that have been successfully controlled by the combination therapy of percutaneous ethanol injection therapy (PEIT) and radiation therapy in a 71-year-old man. PEIT may be one of the adjuvant therapies for recurrent chordomas

Evaporative cooling of antiprotons and efforts to trap antihydrogen

CERN Document Server

Andresen, Gorm Bruun

Evaporative cooling has proven to be an invaluable technique in atomic physics, allowing for the study of effects such as Bose-Einstein condensation. One main topic of this thesis is the first application of evaporative cooling to cold non-neutral plasmas stored in an ion trap. We (the ALPHA collaboration) have achieved cooling of a cloud of antiprotons to a temperature as low as 9 K, two orders of magnitude lowerthan ever directly measured previously. The measurements are well-described by appropriate rate equations for the temperature and number of particles. The technique has direct application to the ongoing attempts to produce trapped samples of antihydrogen. In these experiments the maximum trap depths are ex tremely shallow (~0.6 K for ground state atoms), and careful control of the trapped antiprotons and positrons used to form the (anti)atoms is essential to succes. Since 2006 powerful tools to diagnose and manipulate the antiproton and positron plasmas in the ALPHA apparatus have been developed and ...

Prototype demonstration of radiation therapy planning code system

International Nuclear Information System (INIS)

Little, R.C.; Adams, K.J.; Estes, G.P.; Hughes, L.S. III; Waters, L.S.

1996-01-01

This is the final report of a one-year, Laboratory-Directed Research and Development project at the Los Alamos National Laboratory (LANL). Radiation therapy planning is the process by which a radiation oncologist plans a treatment protocol for a patient preparing to undergo radiation therapy. The objective is to develop a protocol that delivers sufficient radiation dose to the entire tumor volume, while minimizing dose to healthy tissue. Radiation therapy planning, as currently practiced in the field, suffers from inaccuracies made in modeling patient anatomy and radiation transport. This project investigated the ability to automatically model patient-specific, three-dimensional (3-D) geometries in advanced Los Alamos radiation transport codes (such as MCNP), and to efficiently generate accurate radiation dose profiles in these geometries via sophisticated physics modeling. Modem scientific visualization techniques were utilized. The long-term goal is that such a system could be used by a non-expert in a distributed computing environment to help plan the treatment protocol for any candidate radiation source. The improved accuracy offered by such a system promises increased efficacy and reduced costs for this important aspect of health care

Influence of radiation therapy on oral Candida albicans colonization: a quantitative assessment

International Nuclear Information System (INIS)

Rossie, K.M.; Taylor, J.; Beck, F.M.; Hodgson, S.E.; Blozis, G.G.

1987-01-01

An increase in quantity of oral Candida albicans was documented in patients receiving head and neck radiation therapy during and after therapy, as assessed by an oral-rinse culturing technique. The amount of the increase was greater in denture wearers and directly related to increasing radiation dose and increasing volume of parotid gland included in the radiation portal. A significant number of patients who did not carry C. albicans prior to radiation therapy developed positive cultures by 1 month after radiation therapy. The percentage of patients receiving head and neck radiation therapy who carried C. albicans prior to radiation therapy did not differ significantly from matched dental patient controls

Late complications of radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Masaki, Norie [Osaka Prefectural Center for Adult Diseases (Japan)

1998-03-01

There are cases in which, although all traces of acute radiation complications seem to have disappeared, late complications may appear months or years to become apparent. Trauma, infection or chemotherapy may sometimes recall radiation damage and irreversible change. There were two cases of breast cancer that received an estimated skin dose in the 6000 cGy range followed by extirpation of the residual tumor. The one (12 y.o.) developed atrophy of the breast and severe teleangiectasis 18 years later radiotherapy. The other one (42 y.o.) developed severe skin necrosis twenty years later radiotherapy after administration of chemotherapy and received skin graft. A case (52 y.o.) of adenoidcystic carcinoma of the trachea received radiation therapy. The field included the thoracic spinal cord which received 6800 cGy. Two years and 8 months after radiation therapy she developed complete paraplegia and died 5 years later. A truly successful therapeutic outcome requires that the patient be alive, cured and free of significant treatment-related morbidity. As such, it is important to assess quality of life in long-term survivors of cancer treatment. (author)

Late complications of radiation therapy

International Nuclear Information System (INIS)

Masaki, Norie

1998-01-01

There are cases in which, although all traces of acute radiation complications seem to have disappeared, late complications may appear months or years to become apparent. Trauma, infection or chemotherapy may sometimes recall radiation damage and irreversible change. There were two cases of breast cancer that received an estimated skin dose in the 6000 cGy range followed by extirpation of the residual tumor. The one (12 y.o.) developed atrophy of the breast and severe teleangiectasis 18 years later radiotherapy. The other one (42 y.o.) developed severe skin necrosis twenty years later radiotherapy after administration of chemotherapy and received skin graft. A case (52 y.o.) of adenoidcystic carcinoma of the trachea received radiation therapy. The field included the thoracic spinal cord which received 6800 cGy. Two years and 8 months after radiation therapy she developed complete paraplegia and died 5 years later. A truly successful therapeutic outcome requires that the patient be alive, cured and free of significant treatment-related morbidity. As such, it is important to assess quality of life in long-term survivors of cancer treatment. (author)

Two photon laser spectroscopy of antiprotonic helium atoms at CERN’s AD

CERN Document Server

Hori, M

2014-01-01

The ASACUSA collaboration of CERN has carried out two-photon laser spectroscopy of antiprotonic helium atoms using counter-propagating ultraviolet laser beams. This excited some non-linear transitions of the antiproton at the wavelengths λ = 139.8–197.0 nm, in a way that reduced the thermal Doppler broadening of the observed resonances. The resulting narrow spectral lines allowed the measurement of three transition frequencies with fractional precisions of 2.3–5 parts in 109. By comparing these values with three-body QED calculations, the antiproton-to-electron mass ratio was derived as 1836.1526736(23). We briefly review these results.

21 CFR 892.5300 - Medical neutron radiation therapy system.

Science.gov (United States)

2010-04-01

... therapy system. (a) Identification. A medical neutron radiation therapy system is a device intended to... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical neutron radiation therapy system. 892.5300... analysis and display equipment, patient and equipment support, treatment planning computer programs...

Development of local radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Lee, Seung Hoon; Lim, Sang Moo; Choi, Chang Woon; Chai, Jong Su; Kim, Eun Hee; Kim, Mi Sook; Yoo, Seong Yul; Cho, Chul Koo; Lee, Yong Sik; Lee, Hyun Moo

1999-04-01

The major limitations of radiation therapy for cancer are the low effectiveness of low LET and inevitable normal tissue damage. Boron Neutron Capture Therapy (BNCT) is a form of potent radiation therapy using Boron-10 having a high propensityof capturing theraml neutrons from nuclear reactor and reacting with a prompt nuclear reaction. Photodynamic therapy is a similiar treatment of modality to BNCT using tumor-seeking photosenistizer and LASER beam. If Boron-10 and photosensitizers are introduced selectively into tumor cells, it is theoretically possible to destroy the tumor and to spare the surrounding normal tissue. Therefore, BNCT and PDT will be new potent treatment modalities in the next century. In this project, we performed PDT in the patients with bladder cancers, oropharyngeal cancer, and skin cancers. Also we developed I-BPA, new porphyrin compounds, methods for estimation of radiobiological effect of neutron beam, and superficial animal brain tumor model. Furthermore, we prepared preclinical procedures for clinical application of BNCT, such as the macro- and microscopic dosimetry, obtaining thermal neutron flux from device used for fast neutron production in KCCH have been performed.

Development of local radiation therapy

International Nuclear Information System (INIS)

Lee, Seung Hoon; Lim, Sang Moo; Choi, Chang Woon; Chai, Jong Su; Kim, Eun Hee; Kim, Mi Sook; Yoo, Seong Yul; Cho, Chul Koo; Lee, Yong Sik; Lee, Hyun Moo

1999-04-01

The major limitations of radiation therapy for cancer are the low effectiveness of low LET and inevitable normal tissue damage. Boron Neutron Capture Therapy (BNCT) is a form of potent radiation therapy using Boron-10 having a high propensityof capturing theraml neutrons from nuclear reactor and reacting with a prompt nuclear reaction. Photodynamic therapy is a similiar treatment of modality to BNCT using tumor-seeking photosenistizer and LASER beam. If Boron-10 and photosensitizers are introduced selectively into tumor cells, it is theoretically possible to destroy the tumor and to spare the surrounding normal tissue. Therefore, BNCT and PDT will be new potent treatment modalities in the next century. In this project, we performed PDT in the patients with bladder cancers, oropharyngeal cancer, and skin cancers. Also we developed I-BPA, new porphyrin compounds, methods for estimation of radiobiological effect of neutron beam, and superficial animal brain tumor model. Furthermore, we prepared preclinical procedures for clinical application of BNCT, such as the macro- and microscopic dosimetry, obtaining thermal neutron flux from device used for fast neutron production in KCCH have been performed

Thyroid neoplasia following radiation therapy for Hodgkin's lymphoma

International Nuclear Information System (INIS)

McHenry, C.; Jarosz, H.; Calandra, D.; McCall, A.; Lawrence, A.M.; Paloyan, E.

1987-01-01

The question of thyroid neoplasia following high-dose radiation treatment to the neck and mediastinum for malignant neoplasms such as Hodgkin's lymphoma in children and young adults has been raised recently. Five patients, 19 to 39 years old, were operated on for thyroid neoplasms that developed following cervical and mediastinal radiation therapy for Hodgkin's lymphoma. Three patients had papillary carcinomas and two had follicular adenomas. The latency period between radiation exposure and the diagnosis of thyroid neoplasm ranged from eight to 16 years. This limited series provided strong support for the recommendation that children and young adults who are to receive high-dose radiation therapy to the head, neck, and mediastinum should receive suppressive doses of thyroxine prior to radiation therapy in order to suppress thyrotropin (thyroid-stimulating hormone) and then be maintained on a regimen of suppression permanently

Chondronecrosis of the cricoid cartilage following radiation therapy

International Nuclear Information System (INIS)

Tanabe, Masahiro; Isshiki, Nobuhiko; Kojima, Hisayoshi

1979-01-01

Chondronecrosis of the laryngeal cartilage following radiation therapy is a rare but serious complication. We report herein a case of post-radiation chondronecrosis and discuss factors predisposing to its development. A 67-year-old man received telecobalt therapy for cancer of the right vocal cord. A year after the radiation therapy given in a dose of 7,000r, the patient developed dysphagia and dyspnea. Following tracheotomy, he underwent total laryngectomy. The surgical specimen showed no cancer but chondronecrosis of the cricoid cartilage was present. After laryngectomy he developed progressive soft tissue necrosis of the neck and died following a carotid hemorrhage. (author)

Radiation therapy quality control in MRCCC radiotherapy units

International Nuclear Information System (INIS)

Fielda Djuita; Rina Taurisia; Andreas Nainggolan

2011-01-01

Increasing cancer patients in Indonesia is not supported with the number of equipment that is able to treat cancer patients, especially in the radiation therapy field. Therefore, several private hospitals have joined to provide radiation therapy services and one of them is MRCCC. As a new hospital providing services in radiotherapy field, the writer tries to present our quality control program that we have done in our hospital. Purpose: As quality control to radiation therapy clinical practice. Methods: Descriptive essay of what we do in our institution. Conclusion: Average output photon and electron lower more than tolerance dose. (author)

Evolution of radiation therapy: technology of today

International Nuclear Information System (INIS)

Shrivastava, S.K.; Mishra, Shagun

2013-01-01

The three well established arms of treatment are surgery, radiation therapy and chemotherapy. The management of cancer is multidisciplinary; Radiation Oncologists along with Surgical Oncologists and Medical Oncologists are responsible for cancer therapeutics. They all work in close collaboration with Pathologists and Radiologists for cancer diagnosis and staging and rely on Oncology Nurses, Physiotherapists, Occupational Therapists, Nutritionists and Social Workers for optimal treatment and rehabilitation of cancer patients. Therefore cancer management is a team work for getting the best results. Radiation therapy is one of the most effective methods of treating cancer

1-4 Strangeness Production in Antiproton Induced Nuclear Reactions.

Institute of Scientific and Technical Information of China (English)

Feng; Zhaoqing[1

2014-01-01

More localized energy deposition is able to be produced in antiproton-nucleus collisions in comparison withheavy-ion collisions due to annihilation reactions. Searching for the cold quark-gluon plasma (QGP) with antiprotonbeamshas been considered as a hot topic both in experiments and in theretical calculations over the past severaldecades. Strangeness production and hypernucleus formation in antiproton-induced nuclear reactions are importancein exploring the hyperon (antihyperon)-nucleon (HN) potential and the antinucleon-nucleon interaction, whichhave been hot topics in the forthcoming experiments at PANDA in Germany.

Testing quantum chromodynamics in anti-proton reactions

International Nuclear Information System (INIS)

Brodsky, S.J.

1987-10-01

An experimental program with anti-protons at intermediate energy can serve as an important testing ground for QCD. Detailed predictions for exclusive cross sections at large momentum transfer based on perturbative QCD and the QCD sum rule form of the proton distribution amplitude are available for anti p p → γγ for both real and virtual photons. Meson-pair and lepton-pair final states also give sensitive tests of the theory. The production of charmed hadrons in exclusive anti p p channels may have a non-negligible cross section. Anti-proton interactions in a nucleus, particularly J/psi production, can play an important role in clarifying fundamental QCD issues, such as color transparency, critical length phenomena, and the validity of the reduced nuclear amplitude phenomenology

Enhanced antiproton production in Pb(160 A GeV)+Pb reactions evidence for quark gluon matter?

CERN Document Server

Bleicher, M; Bass, S A; Soff, S; Stöcker, H

2000-01-01

The centrality dependence of the antiproton per participant ratio is studied in Pb(160 AGeV)+Pb reactions. Antiproton production in collisions of heavy nuclei at the CERN/SPS seems considerably enhanced as compared to conventional hadronic physics, given by the antiproton production rates in $pp$ and antiproton annihilation in $\\bar{p}p$ reactions. This enhancement is consistent with the observation of strong in-medium effects in other hadronic observables and may be an indication of partial restoration of chiral symmetry.

Comprehensive Study for an Optimized Redesign of the CERN's Antiproton Decelerator Target

CERN Document Server

AUTHOR|(CDS)2089345; Perillo-Marcone, Antonio; Muñoz-Cobo, Jose-Luis

2018-04-16

The Antiproton Decelerator Target (AD-Target) is a unique device responsible for the production of antiprotons at the European Organization for Nuclear Research (CERN). During operation, intense 26 GeV energy proton beams are impacted into its core, made of a 3 mm diameter rod of a high density material such as iridium, creating secondary particles -including antiprotons- from the nuclear reactions induced in its interior. This thesis delves into the characteristics of antiproton production and in particular in the mechanical response of the target core material, which is exposed to a rise of temperature of approximate 2000 degrees Celsius in less than 0.5 microseconds each time is impacted by the primary proton beam. A coupled numerical-experimental approach has been applied for this purpose. Specific computational tools, called hydrocodes, have been used for simulating the extreme dynamic response taking place in the target core and its containing graphite matrix, indicating their potential damage and frag...

Guidelines for radiation therapy in clinical research on bladder cancer

International Nuclear Information System (INIS)

Shipley, W.U.; VanderSchueren, E.; Kitagawa, T.; Gospodarowicz, M.K.; Frommhold, H.; Magno, L.; Mochizuki, S.; VanderBogaert, W.; VanderWerf-Messing, B.

1986-01-01

Bladder cancer is a heterogeneous disease and that there are important tumor characteristics that will predict significant differences in radiation responsiveness. These should in all instances be well documented prospectively in any treatment protocol. However, in this chapter the authors stress a number of factors related to the tumor at presentation as well as the administration of the radiation therapy that can importantly affect the efficacy of the radiation on the patient's tumor, as well as on his or her normal tissues. As Radiation Oncologists, they are most interested in the conducting and reporting of prospective clinical investigations in the use of radiation therapy in the treatment of patients with bladder carcinoma who will be treated with planned preservation of their bladder, but whose radiation therapy may be combined with additional planned bladder-sparing surgery, intraoperative radiation therapy, or chemotherapy

TH-F-202-03: Advances in MRI for Radiation Therapy

Energy Technology Data Exchange (ETDEWEB)

Cai, J. [Duke University Medical Center (United States)

2016-06-15

MRI has excellent soft tissue contrast and can provide both anatomical and physiological information. It is becoming increasingly important in radiation therapy for treatment planning, image-guided radiation therapy, and treatment assessment. It is critically important at this time point to educate and update our medical physicists about MRI to prepare for the upcoming surge of MRI applications in radiation therapy. This session will review important basics of MR physics, pulse sequence designs, and current radiotherapy application, as well as showcase exciting new developments in MRI that can be potentially useful in radiation therapy. Learning Objectives: To learn basics of MR physics and understand the differences between various pulse sequences To review current applications of MRI in radiation therapy.To discuss recent MRI advances for future MRI guided radiation therapy Partly supported by NIH (1R21CA165384).; W. Miller, Research supported in part by Siemens Healthcare; G. Li, My clinical research is in part supported by NIH U54CA137788. I have a collaborative research project with Philips Healthcare.; J. Cai, jing cai.

TH-F-202-03: Advances in MRI for Radiation Therapy

International Nuclear Information System (INIS)

Cai, J.

2016-01-01

MRI has excellent soft tissue contrast and can provide both anatomical and physiological information. It is becoming increasingly important in radiation therapy for treatment planning, image-guided radiation therapy, and treatment assessment. It is critically important at this time point to educate and update our medical physicists about MRI to prepare for the upcoming surge of MRI applications in radiation therapy. This session will review important basics of MR physics, pulse sequence designs, and current radiotherapy application, as well as showcase exciting new developments in MRI that can be potentially useful in radiation therapy. Learning Objectives: To learn basics of MR physics and understand the differences between various pulse sequences To review current applications of MRI in radiation therapy.To discuss recent MRI advances for future MRI guided radiation therapy Partly supported by NIH (1R21CA165384).; W. Miller, Research supported in part by Siemens Healthcare; G. Li, My clinical research is in part supported by NIH U54CA137788. I have a collaborative research project with Philips Healthcare.; J. Cai, jing cai

Energy and energy width measurement in the FNAL antiproton accumulator

Energy Technology Data Exchange (ETDEWEB)

Church, M.; Hsueh, S.; Rapidis, P.; Werkema, S.

1991-10-01

The Fermilab Antiproton Accumulator has recently been used to produce Charmonium resonances (charm quark, anti-charm quark bound states) in proton-antiproton annihilations using an internal H{sub 2} gas jet target. A measurement of the resonance mass and width may be obtained from a precise knowledge of the antiproton beam energy and energy spread. The beam energy is measured to an accuracy of 1 part in 10{sup 4} in the range 6.3 Gev to 4.1 Gev by measuring the orbit length and revolution frequency of the beam. The beam momentum spread is measured to an accuracy of 10% by measuring the beam frequency spread and the parameter {eta} = (P{sub beam}/F{sub rev}){center_dot}(dF{sub rev}/dP{sub beam}). These two measurement techniques are described in this report.

Radiation therapy in the management of childhood cancer

International Nuclear Information System (INIS)

Kun, L.E.

1987-01-01

Over the past two decades, multimodality treatment regimens have produced significant improvement in survival rates for most types of childhood cancer. The role of radiation therapy has been critically evaluated in prospective clinical trials that established the importance of irradiation in assuring local and regional control of disease central to ultimate survival. Indications for cranial and craniospinal irradiation in acute lymphoblastic leukemia are reviewed, as is difficult technical factors important for successful management. The role of radiation therapy in neuroblastoma and Wilms tumor is reviewed in the context of tumor biology and increasing data from multi-institutional trials. Interactions of irradiation with surgery and chemotherapy are stressed in childhood rhabdomyosarcoma and Ewing sarcoma. Current results in the more common central nervous tumors of childhood are presented, including the central role of radiation therapy in medulloblastoma, astrocytoma, and craniopharyngioma. Concerns regarding late effects of radiation therapy are balanced with the importance of achieving disease control

Outcome of radiation therapy for patients with Kasabach-Merritt syndrome

International Nuclear Information System (INIS)

Mitsuhashi, Norio; Furuta, Masaya; Sakurai, Hideyuki; Takahashi, Takeo; Kato, Shingo; Nozaki, Miwako; Saito, Yoshihiro; Hayakawa, Kazushige; Niibe, Hideo

1997-01-01

Purpose: The efficacy of radiation therapy for Kasabach-Merritt syndrome, which is characterized by a huge hemangioma with consumption coagulopathy, remains controversial. In this study, we retrospectively investigated the treatment outcome of radiation therapy for seven neonates with Kasabach-Merritt syndrome. Methods and Materials: During the past 25 years we have seen seven children with Kasabach-Merritt syndrome who were treated with radiation therapy. Their ages ranged from 1 day to 5 months, with a median age of 1 month. The hemangioma was located in the extremities in four of seven children. Tumor sizes ranged from 70 cm to more than 150 cm in greatest diameter. Initial platelet counts were all less than 40,000/mm 3 except for one patient. In principle, the total dose applied to the hemangioma was 8-10 Gy, with a daily dose of 1 Gy five times a week. Results: Four of seven hemangiomas responded dramatically, with a concomitant rise of the platelet count to radiation therapy. Although the remaining three hemangiomas, all of which were ill circumscribed by widespread overlying shiny, dusky purple skin, became less tense during radiation therapy. Disseminated intravascular coagulopathy was not improved, but they have responded favorably to two or three courses of radiation therapy with an extended radiation field by 1.5 years of age. As a result, all seven patients are now surviving with no evidence of hemangioma or hematological abnormalities. Shortening of the extremity was observed in three patients who received multiple courses of radiation therapy. Conclusions: Radiation therapy appears to be one of the effective treatment options for Kasabach-Merritt syndrome despite the risk of growth delay and malignancy

Low energy antiproton experiments - A review

NARCIS (Netherlands)

Jungmann, KP; Yamazaki, Y; Wada, M

2005-01-01

Low energy antiprotons offer excellent opportunities to study properties of fundamental forces and symmetries in nature. Experiments with them can contribute substantially to deepen our fundamental knowledge in atomic, nuclear and particle physics. Searches for new interactions can be carried out by

Postoperative radiation therapy for adenoid cystic carcinoma

International Nuclear Information System (INIS)

Oguchi, Masahiko; Shikama, Naoto; Gomi, Koutarou; Shinoda, Atsunori; Nishikawa, Atsushi; Arakawa, Kazukiyo; Sasaki, Shigeru; Takei, Kazuyoshi; Sone, Syusuke

2000-01-01

The authors retrospectively assessed the usefulness of postoperative radiation therapy after local resection of adenoid cystic carcinoma, with emphasis on organ-conserving treatment and the cosmetic results. Between 1985 and 1995, 32 patients underwent local resection followed by postoperative radiation therapy with curative and organ-conserving intent. None of patients received any form of chemotherapy as part of their initial treatment. Radiation therapy was carried out by techniques that were appropriate for the site and extension of each tumor. The 5-year local control, disease-free, and overall survival rates of all patients were 76%, 68%, and 86%, respectively. The 5-year local control rate and disease-free survival rate of patients with microscopically positive margins were 89% and 75%, respectively, and higher than in patients with macroscopically residual disease, but no significant difference in 5-year overall survival rate was observed. The postoperative cosmetic results in 29 patients with head and neck lesions were evaluated. No difference was documented between the cosmetic results postoperatively setting and after postoperative radiotherapy, and no significant differences in cosmetic results were observed according to radiation dose. The combination of local resection with organ-conserving intent and postoperative radiation therapy provided good cosmetic results in patients with T1 or T2 lesions. Postoperative radiation therapy with smaller fractions is useful, because good local control can be achieved in patients with adenoid cystic carcinoma having microscopically positive margins without inducing any late adverse reactions. However, the number of patients was too small and the follow-up period was too short to draw any definite conclusion in regard to fraction size. A much longer follow-up study with a larger number patients will be required to accurately determine the optimal treatment intensity and duration of treatment. (K.H.)

Antihydrogen formation by autoresonant excitation of antiproton plasmas

Energy Technology Data Exchange (ETDEWEB)

Bertsche, William Alan, E-mail: bertsche@cern.ch [Swansea University, Department of Physics (United Kingdom); Andresen, G. B. [Aarhus University, Department of Physics and Astronomy (Denmark); Ashkezari, M. D. [Simon Fraser University, Department of Physics (Canada); Baquero-Ruiz, M. [University of California, Department of Physics (United States); Bowe, P. D. [Aarhus University, Department of Physics and Astronomy (Denmark); Carpenter, P. T. [Auburn University, Department of Physics (United States); Butler, E. [CERN, Physics Department (Switzerland); Cesar, C. L. [Universidade Federal do Rio de Janeiro, Instituto de Fisica (Brazil); Chapman, S. F. [University of California, Department of Physics (United States); Charlton, M.; Eriksson, S. [Swansea University, Department of Physics (United Kingdom); Fajans, J. [University of California, Department of Physics (United States); Friesen, T. [University of Calgary, Department of Physics and Astronomy (Canada); Fujiwara, M. C.; Gill, D. R. [TRIUMF (Canada); Gutierrez, A. [University of British Columbia, Department of Physics and Astronomy (Canada); Hangst, J. S. [Aarhus University, Department of Physics and Astronomy (Denmark); Hardy, W. N. [University of British Columbia, Department of Physics and Astronomy (Canada); Hayano, R. S. [University of Tokyo, Department of Physics (Japan); Hayden, M. E. [Simon Fraser University, Department of Physics (Canada); Collaboration: ALPHA Collaboration; and others

2012-12-15

In efforts to trap antihydrogen, a key problem is the vast disparity between the neutral trap energy scale ({approx} 50 {mu}eV), and the energy scales associated with plasma confinement and space charge ({approx}1 eV). In order to merge charged particle species for direct recombination, the larger energy scale must be overcome in a manner that minimizes the initial antihydrogen kinetic energy. This issue motivated the development of a novel injection technique utilizing the inherent nonlinear nature of particle oscillations in our traps. We demonstrated controllable excitation of the center-of-mass longitudinal motion of a thermal antiproton plasma using a swept-frequency autoresonant drive. When the plasma is cold, dense and highly collective in nature, we observe that the entire system behaves as a single-particle nonlinear oscillator, as predicted by a recent theory. In contrast, only a fraction of the antiprotons in a warm or tenuous plasma can be similarly excited. Antihydrogen was produced and trapped by using this technique to drive antiprotons into a positron plasma, thereby initiating atomic recombination. The nature of this injection overcomes some of the difficulties associated with matching the energies of the charged species used to produce antihydrogen.

Antihydrogen formation by autoresonant excitation of antiproton plasmas

International Nuclear Information System (INIS)

Bertsche, William Alan; Andresen, G. B.; Ashkezari, M. D.; Baquero-Ruiz, M.; Bowe, P. D.; Carpenter, P. T.; Butler, E.; Cesar, C. L.; Chapman, S. F.; Charlton, M.; Eriksson, S.; Fajans, J.; Friesen, T.; Fujiwara, M. C.; Gill, D. R.; Gutierrez, A.; Hangst, J. S.; Hardy, W. N.; Hayano, R. S.; Hayden, M. E.

2012-01-01

In efforts to trap antihydrogen, a key problem is the vast disparity between the neutral trap energy scale (∼ 50 μeV), and the energy scales associated with plasma confinement and space charge (∼1 eV). In order to merge charged particle species for direct recombination, the larger energy scale must be overcome in a manner that minimizes the initial antihydrogen kinetic energy. This issue motivated the development of a novel injection technique utilizing the inherent nonlinear nature of particle oscillations in our traps. We demonstrated controllable excitation of the center-of-mass longitudinal motion of a thermal antiproton plasma using a swept-frequency autoresonant drive. When the plasma is cold, dense and highly collective in nature, we observe that the entire system behaves as a single-particle nonlinear oscillator, as predicted by a recent theory. In contrast, only a fraction of the antiprotons in a warm or tenuous plasma can be similarly excited. Antihydrogen was produced and trapped by using this technique to drive antiprotons into a positron plasma, thereby initiating atomic recombination. The nature of this injection overcomes some of the difficulties associated with matching the energies of the charged species used to produce antihydrogen.

Centrality and collision system dependence of antiproton production from p+A to Au+Au collisions at AGS energies

International Nuclear Information System (INIS)

Sako, H.; Ahle, L.; Akiba, Y.

1997-12-01

Antiproton production in heavy ion collisions reflects subtle interplay between initial production and absorption by nucleons. Because the AGS energies (10--20 A·GeV/c) are close to the antiproton production threshold, antiproton may be sensitive to cooperative processes such as QGP and hadronic multi-step processes. On the other hand, antiproton has been proposed as a probe of baryon density due to large N anti N annihilation cross sections. Cascade models predict the maximum baryon density reaches about 10 times the normal nucleus density in central Au+Au collisions, where the strong antiproton absorption is expected. In this paper, the authors show systematic studies of antiproton production from p+A to Au+Au collisions

Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy

International Nuclear Information System (INIS)

McDonald, Mark W.; Liu, Yuan; Moore, Michael G.; Johnstone, Peter A. S.

2016-01-01

To evaluate acute toxicity endpoints in a cohort of patients receiving head and neck radiation with proton therapy or intensity modulated radiation therapy (IMRT). Forty patients received comprehensive head and neck radiation including bilateral cervical nodal radiation, given with or without chemotherapy, for tumors of the nasopharynx, nasal cavity or paranasal sinuses, any T stage, N0-2. Fourteen received comprehensive treatment with proton therapy, and 26 were treated with IMRT, either comprehensively or matched to proton therapy delivered to the primary tumor site. Toxicity endpoints assessed included g-tube dependence at the completion of radiation and at 3 months after radiation, opioid pain medication requirement compared to pretreatment normalized as equivalent morphine dose (EMD) at completion of treatment, and at 1 and 3 months after radiation. In a multivariable model including confounding variables of concurrent chemotherapy and involved nodal disease, comprehensive head and neck radiation therapy using proton therapy was associated with a lower opioid pain requirement at the completion of radiation and a lower rate of gastrostomy tube dependence by the completion of radiation therapy and at 3 months after radiation compared to IMRT. Proton therapy was associated with statistically significant lower mean doses to the oral cavity, esophagus, larynx, and parotid glands. In subgroup analysis of 32 patients receiving concurrent chemotherapy, there was a statistically significant correlation with a greater opioid pain medication requirement at the completion of radiation and both increasing mean dose to the oral cavity and to the esophagus. Proton therapy was associated with significantly reduced radiation dose to assessed non-target normal tissues and a reduced rate of gastrostomy tube dependence and opioid pain medication requirements. This warrants further evaluation in larger studies, ideally with patient-reported toxicity outcomes and quality of life

COMPARISON OF HYPOFRACTIONATED RADIATION THERAPY VERSUS CONVENTIONAL RADIATION THERAPY IN POST MASTECTOMY BREAST CANCER

Directory of Open Access Journals (Sweden)

Abhilash

2016-03-01

Full Text Available INTRODUCTION Breast cancer is the most common cancer in women worldwide and a leading cause of cancer death in females and accounts for 1.8 million new cases and approximately 0.5 million deaths annually. Patients who present with locally advanced breast cancer (LABC require multidisciplinary team approach that incorporates diagnostic imaging, surgery, chemotherapy and histopathological assessment, including molecular-based studies, radiation, and, if indicated, biologic and hormonal therapies. Hypofractionated radiation therapy following mastectomy has been used in many institutions for several decades and have demonstrated equivalent local control, cosmetic and normal tissues between 50 Gy in 25 fractions and various hypofractionated radiotherapy prescriptions employing 13-16 fractions. Evidence suggests that hypofractionated radiotherapy may also be safe and effective for regional nodal disease. AIMS AND OBJECTIVES To compare the local control and side effects of hypofractionated radiation therapy with conventional radiation therapy in post mastectomy carcinoma breast with stage II and III and to compare the tolerability and compliance of both schedules. MATERIALS AND METHODS The study was conducted on 60 histopathologically proven patients of carcinoma of breast, treated surgically with modified radical mastectomy. Group I patients were given external radiation to chest flap and drainage areas, a dose of 39 Gy/13 fractions/3.1 weeks, a daily dose 3 Gy for 13 fractions in 4 days a week schedule and Group II patients were given external radiation to chest flap and drainage areas, a dose of 50 Gy/25 fractions/5 weeks, to receive a daily dose 2 Gy for 25 fractions in a 5 days a week schedule. RESULTS The median age at presentation in Group I and II was 48 and 50 years respectively. Locoregional control after completion of radiotherapy in Group I vs. Group II was 26/30 (86.7% vs. 27/30 (90% respectively. Acute reactions and their grades in Group

21 CFR 892.5750 - Radionuclide radiation therapy system.

Science.gov (United States)

2010-04-01

... system. (a) Identification. A radionuclide radiation therapy system is a device intended to permit an... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radionuclide radiation therapy system. 892.5750... patient's body. This generic type of device may include signal analysis and display equipment, patient and...

DOE Research Contributions to Radiation and Cancer Therapy

Science.gov (United States)

dropdown arrow Site Map A-Z Index Menu Synopsis DOE Research Contributions to Radiation and Cancer Therapy Possible: DOE Advanced Biomedical Technology Research, page 10 Over the time span of many years, DOE's research has made many contributions to radiation and cancer therapy, including PEREGRINE and Boron Neutron

Pionic annihilation of antiprotons stopped on 3He

International Nuclear Information System (INIS)

Bendiscioli, G.; Filippini, V.; Rotondi, A.; Salvini, P.; Venaglioni, A.; Bossolasco, S.; Bussa, M.P.; Busso, L.; Fava, L.; Ferrero, L.; Maggiora, A.; Panzieri, D.; Piragino, G.; Piragino, R.; Tosello, F.; Batusov, Yu.A.; Falomkin, I.V.; Pontecorvo, G.B.; Rozhdestvensky, A.M.; Sapozhnikov, M.G.; Tretyak, V.I.; Guaraldo, C.; Haatuft, A.; Halsteinslid, A.; Myklebost, K.; Olsen, J.M.; Zenoni, A.

1990-01-01

The pionic annihilation of antiprotons stopped on 3 He nuclei in a self-shunted streamer chamber exposed to the antiproton beam of LEAR is studied. The data concern charged-particle multiplicity distributions, branching ratios for different final states, the probability of final-state interaction, π - , π + , p and d momentum spectra, like and unlike pion angular correlations, π and other charged-particle angular correlations. The comparison of the 3 He data with those obtained on 1 H, 2 H and 4 He does not reveal relevant effects due to the increase of the nucleon number; the small differences can be seen as due to a weak final-state interaction. (orig.)

Radiation therapy for chordomas

International Nuclear Information System (INIS)

Ikeda, Hajime; Takahashi, Takeo; Nakamura, Yuji; Niibe, Hideo

1995-01-01

Chordomas are slow-growing primary malignant bone tumors which originate from remnants of the fetal notochordal system. They are difficult to control by surgery alone. Four patients with chordomas treated with radiation therapy were studied, and the effectiveness of radiotherapy was evaluated. These 4 (3.8%) patients were among 106 patients with primary malignant bone tumors referred to us from 1959 to 1987. Primary sites were the sacrococcygeal region in three patients and the clivus in one. The patients' ages ranged from 51 to 75 years. The male : female ratio was 1 : 1. Patients received 48 to 60 Gy of radiation to the primary sites. Because the radiosensitivity of the tumors was low, the responses were poor. The duration of survival was 6, 33, 68, and 125 months. The cause of death in each case was local recurrence of tumor. As a result, a dose greater than 60 Gy is thought to be necessary for curative radiotherapy. Proton beam therapy seems to be best choice for chordomas in the clivus, and mixed-beam (proton and megavolt age X-ray) therapy or multiportal irradiation, which gives an ideal spatial dose distribution, seems to be most suitable for sacrococcygeal chordomas. (author)

Radiation Therapy and Hearing Loss

International Nuclear Information System (INIS)

Bhandare, Niranjan; Jackson, Andrew; Eisbruch, Avraham; Pan, Charlie C.; Flickinger, John C.; Antonelli, Patrick; Mendenhall, William M.

2010-01-01

A review of literature on the development of sensorineural hearing loss after high-dose radiation therapy for head-and-neck tumors and stereotactic radiosurgery or fractionated stereotactic radiotherapy for the treatment of vestibular schwannoma is presented. Because of the small volume of the cochlea a dose-volume analysis is not feasible. Instead, the current literature on the effect of the mean dose received by the cochlea and other treatment- and patient-related factors on outcome are evaluated. Based on the data, a specific threshold dose to cochlea for sensorineural hearing loss cannot be determined; therefore, dose-prescription limits are suggested. A standard for evaluating radiation therapy-associated ototoxicity as well as a detailed approach for scoring toxicity is presented.

High-precision spectroscopy of antiprotonic helium-first results from the AD of CERN

CERN Document Server

Widmann, E

2001-01-01

New results of the laser and microwave spectroscopy of antiprotonic helium "atomcules" obtained in the first year of operation of the Antiproton Decelerator (AD) facility of CERN are presented. They include the discovery of three new resonant transitions and the determination of the zero-density wavelength of six transitions with an accuracy of 130 ppb in the best case. Auger rates of those states were also determined, and two of them were found to be several orders of magnitude larger than expected from a simple estimate based on the multipolarity Delta l, i.e., the jump in angular momentum required for the antiproton to reach the next lower-lying state of ionized pHe /sup ++/. Furthermore, a first signal of a two-laser microwave triple resonance to measure the hyperfine splitting in antiprotonic helium was observed. (39 refs).

The physical basis and future of radiation therapy.

Science.gov (United States)

Bortfeld, T; Jeraj, R

2011-06-01

The remarkable progress in radiation therapy over the last century has been largely due to our ability to more effectively focus and deliver radiation to the tumour target volume. Physics discoveries and technology inventions have been an important driving force behind this progress. However, there is still plenty of room left for future improvements through physics, for example image guidance and four-dimensional motion management and particle therapy, as well as increased efficiency of more compact and cheaper technologies. Bigger challenges lie ahead of physicists in radiation therapy beyond the dose localisation problem, for example in the areas of biological target definition, improved modelling for normal tissues and tumours, advanced multicriteria and robust optimisation, and continuous incorporation of advanced technologies such as molecular imaging. The success of physics in radiation therapy has been based on the continued "fuelling" of the field with new discoveries and inventions from physics research. A key to the success has been the application of the rigorous scientific method. In spite of the importance of physics research for radiation therapy, too few physicists are currently involved in cutting-edge research. The increased emphasis on more "professionalism" in medical physics will tip the situation even more off balance. To prevent this from happening, we argue that medical physics needs more research positions, and more and better academic programmes. Only with more emphasis on medical physics research will the future of radiation therapy and other physics-related medical specialties look as bright as the past, and medical physics will maintain a status as one of the most exciting fields of applied physics.

The physical basis and future of radiation therapy

Science.gov (United States)

Bortfeld, T; Jeraj, R

2011-01-01

The remarkable progress in radiation therapy over the last century has been largely due to our ability to more effectively focus and deliver radiation to the tumour target volume. Physics discoveries and technology inventions have been an important driving force behind this progress. However, there is still plenty of room left for future improvements through physics, for example image guidance and four-dimensional motion management and particle therapy, as well as increased efficiency of more compact and cheaper technologies. Bigger challenges lie ahead of physicists in radiation therapy beyond the dose localisation problem, for example in the areas of biological target definition, improved modelling for normal tissues and tumours, advanced multicriteria and robust optimisation, and continuous incorporation of advanced technologies such as molecular imaging. The success of physics in radiation therapy has been based on the continued “fuelling” of the field with new discoveries and inventions from physics research. A key to the success has been the application of the rigorous scientific method. In spite of the importance of physics research for radiation therapy, too few physicists are currently involved in cutting-edge research. The increased emphasis on more “professionalism” in medical physics will tip the situation even more off balance. To prevent this from happening, we argue that medical physics needs more research positions, and more and better academic programmes. Only with more emphasis on medical physics research will the future of radiation therapy and other physics-related medical specialties look as bright as the past, and medical physics will maintain a status as one of the most exciting fields of applied physics. PMID:21606068

Results of radiation therapy in periarthritis humeroscapularis

International Nuclear Information System (INIS)

Schultze, J.; Schlichting, G.; Galalae, R.; Kimmig, B.; Koltze, H.

2004-01-01

Background: radiation therapy is applied in painful degenerative shoulder diseases. Aim of this work was to evaluate the contribution of radiation therapy to symptomatic improvement in periarthritis humeroscapularis. Methods: ninety-four patients with periarthritis humeroscapularis were treated in two institutions. Mean age was 68 years, sex distribution were 32 men and 62 women. In 58 cases the right side was affected, left in 36 cases. At single doses of 0,75 Gy once a week a total dose of 6 Gy was applied The treatment effect was evaluated by the standardized von Pannewitz-score at the end of the treatment up to 6 months thereafter. Results: the treatment results of all the 94 patients were documentated at the end of therapy. Seventy-one patients were followed at least for further 4 months. Radiogenic side-effects were not noticed. The symptoms of 54 patients (57.4%) were improved or vanished, in 40 cases the symptoms were not significantly affected (42.6%). Four months after therapy 42 of 71 patients were improved (59.2%), 29 unchanged (40.8%). The treatment effect occured typically up to 2 months after therapy, there were no age-related differences. Also in recurrent radiation therapies the symptoms improved, in 80 percent after one preceding therapy, however only in 31.2 percent after multiple prior radiotherapies. (orig.)

Two case reports of a cerebrovascular disorder after radiation therapy

International Nuclear Information System (INIS)

Ono, Jiro; Mimaki, Takashi; Tagawa, Tetsuzo

1985-01-01

The use of radiation therapy has significantly improved the prognosis of certain brain tumors. However, a few patients have been reported who developed cerebrovasculopathy accompanying transient ischemic attacks several months to several years after radiation therapy. The present report described cerebrovascular disorders after radiation therapy for brain tumors. The first case was an 8-year-6-month-old boy treated with a total dose of 5,200 rads after partial removal of a right periventricular astrocytoma extending into the thalamus. Two years and 7 months after completion of the radiation therapy, he showed transient ischemic attacks of numbness in the right upper limb and right hemiparesis. Arteriography revealed stenosis or occlusion of the anterior and middle cerebral arteries. Preoperative arteriography did not show occlusion nor narrowing of the cerebral arteries. The second case was a 2-year-8-month-old boy diagnosed as diencephalic syndrome, because of marked emaciation and a huge tumor mass expanding into the diencephalon and frontal lobe on the brain CT scan. He was irradiated with up to 5,000 rads. Seven months after radiation therapy, he developed transient right hemiparesis. Arteriography revealed stenosis or occlusion of the middle sized cerebral arteries. Although radiation therapy is acceptable in children with certain brain tumors, and very few patients develop postradiation vasculopathy, the risk of radiation therapy requires more careful consideration in the treatment of intracranial tumors. (author)

Monte Carlo techniques in radiation therapy

CERN Document Server

Verhaegen, Frank

2013-01-01

Modern cancer treatment relies on Monte Carlo simulations to help radiotherapists and clinical physicists better understand and compute radiation dose from imaging devices as well as exploit four-dimensional imaging data. With Monte Carlo-based treatment planning tools now available from commercial vendors, a complete transition to Monte Carlo-based dose calculation methods in radiotherapy could likely take place in the next decade. Monte Carlo Techniques in Radiation Therapy explores the use of Monte Carlo methods for modeling various features of internal and external radiation sources, including light ion beams. The book-the first of its kind-addresses applications of the Monte Carlo particle transport simulation technique in radiation therapy, mainly focusing on external beam radiotherapy and brachytherapy. It presents the mathematical and technical aspects of the methods in particle transport simulations. The book also discusses the modeling of medical linacs and other irradiation devices; issues specific...

A case showing a blistering disorder in radiation dermatitis during radiation therapy

International Nuclear Information System (INIS)

Nonoshita, Takeshi; Nakamura, Katsumasa; Shioyama, Yoshiyuki

2007-01-01

We experienced a case showing a blistering disorder in radiation dermatitis during radiation therapy for thymic cancer. Application of steroid to the lesion improved blisters. The literature on bullous eruption including radiation-induced bullous pemhigoid was critically reviewed. (author)

Radiation therapy for pleural mesothelioma

International Nuclear Information System (INIS)

Seydel, H.G.

1986-01-01

There is clear evidence that both pleural and peritoneal malignant mesothelioma are increasing in incidence in the United States. There is a recognized long period of latency from asbestos exposure to the emergence and diagnosis of tumor. Considering the levels of asbestos utilization in the mid-20th century, we must expect that the number of cases will continue to increase until the end of this century. Evaluation of treatment options is thus a critical issue in determining treatment approaches for this disease. Recognized only recently, mesothelioma has no effective treatment, and patients are reported only anecdotally as cured. Pleural mesothelioma is the more common presentation, but even here the reports are from small, uncontrolled series. Only one study is available in which a concomitant comparison of treatment methods was carried out. Randomized clinical studies regarding treatment of pleural mesothelioma have only recently been initiated by the clinical cooperative groups. There is thus a paucity of information on treatment in general and radiation therapy specifically for malignant mesothelioma. This chapter reviews the reported experience using radiation therapy alone and combined with other modalities for the treatment of malignant pleural mesothelioma and considers the potential for improvement of the results of current methods of radiation therapy

Multiple collision effects on the antiproton production by high energy proton (100 GeV - 1000 GeV)

International Nuclear Information System (INIS)

Takahashi, Hiroshi; Powell, J.

1987-01-01

Antiproton production rates which take into account multiple collision are calculated using a simple model. Methods to reduce capture of the produced antiprotons by the target are discussed, including geometry of target and the use of a high intensity laser. Antiproton production increases substantially above 150 GeV proton incident energy. The yield increases almost linearly with incident energy, alleviating space charge problems in the high current accelerator that produces large amounts of antiprotons

Examination of X-ray spectra from the antiprotonic helium isotopes 3He and 4He

International Nuclear Information System (INIS)

Schneider, M.

1987-05-01

Using the high intensity antiprotonic LEAR beam at CERN (Geneva), several measurements were done to investigate the X-ray spectra of the antiprotonic Helium isotopes 3 He and 4 He. For the first time antiprotons were stopped in gases at low pressures (600, 375, 72 and 36 mbar), which permitted observations on nearly isolated atoms. A newly developed method for stopping the antiprotons in gases by means of a focusing cyclotron field surrounding the target gas was used. The field was supplied by a superconducting magnet ('cyclotron trap'). The antiprotons were tangentially injected into the cyclotron field, where they slowed down by ionising the target gas. The inhomogeneous magnetic field guided the antiprotons in spiral orbits to the magnetic center. Thus, even at low pressures a very small stopping volume could be achieved. To detect the X-rays different Si(Li)- and Ge-semiconductor detectors were used, some of which were furnished with 'guard-rings'. They were used to investigate the effects of the strong interaction between the antiproton and the nucleus in the (3d → 2p) transition in both isotopes. The analyzis of this transition permitted directly the determination of the shift and width of the 2p-level. The width of the 3d-level could be determined only indirectly using an intensity balance. The utilization of gases with different pressures permitted investigations of the pressure dependence of the antiprotonic deexcitation process. The results for the widths and shifts were compared with earlier measurements and theoretical predictions. The theory agrees only partly with the measurements. The evaluation of a complex scattering length using an optical model contradicts some of the results of calculations. (orig.) [de

On the antiproton discovery

International Nuclear Information System (INIS)

Piccioni, O.

1989-01-01

The author of this article describes his own role in the discovery of the antiproton. Although Segre and Chamberlain received the Nobel Prize in 1959 for its discovery, the author claims that their experimental method was his idea which he communicated to them informally in December 1954. He describes how his application for citizenship (he was Italian), and other scientists' manipulation, prevented him from being at Berkeley to work on the experiment himself. (UK)

Bubble chamber: antiproton annihilation

CERN Multimedia

1971-01-01

These images show real particle tracks from the annihilation of an antiproton in the 80 cm Saclay liquid hydrogen bubble chamber. A negative kaon and a neutral kaon are produced in this process, as well as a positive pion. The invention of bubble chambers in 1952 revolutionized the field of particle physics, allowing real tracks left by particles to be seen and photographed by expanding liquid that had been heated to boiling point.

Optimization of adaptive radiation therapy in cervical cancer: Solutions for photon and proton therapy

NARCIS (Netherlands)

van de Schoot, A.J.A.J.

2016-01-01

In cervical cancer radiation therapy, an adaptive strategy is required to compensate for interfraction anatomical variations in order to achieve adequate dose delivery. In this thesis, we have aimed at optimizing adaptive radiation therapy in cervical cancer to improve treatment efficiency and

Time-dependent density functional calculation of the energy loss of antiprotons colliding with metallic nanoshells

International Nuclear Information System (INIS)

Quijada, M.; Borisov, A.G.; Muino, R.D.

2008-01-01

Time-dependent density functional theory is used to study the interaction between antiprotons and metallic nanoshells. The ground state electronic properties of the nanoshell are obtained in the jellium approximation. The energy lost by the antiproton during the collision is calculated and compared to that suffered by antiprotons traveling in metal clusters. The resulting energy loss per unit path length of material in thin nanoshells is larger than the corresponding quantity for clusters. It is shown that the collision process can be interpreted as the antiproton crossing of two nearly bi-dimensional independent metallic systems. (copyright 2008 WILEY-VCH Verlag GmbH and Co. KGaA, Weinheim) (orig.)

Direct detection of antiprotons with the Timepix3 in a new electrostatic selection beamline

Energy Technology Data Exchange (ETDEWEB)

Pacifico, N., E-mail: nicola.pacifico@cern.ch [Institute of Physics and Technology, University of Bergen, Allgaten 55, 5007 Bergen (Norway); Aghion, S. [Politecnico of Milano, Piazza Leonardo da Vinci 32, 20133 Milano (Italy); INFN Milano, via Celoria 16, 20133 Milano (Italy); Alozy, J. [Physics Department, CERN, 1211 Geneva 23 (Switzerland); Amsler, C.; Ariga, A.; Ariga, T. [Laboratory for High Energy Physics, Albert Einstein Center for Fundamental Physics, University of Bern, 3012 Bern (Switzerland); Bonomi, G. [Department of Mechanical and Industrial Engineering, University of Brescia, via Branze 38, 25123 Brescia (Italy); INFN Pavia, via Bassi 6, 27100 Pavia (Italy); Bräunig, P. [Kirchhoff-Institute for Physics, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg (Germany); Bremer, J. [Physics Department, CERN, 1211 Geneva 23 (Switzerland); Brusa, R.S. [Department of Physics, University of Trento, via Sommarive 14, 38123 Povo, Trento (Italy); TIFPA/INFN Trento, via Sommarive 14, 38123 Povo, Trento (Italy); Cabaret, L. [Laboratory Aimé Cotton, University of Paris-Sud, ENS Cachan, CNRS, University Paris-Saclay, 91405 Orsay Cedex (France); Caccia, M. [INFN Milano, via Celoria 16, 20133 Milano (Italy); Department of Science, University of Insubria, Via Valleggio 11, 22100 Como (Italy); Campbell, M. [Physics Department, CERN, 1211 Geneva 23 (Switzerland); Caravita, R. [Department of Physics, University of Genova, via Dodecaneso 33, 16146 Genova (Italy); INFN Genova, via Dodecaneso 33, 16146 Genova (Italy); Castelli, F. [INFN Milano, via Celoria 16, 20133 Milano (Italy); Department of Physics, University of Milano, via Celoria 16, 20133 Milano (Italy); Cerchiari, G. [Max Planck Institute for Nuclear Physics, Saupfercheckweg 1, 69117 Heidelberg (Germany); Chlouba, K. [Czech Technical University, Prague, Brehov 7, 11519 Prague 1 (Czech Republic); and others

2016-09-21

We present here the first results obtained employing the Timepix3 for the detection and tagging of annihilations of low energy antiprotons. The Timepix3 is a recently developed hybrid pixel detector with advanced Time-of-Arrival and Time-over-Threshold capabilities and has the potential of allowing precise kinetic energy measurements of low energy charged particles from their time of flight. The tagging of the characteristic antiproton annihilation signature, already studied by our group, is enabled by the high spatial and energy resolution of this detector. In this study we have used a new, dedicated, energy selection beamline (GRACE). The line is symbiotic to the AEgIS experiment at the CERN Antiproton Decelerator and is dedicated to detector tests and possibly antiproton physics experiments. We show how the high resolution of the Timepix3 on the Time-of-Arrival and Time-over-Threshold information allows for a precise 3D reconstruction of the annihilation prongs. The presented results point at the potential use of the Timepix3 in antimatter-research experiments where a precise and unambiguous tagging of antiproton annihilations is required.

Oral care of the cancer patient receiving radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Holtzhausen, T [Medical Univ. of Southern Africa, Pretoria (South Africa). Dept. of Community Dentistry

1982-07-01

Radiation therapy is frequently being used for the patient with oral cancer. The survival rate is increasing, due to more effective treatment technique. The question of whether any teeth should be extracted, the mode of therapy and the side effects of radiation like Xerostomia, caries, stomatitis, trismus and osteo-radionecrosis and also post radiation care are discussed.

Radiation therapy: age-related macular degeneration.

Science.gov (United States)

Mendez, Carlos A Medina; Ehlers, Justis P

2013-01-01

Age-related macular degeneration (AMD) is the leading cause of severe irreversible vision loss in patients over the age of 50 years in the developed world. Neovascular AMD (NVAMD) is responsible for 90% of the cases with severe visual loss. In the last decade, the treatment paradigm for NVAMD has been transformed by the advent of anti-vascular endothelial growth factor therapy. Despite the excellent results of anti-vascular endothelial growth factor therapy, frequent injections remain a necessity for most patients. The burden of these frequent visits as well as the cumulative risks of indefinite intravitreal injections demand continued pursuit of more enduring therapy that provides similar functional results. Radiotherapy has been studied for two decades as a potential therapy for NVAMD. Because of its antiangiogenic properties, radiation therapy remains a promising potential adjunctive resource for the treatment of choroidal neovascularization secondary to NVAMD. This review considers the past, present and future of radiation as a treatment or combination treatment of NVAMD. Copyright © 2013 S. Karger AG, Basel.

Computed tomography in radiation therapy planning: Thoracic region

International Nuclear Information System (INIS)

Seydel, H.G.; Zingas, A.; Haghbin, M.; Mondalek, P.; Smereka, R.

1983-01-01

With the explosive spread of computed tomographic (CT) scanning throughout the United States, one of the main applications has been in patients who are treated for cancer by surgery, radiation therapy, or chemotherapy. For the radiation oncologist, the desire to provide local tumor control and avoid geographic misses to achieve an expected prolongation of survival has led to the use of large radiation fields in the treatment of intrathoracic cancer, including bronchogenic carcinoma, cancer of the esophagus, and other malignant tumors. The optimal radiation therapy plan is a balance between local tumor control and the necessity to preserve normal structures by the use of directed and limited fields for bulk disease. CT scanning has been employed to accurately demonstrate the extent of tumor as well as to determine the isodose distribution of radiation, including the spatial distribution of radiation portals in single planar and three-dimensional aspects as well as consideration of tissue inhomogeneities. The accurate planning of the distribution of therapeutic irradiation includes both the tumor-bearing target volume and the critical normal tissues. This chapter provides information regarding these aspects of the application of CT scanning to radiation therapy for bronchogenic carcinoma and carcinoma of the esophagus

Primary populations of metastable antiprotonic $^{4}He$ and $^{3}He$ atoms

CERN Document Server

Hori, Masaki; Hayano, R S; Ishikawa, T; Sakuguchi, J; Tasaki, T; Widmann, E; Yamaguchi, H; Torii, H A; Juhász, B; Horváth, D; Yamazaki, T

2002-01-01

Initial population distributions of metastable antiprotonic **4He and **3He atoms over principal and angular momentum quantum numbers were investigated using laser spectroscopy. The total fractions of antiprotons captured into the metastable states of the atoms were deduced. Cascade calculations were performed using the measure populations to reproduce the delayed annihilation time spectrum. Results showed agreement between the simulated and measured spectra. (Edited abstract) 30 Refs.

Antiproton, positron, and electron imaging with a microchannel plate/phosphor detector

CERN Document Server

Andresen, G B; Bowe, P D; Bray, C; Butler, E; Cesar, C L; Chapman, S; Charlton, M; Fajans, J; Fujiwara, M C; Gill, D R; Hangst, J S; Hardy, W N; Hayano, R S; Hayden, M E; Humphries, A J; Hydomako, R; Jørgensen, L V; Kerrigan, S J; Kurchaninov, L; Lambo, R; Madsen, N; Nolan, P; Olchanski, K; Olin, A; Povilus, A; Pusa, P; Sarid, E; Seif El Nasr, S; Silveira, D M; Storey, J W; Thompson, R I; van der Werf, D P; Yamazaki, Y

2009-01-01

A microchannel plate (MCP)/phosphor screen assembly has been used to destructively measure the radial profile of cold, confined antiprotons, electrons, and positrons in the ALPHA experiment, with the goal of using these trapped particles for antihydrogen creation and confinement. The response of the MCP to low energy (10-200 eV, <1 eV spread) antiproton extractions is compared to that of electrons and positrons.

Radiation optic neuropathy after external beam radiation therapy for acromegaly: report of two cases

International Nuclear Information System (INIS)

Bergh, Alfons C.M. van den; Hoving, Marjanke A.; Links, Thera P.; Dullaart, Robin P.F.; Ranchor, Adelita V.; Weeme, Cees A. ter; Canrinus, Alof A.; Szabo, Ben G.; Pott, Jan-Willem R.

2003-01-01

For diagnosing radiation optic neuropathy (RON) ophthalmological and imaging data were evaluated from 63 acromegalic patients, irradiated between 1967 and 1998. Two patients developed RON: one patient in one optic nerve 10 years and another patient in both optic nerves 5 months after radiation therapy. RON is a rare complication after external beam radiation therapy for acromegaly, which can occur after a considerable latency period

Modeling Internal Radiation Therapy

NARCIS (Netherlands)

van den Broek, Egon; Schouten, Theo E.; Pellegrini, M.; Fred, A.; Filipe, J.; Gamboa, H.

2011-01-01

A new technique is described to model (internal) radiation therapy. It is founded on morphological processing, in particular distance transforms. Its formal basis is presented as well as its implementation via the Fast Exact Euclidean Distance (FEED) transform. Its use for all variations of internal

Radiation Therapy of Suprasellar Germ Cell Tumors

International Nuclear Information System (INIS)

Park, Woo Yoon; Choi, Doo Ho; Choi, Eun Kyung; Kim, Il Han; Ha, Sung Whan; Park, Charn Il

1988-01-01

A retrospective study was performed on 15 patients with suprasellar germ cell tumors treated by megavoltage external beam irradiation between Feb. 1979 and Dec. 1985. Follow-up period of survivors was 30 to 91 months. Histologic diagnosis was obtained before radiation therapy in 10 patients (9 germinomas and 1 mixed). Five patients were treated without histologic verification. In 9 patients with biopsy-proven germinomas radiation therapy was delivered to the craniospinal axis in 6, to the whole brain in 3. In 5 patients with mixed germ cell tumor or elevated tumor marker, irradiation was delivered to the craniospinal axis in 2, to the whole brain in 2, and to the primary site only in 1. Total doses ranged from 5,000 to 5,500 cGy to the primary site, 3,000 to 4,400 cGy to the whole brain, and 1,300 to 3,000 cGy to the spine. In these 14, local tumor was controlled and primary or spinal failure was not observed. One patient without elevated tumor marker was treated to the whole brain, The tumor was not controlled and he had spinal recurrence. It is proven that radiation therapy is an effective treatment for suprasellar germ cell tumors. The neuroendocrinologic presentation, tumor marker status, early response to radiation measured on CT seem to be useful means for selecting patients for radiation therapy when tissue diagnosis is not available

CrossRef Antiproton Flux, Antiproton-to-Proton Flux Ratio, and Properties of Elementary Particle Fluxes in Primary Cosmic Rays Measured with the Alpha Magnetic Spectrometer on the International Space Station

CERN Document Server

Aguilar, M; Alpat, B; Ambrosi, G; Arruda, L; Attig, N; Aupetit, S; Azzarello, P; Bachlechner, A; Barao, F; Barrau, A; Barrin, L; Bartoloni, A; Basara, L; Başeǧmez-du Pree, S; Battarbee, M; Battiston, R; Bazo, J; Becker, U; Behlmann, M; Beischer, B; Berdugo, J; Bertucci, B; Bindi, V; Boella, G; de Boer, W; Bollweg, K; Bonnivard, V; Borgia, B; Boschini, M  J; Bourquin, M; Bueno, E  F; Burger, J; Cadoux, F; Cai, X  D; Capell, M; Caroff, S; Casaus, J; Castellini, G; Cernuda, I; Cervelli, F; Chae, M  J; Chang, Y  H; Chen, A  I; Chen, G  M; Chen, H  S; Cheng, L; Chou, H  Y; Choumilov, E; Choutko, V; Chung, C  H; Clark, C; Clavero, R; Coignet, G; Consolandi, C; Contin, A; Corti, C; Coste, B; Creus, W; Crispoltoni, M; Cui, Z; Dai, Y  M; Delgado, C; Della Torre, S; Demirköz, M  B; Derome, L; Di Falco, S; Dimiccoli, F; Díaz, C; von Doetinchem, P; Dong, F; Donnini, F; Duranti, M; D'Urso, D; Egorov, A; Eline, A; Eronen, T; Feng, J; Fiandrini, E; Finch, E; Fisher, P; Formato, V; Galaktionov, Y; Gallucci, G; García, B; García-López, R  J; Gargiulo, C; Gast, H; Gebauer, I; Gervasi, M; Ghelfi, A; Giovacchini, F; Goglov, P; Gómez-Coral, D  M; Gong, J; Goy, C; Grabski, V; Grandi, D; Graziani, M; Guerri, I; Guo, K  H; Habiby, M; Haino, S; Han, K  C; He, Z  H; Heil, M; Hoffman, J; Hsieh, T  H; Huang, H; Huang, Z  C; Huh, C; Incagli, M; Ionica, M; Jang, W  Y; Jinchi, H; Kang, S  C; Kanishev, K; Kim, G  N; Kim, K  S; Kirn, Th; Konak, C; Kounina, O; Kounine, A; Koutsenko, V; Krafczyk, M  S; La Vacca, G; Laudi, E; Laurenti, G; Lazzizzera, I; Lebedev, A; Lee, H  T; Lee, S  C; Leluc, C; Li, H  S; Li, J  Q; Li, Q; Li, T  X; Li, W; Li, Z  H; Li, Z  Y; Lim, S; Lin, C  H; Lipari, P; Lippert, T; Liu, D; Liu, Hu; Lu, S  Q; Lu, Y  S; Luebelsmeyer, K; Luo, F; Luo, J  Z; Lv, S  S; Majka, R; Mañá, C; Marín, J; Martin, T; Martínez, G; Masi, N; Maurin, D; Menchaca-Rocha, A; Meng, Q; Mo, D  C; Morescalchi, L; Mott, P; Nelson, T; Ni, J  Q; Nikonov, N; Nozzoli, F; Nunes, P; Oliva, A; Orcinha, M; Palmonari, F; Palomares, C; Paniccia, M; Pauluzzi, M; Pensotti, S; Pereira, R; Picot-Clemente, N; Pilo, F; Pizzolotto, C; Plyaskin, V; Pohl, M; Poireau, V; Putze, A; Quadrani, L; Qi, X  M; Qin, X; Qu, Z  Y; Räihä, T; Rancoita, P  G; Rapin, D; Ricol, J  S; Rodríguez, I; Rosier-Lees, S; Rozhkov, A; Rozza, D; Sagdeev, R; Sandweiss, J; Saouter, P; Schael, S; Schmidt, S  M; Schulz von Dratzig, A; Schwering, G; Seo, E  S; Shan, B  S; Shi, J  Y; Siedenburg, T; Son, D; Song, J  W; Sun, W  H; Tacconi, M; Tang, X  W; Tang, Z  C; Tao, L; Tescaro, D; Ting, Samuel C  C; Ting, S  M; Tomassetti, N; Torsti, J; Türkoğlu, C; Urban, T; Vagelli, V; Valente, E; Vannini, C; Valtonen, E; Vázquez Acosta, M; Vecchi, M; Velasco, M; Vialle, J  P; Vitale, V; Vitillo, S; Wang, L  Q; Wang, N  H; Wang, Q  L; Wang, X; Wang, X  Q; Wang, Z  X; Wei, C  C; Weng, Z  L; Whitman, K; Wienkenhöver, J; Willenbrock, M; Wu, H; Wu, X; Xia, X; Xiong, R  Q; Xu, W; Yan, Q; Yang, J; Yang, M; Yang, Y; Yi, H; Yu, Y  J; Yu, Z  Q; Zeissler, S; Zhang, C; Zhang, J; Zhang, J  H; Zhang, S  D; Zhang, S  W; Zhang, Z; Zheng, Z  M; Zhu, Z  Q; Zhuang, H  L; Zhukov, V; Zichichi, A; Zimmermann, N; Zuccon, P

2016-01-01

A precision measurement by AMS of the antiproton flux and the antiproton-to-proton flux ratio in primary cosmic rays in the absolute rigidity range from 1 to 450 GV is presented based on 3.49×105 antiproton events and 2.42×109 proton events. The fluxes and flux ratios of charged elementary particles in cosmic rays are also presented. In the absolute rigidity range ∼60 to ∼500  GV, the antiproton p¯, proton p, and positron e+ fluxes are found to have nearly identical rigidity dependence and the electron e− flux exhibits a different rigidity dependence. Below 60 GV, the (p¯/p), (p¯/e+), and (p/e+) flux ratios each reaches a maximum. From ∼60 to ∼500  GV, the (p¯/p), (p¯/e+), and (p/e+) flux ratios show no rigidity dependence. These are new observations of the properties of elementary particles in the cosmos.

Laser Spectroscopy of Antiprotonic Helium Atoms

CERN Multimedia

2002-01-01

%PS205 %title\\\\ \\\\Following the discovery of metastable antiprotonic helium atoms ($\\overline{p}He^{+} $) at KEK in 1991, systematic studies of their properties were made at LEAR from 1991 to 1996. In the first two years the lifetime of $\\overline{p}He^{+}$ in liquid and gaseous helium at various temperatures and pressures was measured and the effect of foreign gases on the lifetime of these atoms was investigated. Effects were also discovered which gave the antiproton a 14\\% longer lifetime in $^4$He than in $^3$He, and resulted in important differences in the shape of the annihilation time spectra in the two isotopes.\\\\ \\\\Since 1993 laser spectroscopy of the metastable $\\overline{p}He^{+}$ atoms became the main focus of PS205. Transitions were stimulated between metastable and non-metastable states of the $\\overline{p}He^{+}$ atom by firing a pulsed dye laser beam into the helium target every time an identified metastable atom was present (Figure 1). If the laser frequency matched the transition energy, the...

The antiproton ion collider at FAIR

International Nuclear Information System (INIS)

Fabbietti, L.; Faestermann, T.; Homolka, J.; Kienle, P.; Kruecken, R.; Ring, P.; Suziki, K.; Beller, P.; Bosch, F.; Frankze, B.; Kozhuharov, C.; Nolden, F.; Cargnelli, M.; Fuhrmann, H.; Hirtl, A.; Marton, J.; Widmann, E.; Zmeskal, J.; Hayano, R.S.; Yamaguchi, T.; Lenske, H.; Litvinov, Y.; Shatunov, Y.; Skrinsky, A.N.; Vostrikov, V.A.; Wycech, S.

2005-01-01

A novel method is proposed to determine the charge and the matter radii instable and short lived nuclei using an pBar-A collider. The experiment makes use of the appropriately modified electron-ion collider Elise, to collide 30 MeV anti-protons with 740 AMeV ions. The anti-protons are first collected in the CR ring with 3 GeV energy and then cooled in the RESR ring to 30 MeV. The heavy ions produced in the SFRS are precooled in the CR ring, cooled in the RESR ring to 740 AMeV and fed to the NESR ring. The total pBar-nucleon annihilation cross-section is measured detecting the loss of stored ions and the pBar-n, pBar-p cross-sections detecting the A - 1 (Z - 1 or N - 1) nuclei left over after the annihilation, using the Schottcky method. Theoretical predictions show that the annihilation cross-section is proportional to the mean squared radius. (author)

QCD studies with anti-protons at FAIR: Indian participation in PANDA

International Nuclear Information System (INIS)

Kailas, S.; Roy, B.J.; Dutta, D.; Jha, V.; Varma, R.

2011-01-01

The Facility for Antiproton and Ion Research (FAIR) is a future project at GSI which will extend hadron physics studies up to the charm meson region using antiproton beams together with a state-of-the-art detector antiproton annihilation at Darmstadt (PANDA). The physics aim, in a broader sense, is to address the fundamental problems of hadron physics and aspects of quantum chromo-dynamics (QCD) at low energies. The proposed work in India will consist of several parts: R and D studies of silicon micro-strip detector, development of a scintillator hodoscope with silicon photomultiplier (SiPM) readout, studies of SiPM as photon counter and simulation studies of the detector design as well as physics case studies. The present article describes the physics motivation and initial progress made towards achieving these goals. (author)

Radiation Therapy for Neovascular Age-related Macular Degeneration

Energy Technology Data Exchange (ETDEWEB)

Kishan, Amar U. [Harvard Medical School, Boston, Massachusetts (United States); Modjtahedi, Bobeck S.; Morse, Lawrence S. [Department of Ophthalmology and Vision Sciences, University of California, Davis, Sacramento, California (United States); Lee, Percy, E-mail: percylee@mednet.ucla.edu [Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California (United States)

2013-03-01

In the enormity of the public health burden imposed by age-related macular degeneration (ARMD), much effort has been directed toward identifying effective and efficient treatments. Currently, anti-vascular endothelial growth factor (VEGF) injections have demonstrated considerably efficacy in treating neovascular ARMD, but patients require frequent treatment to fully benefit. Here, we review the rationale and evidence for radiation therapy of ARMD. The results of early photon external beam radiation therapy are included to provide a framework for the sequential discussion of evidence for the usage of stereotactic radiation therapy, proton therapy, and brachytherapy. The evidence suggests that these 3 modern modalities can provide a dose-dependent benefit in the treatment of ARMD. Most importantly, preliminary data suggest that all 3 can be used in conjunction with anti-VEGF therapeutics, thereby reducing the frequency of anti-VEGF injections required to maintain visual acuity.

Radiation Therapy of Pituitary Tumors

Energy Technology Data Exchange (ETDEWEB)

Park, Moon Baik; Hong, Seong Eong [Kyunghee University College of Medicine, Seoul (Korea, Republic of)

1989-12-15

Radiation treatment results were analyzed in a retrospective analysis of 47 patients with pituitary adenoma treated with radiation alone or combined with surgery from 1974 through 1987 at the Department of Therapeutic Radiology of Kyung Hee University. The 5-year overall survival rates for all patients was 80.4%. Radiation therapy was effective for improving visual symptoms and headache, but could not normalize amenorrhea and galactorrhoea. There was no difference of survival rate between radiation alone and combination with surgery. Prognostic factors such as age, sex, disease type, visual field, headache and surgical treatment were statistically no significant in survival rates of these patients.

Radiation Therapy of Pituitary Tumors

International Nuclear Information System (INIS)

Park, Moon Baik; Hong, Seong Eong

1989-01-01

Radiation treatment results were analyzed in a retrospective analysis of 47 patients with pituitary adenoma treated with radiation alone or combined with surgery from 1974 through 1987 at the Department of Therapeutic Radiology of Kyung Hee University. The 5-year overall survival rates for all patients was 80.4%. Radiation therapy was effective for improving visual symptoms and headache, but could not normalize amenorrhea and galactorrhoea. There was no difference of survival rate between radiation alone and combination with surgery. Prognostic factors such as age, sex, disease type, visual field, headache and surgical treatment were statistically no significant in survival rates of these patients

Radiation therapy of brain metastases

Energy Technology Data Exchange (ETDEWEB)

Sauer, R; Huenig, R [Kantonsspital Basel (Switzerland). Universitaetsinstitut fuer Medizinische Radiologie

1975-08-01

Experiences are reported obtained with radiation therapy of brain metastases in 121 patients during the last 15 years. The treatment to a lesser extent aimed at prolongation of survival but much more at the attempt to alleviate troubles and to spare pain. The indication thus involved medical points of view as well as ethical ones. The radiotherapy of cerebral metastases comprises the whole cranial volume and requires a focal dose of minimally 4,000 R within four weeks. In 53% of the patients, the regression of neurological symptoms was considerable, in 18% even complete, partly beginning already after a few days of treatment. The number of recurrences was small. Under conditions of rigorous indication, the radiation therapy of brain metastases offers a rewarding palliative measure.

Some computer graphical user interfaces in radiation therapy.

Science.gov (United States)

Chow, James C L

2016-03-28

In this review, five graphical user interfaces (GUIs) used in radiation therapy practices and researches are introduced. They are: (1) the treatment time calculator, superficial X-ray treatment time calculator (SUPCALC) used in the superficial X-ray radiation therapy; (2) the monitor unit calculator, electron monitor unit calculator (EMUC) used in the electron radiation therapy; (3) the multileaf collimator machine file creator, sliding window intensity modulated radiotherapy (SWIMRT) used in generating fluence map for research and quality assurance in intensity modulated radiation therapy; (4) the treatment planning system, DOSCTP used in the calculation of 3D dose distribution using Monte Carlo simulation; and (5) the monitor unit calculator, photon beam monitor unit calculator (PMUC) used in photon beam radiation therapy. One common issue of these GUIs is that all user-friendly interfaces are linked to complex formulas and algorithms based on various theories, which do not have to be understood and noted by the user. In that case, user only needs to input the required information with help from graphical elements in order to produce desired results. SUPCALC is a superficial radiation treatment time calculator using the GUI technique to provide a convenient way for radiation therapist to calculate the treatment time, and keep a record for the skin cancer patient. EMUC is an electron monitor unit calculator for electron radiation therapy. Instead of doing hand calculation according to pre-determined dosimetric tables, clinical user needs only to input the required drawing of electron field in computer graphical file format, prescription dose, and beam parameters to EMUC to calculate the required monitor unit for the electron beam treatment. EMUC is based on a semi-experimental theory of sector-integration algorithm. SWIMRT is a multileaf collimator machine file creator to generate a fluence map produced by a medical linear accelerator. This machine file controls

Drug delivery system and radiation therapy

International Nuclear Information System (INIS)

Shibata, Tokushi

2005-01-01

This paper describes the review of radiation therapy, neutron capture therapy (NCT) and drug delivery system for the latter. In cancer radiation therapy, there are problems of body movement like breathing, needless irradiation of normal tissues, difficulty to decide the correct irradiation position and tumor morphology. NCT has advantages to overcome these, and since boron has a big cross section for thermal neutron, NPT uses the reaction 10 B(n, α) 7 Li in the target cancer which previously incorporated the boron-containing drug. During the period 1966-1996, 246 patients were treated with this in Japan and the treatment has been continued thereafter. The tasks for NCT are developments of drug delivery system efficient to deliver the drug into the tumor and of convenient neutron source like the accelerator. (S.I.)

Computer models for optimizing radiation therapy

International Nuclear Information System (INIS)

Duechting, W.

1998-01-01

The aim of this contribution is to outline how methods of system analysis, control therapy and modelling can be applied to simulate normal and malignant cell growth and to optimize cancer treatment as for instance radiation therapy. Based on biological observations and cell kinetic data, several types of models have been developed describing the growth of tumor spheroids and the cell renewal of normal tissue. The irradiation model is represented by the so-called linear-quadratic model describing the survival fraction as a function of the dose. Based thereon, numerous simulation runs for different treatment schemes can be performed. Thus, it is possible to study the radiation effect on tumor and normal tissue separately. Finally, this method enables a computer-assisted recommendation for an optimal patient-specific treatment schedule prior to clinical therapy. (orig.) [de

Radiation therapy of Graves' ophthalmopathy

Energy Technology Data Exchange (ETDEWEB)

Kawamura, Toshiki; Koga, Sukehiko; Anno, Hirofumi; Komai, Satoshi (Fujita-Gakuen Health Univ., Toyoake, Aichi (Japan))

1992-01-01

During the decade from 1978 to 1987, 20 patients with Graves' ophthalmopathy were treated with irradiation of 2000 cGy to the orbital tissue. We examined the effects of the therapy on 17 such patients. Exophthalmos tended to decrease. When the degree of deviation of the exophthalmic eye was small, the effect of therapy tended to be better than when it was large. Two cases that showed an increase in retrobulbar fatty tissue without thickening of the extraocular muscles did not respond as well as those that had thickening of the extraocular muscles. Diplopia tended to improve both subjectively and objectively. Ocular movement improved in 11 of the 17 patients. There were no serious radiation injuries after the radiation therapy, except for some transient swelling of the eyelid. (author).

The Antiproton Accumulator and Collector and the discovery of the W & Z intermediate vector bosons

CERN Document Server

Chohan, Vinod

2016-01-01

The following sections are included: Preface ; Brief outline of the overall scheme for antiprotons of the SPS as a collider ; Antiproton production and accumulation ; The AA and AC storage rings ; Stochastic cooling and stacking ; Post-acceleration of antiprotons and beams for SPS Collider ; Proton test beams for the AA and AC from the PS ; The W and Z discoveries and the Nobel Prize ; Accumulator performance ; Acknowledgements and conclusions ; References

Scattering of antiprotons from carbon at 46.8 MeV

International Nuclear Information System (INIS)

Garetta, D.; Birien, P.; Bruge, G.; Chaumeaux, A.; Janouin, S.; Legrand, D.; Mallet-Lemaire, M.C.; Mayer, B.; Pain, J.; Drake, D.M.; Peng, J.C.

1984-01-01

Antiproton-carbon elastic and inelastic scattering cross sections have been measured at 46.8 MeV over an angular range 6 0 0 with a magnetic spectrometer. Fits to the elastic and inelastic 4.44 MeV excited state cross sections put realistic limits on the strengths of the real and imaginary parts of the antiproton-carbon optical potential. The continuum cross section due to carbon break-up appears to be smaller than it is for corresponding proton data. (orig.)

Radiation Therapy in Elderly Skin Cancer

Energy Technology Data Exchange (ETDEWEB)

Kim, Jin Hee [Keimyung University College of Medicine, Daegu (Korea, Republic of)

2008-06-15

To evaluate the long term results (local control, survival, failure, and complications) after radiation therapy for skin cancer in elderly patients. The study spanned from January 1990 to October 2002. Fifteen elderly patients with skin cancer were treated by radiotherapy at the Keimyung University Dongsan Medical Center. The age distribution of the patients surveyed was 72 to 95 years, with a median age of 78.8 years. The pathologic classification of the 15 patients included squamous cell carcinoma (10 patients), basal cell carcinoma (3 patients), verrucous carcinoma (1 patient) and skin adnexal origin carcinoma (1 patient). The most common tumor location was the head (13 patients). The mean tumor diameter was 4.9 cm (range 2 to 9 cm). The radiation dose was delivered via an electron beam of 6 to 15 MeV. The dose range was adjusted to the tumor diameter and depth of tumor invasion. The total radiation dose ranged from 50{approx}80 Gy (mean: 66 Gy) with a 2 Gy fractional dose prescribed to the 80% isodose line once a day and 5 times a week. One patient with lymph node metastasis was treated with six MV photon beams boosted with electron beams. The length of the follow-up periods ranged from 10 to 120 months with a median follow-up period of 48 months. The local control rates were 100% (15/15). In addition, the five year disease free survival rate (5YDFS) was 80% and twelve patients (80%) had no recurrence and skin cancer recurrence occurred in 3 patients (20%). Three patients have lived an average of 90 months (68{approx}120 months) without recurrence or metastasis. A total of 9 patients who died as a result of other causes had a mean survival time of 55.8 months after radiation therapy. No severe acute or chronic complications were observed after radiation therapy. Only minor complications including radiation dermatitis was treated with supportive care. The results suggest that radiation therapy is an effective and safe treatment method for the treatment of skin

Accompanying therapy with melatonin at radiation therapy for uterine body cancer

International Nuclear Information System (INIS)

Prokhach, N.E.; Sorochan, P.P.; Gromakova, Yi.A.; Krugova, M.; Sukhyin, V.S.

2011-01-01

The results of treatment for uterine body cancer using post-operative radiation therapy (RT) accompanied by melatonin administration are analyzed. Accompanying therapy with melatonin limited negative RT influence on hematological and immune indices and prevented aggravation of quality of life.

Radiation Induced Rib Fractures on Bone Scan after Breast Cancer Surgery and Radiation Therapy

International Nuclear Information System (INIS)

Kim, Hae Won; Won, Kyoung Sook; Zeon, Seok Kil; Kim, Jin Hee

2009-01-01

This study is to evaluate rib fractures on bone scan in breast cancer patients treated with breast cancer surgery and radiation therapy and to evaluate its relation with radiation therapy and operation modality. Two hundred seventy cases that underwent serial bone scan after breast cancer surgery and radiation therapy were enrolled. Bone scan and chest CT findings of rib fracture were analyzed. The rib uptake was seen in 74 of 270 cases (27.4%) on bone scan and 50 cases (18.5%) were confirmed to have rib fracture by chest CT. The rate of modified radical mastectomy in patients with rib fracture was significantly higher than that in patients without rib fracture (66.0% vs. 27.0%, p=0.000). The rate of additional radiation therapy to axillar or supraclavicular regions in patients with rib fracture was significantly higher than that in patients without rib fracture (62.0% vs. 28.6%, p=0.000). Rib fracture was seen most frequently at 1-2 years after radiation therapy (51.9%) and single rib fracture was seen most frequently (55.2%). Of total 106 rib fractures, focal rib uptake was seen in 94 ribs (88.7%) and diffuse rib uptake was seen in 12 ribs (11.3%). On one year follow-up bone scan, complete resolution of rib uptake was seen in 15 ribs (14.2%). On chest CT, the rate of fracture line in ribs with intense uptake was significantly higher than that in ribs with mild or moderate uptake (p=0.000). The rate of presence of fracture line in ribs with focal uptake was significantly higher than that in ribs with diffuse uptake (p=0.001). Rib fracture in breast cancer patients after radiation therapy was related to radiation portal and operation modality. It should be interpreted carefully as a differential diagnosis of bone metastasis

Radiation Induced Rib Fractures on Bone Scan after Breast Cancer Surgery and Radiation Therapy

Energy Technology Data Exchange (ETDEWEB)

Kim, Hae Won; Won, Kyoung Sook; Zeon, Seok Kil; Kim, Jin Hee [Keimyung University, School of Medicine, Daegu (Korea, Republic of)

2009-08-15

This study is to evaluate rib fractures on bone scan in breast cancer patients treated with breast cancer surgery and radiation therapy and to evaluate its relation with radiation therapy and operation modality. Two hundred seventy cases that underwent serial bone scan after breast cancer surgery and radiation therapy were enrolled. Bone scan and chest CT findings of rib fracture were analyzed. The rib uptake was seen in 74 of 270 cases (27.4%) on bone scan and 50 cases (18.5%) were confirmed to have rib fracture by chest CT. The rate of modified radical mastectomy in patients with rib fracture was significantly higher than that in patients without rib fracture (66.0% vs. 27.0%, p=0.000). The rate of additional radiation therapy to axillar or supraclavicular regions in patients with rib fracture was significantly higher than that in patients without rib fracture (62.0% vs. 28.6%, p=0.000). Rib fracture was seen most frequently at 1-2 years after radiation therapy (51.9%) and single rib fracture was seen most frequently (55.2%). Of total 106 rib fractures, focal rib uptake was seen in 94 ribs (88.7%) and diffuse rib uptake was seen in 12 ribs (11.3%). On one year follow-up bone scan, complete resolution of rib uptake was seen in 15 ribs (14.2%). On chest CT, the rate of fracture line in ribs with intense uptake was significantly higher than that in ribs with mild or moderate uptake (p=0.000). The rate of presence of fracture line in ribs with focal uptake was significantly higher than that in ribs with diffuse uptake (p=0.001). Rib fracture in breast cancer patients after radiation therapy was related to radiation portal and operation modality. It should be interpreted carefully as a differential diagnosis of bone metastasis.

Recent results from proton-antiproton colliders

International Nuclear Information System (INIS)

Geer, S.

1990-03-01

New results from the CERN and Fermilab proton-antiproton colliders are summarised. The areas covered are jet physics, direct photon production, W and Z production and decay, heavy flavor production, the search for the top quark, and the search for more exotic phenomena. 46 refs., 20 figs., 4 tabs

A measurement of the gravitational acceleration of the anti-proton

CERN Document Server

Holzscheiter, M H

1990-01-01

A fundamental experiment in gravity proposed by us, is the measurement of the gravitational force on antimatter. This measurement would constitute the first direct test of the Weak Equivalence Principle (WEP) for antimatter. The availability of low-energy antiprotons at CERN has made such an experiment feasible, and a proposal to carry out such a measurement has been accepted by the CERN Program Committee. We plan to use a time-of-flight technique similar to that pioneered by Fairbank and Witteborn in their measurement of the gravitational force on an electron. Very slow particles are launched into a vertical drift tube and the time-of-flight spectrum of these particles is recorded. This spectrum will exhibit a cut-off point directly related to the gravitational acceleration of the particles. Obtaining very slow antiprotons involves several stages of deceleration. Antiprotons from LEAR will be initially decelerated from 2 MeY to tens of kilovolts by passing them through a thin foil. After capture and cooling ...

Measurements of Wake-Riding Electrons in Antiproton-Carbon-Foil Collisions

CERN Multimedia

2002-01-01

When a charged particle passes through dielectric media, e.g. a thin carbon foil, a ``wake'' is induced. The characteristic wake-potential shows an oscillatory behaviour, with a wavelength of about $ 2 \\pi v _{p} / \\omega _{p} _{l} $ where $ v _{p} $ is the projectile velocity and $ \\omega _{p} _{l} $ the plasmon energy of the target. This induced wake potential is superimposed on the Coulomb potential of the projectile, the latter leading to a pronounced ``cusp'' of electrons leaving the solid at $ v _{e} app v _{p} $ for positively charged projectiles in the MeV region. Correspondingly, an ``anti-cusp'' is expected for antiprotons. \\\\ \\\\ In the solid, the wake-potential leads to an attractive force on electrons, and a dynamic electronic state is predicted both for proton and antiproton projectiles. In the solid, the wake-riding electrons are travelling with the projectile speed $ v _{p} $ Upon exit of the foil, the electron released from the wake-riding state of an antiproton will suddenly find itself in th...

Spontaneous pneumothorax after upper mantle radiation therapy for Hodgkin disease

International Nuclear Information System (INIS)

Paszat, L.; Basrur, V.; Tadros, A.

1986-01-01

Between 1967 and 1981, 158 of 256 consecutive adult patients received upper mantle (UM) radiation therapy as part of initial treatment of Hodgkin disease at the Hamilton Regional Cancer Centre. Chemotherapy was also part of the initial treatment in 21 of 158 patients who received UM radiation therapy. Spontaneous pneumothorax was observed in six of 158 patients during remission after UM radiation therapy in this series. Three cases were incidental findings on follow-up radiographs, but three other patients were seen initially with symptoms of spontaneous pneumothorax. The entity occurred in three of 21 patients (14%) treated with UM radiation therapy and chemotherapy, and in three of 137 (2%) treated with UM radiation therapy (P < .05). Within the range of UM doses (3,500-4,000 cGy in 4 weeks), higher dose was not associated with higher risk of spontaneous pneumothorax. Although these cases of spontaneous pneumothorax are clustered in an age range classic for this entity, the incidence of spontaneous pneumothorax in this group of patients is higher than the anticipated lifetime incidence of 1:500 for the general population. This risk of spontaneous pneumothorax after UM radiation therapy may be even higher in patients who also receive chemotherapy

Extra Low Energy Antiproton ring ELENA : from the conception to the implementation phase

CERN Document Server

Bartmann, W; Breuker, H; Butin, F; Carli, C; Eriksson, T; Maury, S; Pasinelli, S; Tranquille, G; Oelert, W

2014-01-01

The Extra Low Energy Antiproton ring (ELENA) is a CERN project aiming at constructing a small 30 m circumference synchrotron to further decelerate antiprotons from the Antiproton Decelerator AD from 5.3 MeV to 100 keV. Controlled deceleration in a synchrotron equipped with an electron cooler to reduce emittances in all three planes will allow the existing AD experiments to increase substantially their antiproton capture efficiencies and render new experiments possible. The ELENA design is now well advanced and the project is moving to the implementation phase. Component design and construction are taking place at present for installation foreseen during the second half of 2015 and beginning of 2016 followed by ring commissioning until the end of 2016. New electrostatic transfer lines to the experiments will be installed and commissioned during the first half of 2017 followed by the first physics operation with ELENA. Basic limitations like Intra Beam Scattering limiting the emittances obtained under electron ...

Palliative radiation therapy for overloading radiotherapy centre, especially for developing country

International Nuclear Information System (INIS)

Myo, M.; Susworo; San, T.

2001-01-01

In a developing country, most of the cancer cases are diagnosed in the advanced stages. So, the palliative radiation therapy is the only choice of therapy for these inoperable cases where chemotherapy is not effective or affordable. In conventional radiation therapy, a daily dose of 200 cGy for total 4000 cGy in more than 20 fractions (sometimes, up to 6000 cGy) is used. By using linear-quadratic model theory of cell killing by radiation, it can be calculated early and late effects by using alpha and beta ratio. This theory is still the best for radiation cell killing until the new detail one is discovered. These data are obtained by experimental as well as clinical results. The effective radiation dose can be calculated by using the data to different organs which is involved in the radiation fields. This can change the daily dose to palliative cases in which the late effect is unnecessary. The daily doses can be 300, 400, 500, and sometimes 1000 cGy per single fraction. These modalities are well documented. It is recommend to change the short term high-dose palliative radiation therapy instead of using conventional palliative radiation therapy in overloading radiotherapy centre, especially for developing country. The reasons are mainly radiation protection aspect, not only for the patients and those who involved with the radiation therapy but also to reduce the unnecessary radiation exposure to the environment. (author)

Radiation therapy for children: evolving technologies in the era of ALARA

International Nuclear Information System (INIS)

Kun, Larry E.; Beltran, Chris

2009-01-01

The evolution of ever more sophisticated oncologic imaging and technologies providing far more precise radiation therapy have combined to increase the utilization of sophisticated radiation therapy in childhood cancer. For a majority of children with common central nervous system, soft tissue, bone, and dysontogenic neoplasms, local irradiation is fundamental to successful multi-disciplinary management. Along with more precise target volume definition and radiation delivery, new technologies provide added certainty of patient positioning (electronic portal imaging, cone beam CT) and conformality of dose delivery (3-D conformal irradiation, intensity modulated radiation therapy, proton beam therapy). Each of the major areas of technology development are able to better confine the high-dose region to the intended target, but they are also associated with the potential for larger volumes of uninvolved tissues being exposed to low radiation doses. The latter issue plays a role in documented levels of secondary carcinogenesis, sometimes with greater anticipated incidence than that seen in conventional radiation therapy. Parameters related to carcinogenesis, such as dose-volume relationships and neutron contamination that accompanies high-energy photon irradiation and proton therapy, can be identified, sometimes modulated, and accepted as part of the clinical decision process in fine tuning radiation therapy in this more vulnerable age group. (orig.)

Intensity-Modulated Radiation Therapy (IMRT)

Science.gov (United States)

... type your comment or suggestion into the following text box: Comment: E-mail: Area code: Phone no: Thank ... Accelerator Prostate Cancer Treatment Head and Neck Cancer Treatment Introduction to Cancer Therapy (Radiation Oncology) ...

Radiation therapy technology (radiation therapists) manpower needs 1992 comparison of radiation therapeutic technology education in Europe and the United States 1994

International Nuclear Information System (INIS)

Rominger, C. Jules; Owen, Jean; Thompson, Phyllis; Giordano, Patricia; Buck, Beverly; Hanks, Gerald

1995-01-01

The shortage of radiation therapists (radiation therapy technologists) has existed in the United States for many years. It now appears the supply may be matching the demand. This report analyzes the data from the most recent manpower study from ACR/ASTRO carried out in 1990 using the Patterns of Care Master Facility list. The report is a comparison of these figures with similar figures published in IJROBP in December, 1983. Between 1980 and 1990 the number of radiation therapists rose from 3096 to 5353, an increase of 72%. During this period of time, the number of radiation therapy machines increased 47%, and the number of patients being treated increased 30%. The total number of educational programs in radiation therapy technology increased from 101 in 1989 to 123 in 1993. The total enrollment in these programs grew from 806 in 1989 to 1591 in 1993. The number of first time examinees in radiation therapy technology by ARRT in 1983 was 387 and increased to 943 in 1994. It is apparent that as a result of the increase in the number of radiation therapy educational programs and the more effective recruitment into these program, the supply of graduating radiation therapists has reached the demand. The future needs for entry level radiation therapists should be based on current data as well as new Blue Book standards that are being developed

PROTON RADIATION THERAPY: CLINICAL APPLICATION OPPORTUNITIES AND RESEARCH PROSPECTS

Directory of Open Access Journals (Sweden)

M. V. Zabelin

2018-01-01

Full Text Available This article is the review of literature concerning use of proton beam therapy in treatment of oncology. The staticized data on comparison of effi ciency of this method at an eye melanoma are lit. Advantages of proton therapy on the level of local control and depression of frequency of development of the radio induced cataract are refl ected in the provided data. In evident material the technology of preparation and carrying out radiation of an eye is shortly covered with a fascicle of protons. The experience of use of proton therapy of tumors of a skull base got for the last several decades, showed good results. Physical properties of a fascicle of protons allow to achieve the maximum dose conformality, having lowered, thereby, a radial load on the next crucial anatomical structures. The presented material on an oncopediatrics shows insuffi cient knowledge of scientists concerning advantage of a fascicle of protons over modern methods of photon radiation. There are only preliminary clinical results concerning generally of treatment of cranyopharyngiomas. At cancer therapy of a mammary gland, proton therapy showed the best local control of postoperative recurrent tumors, and also depression of a dose load on the contralateral party. The available results of the retrospective analysis of clinical data in the University medical center of Lome Linda, testify to advantages of proton therapy of the localized prostate cancer. The lack of a biochemical recurrence and a local tumoral progression within 5 years after radiation was shown. The data obtained from experience of use of proton radiation therapy with passively scattered fascicle for cancer therapy of a prostate at an early stage showed the admixed results in comparison with modern methods of radiation therapy with the modulated intensity. In treatment of non-small cell cancer of mild advantage of proton therapy aren’t absolutely proved yet. There are data on extreme toxicity of a combination

Centrifugal Separation and Equilibration Dynamics in an Electron-Antiproton Plasma

International Nuclear Information System (INIS)

Andresen, G. B.; Bowe, P. D.; Hangst, J. S.; Ashkezari, M. D.; Hayden, M. E.; Baquero-Ruiz, M.; Chapman, S.; Fajans, J.; Povilus, A.; So, C.; Bertsche, W.; Butler, E.; Charlton, M.; Deller, A.; Eriksson, S.; Humphries, A. J.; Madsen, N.; Werf, D. P. van der; Cesar, C. L.; Friesen, T.

2011-01-01

Charges in cold, multiple-species, non-neutral plasmas separate radially by mass, forming centrifugally separated states. Here, we report the first detailed measurements of such states in an electron-antiproton plasma, and the first observations of the separation dynamics in any centrifugally separated system. While the observed equilibrium states are expected and in agreement with theory, the equilibration time is approximately constant over a wide range of parameters, a surprising and as yet unexplained result. Electron-antiproton plasmas play a crucial role in antihydrogen trapping experiments.

Centrifugal separation and equilibration dynamics in an electron-antiproton plasma

CERN Document Server

Andresen, G B; Baquero-Ruiz, Marcelo; Bertsche, William; Bowe, Paul D; Butler, Eoin; Cesar, Claudio L; Chapman, Steven; Charlton, Michael; Deller, A; Eriksson, S; Fajans, Joel; Friesen, Tim; Fujiwara, Makoto C; Gill, David R; Gutierrez, A; Hangst, Jeffrey S; Hardy, Walter N; Hayden, Michael E; Humphries, Andrew J; Hydomako, Richard; Jonsell, Svante; Madsen, Niels; Menary, Scott; Nolan, Paul; Olin, Art; Povilus, Alexander; Pusa, Petteri; Robicheaux, Francis; Sarid, Eli; Silveira, Daniel M; So, Chukman; Storey, James W; Thompson, Robert I; van der Werf, Dirk P; Wurtele, Jonathan S; Yamazaki, Yasunori

2011-01-01

Charges in cold, multiple-species, non-neutral plasmas separate radially by mass, forming centrifugally-separated states. Here, we report the first detailed measurements of such states in an electron-antiproton plasma, and the first observations of the separation dynamics in any centrifugally-separated system. While the observed equilibrium states are expected and in agreement with theory, the equilibration time is approximately constant over a wide range of parameters, a surprising and as yet unexplained result. Electron-antiproton plasmas play a crucial role in antihydrogen trapping experiments.

The role of radiation therapy in the management of desmoid tumors

International Nuclear Information System (INIS)

Schulz-Ertner, D.; Zierhut, D.; Mende, U.; Harms, W.; Branitzki, P.; Wannenmacher, M.

2002-01-01

Purpose: To investigate the role of radiation therapy (RT) in the management of desmoid tumors. Patients and Methods: Retrospective analysis was performed on 28 patients with desmoid tumors treated with radiation therapy between March 1989 and March 1999. Tumor site was intraabdominal in three, abdominal wall in three and extraabdominal in 22 patients. Median tumor dose was 48 Gy (range 36-60 Gy). Radiation therapy was delivered postoperatively in 26 of 28 patients, two patients received radiation therapy for unresectable recurrent tumors. Results: Median follow-up was 46 months (range 13-108 months). Actuarial 5-year control rate was 73%. We observed six recurrences, located within the radiation field in one patient, out of field in two and at the field margin in three patients. All patients with intraabdominal tumors have been controlled without severe side effects. Conclusions: Radiation therapy is an effective treatment after incomplete resection of desmoid tumors. We did not observe a benefit for tumor doses exceeding 50 Gy. In some patients with circumscribed intraabdominal desmoid tumors, radiation therapy might be a treatment option with low toxicity, if 3-D treatment planning is utilized. (orig.) [de

START: an advanced radiation therapy information system.

Science.gov (United States)

Cocco, A; Valentini, V; Balducci, M; Mantello, G

1996-01-01

START is an advanced radiation therapy information system (RTIS) which connects direct information technology present in the devices with indirect information technology for clinical, administrative, information management integrated with the hospital information system (HIS). The following objectives are pursued: to support decision making in treatment planning and functional and information integration with the rest of the hospital; to enhance organizational efficiency of a Radiation Therapy Department; to facilitate the statistical evaluation of clinical data and managerial performance assessment; to ensure the safety and confidentiality of used data. For its development a working method based on the involvement of all operators of the Radiation Therapy Department, was applied. Its introduction in the work activity was gradual, trying to reuse and integrate the existing information applications. The START information flow identifies four major phases: admission, visit of admission, planning, therapy. The system main functionalities available to the radiotherapist are: clinical history/medical report linking function; folder function; planning function; tracking function; electronic mail and banner function; statistical function; management function. Functions available to the radiotherapy technician are: the room daily list function; management function: to the nurse the following functions are available: patient directing function; management function. START is a departmental client (pc-windows)-server (unix) developed on an integrated database of all information of interest (clinical, organizational and administrative) coherent with the standard and with a modular architecture which can evolve with additional functionalities in subsequent times. For a more thorough evaluation of its impact on the daily activity of a radiation therapy facility, a prolonged clinical validation is in progress.

Combinations of Radiation Therapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes

International Nuclear Information System (INIS)

Barker, Christopher A.; Postow, Michael A.

2014-01-01

Radiation therapy has long played a role in the management of melanoma. Recent advances have also demonstrated the efficacy of immunotherapy in the treatment of melanoma. Preclinical data suggest a biologic interaction between radiation therapy and immunotherapy. Several clinical studies corroborate these findings. This review will summarize the outcomes of studies reporting on patients with melanoma treated with a combination of radiation therapy and immunotherapy. Vaccine therapies often use irradiated melanoma cells, and may be enhanced by radiation therapy. The cytokines interferon-α and interleukin-2 have been combined with radiation therapy in several small studies, with some evidence suggesting increased toxicity and/or efficacy. Ipilimumab, a monoclonal antibody which blocks cytotoxic T-lymphocyte antigen-4, has been combined with radiation therapy in several notable case studies and series. Finally, pilot studies of adoptive cell transfer have suggested that radiation therapy may improve the efficacy of treatment. The review will demonstrate that the combination of radiation therapy and immunotherapy has been reported in several notable case studies, series and clinical trials. These clinical results suggest interaction and the need for further study

Combinations of Radiation Therapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes

Energy Technology Data Exchange (ETDEWEB)

Barker, Christopher A., E-mail: barkerc@mskcc.org [Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York (United States); Postow, Michael A. [Department of Medicine, Melanoma and Sarcoma Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York (United States)

2014-04-01

Radiation therapy has long played a role in the management of melanoma. Recent advances have also demonstrated the efficacy of immunotherapy in the treatment of melanoma. Preclinical data suggest a biologic interaction between radiation therapy and immunotherapy. Several clinical studies corroborate these findings. This review will summarize the outcomes of studies reporting on patients with melanoma treated with a combination of radiation therapy and immunotherapy. Vaccine therapies often use irradiated melanoma cells, and may be enhanced by radiation therapy. The cytokines interferon-α and interleukin-2 have been combined with radiation therapy in several small studies, with some evidence suggesting increased toxicity and/or efficacy. Ipilimumab, a monoclonal antibody which blocks cytotoxic T-lymphocyte antigen-4, has been combined with radiation therapy in several notable case studies and series. Finally, pilot studies of adoptive cell transfer have suggested that radiation therapy may improve the efficacy of treatment. The review will demonstrate that the combination of radiation therapy and immunotherapy has been reported in several notable case studies, series and clinical trials. These clinical results suggest interaction and the need for further study.

Temporary corneal stem cell dysfunction after radiation therapy

International Nuclear Information System (INIS)

Hiroshi, Fujishima; Kazuo, Tsubota

1996-01-01

Radiation therapy can cause corneal and conjuctival abnormalities that sometimes require surgical treatment. Corneal stem cell dysfunction is described, which recovered after the cessation of radiation. Methods - A 44-year-old man developed a corneal epithelial abnormality associated with conjuctival and corneal inflammation following radiation therapy for maxillary cancer. Examination of brush cytology samples showed goblet cells in the upper and lower parts of the cornea, which showed increased fluorescein permeability, and intraepithelial lymphocytes. Impression cytology showed goblet cells in the same part of the cornea. Specular microscopy revealed spindle type epithelial cells. Patient follow up included artificial tears and an antibiotic ophthalmic ointment. The corneal abnormalities resolved after 4 months with improved visual acuity without any surgical intervention, but the disappearance of the palisades of Vogt did not recover at 1 year after radiation. Radiation therapy in this patient caused temporary stem cell dysfunction which resulted in conjunctivalisation in a part of the cornea. Although limbal stem cell function did not fully recover, this rare case suggested that medical options should be considered before surgery. (Author)

ASACUSA measures microwave transition in antiprotonic helium

CERN Document Server

Eades, John

2003-01-01

The ASACUSA collaboration has reinforced its status as a paragon of precision physics by following up its impressive six parts in 10/sup 8/ measurement of the antiproton's charge and mass with new measurements of its magnetism. (4 refs).

Radiation therapy

International Nuclear Information System (INIS)

Matsuura, Keiichi; Miyoshi, Makoto; Jinguu, Ken-ichi

1982-01-01

Of the cases of lung cancer in which radiation therapy was given between 1961 and November 1981, 399 cases for which histological type was confirmed, and irradiated as follows were reviewed. The cases of squamous cell carcinoma and adenocarcinoma irradiated with more than 5,000 rad or more, those of undifferentiated carcinoma irradiated with 3,000 rad or more, and those irradiated pre- and post-operatively with 3,000 rad or more. The actual 5 year survival rate for stages I, II, III and IV were 29.6, 9.3, 7.5 and 1.9% respectively, and the survival rate tended to be better for adenocarcinoma than squamous cell carcinoma at stages I, II and III, but not different at stage IV. There was no difference between large cell, small cell and squamous cell carcinomas. Irradiation with 200 rad every other day or 150 rad daily was better than that with 200 rad, and daily irradiation with 150 rad was used since 1976. The therapy of stage III small cell carcinoma at the age of up to 80 years was improved with the combination of anticancer agents, maintenance therapy and immunotherapy, but these combined therapies were not significantly effective for the cancers with other histological types or at other stages. Although there was no significant difference in statistics for resectable cases, clinically, the results were experienced to be better after resection, and surgery was done in combination as much as possible. (Kaihara, S.)

Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer

International Nuclear Information System (INIS)

McMillan, Matthew T.; Ojerholm, Eric; Roses, Robert E.; Plastaras, John P.; Metz, James M.; Mamtani, Ronac; Karakousis, Giorgos C.; Fraker, Douglas L.; Drebin, Jeffrey A.; Stripp, Diana; Ben-Josef, Edgar; Datta, Jashodeep

2015-01-01

Purpose: Prolonged radiation therapy treatment time (RTT) is associated with worse survival in several tumor types. This study investigated whether delays during adjuvant radiation therapy impact overall survival (OS) in gastric cancer. Methods and Materials: The National Cancer Data Base was queried for patients with resected gastric cancer who received adjuvant radiation therapy with National Comprehensive Cancer Network–recommended doses (45 or 50.4 Gy) between 1998 and 2006. RTT was classified as standard (45 Gy: 33-36 days, 50.4 Gy: 38-41 days) or prolonged (45 Gy: >36 days, 50.4 Gy: >41 days). Cox proportional hazards models evaluated the association between the following factors and OS: RTT, interval from surgery to radiation therapy initiation, interval from surgery to radiation therapy completion, radiation therapy dose, demographic/pathologic and operative factors, and other elements of adjuvant multimodality therapy. Results: Of 1591 patients, RTT was delayed in 732 (46%). Factors associated with prolonged RTT were non-private health insurance (OR 1.3, P=.005) and treatment at non-academic facilities (OR 1.2, P=.045). Median OS and 5-year actuarial survival were significantly worse in patients with prolonged RTT compared with standard RTT (36 vs 51 months, P=.001; 39 vs 47%, P=.005); OS worsened with each cumulative week of delay (P<.0004). On multivariable analysis, prolonged RTT was associated with inferior OS (hazard ratio 1.2, P=.002); the intervals from surgery to radiation therapy initiation or completion were not. Prolonged RTT was particularly detrimental in patients with node positivity, inadequate nodal staging (<15 nodes examined), and those undergoing a cycle of chemotherapy before chemoradiation therapy. Conclusions: Delays during adjuvant radiation therapy appear to negatively impact survival in gastric cancer. Efforts to minimize cumulative interruptions to <7 days should be considered

Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer

Energy Technology Data Exchange (ETDEWEB)

McMillan, Matthew T. [Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Ojerholm, Eric [Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Roses, Robert E., E-mail: Robert.Roses@uphs.upenn.edu [Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Plastaras, John P.; Metz, James M. [Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Mamtani, Ronac [Department of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Karakousis, Giorgos C.; Fraker, Douglas L.; Drebin, Jeffrey A. [Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Stripp, Diana; Ben-Josef, Edgar [Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States); Datta, Jashodeep [Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania (United States)

2015-10-01

Purpose: Prolonged radiation therapy treatment time (RTT) is associated with worse survival in several tumor types. This study investigated whether delays during adjuvant radiation therapy impact overall survival (OS) in gastric cancer. Methods and Materials: The National Cancer Data Base was queried for patients with resected gastric cancer who received adjuvant radiation therapy with National Comprehensive Cancer Network–recommended doses (45 or 50.4 Gy) between 1998 and 2006. RTT was classified as standard (45 Gy: 33-36 days, 50.4 Gy: 38-41 days) or prolonged (45 Gy: >36 days, 50.4 Gy: >41 days). Cox proportional hazards models evaluated the association between the following factors and OS: RTT, interval from surgery to radiation therapy initiation, interval from surgery to radiation therapy completion, radiation therapy dose, demographic/pathologic and operative factors, and other elements of adjuvant multimodality therapy. Results: Of 1591 patients, RTT was delayed in 732 (46%). Factors associated with prolonged RTT were non-private health insurance (OR 1.3, P=.005) and treatment at non-academic facilities (OR 1.2, P=.045). Median OS and 5-year actuarial survival were significantly worse in patients with prolonged RTT compared with standard RTT (36 vs 51 months, P=.001; 39 vs 47%, P=.005); OS worsened with each cumulative week of delay (P<.0004). On multivariable analysis, prolonged RTT was associated with inferior OS (hazard ratio 1.2, P=.002); the intervals from surgery to radiation therapy initiation or completion were not. Prolonged RTT was particularly detrimental in patients with node positivity, inadequate nodal staging (<15 nodes examined), and those undergoing a cycle of chemotherapy before chemoradiation therapy. Conclusions: Delays during adjuvant radiation therapy appear to negatively impact survival in gastric cancer. Efforts to minimize cumulative interruptions to <7 days should be considered.

Oray surgery and radiation therapy

Energy Technology Data Exchange (ETDEWEB)

Carl, W

1975-07-01

Clinical evidence seems to indicate that careful oral surgery after radiation therapy contributes little, if anything at all, to the onset of osteoradionecrosis. In many cases the process of bone dissolution has already well progressed before teeth have to be extracted. The bone changes can be demonstrated radiographically and clinically. The teeth in the immediate area become very mobile and cause severe pain during mastication. Whether this condition could have been prevented by extractions before radiation therapy is difficult to establish. Osteoradionecrosis may be encountered in edentulous jaws. It manifests itself clinically by bone segments which break loose and penetrate through the mucosa leaving a defect which does not heal over. More research and more comparative studies are needed in this area in order to make reasonably accurate predictions.

Challenging the standard model by high-precision comparisons of the fundamental properties of protons and antiprotons

Science.gov (United States)

Ulmer, S.; Mooser, A.; Nagahama, H.; Sellner, S.; Smorra, C.

2018-03-01

The BASE collaboration investigates the fundamental properties of protons and antiprotons, such as charge-to-mass ratios and magnetic moments, using advanced cryogenic Penning trap systems. In recent years, we performed the most precise measurement of the magnetic moments of both the proton and the antiproton, and conducted the most precise comparison of the proton-to-antiproton charge-to-mass ratio. In addition, we have set the most stringent constraint on directly measured antiproton lifetime, based on a unique reservoir trap technique. Our matter/antimatter comparison experiments provide stringent tests of the fundamental charge-parity-time invariance, which is one of the fundamental symmetries of the standard model of particle physics. This article reviews the recent achievements of BASE and gives an outlook to our physics programme in the ELENA era. This article is part of the Theo Murphy meeting issue `Antiproton physics in the ELENA era'.

Challenging the standard model by high-precision comparisons of the fundamental properties of protons and antiprotons.

Science.gov (United States)

Ulmer, S; Mooser, A; Nagahama, H; Sellner, S; Smorra, C

2018-03-28

The BASE collaboration investigates the fundamental properties of protons and antiprotons, such as charge-to-mass ratios and magnetic moments, using advanced cryogenic Penning trap systems. In recent years, we performed the most precise measurement of the magnetic moments of both the proton and the antiproton, and conducted the most precise comparison of the proton-to-antiproton charge-to-mass ratio. In addition, we have set the most stringent constraint on directly measured antiproton lifetime, based on a unique reservoir trap technique. Our matter/antimatter comparison experiments provide stringent tests of the fundamental charge-parity-time invariance, which is one of the fundamental symmetries of the standard model of particle physics. This article reviews the recent achievements of BASE and gives an outlook to our physics programme in the ELENA era.This article is part of the Theo Murphy meeting issue 'Antiproton physics in the ELENA era'. © 2018 The Authors.

New three-dimensional moving field radiation therapy for brain tumors

Energy Technology Data Exchange (ETDEWEB)

Mitsuyama, Fuyuki; Kanno, Tetsuo; Nagata, Yutaka; Koga, Sukehiko [Fujita-Gakuen Health Univ., Toyoake, Aichi (Japan); Jain, V K

1992-06-01

A new modified rotation radiation method called 'three-dimensional moving field radiation therapy' is described. The new method uses rotation in many planes while maintaining the same isocenter to achieve a good spatial dose distribution. This delivers a high dose to tumors and spares the surrounding normal structures. This easy method can be carried out using the equipment for conventional rotation radiation therapy. The new method was superior to the one plane rotation radiation therapy using a physical phantom with film, a chemical phantom using the iodine-starch reaction, and a new biological model using tumor cells. Treatment of six brain tumors irradiated with total air doses of 50-60 Gy caused no hair loss or radiation necrosis. (author).

Some method for teaching physics to residents in radiation therapy

International Nuclear Information System (INIS)

Hughes, D.B.

A method is presented for teaching physics to residents in radiation therapy. Some of the various responsabilities of a hospital physicist are listed, with particular reference to radiation therapy departments [pt

Perspectives of radiation therapy in benign diseases

International Nuclear Information System (INIS)

Schultze, J.; Eilf, K.

2006-01-01

Purpose: the numbers of patients with nonmalignant diseases referred for radiation therapy had to be evaluated for the last 4 years. Patients and methods: in the years 2002, 2004, and 2005 radiation therapy was performed in 61, 40, and 26 patients, respectively. Regularly, more women than men were treated, median age annually was 57, 54, and 55 years, respectively (table 1). The radiotherapy scheme was not modified within the evaluated period. Results: the proportion of nonmalignant diseases among all patients treated decreased from 4.7% in 2002 to 3.3% in 2004 and 2.2% in 2005, respectively. A shift was noticed toward the treatment of four main diseases (endocrine orbitopathy, prevention of heterotopic ossification, meningeoma, tendinitis, table 2). The number of referring physicians decreased from 19 to six. Conclusion: due to administrative restrictions for treatment in hospitals, budget restrictions in private practices and lasting, insufficient revenues for radiotherapy in nonmalignant diseases, radiation therapy for the entire group of benign diseases is endangered. (orig.)

Radiation therapy in pseudotumour haemarthrosis